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Scope of the thesis 
The thesis is divided into two parts corresponding to structural studies on two 
different proteins. The first part concerns the study of two UDP-glucose 
dehydrogenases (UGDs) from Sphingomonas elodea ATCC 31461 and 
Burkholderia cepacia IST 408, both involved in exopolysaccharide production. 
Their relevance arises because some of these bacterial exopolysaccharides are 
valuable as established biotechnological products, the former case, whilst others 
are highly problematic, when used by pathogens in biofilm formation over 
biological surfaces, as the latter case, namely in the human lungs. The goal of 
these studies is to increase our knowledge regarding UGDs structural 
properties, which can potentiate either the design of activity enhancers to 
respond to the increased demand of useful biofilms, or the design of inhibitors 
of biofilm production, in order to fight invading pathogens present in several 
infections. The thesis reports the production and crystallisation of both proteins, 
the determination of initial phases by single-wavelength anomalous dispersion 
(SAD) in S. elodea crystals using a seleno-methionine isoform, and phasing of 
B. cepacia crystals by molecular replacement (MR) using the S. elodea model, 
as well as the refinement, structural analysis and comparison between the 
several UGDs structures available during this work. The second part of the 
thesis concerns the structural characterisation of a nitroreductase from 
Rhodobacter capsulatus B10 (NprA), a flavoenzyme with as yet unknown 
physiological substrate, which exhibits nitroreductase activity towards several 
nitroaromatic compounds making it of potential use in bioremediation or cancer 
therapy. The thesis reports the isolation and crystallisation of the native protein 
with bound FMN, the structural determination by MR using Enterobacter 
cloacae nitroreductase as search model, the building of the structure model, its 
refinement and analysis, and a comparison with related proteins. 
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Abstract 
The expression, purification and crystallisation of two uridine-5’-diphospho-
glucose dehydrogenases (UGDs) from Sphingomonas elodea ATCC 31461 and 
Burkholderia cepacia IST 408 were carried out and their three-dimensional 
structure determination pursued in presence of different ligands, namely 
nicotinamide adenine dinocleotide (NAD(H)) and uridine-diphospho-
glucuronic acid (UDP-GlcA). S. elodea ATCC 31461 UGD, termed UgdG, was 
expressed, purified and crystallised in the presence of NAD
+
, in both native and 
SeMet derivatised forms. The phase problem was solved by single anomalous 
dispersion (SAD) using a SeMet derivatised crystal form of UgdG, and this 
solution was successfully applied by molecular replacement to the crystal form 
of the native protein, originating a higher resolution structure of UgdG bound to 
an adenosine-diphospho-ribose molecule, a NAD
+
 degradation product. The 
structural comparison of available UGDs shows conservation of protein-
cofactor (visible part) interactions, except for an extra hydrogen bond in UgdG. 
A 3D phyletic analysis of UGD/GMD family places UgdG in prokaryotic 
subfamily (group I) closer to eukaryotic members than to the prokaryotic group 
II proteins. B. cepacia IST 408 UGD, termed BceC, was expressed, purified 
and crystallised in the presence of its final reaction product, UDP-GlcA. Due to 
their high sequence homology, the phase problem of BceC was addressed by 
the molecular replacement method using the previously determined UgdG 
structure as a search model. The refined structure of BceC shows a dimeric 
protein with one molecule of UDP-glucuronic acid bound per monomer. NAD 
binding proteins share a glycine-rich signature motif that in the UGD/GMD 
family includes a conserved tyrosine, GXGYXG. The mutation of this tyrosine 
in BceC led to almost inactive mutants, thus demonstrating a relevant role 
within the UGD/GMD enzymatic activity. A comparison of the native and two 
mutant crystal structures together with enzymatic assays led to the elucidation 
vii 
of the tyrosine role in the enzymatic mechanism, namely in the final hydrolysis 
step of the reaction thioester intermediate, where the tyrosine works as final 
proton conveyer from the aqueous media to the leaving thiolate group. This 
study also enabled a detailed comparison of human UGD and BceC structures, 
in order to explore potential medicinal applications. However, the substrate 
binding pockets of both proteins seem too similar for the design of a potentially 
selective inhibitor. 
The major nitroreductase (NR) of Rhodobacter capsulatus B10, termed NprA, 
was expressed, purified and crystallised in the presence of an in-vitro substrate, 
2,4-dinitrophenol (DNP). Molecular replacement was used to solve the phase 
problem, using the Enterobacter cloacae nitroreductase structure as search 
model. The structure revealed a dimeric arrangement with two flavin 
mononucleotide (FMN) molecules bound at symmetrical crevices of the dimer 
interface, but with no trace of the substrate. Instead, an acetate molecule, a 
known inhibitor of Type I nitroreductases, was found bound directly above the 
cofactor molecule. NprA presents the same overall fold found in known NR 
structures, in spite of its low sequence identity against family members with 
available structure. The physiological role of NprA and the mapping of its key 
catalytic residues remained as yet open questions. Attempts were essayed to 
obtain NprA complexes with different ligands, but all have remained 
unsuccessful, eventually due to the rather low reproducibility of NprA crystals. 
Nevertheless, previous biochemical characterisation has shown that NprA is 
highly induced by several nitroaromatic compounds, suggesting NprA as a 
novel candidate for biological remediation or for anti-tumoral therapies. 
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Sumário 
Expressaram-se, purificaram-se e cristalizaram-se as uridina-difosfoglucose 
desidrogenases (UGDs) de Sphingomonas elodea ATCC 31461 e Burkholderia 
cepacia IST 408, e prosseguiu-se com a determinação das suas estruturas 
tridimensionais na presença de diferentes ligandos, respectivamente do cofactor 
nicotinamida adenina dinucleotídeo (NAD
+
) e de ácido uridina-
difosfoglucurónico (UDP-GlcA). A UGD de S. elodea ATCC 31461, 
denominada UgdG, foi expressa, purificada e cristalizada nas formas nativa e 
derivatizada com selénio-metionina. O problema da fase foi resolvido por 
dispersão anómala de comprimento de onda único (SAD), utilizando dados de 
difracção de raios-X do cristal da forma derivatizada. A solução obtida foi de 
seguida usada com o método de substituição molecular no cristal de UgdG 
nativa, originando assim uma estrutura a resolução mais elevada de um 
complexo de UgdG e adenosina-difosforibose, um produto de degradação do 
NAD
+
. A comparação estrutural de diversas UGDs mostrou que se conservam 
as interacções proteína-cofactor (parte não degradada), mas observa-se uma 
nova ponte de hidrogénio entre a UgdG e a ribose. Uma analise filética 3D da 
família UGD/GMD coloca a UgdG no grupo procariótico I, mais próximo do 
grupo eucariota que dos restantes procariotas do grupo II. A UGD de B. cepacia 
IST 408, designada BceC, foi expressa, purificada e cristalizada na presença do 
produto final de reacção, o ácido UDP-glucurónico, UDP-GlcA. Devido à 
elevada homologia nas sequências das duas proteínas o problema da fase em 
BceC foi resolvido usando a estrutura de UgdG como modelo inicial na 
substituição molecular. A estrutura refinada exibe uma proteína dimérica com 
cada monómero de BceC complexado a uma molécula de UDP-GlcA. As 
proteínas que ligam NAD contêm um motivo rico em glicinas, que na família 
das UGD/GMDs incluem também uma tirosina conservada, GXGYXG. A 
mutação desta tirosina em BceC originou mutantes praticamente inactivos, o 
ix 
que demonstra a importância dessa tirosina na actividade enzimática das 
UGD/GMDs. A comparação das estruturas nativa e de dois mutantes da BceC 
conjuntamente com as suas diferentes actividades conduziu à elucidação do 
papel da tirosina no mecanismo enzimático, nomeadamente no último passo do 
mecanismo reaccional, a hidrólise do intermediário de tioéster, onde a tirosina 
facilita a transferência de um protão do meio aquoso para o grupo tiolato em 
formação. Um dos objectivos deste trabalho consistiu ainda na comparação 
detalhada entre as estruturas da BceC e da UGD humana, tendo em vista 
potenciais aplicações à medicina. No entanto as cavidades de ligação do 
substrato reaccional aparecem como demasiado semelhantes para o design de 
um potencial inibidor selectivo. A nitroreductase (NR) maioritária de 
Rhodobacter capsulatus B10, denominada NprA, foi expressa, purificada e 
cristalizada na presença de um substrato in-vitro, o 2,4-dinitrofenol. A estrutura 
da NR de Enterobacter cloacae foi usada como modelo para a substituição 
molecular, permitindo a resolução do problema da fase. A estrutura de NprA 
revelou-se como um homodímero com duas moléculas de flavina 
mononucleótido (FMN) ligadas a cada uma das cadeias peptídicas, em bolsos 
localizados simetricamente na interface dimérica, mas sem vestígios de ligação 
ao substrato. No entanto, um ião acetato, conhecido inibidor desta família de 
NRs, foi encontrado ligado à proteína adjacente a cada cofactor. A estrutura de 
NprA apresenta a topologia das nitroreductases com estrutura conhecida, ainda 
que a identidade da sua sequência com os vários membros da família seja baixa. 
Ate à data, a função biológica da NprA e os resíduos cataliticamente relevantes 
são ainda questões em aberto. Para as aprofundar, tentou-se a obtenção de 
complexos de NprA com diversos ligandos, até agora infrutíferas, 
possivelmente devido à fraca reprodutibilidade dos cristais. Ainda assim, uma 
prévia caracterização bioquímica demonstrou que a NprA é altamente induzida 
por diversos compostos nitroaromáticos, sugerindo a possibilidade da sua 
aplicação em biorremediação e no design racional de drogas antitumorais. 
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1.1. Bacterial Polysaccharides 
 
Complex carbohydrates comprise the most abundant group of natural products 
on Earth and in the oceans, as they surround all living cells and play multiple 
functions in all forms of life (Ruffing & Chen 2006). From their role as energy 
source or metabolic intermediates, carbohydrates are the major constituents of 
the shells of insects, arthropodae and also the supporting tissue of plants 
(Geremia & Rinaudo 2004; Vigetti et al. 2006). Moreover, they are present as 
components of all cell walls, spanning from the world of plants to microbes. In 
this sense, all organisms have evolved to be able to capture, process, store and 
sometimes synthesise these carbohydrates. Many bacterial species, fungi and 
algae are known to produce these compounds. It is estimated that approximately 
4x10
11
 tons of carbohydrates per year are biosynthesised by plants and bacteria, 
the majority being produced as polysaccharides, molecules consisting of a large 
number of one (homopolysaccharide) or more types (heteropolysaccharide) of 
monosaccharide residues (Broadbent et al. 2003; Lidhorst 2007). Because these 
polymeric compounds are produced by an enormous variety of organisms, 
including microbes, algae, plants and animals, the diversity of the produced 
polysaccharides is great (Geremia & Rinaudo 2004). One example of this group 
of macromolecules is xanthan (Figure 1.1.), a polymer produced by the 
bacterium Xanthomonas spp. that confers dessication resistance properties 
(Blanch et al. 2006). Others include the known fructans, other bacterial gel 
polysaccharides, capsule polysaccharides or agar. The unique physiochemical 
properties of these compounds are mainly determined by their sugar 
composition and polymerisation (linear or branched polymers), and therefore 
have been the subject of intensive studies (Vanhooren & Vandamme 1998; 
Sutherland 2001). 
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Figure 1.1. Structure of the polysaccharide xanthan. 
Xanthan gum is an anionic polymer with a !-(1 4)-D-glucopyranose glucan (as celullose) 
backbone with side chains of -(3 1)-"-linked D-mannopyranose-(2 1)-!-D-glucuronic 
acid-(4 1)-!-D-mannopyranose on alternating residues. Around ~40% of the terminal 
mannose residues are 4,6-pyruvated and the inner mannose is mostly 6-acetylated (from 
http://www.lsbu.ac.uk/water/hyxan.html). 
 
The increased demand for natural or modified polymers for various industrial 
applications in recent years, has led to a renewed interest in these 
macromolecules. Bacterial polysaccharides have emerged as new industrially 
important polymeric materials, which are proving economically competitive to 
some natural gums produced by plants and marine algae (Morin 1998). Both 
polysaccharides and monosaccharides have a wide application in industry, 
ranging across the fields of medicine, food industry or crude oil recovery. Some 
polysaccharides have also been used for the removal of heavy metals from the 
environment. This is the case of the exopolysaccharides produced by the marine 
bacteria Zooglea sp. and Enterobacter cloacae, which has the capacity to 
chelate chromium, lead and iron ions in solution (Kong et al. 1998; Iyer et al. 
2004). Some of the most relevant bacterial polysaccharides with 
biotechnological applications are described in Table 1.1. The expression of 
extracellular polysaccharide (EPS) material is a common feature of several 
bacteria. Bacterial EPS can be either identical, or closely related to 
polysaccharides found in eukaryotic species (Sutherland 2004). 
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Table 1.1. Examples of bacterial polysaccharide diversity and their industrial application. 
(Compiled from De Vuyst & Degeest 1999; Vanhooren & Vandamme 2000; Levander et al. 
2001; Kumar et al. 2007) 
 
Organism Polysaccharide Application 
Pseudomonas 
aeruginosa 
Alginate 
Immobilisation matrix for viable cells and enzymes; 
coating of roots of seedlings and plants to prevent 
dessication; microencapsulation matrix for 
fertilisers, pesticides and nutrients; hypo-allergic 
wound-healing tissue. 
Streptococcus equii 
and Streptococcus 
zooepidemicus 
Hyaluronic acid 
Replacer of eye fluid in ophthalmic surgery, in 
artificial tear-liquid, synovial fluid replica, wound-
healing, lotion and moiturising agent in cosmetic 
industry. 
Xanthomonas Xanthan (E415) 
Crude-oil recovery, paints and inks, pesticide and 
detergent formulations, cosmetics, pharmaceuticals, 
as a stabiliser and thickner agent in food. 
Acetobacter spp. Cellulose 
Temporary artificial skin to heal burns or surgical 
wounds, nutritional fibers in diet, hollow fibres or 
membranes in separation technology 
Leuconostoc 
mesenteroids 
Dextran 
Blood plasma extender or flow improving agent, 
cholesterol lowering agent, micro-carrier in 
tissue/cell culture 
Clavibacter spp. Clavan 
Potencial in preventing tumour cell colonisation of 
the lung and the treatment of rheumatoid arthritis, 
antibody production stimulating agent, in cosmetics 
as skin moisturising agent. 
Lactic acid bacteria 
Glucose/galactose 
rich polymers 
Used extensively in dairy product industry, provide 
beneficial microflora in the gastric tract 
 
The main differences rely on the lack of extensive branching of the bacterial 
extracellular polymer, as these EPS are usually linear molecules with regular 
repeating side-chains of not more than tetra- or at most pentasaccharide units 
(Sutherland 1997). They are synthetised and excreted from the cell either as 
soluble or insoluble polymers. This EPS coats the outside of the bacterial cell 
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and as a consequence plays an intimate role in mediating interactions between 
the bacterium and its surrounding environment (Kumar et al. 2007). Bacterial 
exopolysaccharides produced by several strains have a multitude of applications 
and occur in two basic forms. In some cases, the polysaccharide may be tightly 
associated, even covalently bound to the cell surface (Vanhooren & Vandamme 
1998), forming a discrete structure termed capsule which is usually associated 
with some pathogenic bacteria, as in the case of group A streptococci or 
Pseudomonas aeruginosa (Hung et al. 2007b); or it may be shed in the form of 
EPS or “slime”, which is loosely bound to the cell surface and, as mentioned, in 
some cases has a wide range of industrial applications. Recent examples are the 
EPS producers Lactococcus and Streptococcus, widely used in the dairy 
product industry. Work has shown that the EPS produced by Streptococcus 
thermophilus can improve the functional properties of low-fat and partly-
skimmed mozzarella cheese (Broadbent et al. 2003; Savadogo et al. 2004; 
Ruffing & Chen 2006). The precise role of the exopolysaccharide in EPS-
producing bacteria is of course dependent upon the ecological niche and the 
natural environment surrounding the microorganism (Kumar et al. 2007). 
Microorganisms producing EPS are found in various ecological niches (as long 
as the medium offers a high carbon/nitrogen ratio), such as water effluents from 
the sugar, paper or food industries (Morin 1998). However, most of the 
functions attributed to the EPS are related with the cell protection (Kumar et al. 
2007). The ability of a microorganism to surround itself with an EPS provides it 
with a protection against dessication in low-moisture environments due to the 
excellent water-binding properties (Broadbent et al. 2003), predation of 
protozoans and phage attack (Roberts 1996; Jolly et al. 2002), osmotic stress 
(Sutherland 1994). It also allows surface adhesion, affects the diffusion 
properties into and out of the cells and the penetration of both useful and toxic 
material, such as metal ions or even antibiotics (Dudman 1977; Sutherland 
2001). In the case of pathogenic bacteria the production of the capsular EPS 
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enables the evasion of phagocytosis as its structure mimics the host cell surface 
components (Vuong et al. 2004; Ventura et al. 2006). Exopolysaccharides are 
also known to play a major role in the formation of cell aggregates and in 
biofilm adherence on inert and biological surfaces (Vanhooren & Vandamme 
1998).  
This thesis is centered on the study of the biosynthetic pathway of the 
exopolysaccharides (EPS) of Sphingomonas elodea ATCC 31461, a gram-
negative bacterium with the ability to produce gellan, and Burkholderia cepacia 
IST408, a bacterium capable of producing cepacian. In the first case, the EPS is 
widely used in different industrial applications, while the second is an example 
of an EPS produced by an opportunistic pathogenic bacterium capable of 
colonising cystic fibrosis patient’s lungs by adhesion to the mucosa. More 
specifically, the present work focuses on the expression, purification, 
biochemical characterisation and three-dimensional structure determination of  
UDP-glucose dehydrogenase, an enzyme involved in the biosynthetic pathway 
of EPS formation of both bacteria, with the goal of providing new structural 
information that can model the enzyme’s activity and drive drug design and 
development (but see below). 
1.1.1. Sphingomonas elodea and gellan gum 
Many gram-negative bacteria synthesise and excrete EPS, which may have 
different biological roles. As mentioned before, in some cases bacterial EPS are 
potential or already successful products of biotechnology (Sá-Correia et al. 
2002; Wang et al. 2002). “Sphingans” are structurally related polysaccharides 
secreted by some species of the genus Sphingomonas. This genus is found in a 
variety of habitats, including many terrestrial and water environments, in plant 
roots or clinical isolates (White at al. 1996). Due to the broad metabolic 
pathways present in these bacteria, Sphingomonas sp. have been widely used in 
biotechnological applications, ranging from bioremediation to extracellular 
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polymer production (Pollock 1993), such as the commercial gellan gum 
produced by large-scale fermentation of the strain Sphingomonas elodea ATCC 
31461, previously known as Pseudomonas elodea (Granja et al. 2007; Aragão 
et al. 2007).  
Gellan gum is a polymer first discovered in the laboratories of Kelco Division 
of Merck and Co. in 1978 (Figure 1.2; Kaneko & Kang 1979) and it had 
previously been referred to by the code names S-60 or PS-60. The 
microorganism was isolated from the Elodea plant tissue, and further studies 
revealed that the gellan gum-producing bacterium was a new strain of the 
species Pseudomonas, and thus baptised as Pseudomonas elodea. Successful 
toxicity trials were completed and gellan gum received approval for use in food 
in Japan in 1988. In 1994, it was discovered that gellan-producing bacterium 
was actually a member of the genus Sphingomonas, and was thus rebaptised as 
Sphingomonas elodea or Sphingomonas paucimobilis. The US FDA approved 
gellan gum for use as a food additive in 1992 (Bajaj et al. 2007). Gellan, also 
known under the food additive code E418, is used as a natural biothickner, 
stabilising and suspending agent, (Sutherland 1998) approved both in the 
United States and European Union for applications in food, such as puddings, 
dessert gels, beverages, dairy products such as yogurt, milk shakes, gelled milk 
and ice cream, fruit spreads, jams and marmalades, bakery fillings and sauces 
(Chandrasekaran & Radha 1995; Gonçalves et al. 2009). It is also used in 
fabricated foods, such as restructured meat, fruits and vegetables, and in 
canned/gelled pet foods (Bajaj et al. 2007). In its native form, the polymer is a 
linear anionic polysaccharide based on a tetrasaccharide repeating unit 
composed of two molecules of D-glucose (D-Glc), one molecule of L-rhamnose 
(L-Rha) and another of D-glucuronic acid (D-GlcA), partially sterified with L-
glycerate and/or acetate (Figure 1.2.; Omoto et al. 1999; Harding et al. 2004). 
Acyl substituents drastically affect the rheology of the formed gels. Deacylation 
by alkali treatment results in a change from soft and more elastic 
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thermoreversible gels, to hard, firm and brittle gels (Harding et al. 2004; Granja 
et al. 2007).  
 
 
 
 
 
 
 
Figure 1.2. Structure of the tetrasaccharide repeating unit of gellan. 
Gellan gum is a linear polymer based on a tetrasaccharide repeating unit [ 4)-L-
rhamnopyranosyl-(!-1 3)-D-glucopyranosyl-("-1 4)-D-glucuronopyranosyl-("-1 4)-D-
glucopyranosyl-("-1 ] with O(2) L-glyceryl and O(6) acetyl substituents on the 3-linked 
glucose. It has a high molecular weight, consists of about 50,000 residues and is normally de-
esterified by alkali treatment before use in food. (http://www.lsbu.ac.uk/water/hygellan.html). 
 
Compared to other polysaccharides, gellan has important advantages for food 
applications, such as excellent thermal and acid stabilities, adjustable gel 
elasticity or rigidity, high transparency, and good flavour release (Fialho et al. 
2008). However, due to its rheological properties, gellan gum is also exploited 
in non-food applications such as microbial and plant tissue culture media, solid 
matrix for DNA gel electrophoresis, the controlled release of certain drugs in 
the stomach, excipient for nasal and ocular drug delivery (Jansson et al. 2005), 
material for the construction of scaffolds in tissue engineering, and in personal 
care products such as deodorant gels, sun screens, body lotions, hair 
conditioners and clear gel toothpaste (Chandrasekaran & Radha 1995; Bajaj et 
al. 2007). The gellan biosynthetic pathway is a multi-step process that initiates 
with the cytosolic formation of the nucleotide sugars precursors UDP-glucose 
(UDP-Glc), UDP-glucuronic acid (UDP-GlcA) and TDP-L-Rhamnose (TDP-
Rha) (Figure 1.3.), followed by the sequential transfer of the sugar donors to a 
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lipid carrier, gellan polymerisation and export (Granja et al. 2007; Fialho et al. 
2008). The enzymes involved in TDP-Rha formation belong to the gellan 
biosynthetic gel cluster and are encoded by the rhsABCD genes. These genes 
encode for glucose-1-phosphate thymidylyltransferase (rhsA), dTDP-glucose-4, 
6-dehydratase (rhsB), dTDP-4-keto-L-rhamnose-3,5-epimerase (rhsC) and 
dTDP-L-rhamnose synthase (rhsD). The enzymes involved in formatting the 
other UDP-sugars are phosphoglucomutase (PgmG, EC 5.4.2.2) that catalyses 
the conversion of D-glucose-6-phosphate into D-glucose-1-phosphate, UDP-D-
glucose pyrophosphorylase (UgpG, EC 2.7.7.9) that converts D-glucose-1-
phosphate into UDP-D-glucose, and UDP-glucose dehydrogenase (UGD; EC 
1.1.1.22) (Sá-Correia et al. 2002) forming UDP-D-glucuronic acid from UDP-
D-glucose.  
 
 
 
 
 
 
 
         
 
Figure 1.3. Organisation of the gel cluster and the pathway of gellan biosynthesis.  
UDP-D-glucose, UDP-D-glucuronic acid and TDP-L-rhamnose are the activated forms of the 
sugars units that compose gellan (compiled from Sá-Correia et al. 2002; Harding et al. 2004). 
 
Interestingly, these three genes are not located in the gel cluster of 
Sphingomonas elodea ATCC 31461, but elsewhere in the genome, thus 
implying a more general role of these proteins in the cell metabolic pathways, 
and not only in the exopolysaccharide biosynthesis (Silva et al. 2005; Fialho et 
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al. 2008). The gel cluster also comprises all the genes involved in the 
polymerisation and export of gellan to the outside of the cell (Sá-Correia et al. 
2002; Silva et al. 2005). The gelB, gelK, gelL and gelQ genes encode for 
glycosyltransferases, the enzymes involved in the tetrasaccharide repeating unit 
formation, starting with the sequential addition of the first glucose monomer to 
a lipid carrier, followed by the second, third and fourth sugar monomers, 
glucuronic acid, glucose and rhamnose, respectively (Sá-Correia et al. 2002; 
Harding et al. 2004). The assembly of the repeat unit is completed with the 
modification of the tetrasaccharide, by the addition of glycerate and acetate 
groups to the first glucose monomer. This action is carried out by acetyl- and 
glyceryltransferases, whose genes are also not located in the gel cluster, and are 
elsewhere in the genome of Sphingomonas elodea ATCC 31461 (Fialho et al. 
2008). The gelC and gelE genes encode for a polysaccharide co-polymerase 
(PCP) responsible for the polymerisation and extension of the polysaccharide 
chain. Finally, the export of the polymer is performed via an outermembrane 
auxiliary (OMA) protein channel encoded by the gelD gene.  
Despite the characterisation of many of the gel gene products, there are still 
some genes with unknown function, some are believed to participate either in 
regulation mechanisms or as secretion sorting systems by homology with 
known proteins from EPS operons in other bacteria (Sá-Correia et al. 2002; 
Harding et al. 2004). Identification of the genes and elucidation of crucial steps 
of the gellan biosynthetic pathway indicates some possibilities for the 
manipulation of gellan production at any of the three levels of its biosynthesis: 
(i) at the level of synthesis of sugar-activated precursors, (ii) at the level of the 
repeat unit assembly or, (iii) at polymerisation and export. By modifying the 
expression of any of the individual genes, or even of a group of these genes, the 
conversion efficiency and gellan gum yield can be increased. In effect, a few 
strategies have been applied to the early steps in gellan biosynthesis, for 
example, the simultaneous overexpression in Sphingomonas elodea ATCC 
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31461 of PgmG and UgdG, which was reported to lead to a 20% increase in 
gellan yield and EPS viscosity (Sá-Correia et al. 2002; Fialho et al. 2008). 
1.1.2. Burkholderia cepacia and cepacian 
Until the early 80’s Burkholderia cepacia was known as the phytopathogen 
causing the soft rot of onion bulbs, described by Burkholder (Govan & Deretic, 
1996). However, during the last 20 years, this bacterium emerged as an 
opportunistic pathogen in the lungs of immunocompromised individuals, 
especially cystic fibrosis (CF) patients (Hughes et al. 1997; Sist et al. 2003). B. 
cepacia is a gram-negative motile rod that belongs to the B. cepacia complex 
(BCC), a group of phenotypically similar (but genetically distinct) 
environmental bacteria (Goldberg 2007). Although organisms from all 
genomovars composing the complex have been isolated from patients with CF, 
B. cepacia has been of particular concern, because it is more invasive than other 
genomovars and possesses several characteristics that render it different from 
other pathogens (Conway et al. 2004; Herashimenka et al. 2007). It is highly 
transmissible, has inherent resistance to multiple antibiotics and antimicrobial 
peptides (APs) (Ortega et al. 2007) and is associated with great virulence. 
However, little is known about these virulence factors or mechanisms. All these 
factors combined make the management and treatment of B. cepacia infected 
patients difficult (Jones et al. 2001). Because B. cepacia is found in lung 
infections in CF patients, it is often compared with the more common CF 
pathogen P. aeruginosa (Goldberg 2007). B. cepacia infection can result in 
asymptomatic carriage and chronic infection similar to that observed with P. 
aeruginosa infection, but in some cases can result in terminal disease (the so 
called “cepacian syndrome”), that is characterised by a confluent 
bronchopneumonia and septicemia, which results in death over a period of 
days, unlike any other CF clinical situation (Hughes et al. 1997; Jones et al. 
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2001). A number of investigations carried out on P. aeruginosa pointed out to 
the role of the extracellular polysaccharide alginate in biofilm formation and in 
the virulence mechanisms of this bacterium (Leid et al. 2005). Biofilm 
formation (Figure 1.4.) is important in CF-associated pulmonary infection and 
has been well studied in the CF-associated pathogen Pseudomonas aeruginosa. 
Alginate exopolysaccharide (EPS) produced by P. aeruginosa makes up its 
biofilm matrix and mucoid capsule, and protects the cell against the host 
immune response and antibiotics. It allows adhesion to the host cells, 
persistence and colonisation of the respiratory tract of patients (Sist et al. 2003; 
Snook et al. 2003). The emergence of mucoid P. aeruginosa in colonised CF 
patients is often correlated with the declination of lung function (Conway et al. 
2004). EPS production also occurs in B. cepacia strains. In effect, more than 
80% of BCC isolates from CF infected patients were exopolysaccharide 
producers, indicating that EPS production by these organisms may be important 
in their pathogenesis (Richau et al. 2000; Conway et al. 2004). 
 
 
 
 
 
 
Figure 1.4. The biofilm life cycle.  
(1) Individual cells populate and attach to the surface, (2) EPS is produced - the biofilm 
architecture develops and matures (3) Single cells are released from the biofilm and disperse 
(adapted from the Center for Biofilm Engineering, Montana State University. 
http://www.erc.montana.edu/biofilmbook). 
 
Several types of EPS have been detected in strains from BCC clinical isolates 
from all over the world (Herashimenka et al. 2007; Zlosnik et al. 2008) but 
curiously, there is one that is most prominent and BCC-specific (Linker et al. 
1 
2 
3 
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2001): a branched acetylated heptasaccharide repeating unit, commonly known 
as cepacian (Figure 1.5.; Cerantola et al. 2000). Although the role of cepacian 
as a persistence and virulence factor of BCC in CF patients is still not well 
understood, the production of this EPS is thought to confer enhanced 
pathogenecity of B. cepacia when infecting these patients (Conway et al. 2004; 
Cunha et al. 2004).  
 
            
 
 
 
 
Figure 1.5. Heptasaccharide repeating unit of the BCC exopolysaccharide, cepacian.  
Gal, galactose; Rha, rhamnose; Glc, glucose; GlcA, glucuronic acid; and Man, mannose. The 
structure includes one acetyl group per repeating unit whose position is unknown (Cescutti et 
al. 2010). 
 
Furthermore, cepacian inhibits neutrophil chemotaxis and scavenges reactive 
oxygen species in vitro, similarly to the alginate produced by Pseudomonas 
aeruginosa in the CF lung, suggesting that it may protect the producing bacteria 
from host defenses (Bylund et al. 2006). Moreira and co-workers first described 
the genes involved in cepacian biosynthesis and their physical organisation. 
Almost all of the genes involved in cepacian formation are located in the same 
DNA region, in a 16.5 kb operon, the bce gene cluster (Figure 1.6.; Moreira et 
al. 2003). At the beginning of the bce cluster, bceA codes for a bifunctional 
protein with phosphomannose isomerase (PMI) and GDP-D-mannose 
pyrophosphorylase (GMP) activities. The resulting product, D-mannose, is 
incorporated in the cepacian polysaccharide and serves as precursor for GDP-D-
rhamnose formation (Richau et al. 2000). The bceC gene encodes for an UDP-
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glucose dehydrogenase (UGD). The reaction product, UDP-glucuronic acid, is 
the activated donor of D-glucuronic acid for the synthesis of the heptasaccharide 
repeating unit. The genes bceB, G, H, J and K are likely to code for 
glycosyltransferases (GTs) involved in the assembly of the repeating unit. 
According to the similarity studies preformed by Moreira and coworkers 
(Moreira et al. 2003), bceB codes for an undecaprenyl-phosphate glycosyl-1-
phosphate transferase (UndPGPT), responsible for the transfer of the first sugar 
unit into the lipid carrier, which is the first step in the subunit assembly, while 
the other genes code for all the other glycosyl transferases involved in the 
transfer of the sugar moieties that compose cepacian.  
 
 
 
 
 
 
 
 
Figure 1.6. Organisation of the bce gene cluster for cepacian biosynthesis and the pathway for 
EPS synthesis by B. cepacia (adapted from Moreira et al. 2003). 
 
The genes bceD, E, F, I and L exhibit homology with genes involved in the 
polymerisation and export of bacterial surface polysaccharides (Moreira et al. 
2003). The bceE gene encodes an outer-membrane auxiliary (OMA) protein, 
homologue to the GelD protein of the previously referred Sphingomonas 
elodea. The amino acid sequence analysis of the BceF protein led to the 
identification of an autophosphorylating protein tyrosine kinase (PTK), 
belonging to the membrane periplasmic auxiliary (MPA1) protein family, while 
the same studies identified BceD as a low-molecular mass phosphotyrosine 
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protein phosphatase (PTPase). The encoded protein BceL is thought to catalyse 
the translocation of the membrane bound heptasaccharide unit to the 
periplasmic face of the plasma membrane. Finally, BceI shows similarity to 
hypothetical proteins from Burkholderia fungorum and Nostoc punctiform that 
have been implicated in the polymerisation of the repeating unit in the 
periplasmic side of the plasma membrane, originating the exopolysaccharide. 
Genes encoding the enzymes needed for the other nucleotide sugars precursors, 
such as PGM (with both phosphoglucomutase and phosphomannomutase 
activities) and UGP (UDP-glucose pyrophosphorylase) are absent from the bce 
locus. Moreover, B. cepacia EPS is an acetylated polysaccharide, although the 
gene coding for the O-acetyltransferase enzyme required for acetylation is also 
not present in the locus. This is consistent with previous reports for other EPS 
clusters described for gram-negative bacterial species for example, 
Sphingomonas elodea (Moreira et al. 2003) referred to earlier.  
 
1.1.3. UDP-Glucose Dehydrogenase (UGD) 
 
To fully understand the biosynthesis of polysaccharides it is necessary to 
investigate the upstream source of their component sugars. In many cases, the 
immediate donors of the monomers that compose the polysaccharides are the 
nucleotide sugars. These are activated forms of monosaccharides, ready to be 
incorporated into oligo- or polysaccharides. In mammals there are nine different 
nucleotide sugars, and in plants there are even more but the majority, including 
the nucleotide-sugars used in bacterial systems, are uridine-diphospho-sugars 
(UDP-sugars). These compounds may be generated from appropriate 
monosaccharides and sugar phosphates resulting from metabolism, or they can 
be generated through the interconversion of existing nucleotide sugars (Figure 
1.7.). An example of the latter case is the pathway centered on uridine-
diphospho-glucuronic acid (UDP-GlcA; Griffith et al. 2004).  
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UDP-GlcA is the activated donor of the glucuronic acid moiety and it serves 
many critical roles in a variety of organisms ranging from mammals to bacteria 
(Campbell et al. 2000; Kärkönen & Fry 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7. Enzymatic conversion of UDP-glucuronic acid to different sugars.  
(Adapted from http://www.chem.qmul.ac.uk/iubmb/enzyme /reaction/polysacc/UDPAra.html). 
 
In animals, UDP-GlcA is the substrate for UDP-glucuronosyl transferases in 
liver and gastrointestinal tract, promoting glucuronidation of xenobiotic 
compounds solubilising these agents (Hempel et al. 1994), and it is also 
essential for biosynthesis of hyaluronan and other glucosaminoglycans (Easley 
et al. 2007; Hung et al. 2007b). Matrix polysaccharides in plants may derive 
UDP-
Glucuronic acid 
UDP-Glucose 
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half their mass from monosaccharides generated from UDP-GlcA, as it is the 
precursor of other nucleotide-sugars like UDP-xylose or UDP-arabinose 
(Griffith et al. 2004; Klinghammer & Tenhaken 2007). In bacteria, UDP-GlcA 
is used for exopolysaccharide production, being formed exclusively by the 
action of UDP-glucose dehydrogenase (UGD, EC 1.1.1.22; Wang et al. 2003; 
Moyrand & Janbon 2004). UGD, a sugar nucleotide modifying enzyme, is a 
member of a small group of NAD
+
 dependent four-electron transferring 
oxidoreductases responsible for the conversion of uridine-diphospho-glucose 
(UDP-Glc) to UDP-GlcA (Hempel et al. 2004). The oxidation is irreversible 
and gives rise to two moles of NADH per mole of UDP-glucose (Figure 1.8.; 
De Luca et al. 1996).  
 
 
 
 
 
Figure 1.8. Reaction performed by UDP-glucose dehydrogenase. 
The OH groups of C2, C3 and C4 were omitted for clarity (adapted from Gainey et al. 1975). 
 
Other members of this small group include GDP-mannose dehydrogenase and 
UDP-N-acetylmannosamine dehydrogenase (Campbell et al. 2000; Ge et al. 
2004). Since the discovery of this enzyme in guinea pig and bovine liver more 
than 50 years ago (Strominger et al. 1954), other UGDs have been reported in 
bacteria (Arrecubieta et al. 1996; Campbell et al. 1997), plants (Stewart & 
Copeland, 1998; Kärkönen et al. 2005), fungi (Griffith et al. 2004), viruses 
(Landstein et al. 1998) and mammals, including the human UDP-glucose 
dehydrogenase (Sommer et al. 2004; Huh et al. 2004). The bacterial UGD was 
described as an active 45 kDa monomer or as a 90 kDa dimer (Campbell et al. 
1997, 2000), although the degree of oligomerisation varies between organisms. 
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Figure 1.9. Amino acid sequence alignment of representative UGDs.  
UGDs sequence alignment using ClustalW (Higgins et al. 1994) from mammal (human, Spicer 
et al. 1998; bovine, Hempel et al. 1994), plant (A. thaliana; Kaneko et al. 2000), fungi (C. 
neoformans, Moyrand & Janbon 2004), bacteria (E. coli, Roman et al. 2003; S. pyogenes, 
Dougherty & van de Rijn 1993) and archaea (P. furiosus; Robb et al. 2001) sources. 
Functionally conserved residues are highlighted, in particular those involved in NAD
+
 binding 
(green); structural integrity/fold (blue); catalytic activity (red); hydrogen bonding with the 
UDP-sugar nested at the dimer partner (orange), as described by Campbell and co-workers 
(Campbell et al. 2000). 
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Most eukaryotic UGDs are described as functional hexamers or “trimers of 
dimers” of approximately 300 kDa (Feingold & Frazen 1981) with a few 
exceptions, for example, Cryptococcus fungi in which UGD is dimeric (Bar-
Peled et al. 2004). Regardless of its multimericity and due to high level of 
similarity in the primary amino acid sequence, UGDs from different organisms 
are thought to have the same action mechanism, and thus the same residues 
involved in the two hydrides transfer reaction. A sequence alignment of several 
UGDs (see Figure 1.9. above) highlights the functional residues of UGD, 
including those involved in the redox reactions, as described by Campbell and 
co-workers (Campbell et al. 2000). In 2000, Campbell and co-workers 
described the first three-dimensional structure of the UDP-glucose 
dehydrogenase from Streptococcus pyogenes (Figure 1.10.) elucidating the 
mechanism of action of this enzyme and some of the residues involved in the 
oxidation of UDP-glucose to UDP-glucuronic acid (Campbell et al. 2000). The 
exact role of each residue involved has been extensively described later, for 
both the bacterial (Ge et al. 2004) and human (Easley et al. 2007) enzymes. The 
S. pyogenes enzyme comprises 402 residues and has two distinct !/" domains, 
each containing a core "-sheet surround by !-helices. The N-terminal domain 
(residues 1-196) is a classical NAD
+
 binding Rossmann fold domain, and the C-
terminal (residues 229-402), a UDP-sugar binding domain also showing a 
dinucleotide-like binding fold. These domains are connected by a long central 
!-helix (residues 197-228) that serves as the core for the dimer interface 
(Campbell et al. 2000). 
When the present studies started, only the structure of Streptococcus pyogenes 
UDP-glucose dehydrogenase was available (PDB entries 1DLI and 1DLJ). 
Meanwhile, the UGD structures of Caenorhabditis elegans, human and 
Porphyromonas gingivalis were determined and deposited in the PDB (PDB 
codes 2O3J, 2Q3E/2QG4 and 3GG2, respectively). 
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(a) (b) 
 
 
 
 
 
 
 
 
 
 
Figure 1.10.  The three dimensional structure of S. pyogenes UGD (Cys260Ser mutant). 
(a) Overall view of S. pyogenes UGD monomer (in cartoon representation coloured blue) with 
bound NADH and UDP-GlcA in stick representation coloured in grey for carbon atoms, red for 
oxygen, blue for nitrogen and orange for phosphorous. (b) Detailed view of the reaction site 
with the catalytic and !–loop residues as described by Campbell. (PDB code 1DLI; Campbell 
et al. 2000). Residues in stick representation coloured as in a. Images prepared with Pymol 
(DeLano 2008). 
 
1.1.4. Mechanism of action of UDP-glucose dehydrogenase 
 
This enzyme is thought to follow a “Bi-Uni-Uni-Bi ping pong” mechanism, in 
which the alcohol binds first and the acid is released last (Campbell et al. 1997). 
The first step of the reaction is the initial oxidation of UDP-glucose and the 
transfer of one of the C6’ hydrides of the sugar moiety to the NAD
+
 molecule, 
to form the first molecule of NADH and an aldehyde intermediate (Figure 
1.11.). The covalent catalysis proceeds with a nucleophilic attack of a cysteine 
residue onto the aldehyde to form a thiohemiacetal. This intermediate is 
covalently bound to the enzyme and not accessible to aldehyde trapping agents, 
so that previous studies of this intermediate have failed (Nelsestuen & 
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Kirkwood 1971; Campbell et al. 2000). The thiohemiacetal is then oxidised to a 
thioester and the second hydride transfer occurs, with the formation and release 
of a second NADH molecule. The thioester is then irreversibly hydrolysed to 
UDP-glucuronic acid (Figure 1.11.; Ge et al. 1998; Campbell & Tanner 1999). 
In subsequent work done by Ge and co-workers, mutagenesis studies were 
performed on the UGD of Streptococcus pyogenes, thus revealing the role of 
some of the residues involved in the two redox reactions, such as the catalytic 
cysteine or a lysine residue that could serve as key acid/base residue for the first 
redox reaction (residues 260 and 204 respectively, in the streptococcal UGD) 
(Campbell et al. 2000; Ge et al. 2004).  
 
 
 
 
 
 
 
 
 
Figure 1.11. Proposed reaction mechanism for the human UDP-glucose dehydrogenase.  
The first oxidation from UDP-Glc to an aldehyde is carried out by a key acid/base residue. The 
catalytic cysteine attacks the aldehyde intermediate to proceed with the second redox reaction. 
Residue’s numbering according to the human UGD. (Adapted from Easley et al. 2007). 
 
Easley carried out the studies on the human UGD and revealed the importance 
of other residues involved in the reaction mechanism, such as the aspartate 280 
(residue 264 on the bacterial enzyme) and a catalytic water molecule, 
elucidating more clearly how the two reactions occur (Easley et al. 2007). 
According to the results of Easley and others, obtained for the human UGD, the 
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two-fold oxidation initiates upon the nucleophilic attack of aspartate 280 to a 
water molecule, which positions and activates this water for catalysis. The 
activated water can then attack the proton of the C6’ hydroxyl and start the first 
oxidation reaction. The solvent exposed Asp280 attacks the water molecule for 
a second cycle, which in turn attacks the catalytic Cys276, as this residue has to 
be deprotonated for the second oxidation and the thiohemiacetal intermediate 
formation to occur. The positive charge of Lys220 would stabilise the oxyanion 
whilst the second oxidation and thioester hydrolysis took place (Figure 1.12). 
This thioester intermediate is then finally hydrolysed, and the final product; 
UDP-glucuronic acid is released (Ge et al. 2004; Easley et al. 2007). 
 
 
 
 
 
 
 
 
 
Figure 1.12. Residues involved in the (A) first and (B) second oxidation reactions of  
UDP-glucose dehydrogenase.  
Residues numbered according to the human UGD (Ge et al. 2004; Easley et al. 2007). 
 
In this thesis, the three dimensional structure of the UDP-glucose 
dehydrogenase from Sphingomonas elodea ATCC 31461 (UgdG) and from 
Burkholderia cepacia IST408 (BceC) are presented. The aim of their structural 
characterisation and of the present studies is to provide new information on the 
proteins, which may allow the design of potential activators (the case of UgdG) 
or inhibitors (the case of BceC) and manipulation of the enzyme’s activity. 
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1.2. Bacterial degradation of nitroaromatic 
compounds 
 
Over the past decades, the massive consumption of natural resources and the 
development of the industrial synthesis of chemicals have generated a number 
of environmental problems. This is especially the case with increasing amounts 
of nitroaromatic compounds and their limited incorporation into biological life 
cycles (Kulkarni & Chaudari 2007). These xenobiotic compounds are 
recalcitrant and persist in the environment because they exhibit structural 
elements or substituents that are rare in nature and limit their biodegradability, 
thus making them an impairment to survival and causing a huge impact on 
living organisms and ecosystems (Esteve-Núñez et al. 2001). Apart from a few 
naturally occurring products (Figure 1.13), like chloramphenicol (Smith et al. 
2007), nitropyoluteorin (Ohmori et al. 1978), oxypyrrolnitrin (Kirner et al. 
1998) and phidolopin, no other natural nitroaromatic compound has been 
described to date. Nitroheterocyclic and nitroaromatic compounds constitute an 
enormous range of chemicals that are characterised by the presence of one or 
more nitro (NO2) groups on a heterocyclic or aromatic nucleus (Whiteway et al. 
1998). Only few aromatic compounds, bearing one nitro group as a substituent 
of the aromatic ring, are produced as secondary metabolites by microorganisms 
(Higson 1992). The majority of nitroaromatic compounds present in the 
biosphere, like nitrobenzene, nitrotoluenes, nitrophenols and nitrobenzoates are 
used and/or produced in chemical industry in the manufacture of dyes, 
polyurethane foams, herbicides, insecticides, pesticides such as parathion and 
dinoseb, and solvents (Bryant and Deluca 1991), but also in pharmaceuticals 
and explosives, like TNT (Dillert et al. 1995; Esteve-Núñez et al. 2001). They 
can also be generated during a variety of combustion processes (Chaignon et al. 
2006). The resulting waste products deriving from all of these activities cause 
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deleterious effects in biological systems due to their acute toxicity (Kim & 
Song 2005; Chen et al. 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 1.13. Chemical structure of some of the most relevant natural- and non-natural nitro 
compounds.  
RDX, hexahydro-1,3,5-trinitro-1,3,5-triazine; GTN,  nitroglycerin; PETN, pentaerythritol 
tetranitrate. (Adapted from Roldán et al. 2008). 
 
The stability, persistence and toxicity that make nitroaromatic compounds so 
valuable to industry render them hazardous when released into the environment 
(Marvin-Sikkema & Bont 1994). Most of these compounds are (i) considered as 
poisonous by ingestion, subcutaneous, interperitoneal and intramuscular routes, 
(ii) exhibit mutagenic and carcinogenic potential (Padda et al. 2003; Maeda et 
al. 2007), (iii) and normally decompose and emit toxic fumes of nitrogen oxides 
(Kulkarni & Chaudari 2007).  
Natural 
Product
s 
Non-
natural 
Products 
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2,4,6-Trinitrotoluene (TNT) is a polynitroaromatic compound and one of the 
most commonly known bulk explosives. TNT is used in military munitions and 
in civilian mining and quarrying activities (Spain 2000). It was first used on a 
wide scale during World War I and is still used today. However, the decades of 
manufacture, manipulation and processing of TNT resulted in high 
concentrations of contaminants accumulating in soil and water (Funk et al. 
1996; González-Pérez et al. 2007). TNT and its metabolites are known to be 
toxic, mutagenic and carcinogenic to various organisms, including humans 
(Honeycutt et al. 1996; Esteve-Núñez et al. 2001).  
2,4-Dinitrophenol (2,4-DNP) is frequently used as a starting material in the 
production of pesticides, as a polymerisation inhibitor of vinyl aromatics in 
petrochemical industries (Wang et al. 2009), herbicides and dyes. However, it 
is a very toxic compound for animals, plants and microorganisms because it 
uncouples the oxidative phosphorylation process in mitochondria (Blasco & 
Castillo 1997; Kimura et al. 2000; Hirooka et al. 2005). In living cells, 2,4-
DNP can shuttle protons across mitochondria and chloroplast membranes. It 
defeats the proton gradient across biological membranes, collapsing the proton 
driving force that the cell uses to produce most of its ATP chemical energy. 
Instead of producing ATP, the energy of the proton gradient is lost as heat. In 
this situation, cells counteract the low yields of ATP by further oxidising their 
reserves of carbohydrates and fat. That was the reason why in the 1930’s 2,4-
DNP was used in diet pills. The cell’s inability to produce ATP is proportional 
to the dose of 2,4-DNP that is taken. Thus, as the dose increases and energy 
production is made less efficient, the metabolic rate is increased and more fat is 
burned. Interestingly, the factor that limits increasing doses is not the lack of 
energy production, but rather an excessive rise in body temperature due to the 
heat produced during uncoupling. As a consequence, a 2,4-DNP overdose will 
cause a fatal fever (Pace & Pace 2002; McFee et al. 2002).  
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Given the increased prevalence of nitroaromatics within our environment, a 
great deal of interest has focused on the adverse health effects associated with 
exposure to nitroaromatic compounds, as these are amongst the most potent 
chemical mutagens and carcinogens identified so far (Bryant and Deluca 1991). 
Although several cleaning methods, such as carbon adsorption, chemical 
oxidation, incineration or combustion, are currently in use for the removal of 
nitroaromatics, none has proved to be sustainable (Kanekar et al. 2003; Symons 
& Bruce 2006; Chen et al. 2007; Wang et al. 2009). Recently, biological 
remediation has attracted worldwide attention for the decontamination of 
nitroaromatic polluted sites (Kulkarni & Chaudhari 2007). The presence of non-
natural polynitroaromatic compounds in the environment creates an intense 
selective pressure, which has led to the evolution of microorganisms capable of 
degrading nitroaromatic compounds (Blasco & Castillo 1992; Ahmad & 
Hughes 2002). The incredible versatility inherited by several microbes enabled 
them to catalyse the mineralisation and/or non-specific transformation of 
nitroaromatics either by aerobic or anaerobic processes (Kulkarni & Chaudhari 
2007). For example, certain strains of Pseudomonas (Robertson & Jemba 2005; 
Kahng et al. 2007) and fungi are able to metabolise TNT and use it as nitrogen 
source (Bayman & Radhkar 1997; Hawari et al. 2000). During the last few 
decades, intensive research has led to the discovery of microbes that are capable 
of degrading a vast array of toxic compounds. At the same time, an increasing 
number of nitroaromatic compounds susceptible to microbial degradation has 
been discovered and a considerable amount of knowledge has been developed 
about the biodegradation of these compounds (Kulkarni & Chaudhari 2007). 
Oxygen is the reactive molecule mostly used in the metabolism of many 
naturally occurring aromatic molecules, through the action of mono- and di-
oxygenases. These enzymes give cells the possibility to degrade aromatic 
compounds and generate many useful intermediates of central metabolic 
pathways (Spain 1995; Johnson & Spain 2003).  
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A similar mechanism of oxidative attack of the nitrated aromatic compounds 
leading to hydroxyl derivatives, via mono or di-oxygenases, followed by the 
opening of the aromatic ring, is also the expected pathway for the metabolism 
of mononitroaromatic and even for some dinitroaromatic compounds (Roldán et 
al. 1998; Caballero et al. 2005a). However, in the case of polynitrated 
aromatics, the presence of more nitro groups in the aromatic ring renders the 
oxidative pathway less efficient. In effect, the deficiency of electrons in the 
ring, due to the nitro substituents impairs the oxygenase mediated electrophilic 
attack on the aromatic ring. As a consequence, the reduction of 
polynitroaromatic compounds is usually favoured both in aerobic or anaerobic 
conditions (Khan et al. 1997; Johnson & Spain 2003; Kim and Song 2005).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14. Reductive pathways of polynitroaromatic compounds in bacteria.  
Two pathways are possible: reduction of the aromatic ring through the addition of H
-
 ions to 
generate hydride-Meisenheimer complexes catalysed by hydride transferases, or the reduction 
of the nitro groups (nitroreduction) through the successive addition of electrons, catalysed by 
nitroreductases. In both cases, an inorganic nitrogen source is generated and it might be used for 
bacterial growth (adapted from Roldán et al. 2008). 
HYDRIDE 
TRANSFERASES 
 
NITROREDUCTASES 
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Reduction is an initial step in the metabolism of a variety of structurally diverse 
nitroaromatic compounds, including nitrofurans, nitropyrenes, nitrobenzenes 
and nitrophenols. This reduction can occur by two dinstinct pathways: (a) the 
reduction of the aromatic ring by the addition of hydride ions by hydride 
transferases, forming Hydride-Meisenheimer complexes, which can be further 
metabolised with the concomitant release of nitrite, or (b) by the reduction of 
the nitro groups to hydroxylamino or amino compounds, by the actions of 
nitroreductases, with the release of ammonium if further metabolised (see 
Figure 1.14. above; Esteve-Núñez et al. 2001; Kim and Song 2005). 
 
1.2.1. Bacterial Nitroreductases (NRs)  
 
Nitroreductases belong to the family of flavin-coupled dehydrogenases and 
reductases that are able to reduce a broad range of nitroaromatic compounds as 
well as quinones and flavins. These enzymes require reduced nicotinamide 
adenine dinucleotide (NADH) or reduced NADPH for catalysis (Haynes et al. 
2002; Chaignon et al. 2006; Choi et al. 2008). Enzymatic nitroreduction can be 
performed either through a one- or two-electron mechanism (Figure 1.15.). In 
the presence of O2, the one-electron reduction of the nitro moiety leads to 
superoxide radical formation (Caballero et al. 2005b). These enzymes are 
termed oxygen-sensitive or type II nitroreductases, because these radicals can 
be easily reoxidised to the parent compounds by O2, in the so-called “futile 
cycle”, generating superoxide. Thus, these enzymes can mediate the reduction 
of nitroaromatics only under anaerobic conditions (Watanabe et al. 1998; Lee at 
al. 2008). The second reaction is performed by enzymes denominated oxygen-
insensitive or type I nitroreductases. In the presence or absence of O2, they 
catalyse the sequential reduction of the nitro groups through the addition of 
electron pairs from NAD(P)H to produce nitroso, hydroxylamine and amino 
derivatives. However, some of the hydroxylamine intermediates are even more 
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hazardous than the parent compounds (Koder & Miller 1998; Watanabe et al. 
1998; Roldán et al. 2008). 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.15. Mechanism of action of Type I and Type II nitroreductases.  
Type II nitroreductases catalyse the 1e
-
 reduction of the nitroaromatic compound forming a 
nitro anion radical, which in the presence of O2 will generate superoxide and the parental 
compound in the so called “futile cycle”. Type I nitroreductases catalyse the reduction to a 
nitroso intermediate, after the 2e
-
 addition to the nitroaromatic compound. Successive 
enzymatic addition of pairs of electrons leads to the final amino product. The aromatic ring may 
have several substituents that have been omitted for clarity (adapted from Roldán et al. 2008). 
 
Nitroreductases are widely distributed in the bacterial kingdom, but several 
examples of nitroreductase-like enzymes can also be found in archaea and 
eukaryotic organisms (Marques de Oliveira et al. 2007). Moreover, most 
bacteria contain several types of nitroreductases, although the best studied 
belong to the type I oxygen-insensitive enzymes, as several have been purified 
and/or their genes have been cloned and characterised. Some examples of the 
most relevant nitroreductases are listed in Table 1.2. 
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Table 1.2. Examples of the most relevant bacterial Type I oxygen-insensitive bacterial 
nitroreductases. (Adapted from Kulkarni & Chaudhari 2007; Roldán et al. 2008). 
 
Bacterial 
Nitroreductases 
Main substrates / Metabolic 
pathway (if known) 
Electron 
donor(s) 
References 
Escherichia coli 
NfsA 
(major 
nitroreductase) 
Nitrofurazone (antibiotic) and 
other nitro compounds, chromate 
NADPH 
Bryant et al. 1981; 
Zenno et al. 1996a; 
Zenno et al. 1998. 
Escherichia coli 
NfnB 
(minor 
nitroreductase) 
Nitrofurazone (antibiotic) and 
different nitro compounds 
(including CB1954 and CL-20), 
chromate 
NADPH 
NADH 
Zenno et al. 
1996b-c; Race et 
al. 2005. 
Salmonella enterica 
NfnB 
p-nitrophenol, p-nitrobenzoate, 1-
nitropyrene, 2-aminofluorene, 
menadione, flavins 
NADPH 
NADH 
Watanabe et al. 
1998; Salamanca-
Pinzón et al. 2006 
Enterobacter 
cloacae NTR 
Nitrofurans, nitrobenzenes, 
quinones, nitroimidazoles, TNT 
(reduction to Meisenheimer 
complex with release of nitrite) 
NADPH 
NADH 
Bryant & Deluca 
1991; Bryant et al. 
1991; Haynes et al. 
2002. 
Klebsiella sp. NtrI 
2,4-dinitrotoluene, TNT 
(reduction to hydroxylamino 
dinitrotoluenes, 
aminonitrotoluenes and to nitrite 
via denitration)   
NADPH 
NADH 
Kim et al. 2003; 
Kim & Song 2005. 
Vibrio fischerii 
FraseI 
FMN, quinones, different nitro 
compounds 
NADPH 
NADH 
Zenno et al. 1994. 
Vibrio harveyi FRP 
FMN, different nitrocompounds, 
chromate 
NADPH Lei et al. 1994. 
Bacillus subtilis 
YwrO 
CB1954 (used in antibody-
directed enzyme prodrug therapy) 
NADPH 
NADH 
Anlezark et al. 
2002. 
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Bacillus subtilis 
YwcG (NfrA1) 
Flavins, nitrofurazone, 
nitrofurantoin 
NADPH 
Zenno et al. 
1998b; Chaignon 
et al. 2006. 
Staphylococcus 
aureus NfrA 
Flavins, nitrofurazone, 
nitrofurantoin 
NADPH Streker et al. 2005. 
Clostridium 
acetobutylicum NitA 
TNT, 2,4-dinitrotoluene NADH 
Kutty & Bennet 
2005 
Clostridium 
acetobutylicum NitB 
TNT, 2,4-dinitrotoluene 
NADPH 
NADH 
Kutty & Bennet 
2005 
Pseudomonas 
pseudoalcaligenes 
NbzA 
Nitrobenzene (release of 
ammonia), TNT (formation of 2,4-
dihydroxylamino-6-nitrotoluene), 
4-nitrobiphenyl ether 
NADPH 
Sommerville et al. 
1995; Fiorella & 
Spain 1997. 
Pseudomonas putida 
PnrA 
TNT, 2,4-dinitrotoluene, 4-
nitrotoluene,4-nitrobenzoate, 3,5-
dinitroaniline, 2-nitrophenol 
(release of nitrite, formation of 
cathecol), 4-nitrophenol  
NADPH 
Zeyer & Kocher 
1988; Caballero et 
al. 2005b;  
Kulkarni & 
Chaudhari 2006. 
 
A phylogenetic analysis of several annotated sequences of bacterial 
nitroreductases shows that the enzymes belonging to the type I class can be 
further classified into two groups. Group A are usually NADPH-dependent 
enzymes, of which NfsA from Escherichia coli is the main representative (as 
well as the homologue SnrA from Salmonella enterica); and Group B, which 
are able to use both NADH and NADPH as electron donors, with NfnB from 
Escherichia coli being the representative enzyme (Figure 1.16.). The crystal 
structure of several nitroreductases has been determined, including the major 
nitroreductase NfsA from E. coli and FRP from V. harveyi (pdb codes 1F5V 
and 1BKJ, respectively) and the minor nitroreductase from E. coli NfsB, E. 
cloacae NTR and V. fischerii FraseI (pdb codes 1DS7, 1KQB and 1VFR, 
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respectively) (Tanner et al. 1996; Koike et al. 1998; Parkinson et al. 2000; 
Kobori et al. 2001; Haynes et al. 2002). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.16. Phylogenetic tree of the Type I oxygen-insensitive bacterial nitroreductases. 
Sequence alignment and dendogram were performed with the program ClustalW (Higgins et al. 
1994). The NfsA from Escherichia coli (Zenno et al. 1996a), its homologous SnrA from 
Salmonella typhimurium and PnrA from Pseudomonas putida JLR11 (Caballero et al. 2005b) 
amongst others, belong to Group A. Group B includes Enterobacter cloacae retronitroreductase 
(RNR) (Koder et al. 2001) and nitroreductase (NTR) (Bryant et al. 1991), Salmonella enterica 
Cnr, Pseudomonas putida JLR11 PnrB (Caballero et al. 2005a), Vibrio fischerii NAD(P)H-
flavin oxidoreductase FraseI (Zenno et al. 1994) as well as other uncharacterised 
nitroreductases (YdjA) from E. coli and Salmonella. 
 
The analysis of the available three-dimensional structures, together with amino 
acid comparisons reveals that the overall fold of these proteins is similar, even 
if the sequence similarity is low between the different members (Zenno et al. 
1994). Bacterial nitroreductases are globular proteins with an !+" fold (Figure 
1.17.) including conserved binding domains for the redox centre (FMN) and the 
electron donor NAD(P)H. Interestingly, nitroreductases lack the canonical 
Rossmann fold, typical of nucleotide binding proteins (Hecht et al. 1995).  
Group B 
Uses both NADH 
and NADPH 
Group A 
Uses NADPH 
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Figure 1.17. Three-dimensional structure of NfnB, the minor nitroreductase from E. coli.  
(a) The dimeric structure of NfnB (PDB code 1DS7; Parkinson et al. 2000) with prosthetic 
groups FMN bound at the dimer interface. Macromolecule in cartoon representation coloured 
blue and brown for monomers A and B, respectively. (b) FMN binding pocket. Polypeptide 
represent by its transparent solvent accessible surface and cartoon (coloured as in a). Cofactor 
in stick representation coloured yellow for carbon, blue for nitrogen, red for oxygen and orange 
for phosphorous atoms. Figures were produced using Pymol (DeLano 2008). 
 
Nitroreductases are homodimeric enzymes with the two polypeptide chains of 
24-30 kDa each, tightly associated, forming an extensive interface with deep 
pockets where the FMN prosthetic groups are found, establishing hydrogen 
bonds and hydrophobic interactions with residues from both monomers and 
therefore, homodimers are likely to be the physiological units of nitroreductases 
(Koike et al. 1998). These interactions are somewhat conserved and involve 
similar residues in the members of the type I nitroreductase family. Despite the 
little sequence identity, the core of these proteins is structurally equivalent, 
possibly indicating a common ancestral flavoprotein (Parkinson et al. 2000). 
The enzymatic reaction follows a “ping-pong bi-bi” mechanism, where the 
substrate NAD(P)H enters the binding pocket, is oxidised and leaves it in the 
form of NAD(P)
+
 before the second substrate enters and binds (Zenno et al. 
1996b).   
(a) (b) 
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1.2.2. Physiological role of bacterial nitroreductases 
 
Although nitroreductases have been well characterised both structurally and 
biochemically, particularly the minor nitroreductase from E. coli, NfnB, the 
physiological role of these proteins is still an unanswered question. The 
intensive pressure and selectivity imposed by the growing presence of 
xenobiotics in the environment has led to the adaptation of microbes and 
evolution of new metabolic pathways. Such adaptation may encompass 
mutations at the nitroreductase active sites, decreasing the substrate specificity 
and allowing the degradation of a wider range of nitroaromatic and 
nitroheterocyclic compounds (Timmis & Pieper 1999, Roldán et al. 2008). 
Moreover, different physiological roles have been proposed for bacterial 
nitroreductases. Due to their capacity to reduce flavins, quinones and many 
types of polynitrated compounds, their role in detoxification has been well 
accepted. Some nitroreductases seem to have a specific role in the 
transformation of certain nitroaromatic compounds, as they are located in 
operons whose genes are involved in particular metabolic pathways. For 
example, in Pseudomonas putida the gene cluster encoding the enzymes for    
4-chloronitrobenzene metabolism includes a chlorobenzene nitroreductase, 
which has a preference for chloronitrobenzene as the substrate (Xiao et al. 
2006). Another example is the major nitroreductase NfsA from E. coli that is 
highly induced by paraquat, a potent oxidant that generates superoxide. Also, 
the nfsA gene is under the control of the SoxRS system, which is involved in the 
oxidative stress response (Liochev et al. 1999, Patterson et al. 2002). A third 
example is FraseI from Vibrio fischerii which is involved in the bioluminescent 
process, catalysing the reduction of the flavin by NAD(P)H, which is required 
for the luciferase reaction (Lei et al. 1994). Interestingly, FraseI and E. coli 
minor nitroreductase, NfnB, are structurally and biochemically very similar. In 
effect, Zenno and co-workers showed that a single-residue mutation could 
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transform NfnB into a flavin reductase similar to the FraseI of V. fischeri 
(Zenno et al. 1996c). In the same manner, the major nitroreductase from E. coli, 
NfsA, can be converted into a flavin oxidoreductase with similar properties to 
that of FRP from V. harveyi (Zenno et al. 1996, 1998a). Recent studies 
performed with the DrgA protein from the cyanobacterium Synechocystis sp. 
suggest that this enzyme, besides nitroreductase, flavin reductase and quinone 
reductase activities, may also participate in iron metabolism (Takeda et al. 
2007). Nevertheless, bacterial type I nitroreductases have received great 
attention over the last years because of their main role in reducing the toxicity 
of nitroaromatic compounds, and therefore of their potential use in 
bioremediation, but also in biomedicine, particularly in cancer therapies 
(Roldán et al. 2008). The ability of these enzymes to also metabolise inert 
pharmaceutical nitroaromatics into the corresponding highly reactive and 
cytotoxic hydroxylamine derivatives, allows them to be used as prodrug 
activators (Johansson et al. 2003; Emptage et al. 2009). The most widely 
studied nitroreductase for cancer chemotherapy is the NfnB from E. coli, 
mainly with the dinitrobenzamide prodrug class, and in particular with the 5-
aziridinyl-2,4-dinitrobenzamide CB1954. This drug is enzymatically converted 
by NfnB into the 4-hydroxylamino (highly toxic) and the 2-hydroxylamino (less 
toxic) derivatives. The 4-hydroxylamino derivative is then converted 
intracellularly to a DNA-reactive species (Anlezark et al. 1992; Green et al. 
2004). In the antibody-directed enzyme prodrug therapy (ADEPT), NfnB is 
conjugated with a specific antibody for tumour cells (directing the enzyme to 
the tumour) and then converts an inert drug, like CB1954, into the cytotoxic 
hydroxylamine derivative that kills the tumour cells. Two other approaches 
consist in delivering the enzyme-encoding gene directly to the tumour cells via 
a tumour-specific vector, either viral-directed (VDEPT) or gene-directed 
(GDEPT) enzyme prodrug therapy (Green et al. 2004). The success of these 
concepts lies in using an enzyme not normally present in human cells, and a 
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prodrug that can be converted by the enzyme rapidly and specifically to give a 
much more cytotoxic product (Anlezark et al. 2002). Recently, a nitroreductase 
from Bacillus licheniformis was reported. It is able to convert the CB1954 
prodrug but, it is more stable and efficient than NfnB, and thus suitable for use 
in the “suicide gene therapy”, as it produces only the desirable cytotoxic 
derivative (Emptage et al. 2009). The potential application of emergent 
nitroreductases from many different bacterial species in these antitumoural 
techniques and, of course, in bioremediation of polynitroaromatic contaminated 
areas remains unexplored (Roldán et al. 2008).  
 
1.2.3. Rhodobacter capsulatus and 2,4-dinitrophenol  
 
Rhodobacter capsulatus B10 is a purple nonsulphur aquatic bacterium that 
exhibits an extensive range of metabolic capacities (Pérez-Reinaldo et al. 
2005). These include photosynthesis, lithotrophy, and aerobic and anaerobic 
respiration (Tichi & Tabita 2001). It can also fix nitrogen and synthesise 
tetrapyrroles, chlorophyls, and vitamin B12. The biochemical versatility 
together with its genetic characteristics (it possesses one chromosome and an 
endogenous plasmid of about 130kb (Fonstein & Haselkorn 1993)) allows the 
bacterium to survive in a variety of habitats, including nitroaromatic 
contaminated environments. This bacterium is able to use 2,4-dinitrophenol 
(2,4-DNP) as an electron acceptor, reducing it to 2-amino-4-nitrophenol (2,4-
ANP) in anaerobic conditions and in the presence of light (Figure 1.18.; Blasco 
& Castillo 1992, 1993). 2,4-ANP can be further metabolised under 
microaerobiosis, through a reaction that releases nitrite into the medium. This is 
a co-metabolic process, as the photoreduction depends on alternative nitrogen 
and carbon sources (Pérez-Reinaldo et al. 2005, 2008). It is also an inducible 
pathway that can be reversely inhibited by darkness or ammonium (Blasco & 
Castillo 1997). 
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Figure 1.18. The reduction of 2,4-dinitrophenol to 2-amino-4-nitrophenol. 
(Adapted from Blasco & Castillo, 1993). 
 
Two putative genes encoding for the major oxygen-insensitive nitroreductases, 
involved in the metabolism of 2,4-DNP, were reported in Rhodobacter 
capsulatus B10, nprA and nprB, although some evidence points to the existence 
of other non-specific nitroreductases in the bacterium genome (Pérez-Reinado 
et al. 2005). These enzymes show only 14% identity between themselves and, 
whereas the expression of the NprB protein is constitutive, NprA was shown to 
be inducible by several aromatic, nitroaromatic and heterocyclic compounds, 
including benzopyrene, nitrofurazone, the prodrug CB1954, paraquat and of 
course, 2,4-dinitrophenol (Pérez-Reinado et al. 2005, 2008). Recent studies on 
NprA show that, besides metabolising polynitroaromatic compounds in vitro, 
this enzyme also has high dihydropteridine reductase activity, higher than the 
activity shown for 2,4-DNP (Pérez-Reinado et al. 2008). Dihydropterine 
reductases (DHPR; EC 1.5.1.34) are involved in the recycling of 
tetrahydropterine cofactor used, for example, in the hydroxylating reaction of   
L-phenylalanine to L-tyrosine. Interestingly, N-terminal sequencing of the 
NfnB and a dihydropteridine reductase from E. coli showed that they are 
similar suggesting homology between the two proteins, and this is the reason 
why several nitroreductase-like proteins are annotated on databases as putative 
dihydropteridin reductases (Vasudevan et al. 1988, Pérez-Reinado et al. 2008). 
At present, most of the well characterised nitroreductases, at the biochemical 
and/or structural level are from enterobacteria. The goal of the present studies 
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was firstly to express, purify and characterise both biochemically and 
structurally, the inducible type I nitroreductase (NprA) of Rhodobacter 
capsulatus B10, both in the native or ligand-bound forms; and secondly, to map 
the catalytically important residues, providing new insights into the mechanistic 
pathway of nitroaromatic reduction. If achieved, these results may help to 
elucidate the true physiological role of these enzymes. 
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2. Cloning, expression, purification, crystallisation and 
preliminary crystallographic studies of BceC, an UDP-
glucose dehydrogenase from Burkholderia cepacia IST 
408  
 
The work described here is based on the published refereed paper but now includes a 
more detailed description of the materials and methods, as well as further figures. 
Reference: Rocha, J; Popescu, A.; Sá-Correia, I. Fialho, A.; and Frazão, C. (2010b) 
“Cloning, expression, purification, crystallisation and preliminary crystallographic 
studies of BceC, an UDP-glucose dehydrogenase from Burkholderia cepacia IST 408.” 
Acta Crystallographica Section F66: 269-271.  
 
2.1. Abstract 
 
Burkholderia cepacia is an opportunistic pathogen in cystic fibrosis patients. 
The production of its virulent polysaccharide biofilms requires UDP-glucose 
dehydrogenase (UGD) enzymatic activity. This enzyme is responsible for the 
NAD+-dependent two-fold oxidation of UDP-glucose into UDP-glucuronic 
acid, a biofilm precursor. The 470 amino-acid residue B. cepacia IST 408 
UGD, usually known as BceC, was cloned, expressed, purified and crystallised. 
Its preliminary crystallographic analysis at 2.09 Å resolution and a molecular 
replacement study are reported herein. Crystals belong to orthorhombic space 
group P212121 and contain four molecules in the asymmetric unit. 
 
2.2. Introduction 
Bacteria belonging to the Burkholderia cepacia complex (BCC), a group of 
seventeen closely related species, have emerged as highly problematic 
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opportunistic human pathogens in patients with cystic fibrosis (CF). BCC 
members often express a mucoid phenotype, associated with the production of 
large amounts of exopolysaccharides (EPS), suggesting a possible role of EPS 
in BCC persistence in the CF airways (Cunha et al. 2003; Sousa et al. 2007). 
Since the sugar composition of the EPS produced by different members of the 
BCC complex is somewhat similar, this type of extracellular polysaccharide 
was termed as cepacian (Sist et al. 2003). Cepacian is composed of a branched 
acetylated heptasaccharide repeat-unit with D-glucose, D-rhamnose, D-mannose, 
D-galactose and D-glucuronic acid in the ratio 1:1:1:3:1, respectively (Cescutti 
et al. 2000). The pathway leading to the nucleotide sugar precursors necessary 
for cepacian biosynthesis has been proposed for the mucoid CF clinical isolate 
B. cepacia IST 408 (Richau et al. 2000), and the cepacian cluster of genes 
(named bce) directing its biosynthesis has been identified (Moreira et al. 2003). 
Our interest in B. cepacia IST 408 uridine-5'-diphosphoglucose (UDP-glucose) 
dehydrogenase (encoded by the cepacian gene called bceC) arises from its 
pivotal role in providing the UDP-glucuronic acid (UDP-GlcA) precursor 
necessary for cepacian biosynthesis. UDP-glucose dehydrogenase (UGD; EC 
1.1.1.22) catalyses the two-fold NAD+-dependent oxidation of UDP-glucose 
(UDP-Glc) to UDP-glucuronic acid (UDP-GlcA) (Campbell et al. 1997; 
Campbell & Tanner 1999). UGDs have been the subject of several studies 
because they are present not only in bacteria, but also in multiple prokaryotic 
and eukaryotic cells, where UDP-GlcA is the activated donor of D-glucuronic 
acid, which can be converted into other compounds and serves in many critical 
roles in different metabolic pathways, ranging from mammals to bacteria 
(Campbell et al. 2000; Hwang & Horowitz 2002; Griffith et al. 2004; Sommer 
et al. 2004; Stewart & Copeland 2006). At the time of writing, only four X-ray 
crystal structures of UGD enzymes are publicly available, namely from the 
prokaryotic Streptococcus pyogenes (Campbell et al. 2000) with PDB entries 
1DLI and 1DLJ; UGD from Porphyromonas gingivalis (Bonanno et al.; not 
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published) with PDB entry 3GG2, and two eukaryotic representatives from 
Caenorhabditis elegans PDB code 2O3J, not published, and the human UGD, 
PDB codes 2QG4 and 2Q3E, also not published. The determination of several 
3D structures of UGDs allows the identification of the conserved 
stereochemical features within this family of enzymes, which may lead to a 
deeper understanding of its reaction mechanism.  
 
2.3. Materials and Methods 
 
2.3.1. Cloning and expression of bceC gene from B. cepacia IST 
408 
 
The bceC gene from Burkholderia cepacia IST 408 was amplified by 
polymerase chain reaction (PCR) using its genomic DNA as the template, Pwo 
DNA polymerase (Roche Diagnostics, Mannheim, Germany), and the 
oligonucleotides BPCRbceC (5’-GGGGGATCCATGAATCTGACTAT-3’) 
and HPCRbceC (5’-GGGAAGCTTGAAACGGGTTAC-3’) designed based on 
the bceC nucleotide sequence. The PCR product (1,413 bp) was digested with 
BamHI and HindIII (recognition sites underlined) and cloned into the cloning 
vector pWH844 (Schirmer et al. 1997), generating pBceC. This plasmid carries 
the bceC gene preceded by a sequence coding for six histidines, a glycine and a 
serine residue present for purification purposes. The DNA insert cloned in 
pBceC was sequenced to confirm the fidelity of DNA amplification. The 
nucleotide sequence of the bceC gene from B. cepacia IST408 has been 
deposited in the GenBank database under the accession number GQ451909. 
Overexpression of the bceC gene was carried out by cultivation of Escherichia 
coli SURE (Stratagene) transformants harbouring the plasmid pBceC, in 1000 
ml LB medium supplemented with 100 µg!ml-1 of ampicillin at 310 K, until an 
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OD600nm of 0.6 was reached. The cells were then induced with 0.3 mM isopropyl 
!-D-thiogalactoside (IPTG) for 6h at 301 K, harvested by centrifugation        
(10 000g, 30 min, 277 K) and the obtained pellets were stored at 253 K. 
 
2.3.2. Protein purification 
 
Cells were resuspended in 20 mM Na2HPO4/NaH2PO4 buffer pH 7.4, 20 mM 
imidazole, 1 M NaCl and disrupted in a French press. Crude cell extract was 
obtained by centrifugation at 27 000 g for 40 min at 277 K and the supernatant 
was applied onto a 5 ml HisTrap column (GE Healthcare), pre-equilibrated with 
20 mM Na2HPO4/NaH2PO4 buffer pH 7.4, 20 mM imidazole, 1 M NaCl, and 
connected to an ÄKTA Explorer Instrument (GE Healthcare) according to the 
manufacturer's recommendation. The column was washed with buffer A (20 
mM Na2HPO4/NaH2PO4 buffer pH 7.4, 20 mM imidazole, 1 M NaCl) to remove 
any unbound protein, and a concentration gradient of imidazole (20-500 mM) 
was applied. The BceC protein eluted at approximately 250 mM imidazole in a 
symmetrical chromatography peak (Figure 2.1.). The eluted fractions were 
immediately pooled and buffer-exchanged with 25 mM Tris-HCl pH 8.3, 50 
mM NaCl, 2.5 mM dithiothreitol (DTT), 0.25 mM UDP-GlcA and 0.5 mM 
oxidised nicotinamide adenine dinucleotide (NAD+), using a PD10 desalting 
column (GE Healthcare). The composition and purity of the eluted fractions 
were confirmed by SDS-Page analysis and only homogenous fractions were 
used thereafter. The protein migrates as a single polypeptide with an estimated 
molecular mass of approximately 52.6 kDa (51.3 kDa from the native protein, 
plus 1.3 kDa corresponding to the 6xHis-tag).  
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Figure 2.1. The purification of the BceC native protein.  
(a) Affinity chromatogram for the purification of the his-tagged BceC protein. Protein detected 
by the absorbance at 280nm (y coordinates; blue line). BceC elutes in approximately 20 ml (x 
coordinates) almost pure in a symmetrical peak at approximately 250 mM of imidazole 
concentration (green line). (b) SDS-Page analysis of the HisTrap purified fractions of BceC 
using the Comassie blue staining. Fractions containing BceC were pooled together and the 
protein was concentrated up 10 mg!ml-1. Legend Gel1: 1/12. Sigma MW marker (Sigma 
Aldrich); 2-9. Peak eluted fractions; 10-11. Soluble BceC. Legend Gel2: 1-13. Peak eluted 
fractions (cont.); 14. Sigma MW marker (Sigma Aldrich).  
 
The protein was concentrated in a Vivapore 10/20 concentrator (Vivascience 
Ltd, UK) to approximately 10 mg!ml-1 before storage at 193 K. The protein 
concentration was determined by Bradford's method (Bradford, 1976) using 
bovine serum albumin fraction V (Sigma, France) as the standard, and by direct 
measurement of absorbance at 280 nm in a NanoDrop ND-1000 
Spectrophotometer using an extinction coefficient of 38120 M-1!cm-1.  
 
(a) (b) 
1    2      3    4     5     6    7     8    9   10   11  12 
1    2    3   4    5   6   7   8   9   10  11  12  13 14 
Gel 1 
Gel 2 
Buffer A (wash): 
20 mM phosphate pH 7.4 
1M sodium chloride 
20 mM Imidazole 
Buffer B (elution): 
20 mM phosphate pH 7.4 
1M sodium chloride 
500 mM Imidazole 
Imidazole 
Gradient  
(to 500 mM) 
50 mM 
Imidazole  
wash 
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2.3.3. Protein crystallisation  
 
Protein crystallisation screens were performed with a "Honeybee" Microsys 
4000 XL Cartesian™ Dispensing Systems robot (Genomic Solutions, USA) 
using the vapour-diffusion method. 768 sitting drops consisting of 100 nl of 
protein solution at 10 mg.ml-1 plus 100 nl of precipitant solution were 
equilibrated against 100 µl of precipitant solutions from crystallisation screens 
Classics, PEGs, MbClass, MbClass II, pHClear, pHClear II, Ammonium sulfate 
and MPD from Qiagen Canada Inc. (Montreal, Canada). A crystalline 
precipitate was found in various drops from the different screens, but only 
MbClass II and pHClear II screens generated visible single crystals. In 
particular, solution F7 of MbClass II (200 mM (NH4)2SO4, 100 mM NaCH3CO2 
pH 4.6 and 12% (w/v) PEG 4K) and solution D8 of pHClear II (100 mM citric 
acid pH 5.0 and 30% (v/v) isopropanol) gave the most regularly shaped 
crystals. Manual reproduction and further optimisation of these conditions was 
tried in order to decrease nucleation and promote further crystal growth. 
Finally, only the F7 condition of MbClass II showed reproducible results at the 
microlitre scale, and its crystals were improved by changing parameters such as 
the ratio of protein vs. precipitant volumes and by the use of additives from the 
96 solutions of the Additive Screen, Hampton Research (Aliso Viejo, USA). 
Crystals were allowed to grow up to 24h, as longer times led to higher 
instability during cryoprotection and lower resolution in diffraction 
experiments. The best crystals (Figure 2.2.) were obtained at 293 K from sitting 
drops of 1 µl of protein solution 5 mg!ml-1 (see above section 2.3.2.) and 1 µl of 
precipitant solution 200 mM (NH4)2SO4, 100 mM NaCH3CO2 pH 4.5, 11% 
(w/v) PEG 4K and 50 mM NaF, against 500 µl of precipitant solution in the 
well. Cryoprotection of crystals was achieved in a two-step procedure i) by 
transferring them into a washing (and stabilising) solution of mother liquor 
containing 15% (w/v) PEG 4K to remove precipitated protein surrounding 
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crystals, followed by ii) a quick soak in a cryoprotective solution (the same as 
step i) supplemented with 25% (v/v) glycerol.  
 
 
 
 
 
 
 
 
Figure 2.2. Photographs of BceC crystals. 
(a) Native B. cepacia BceC forms octahedral-like crystals that reach an approximate size of 
0.05, 0.05, and 0.07 mm within 24 h of growing time. (b) A cryo-cooled crystal mounted on a 
loop at the beam line ID14-1 of ESRF (Grenoble, France) ready for data collection. 
 
2.3.4. X-ray diffraction analysis and phase problem solution 
 
Cryoprotected crystals were flash cooled in liquid nitrogen and diffraction data 
collected at the European Synchrotron Radiation Facility (ESRF), Grenoble, 
France, at station ID14-1 on an ADSC Q210 CCD detector. 
Diffraction images were processed with MOSFLM (Leslie 1992) to reflection 
intensities, scaled and merged together with SCALA, and reduced to structure 
factor amplitudes using TRUNCATE from the CCP4 Suite (Collaborative 
Computational Project, Number 4, 1994) (see Table 2.1 for crystal and 
diffraction data and statistics). A molecular replacement search by PHASER 
(McCoy et al. 2007) using a preliminary model at 3.4 Å resolution of the 
bacterial UGD from Sphingomonas elodea (see section 4.3.4.) with 42 % 
sequence identity as the target structure led to final translation function Z-scores 
of 12.0, 9.9, 9.6 and 5.1 for each of the four molecules and final log likelihood 
gain (LLG) of 293. 
(b) (a) 
0.05 mm 
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Table 2.1. Crystal and diffraction data statistics for a native crystal of BceC. 
Crystal BceC_native 
ESRF beam line ID14-1 
Wavelength (Å) 0.934 
Resolution (Å) 40.23-2.09 (2.20-2.09) 
Space group P2
1
2
1
2
1
 
Unit cell dimensions  
a (Å) 97.49 
b (Å) 109.08 
c (Å) 187.69 
No. of measured reflections 442772 (61050) 
No. of unique reflections 118686  (17111) 
Reflection redundancy 3.7 (3.6) 
<I>/<!(I)> 11.8 (4.2) 
R
pim
a
 0.028 (0.101) 
R
rim
b
 0.054 (0.195) 
R
sym
c
 0.046 (0.166) 
Completeness (%) 99.8 (99.7) 
Mosaicity (º) 0.26 
V
M
 (Å
3
Da
-1
) 2.36 
Solvent content (%) 47.9 
Wilson B (Å
2
) 24.2 
Estimated no. of molecules in ASU 4 
 
Data within parentheses refer to the outer resolution shell; 
a
Rpim = !
h 
[1/(N-1)]
1/2
 !
i
 |I
i
(h)
 
- <I(h) >| / !
h
 !
i
 I
i 
(h), where N is the data redundancy, I is the observed intensity and <I> is the average 
intensity of multiple observations from symmetry-related reflections. It is an indicator of the precision of the final merged and averaged data-set; 
b
Rrim = Rmeas = !
 h 
["/("#1)]
1/2
 !
 i
 |I
i
(h)
 
- 
<I(h)>| / !
 h
 !
 i
 I
i 
(h),, where N is the data redundancy, I is the observed intensity and <I> is the average intensity of multiple observations of symmetry-related reflections.  It is an indicator of the 
average spread of the individual measurements; 
c
Rsym = !
h
 !
i
 |I
i
(h)
 
- <I(h)> / | !
h
 !
i
 I
i 
(h), where I is the observed intensity and <I> is the average intensity of multiple observations from 
symmetry-related reflections. 
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2.3.5. In vitro oligomerisation analysis of BceC 
 
An estimation of the number of molecules in the asymmetric unit (a.u.) 
(Matthews 1968) taking into account the resolution dependent distribution of 
the Matthews coefficient in the PDB (Kantardjieff & Rupp 2003), indicated 4 
molecules in the a.u. with a probability of 72 % (3 or 5 molecules would 
correspond to probabilities of 13 or 14 %, respectively). To access the 
oligomeric state of BceC (both in solution and crystal structure) several 
techniques were used. Size exclusion chromatography was carried out for 
molecular weight determination, by comparison with molecular weight 
standards (Sigma-Aldrich) ran under the same conditions. A Superdex 200 
10/300 GL column (GeHealthcare) was used with a flow rate of 0.25 ml!min
-1
. 
The BceC protein elutes (both in the presence or absence of substrates) in a 
single chromatography peak at 13.4 ml of elution volume, corresponding to an 
estimated molecular weight of about 100 kDa (according to the calibration 
curve).  
 
 
 
 
 
 
 
 
 
Figure 2.3. Determination of the oligomeric state of BceC in solution using size exclusion 
chromatography.  
Experiments were performed on a Superdex 200 10/300 GL column (GE Healthcare) and a 
protein concentration of 10 mg!ml
-1
. (a) BceC with bound substrates UDP-GlcA (0.25 mM) and 
NAD(H) (0.2 mM). 
(a) 
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Figure 2.3. (cont). Determination of the oligomeric state of BceC in solution using size 
exclusion chromatography.  
(b) BceC without bound substrates. In both cases, the protein elutes at 13.4 ml corresponding to 
a calculated molecular weight of approximately 100 kDa (according to a calibration curve). 
Molecular weight standards (Biorad): thyroglobulin, 669 kDa (9 ml); catalase, 232 kDa (12 ml); 
ovalbumin 43 kDa (15.15 ml); chymotrypsinogen A 25 kDa (15.7 ml) and ribonuclease A 13.7 
kDa (17.7 ml). The calibration curve is shown as insert.  
 
These results suggest that BceC is a homodimeric species under the 
experimental conditions used (see Figure 2.3. a, b above). 
Dynamic Light Scattering (DLS) assays were performed with BceC (2 mg!ml
-1
) 
at 20°C in both presence and absence of bound substrates. The experimental 
conditions used were the same as the size exclusion chromatography assays 
(Figure 2.3.). A single peak with an average particle diameter of about 8.7 nm 
was obtained. This corresponds to a single species in solution with an estimated 
molecular weight of approximately 100 kDa. These results suggest that, in these 
experimental conditions, BceC is a dimer regardless of the presence or absence 
of bound ligands (Figure 2.4. a, b). 
 
 
 
(b) 
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Figure 2.4. BceC oligomeric state determination using DLS. 
(a) DLS curves for native BceC with no ligands bound. (b) DLS studies for BceC with UDP-
GlcA (0.25 mM) and NAD(H) (0.5 mM)  bound. Assays were performed in triplicate, using a 
solution of 25 mM Tris-HCl pH 8.3 supplemented with 150 mM NaCl, as the eluent buffer 
(same as chromatographic curves on Figure 2.3.). The assay was performed also for BceC with 
bound UDP-Glc or UDP-GlcA alone (data not shown), exhibiting the same results. In all cases, 
the average particle diameter is around 8.7 nm, which corresponds to an estimated molecular 
weight of approximately 100 kDa suggesting a homodimer of BceC (2 x 52.6 kDa). 
 
The pH dependent oligomerisation state of BceC (over a range of 4-9) was also 
evaluated, both in the presence or absence of bound ligands (Figure 2.5. a, b).  
In the pH 6-9 ranges, a single peak with an average particle diameter of about 
8.7 nm is shown. Again, this corresponds to a species with a molecular weight 
of approximately 100 kDa. In the acidic 4-5 range, a single peak is also shown 
but with a much higher diameter, indicating severe aggregation.  
(a) 
(b) 
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These results show BceC as a stable dimeric species over pH 6-9, with or 
without bound ligands.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5. BceC oligomeric state determination using DLS, over a pH range 4-9. 
(a) Dynamic light scattering (DLS) curves for native BceC with no ligands bound at different 
pHs ranging from 4-9. (b) DLS curves for BceC with bound UDP-GlcA and NAD(H) at pH 
ranges 4-9. All assays were performed in triplicate. The assay was performed also for BceC 
with bound UDP-Glc or UDP-GlcA alone (data not shown), exhibiting the same results. In pH 
range 6-9, the average particle diameter is around 8.7 nm, which corresponds to an estimated 
molecular weight of approximately 100 kDa suggesting that, in solution, BceC is a 
homodimeric species (2 x 52.6 kDa). At pH range 4-5, both native and ligand bound forms 
show severe aggregation, judging by the excessive average particle diameter (1000 or 3000 nm, 
respectively). 
 
Taking this into consideration, the Matthews Coefficient (Vm= 2.36 Å3/Da) 
may indicate the presence of two BceC dimers in the asymmetric unit with 
approximately 48 % solvent content. 
(a) 
(b) 
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2.4. Results 
 
Uridine-diphospho-glucose dehydrogenase from Burkholderia cepacia IST 408 
termed BceC, was cloned and expressed. Extensive crystallisation screens were 
performed. Octahedral-shaped crystals were obtained and diffraction data were 
collected and characterised. The best crystal diffracted up to 2.09 Å resolution 
and belonged to the orthorhombic space group P212121. The phase problem was 
solved by molecular replacement using a preliminary model of the homologous 
structure of Sphingomonas elodea enzyme, UgdG. The BceC crystal contains 
four molecules in the asymmetric unit, which are arranged as a pair of dimers, 
corroborating the experimental results obtained in solution with other 
biochemical techniques. 
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3. Structure of Burkholderia cepacia IST 408 UDP-glucose 
dehydrogenase (BceC) and the role of Tyr10 in the 
intermediate thioester hydrolysis 
 
The work described in the following sections is based on a paper prepared for 
submission to a referee evaluated scientific journal, but here including a more detailed 
description of the materials and methods, as well as further figures and results. 
Reference: Rocha, J.; Popescu, A.; Sá-Correia, I.; Fialho, A. and Frazão, C. (2010c) 
“Structure of Burkholderia cepacia IST 408 UDP-glucose dehydrogenase (BceC) and 
the role of Tyr10 in the intermediate thioester hydrolysis.” 
 
3.1. Abstract 
 
Members of the Burkholderia cepacia complex (BCC) are serious respiratory 
pathogens in immunocompromised individuals and in patients with cystic 
fibrosis (CF). They are exceptionally resistant to many antimicrobial agents, 
have the capacity of spreading between patients and lead to declining lung 
function, with necrotising pneumonia. BCC members often express a mucoid 
phenotype, associated with the secretion of an exopolysaccharide (EPS), known 
as cepacian. There is much evidence supporting the fact that cepacian is a major 
virulence factor of BCC bacteria. Uridine-5'-diphosphoglucose dehydrogenase 
(UGD) is the enzyme responsible for the NAD-dependent two fold oxidation of 
UDP-glucose (UDP-Glc) to UDP-glucuronic acid (UDP-GlcA), which is a key 
step in cepacian biosynthesis. UGD is therefore a logical target for the 
development of inhibitors or blockers of cepacian biosynthesis, preventing BCC 
lung colonisation and avoiding chronical infections in CF patients. Extensive 
mutagenic studies have been performed on the active site of UDP-glucose 
dehydrogenases and several crystallographic structures have been produced in 
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order to elucidate the mechanism of action in this family of sugar-nucleotide 
modifying enzymes. The UGD family is built up of two Rossmann-like 
domains connected by a whole alpha-region. This subdomain, similarly to other 
dehydrogenases, harbours the catalytic centre and is the main contributor to 
homodimerisation. The UGD family contains a strictly conserved tyrosine 
residue (Y10 in BceC) within the glycine-rich motif (GXGYXG) of its first 
Rossmann-like domain. Several BceC Y10 mutants were produced and revealed 
severely impaired dehydrogenase activity. Crystal structures of native BceC and 
its Y10K and Y10S mutants were obtained as complexes with the reaction 
product UDP-GlcA at 1.75, 2.8 and 1.70 Å resolution, respectively. In order to 
evaluate potential selective inhibitors of BceC vs. the human UGD, a 
superposition of the UGD structures from both sources was examined, but 
showed a very high structural homology. Additionally, the activity studies of 
BceC mutants together with the examination of Tyr10 environment, led to its 
identification as the key catalytic residue in the final hydrolytic step of 
nucleotide-sugar 6-dehydrogenases. 
 
3.2. Introduction 
 
The BCC consists of at least 17 species that have been isolated from sputum of 
CF patients. Over the last 15 years, members of the BCC have emerged as 
highly problematic opportunistic human pathogens in immunocompromised 
individuals and in patients with cystic fibrosis (CF) (Sá-Correia et al. 2002; 
Moreira et al. 2003). CF patients are likely to see their disease accelerating, as 
BCC pulmonary colonisation leads to a rapid decline of the lung function and in 
some cases the development of the “cepacian syndrome”, a fatal condition that 
is characterised by necrotising pneumonia with fever and bacteremia (Govan & 
Deretic 1996; Jones et al. 2001). Treatment of B. cepacia (a member of BCC) 
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infected patients has proved to be of great difficulty as this bacterium is 
intrinsically resistant to multiple antibiotics including the potent 
antipseudomonal compounds available, is associated with great virulence and it 
is highly transmissible. Despite all of the intensive studies carried out on B. 
cepacia, little is known about the pathogenic mechanisms of this bacterium, 
although it has been shown to possess many of the virulence factors known to 
play a role in P. aeruginosa CF infection (Mahenthiralingam et al. 2002). In the 
CF lung, P. aeruginosa secretes abundant amounts of the exopolysaccharide 
(EPS) alginate which is believed to afford protection from the host immune 
system response and antibiotic therapy and promotes persistence of the bacteria 
in the respiratory tract (Snook et al. 2003). Interestingly, it was observed that a 
vast range of the BCC isolates amongst the CF patients often express a mucoid 
phenotype associated with the production of EPS. Cepacian is the main EPS 
produced by BCC isolates and is composed of a branched acetylated 
heptasaccharide repeat unit with D-glucose, D-rhamnose, D-mannose, D-
galactose and D-glucuronic acid in the ratio 1:1:1:3:1, respectively (Sist et al. 
2003). The cepacian biosynthesis is a multi-step process directed by genes 
belonging to the cepacian gene cluster bce (Moreira et al. 2003). A potential 
strategy for combating BCC infection is to block cepacian biosynthesis, 
through the application of specific inhibitors for the biosynthetic enzymes. 
Because UDP-glucose dehydrogenase is a key enzyme required for the 
synthesis of the cepacian polysaccharide precursor UDP-glucuronic acid, it is a 
logical target for this approach (Snook et al., 2003, Hung et al., 2007).  
UDP-glucose dehydrogenase (UGD) (EC 1.1.1.22) catalyses two successive 
NAD-dependent oxidations of UDP-glucose, producing UDP-glucuronic acid 
(Campbell et al. 2000; Easley et al. 2007). Due to the striking similarity in the 
primary amino acid sequence of the active site in the UGDs from different 
species, it has been proposed that the reaction mechanism is probably the same 
for all the species ranging from bacteria, to animals and plants (Hempel et al., 
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1994, Roman et al., 2003, Ge et al., 2004). Intensive studies on the reaction 
mechanism have therefore been carried out, both on the bacterial and human 
enzymes (Campbell et al. 2000, Ge et al. 2004, Sommer et al. 2004, Easley et 
al. 2007). In this work, the structure of B. cepacia IST 408 UDP-glucose 
dehydrogenase (BceC) was determined and its biochemical characterisation was 
performed. Mutagenic studies were also performed on a strictly conserved 
residue amongst all UGDs, Tyr10, which is present in the Rossmann fold motif 
GXGYXG, and not in the protein's active site. Studies on several Y10 mutants, 
described here, show that this residue plays an important role in the enzymatic 
activity, as the mutations proved to produce an inactive protein. 
 
3.3. Experimental Procedures 
 
3.3.1. DNA manipulation and generation of Y10 mutants  
 
Point mutants of the BceC protein were generated from the wild-type pBceC 
construct using a protocol based on the Quickchange site-directed mutagenesis 
kit (Stratagene, La Jolla, CA) (see section 2.3.1.). Based on the nucleotide 
sequence of bcec, the oligonucleotides Y10S_up (5' – ATC ATC GGC AGC 
GGT TCC GTA GGT CTT GTC ACC – 3'), Y10S_rev (5' – GGT GAC AAG 
ACC TAC GGA ACC GCT GCC GAT GAT – 3'), Y10K_up (5' – CT ATC 
ATC GGC AGC GGT AAG GTA GGT CTT GTC ACC GG – 3'), Y10K_rev 
(5' – CC GGT GAC AAG ACC TAC CTT ACC GCT GCC GAT GAT AG – 
3'), Y10F_up (5' - ATC GGC AGC GGT TTC GTA GGT CTT GTC -3') and 
Y10F_rev (5' - GAC AAG ACC TAC GAA ACC GCT GCC GAT -3') were 
designed for mutants Y10S, Y10K and Y10F, respectively (mutated codons are 
underlined). The mutated sequences were confirmed by N-terminal sequencing, 
and the plasmids harbouring the Y10 mutants were transformed into 
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Escherichia coli SURE strain (Stratagene, La Jolla, CA). The oligonucleotides 
were purchased from MWG Biotech. Restriction enzymes were from Gibco 
BRL and DNA polymerases from Roche Diagnostics (Mannheim, Germany). 
 
3.3.2. Protein purification and crystallisation 
 
BceC wild type and Y10 mutants were expressed and purified as previously 
described (see sections 2.3.1. and 2.3.2.). Briefly, the cells harbouring the 
recombinant constructs of pBceC, pBceC_y10f, pBceC_y10s and pBceC_y10k 
were grown at 37º C up to an OD600nm of approximately 0.6 in LB medium 
supplemented with 100 µg!ml
-1
 ampicillin, and induced at 28º C for about 6 
hours by addition of IPTG to a final concentration of 0.3 mM. Cells were 
harvested by centrifugation (7 000g, 40 min, 4º C), resuspended in phosphate 
buffer 20 mM, pH 7.4, containing sodium chloride 1 M, imidazole 20 mM and 
an EDTA-free protease inhibitor cocktail (Roche Diagnostics, Mannheim, 
Germany), and disrupted on a French press. Nucleic acids and cell debris were 
removed by centrifugation, 17 000g for 40 min at 4º C, and the supernatant was 
applied onto a 5 ml nickel-chelating column (HisTrap FF, Ge-Healthcare), 
previously equilibrated in the same phosphate buffer. Proteins were eluted 
using a linear imidazole gradient up to 500 mM (Figure 3.1. a, b, c), pure 
fractions were pooled and the buffer exchanged to Tris-HCl 25 mM pH 8.3, 
sodium chloride 50 mM, dithiothreitol (DTT) 2.5 mM, UDP-glucuronic acid 
0.25 mM, and nicotinamide adenine dinucleotide (NAD
+
) 0.5 mM. All proteins 
were stored at -80 ºC with final concentration of approximately 10 mg!ml
-1
. 
UDP-glucuronic acid and NAD
+
 were obtained from Sigma. Wild-type crystals 
of BceC were obtained as described elsewhere (see section 2.3.3.). A sitting-
drop, vapour diffusion, crystallisation screen around those conditions also 
provided crystals for mutant proteins Y10S and Y10K. 
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Figure 3.1. Purification of the Y10 BceC mutants.  
All mutants were purified on a HisTrap FF Affinity chromatography column (GE Healthcare) 
using the native BceC protein purification protocol. Mutant proteins exhibit the behaviour of 
native BceC and elute at approximately 250 mM of imidazole concentration (green line; see 
section 2.). Protein and DNA contents were monitored by UV absorbance (mAU) at 280 nm 
(blue curve) and 254 nm (red curve), respectively. (a) Chromatogram and SDS-PAGE gel 
analysis (insert) of the Y10F BceC mutant. (b) Chromatogram and SDS-PAGE gel analysis 
(insert) of the Y10K BceC mutant. (c) Chromatogram and SDS-PAGE gel analysis (insert) of 
the Y10S BceC mutant. The SDS-PAGE gels (inserts) show only the peak fractions for each of 
the purifications. 
 (c)  
 (a)  (b)  
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In spite of more extensive crystallisation screens, no crystals were obtained for 
the Y10F mutant. Optimised Y10S and Y10K mutant crystals were obtained by 
equilibration of 1 µl of mutant proteins solution and 1 µl of a precipitant 
solution of sodium acetate buffer 100 mM pH 4.5, ammonium sulphate 200 mM 
and PEG 4K 11-14% (w/v). Octahedral shaped crystals appeared and grew 
within 24 hours, reaching dimensions up to 0.06-0.1 mm (Figure 3.2.). 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. Crystals of the Y10 BceC mutants.  
The crystals were obtained for mutants Y10K and Y10S using a crystallisation solution equal 
(or very similar) to that used for the native BceC protein. The BceC mutant Y10F did not 
crystallise, even though an extensive screening of different crystallisation conditions was 
performed. (a) Crystals of the Y10K mutant; (b) Crystals of the Y10S mutant. 
 
3.3.3. Standard enzymatic activity 
 
BceC catalyses the 1:1 conversion of UDP-glucose to UDP-glucuronic acid, 
while reducing two
 
molecules of NAD
+
 to NADH. For the screening of UDP-
glucose dehydrogenase enzymatic activity of both native and mutant BceC 
proteins, the change in absorbance at 340 nm that accompanies the NAD
+
 
reduction to NADH was monitored. The assays were performed for 60 minutes 
(b)  
  0.1 mm 
(a)  
0.1 mm 
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at 30 °C in 1 ml reaction volume containing Tris-HCl 100 mM pH 8.7, MgCl2 
10 mM, DTT 2 mM, UDP-glucose 2 mM and NAD
+
 1.5 mM. The reaction 
started with the addition of 3 µg of pure protein to the cuvette. Control assays 
were performed with reaction mixtures lacking the enzyme. All assays were 
performed in triplicate and specific activities were calculated from the 
measured absorbance values at 340 nm using 6220 M
-1
cm
-1
 as the molar 
extinction coefficient of NADH. UDP-Glucose was obtained from Sigma 
(Sigma-Aldrich). 
 
3.3.4. Diffraction data collection and processing 
 
Native crystals were cryoprotected by transferring them directly into a drop of a 
solution of mother liquor including glycerol 25% (v/v). Cryoprotection of the 
Y10S and Y10K mutant crystals required consecutive transfer between drops of 
solutions of mother liquor including glycerol at increasing concentrations, up to 
25% (v/v). Crystals were then rapidly plunged into liquid nitrogen and stored 
for diffraction data collection. Diffraction data were measured at beam line 
ID14-1 of the European Synchrotron Radiation Facility (ESRF), Grenoble, 
France. Diffraction images were processed with MOSFLM (Leslie 1992), 
intensities were merged and scaled with SCALA (Evans 2006), and the 
corresponding magnitudes calculated with TRUNCATE (French 1978), from the 
CCP4 suite (The CCP4 suite: programs for protein crystallography 1994). 
 
3.3.5. Structural solution and refinement 
 
Native BceC initial phases were obtained by molecular replacement using 
PHASER (McCoy et al. 2007) and a preliminary model of UDP-glucose 
dehydrogenase from S. elodea UgdG (sections 4. and 5.) as the search structure. 
RESOLVE prime-and-switch was used to remove the bias from the search 
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structure, and to further improve the phases (Terwilliger 2004b). ARPWARP 
extended the docked model (Perrakis et al. 2001), which was iteratively 
completed and corrected on a graphics workstation using COOT (Emsley & 
Cowtan 2004) and structurally refined with PHENIX.REFINE (Afonine et al. 
2005). The phases for the mutants were obtained from the BceC native structure 
upon truncation of Tyr10 into Ala, using a rigid-body refinement with REFMAC5 
(Murshudov et al. 1997) in the case of the Y10S mutant and a molecular 
replacement step with PHASER (McCoy et al. 2007) in case of Y10K. Models 
were iteratively refined with PHENIX.REFINE (Afonine et al. 2005), and edited 
and fitted to their electron density and completed with COOT (Emsley & 
Cowtan 2004). Model completion of disordered loops was facilitated using non-
crystallographic symmetry (NCS) averaged maps within COOT.  
The progress of the refinement was monitored by the use of Rfree, where 5% of 
the reflections were constantly set aside for cross-validation. 
 
3.3.6. Structural analysis 
 
Detection and selection of translation-libration-screw domains in the protein 
chains were performed with the TLMSD server (http://skuld.bmsc. 
washington.edu/~tlsmd; Painter & Merrit 2006). Molecular stereochemistry was 
checked within COOT (Emsley & Cowtan 2004), intermolecular contacts and 
crystallographic packing were checked with PISA (Krissinel & Henrick 2007) 
and structural comparisons amongst the models were performed with SSM 
(Krissinel & Henrick 2004). Images were prepared with PYMOL (Delano 2008). 
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3.4. Results and Discussion 
 
3.4.1. Crystal characterisation and diffraction data processing of 
native BceC and its Y10 mutants  
 
Upon successive crystal optimisation and data collection sessions at ESRF, data 
sets of native BceC and its Y10S and Y10K mutants reached final resolutions 
of 1.75, 1.70 and 2.80 Å, respectively (Figure 3.3.). All data were integrated 
with MOSFLM (Leslie 1992) and the intensities scaled, merged and reduced to 
structure factors magnitudes using SCALA (Evans 2006). All crystals belong to 
space group P212121, show similar cell dimensions, and contain 4 molecules in 
the asymmetric unit (a.u.), corresponding to calculated solvent contents in the 
range 47.5-49.5 % and Matthews coefficients within 2.34-2.41 Å3Da-1 (see 
Table 3.1. for further details). 
 
 
 
 
 
 
 
 
 
Figure 3.3. Diffraction images from the crystals of native and Y10 BceC mutants. 
Diffraction patterns of (a) native BceC crystal; (b) Y10K mutant; (c) Y10S mutant. Crystals of 
native and mutant BceC were tested and collect at the ESRF (Grenoble, France). 
 
(a) (c) (b) 
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Table 3.1. Data collection and crystallographic statistics for native BceC and Y10 mutants. 
Crystal Native Y10S Y10K 
ESRF beam line ID14-1 ID14-1 ID14-1 
Wavelength (Å) 0.9334 0.9334 0.9334 
Resolution (Å) 47.56 – 1.75 (1.84 – 1.75)
 
47.40 – 1.70 (1.79 - 1.70) 57.83 – 2.80 (2.95 - 2.80) 
Space-group P2
1
2
1
2
1 
P2
1
2
1
2
1 
P2
1
2
1
2
1 
a (Å) 97.63 97.36  101.62  
b (Å) 108.93 108.62  109.25  
c (Å) 187.71 187.46  183.44 
No. measured refs. 750258 (109058) 803863 (115360) 206820 (30278) 
No. unique refs. 197721 (29063) 217359 (31490) 50832 (7331) 
Redundancy 3.8 (3.8) 3.7 (3.7) 4.1(4.1) 
I/!(I) 6.7 (2.0) 7.6 (2.0) 2.8 (1.7) 
R
pim
a
 0.038 (0.188) 0.044 (0.283) 0.119 (0.241) 
R
rim
b
 0.076 (0.369) 0.087 (0.554) 0.249 (0.501) 
R
sym
c
 
0.066 (0.315) 0.074 (0.474) 0.217 (0.436) 
Completeness (%) 98.4 (99.7) 99.8 (100.0) 99.8 (100.0) 
Mosaicity (º) 0.26 0.25 0.8 
V
M
 ( Å
3
Da
-1
) 2.43 2.34 2.41 
Solvent content (%) 49.5 47.5 48.9 
No. molecules in a.u. 4 4 4 
Wilson B (Å
2
) 18.31 17.66 42.22 
 
Data within parentheses refer to the outer resolution shell; 
a
R
pim
 = !
h 
[1/(N-1)]
1/2
 !
i
 |I
i
(h)
 
- <I(h) >| / !
h
 !
i
 I
i 
(h), where N is the data redundancy, I is the observed intensity and <I> is the average 
intensity of multiple observations from symmetry-related reflections. It is an indicator of the precision of the final merged and averaged data-set; 
b
R
rim
 = R
meas
 = !
 h 
["/("#1)]
1/2
 !
 i
 |I
i
(h)
 
- <I(h)>| / !
 h
 !
 i
 
I
i 
(h), where N is the data redundancy, I is the observed intensity and <I> is the average intensity of multiple observations of symmetry-related reflections.  It is an indicator of the average spread of the 
individual measurements; 
c
R
sym
 = !
h
 !
i
 |I
i
(h)
 
- <I(h)> / | !
h
 !
i
 I
i 
(h), where I is the observed intensity and <I> is the average intensity of multiple observations from symmetry-related reflections. 
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3.4.2. Phase determination and structural refinement of native 
BceC 
 
Initial molecular replacement attempts of native BceC using the PDB entry 
1DLI, the structure of UDP-glucose dehydrogenase from Streptococcus 
pyogenes (Campbell et al. 2000) as the model, were not successful, most 
probably due to their too low homology as their sequence identity is about       
23 %. However, once a preliminary model of UDP-glucose dehydrogenase 
from Sphingomonas elodea was obtained in our laboratory (see section 4.), with 
a sequence identity of 42 % against BceC, the molecular replacement solution 
was readily obtained (see section 2.). RESOLVE, with automatically implemented 
four-fold NCS averaging and the “prime and switch” procedure (Terwilliger 
2004b) was used to improve the phases of the native BceC molecular 
replacement solution. Readily interpretable electron density maps were 
produced with a figure of merit of 0.48, which included well defined densities 
for an activated sugar UDP-glucuronic acid molecule nestled in each BceC 
monomer, in a model with 1358 out of 1912 possible residues in the a.u. 
Nevertheless, only 349 residues were docked in sequence. Using the 1.75 Å 
resolution diffraction dataset of native BceC, obtained in the meantime, and the 
program ARPWARP (Perrakis et al. 2001), the four chains model was extended to 
1604 residues, of which 1530 were docked in the sequence. The protein and 
solvent structure were examined at a graphics workstation against their !A maps 
(Read 1986), and the model improved accordingly. As result of a translation, 
libration and screw motion (TLS) determination of the models using TLMSD 
(Painter & Merrit 2006), four homologous sequential domains were assigned to 
each chain and used both for TLS refinement and to define NCS restraints 
among chains, in atomic positional and isotropic a.d.p. refinement. Steps of 
structure refinement and editing were iteratively repeated until convergence of 
Rwork/Rfree to 16.3/19.5 %. Using all data the final R factor is 16.7 %. 
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3.4.3. Phase problem solution and structural refinement of Y10K 
and Y10S BceC mutants 
 
As native BceC and its Y10S mutant produced isomorphous crystals, cell 
dimensions differ only up to 0.3 %, a rigid-body refinement of the four chains 
BceC model produced suitable phases for the Y10S mutant. For the non-
isomorphous Y10K mutant crystal (cell lengths differ up to 4% in the a 
direction) phases were obtained by molecular replacement using the refined 
structure of native BceC as the search model. For the two mutants, iterative 
molecular refinement, inspection and edition of the structures proceeded 
similarly to that described for the native case. Their Rwork/Rfree are 16.8/19.8 % 
and 22.8/26.63 %, and final R-values of 16.6 and 21.7 %, for the Y10S and 
Y10K cases, respectively. 
 
3.4.4. Crystal contents of native BceC and Y10 mutants 
 
While the two residues of the linker between the His-tag (see section 2.3.1.) and 
the first methionine of the protein could be modelled as Gly-1 and Ser0 (except 
for Y10K mutant where only the serine was visible), the 6 histidine residues of 
the tag and the last 10 residues (up to 15 in the case of the Y10K mutant) of the 
C-termini were not visible in the electron density maps and therefore omitted 
from the models. Several main-chain residues are not entirely visible in the 
electron density in all the three structures but they were modelled according to 
their NCS consensual positions. They belong mainly to loops exposed to the 
solvent and their refined a.d.p. values reflect their disordered behaviour. 
Similarly, some side-chains, mainly from hydrophilic residues, were modelled 
in alternate conformations (see Table 3.2 for further details). Globally, 1841, 
1841 and 1796 out of 1912 (four chains each with 8+470) residues were 
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A total of 1415, 1311 and 8 solvent molecules were modelled as waters in the 
native, Y10S and Y10K structures, respectively. Additionally, each protein 
chain also encompasses a docked UDP-glucuronic acid molecule, and whenever 
a persistent positive (mFo-DFc) density (Read 1986), was found in a chemically 
suitable environment, acetate, sulphate, glycerol or Tris molecules were 
modelled, in particular for the higher resolution crystals of native and Y10S 
mutant (see Table 3.2. for further details). 
 
3.4.5. BceC monomer topology 
 
A topology analysis of the BceC monomer (dimensions of approximately 75, 45 
and 35 Å) using TOPS (Westhead et al. 1999) shows two !"! sandwich type 
dinucleotide binding Rossmann-like domains, at the N- and C-terminal sections 
of the protein (residues 1-205 and 305-459, respectively) linked together by an 
entirely !-helical sub-domain (residues 206-304) (Figure 3.4.). We succeeded to 
co-crystallise BceC only with the reaction product UDP-GlcA, but in other 
UGD structures (Campbell et al. 2000; Kavanagh et al. 2007 a, b, unpublished, 
PDB entries 1DLJ and 2Q3E) the active site could be mapped with the two 
enzyme substrates of (di)-nucleotide type, the oxidising nicotinamide adenine 
dinucleotide (NAD+) at the nucleotide binding N-domain (NBD), and 
nucleotide-sugars analogues at the C-domain, hence denominated as the sugar 
binding domain (SBD) (Campbell et al. 2000) (but see below). Each !"! 
domain includes two consecutive Rossmann-fold motifs built up of three 
parallel beta strands interspersed by (one or two) alpha helices interconnected 
by variable sized loops. In the NBD ("1 to "8), and after the last strand ("6) of 
the canonical dinucleotide binding Rossmann-like fold, one finds a 2x(!") 
motif (!7-"7-!8-"8), in which the two "-strands extend the molecule central 
twisted "-sheet in an anti-parallel fashion, via two main-chain hydrogen bonds 
connecting strands "6 and "7. 
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Table 3.2. Refinement and model quality statistics for native and Y10 mutants BceC. 
 
Parameter Native Y10S Y10K 
R
work
 (%) 16.3 16.8 22.8 
R
free
 (%) 19.5 19.8 26.3 
R (%) 16.7 16.6 22.2 
a
 Protein chain <a.d.p.> (Å
2
) 22, 24, 30, 23 (25) 22, 24, 31, 22 (24) 30, 26, 29, 25 (28) 
a
 Glucuronic acid <a.d.p.> (Å
2
) 12, 11, 12, 12 (12) 12, 11, 14, 12 (12) 25, 25, 25, 17 (23) 
No. of residues per chain 461, 460, 460, 460 461, 460, 460, 460 449, 447, 451, 449
 
No. of solvent waters 1415 1311 8 
No. of solvent sulphates 16 14 6 
No. of solvent acetates 4 5 -- 
No. of solvent glycerol 9 6 -- 
No. of solvent Tris -- 1 -- 
No. atoms modelled in alternating 
conformations 
341 333 0 
Bond distances rmsd (Å) 0.005 0.005 0.008 
Bond angles rmsd (º) 1.0 1.0 1.3 
Residues distribution in preferred, 
allowed, or outlier regions of 
Ramachandran diagram (%) 
96.8, 2.9, 0.3 97.1, 2.7, 0.2 95.8, 3.9, 0.3 
 
a
Values for each of the four crystallographically independent molecules (chains) followed by their average in parentheses. 
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Such a 2x(!") motif is also found in the available UGD structures, but whilst in 
UGDs from Caenorhabdtis (C.) elegans (Zhang et al. 2006, unpublished, PDB 
entry 2O3J) or from Homo (H.) sapiens (Kavanagh et al. 2007a, b, unpublished, 
PDB entries 2QG4 and 2QE3), or from Porphyromonas gingivalis (Bonnano et 
al. 2009, unpublished, PDB entry 3GG2) there are two main-chain hydrogen 
bonds linking this motif with the central sheet, in Streptococcus (S.) pyogenes 
UGD one only finds a single hydrogen bond, and thus its 2x(!") motif was 
assigned as a small and independent additional "-sheet (Campbell et al. 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4. The three-dimensional crystal structure of BceC monomer. 
Cartoon representation of UDP-glucose dehydrogenase from B. cepacia IST408 (BceC). The 
BceC monomer has dimensions of approximately 75, 45 and 35 Å. The structure consists of two 
!"! sandwich dinucleotide binding Rossmann fold domains, at the N- (blue) and C-terminal 
(red) sections, connected by a !-helical sub-domain (green), responsible for the homodimer 
formation. UDP-GlcA in stick representation coloured yellow for carbons, red for oxygen, blue 
for nitrogen and orange for phosphorus. Secondary structure elements classified numerically. 
 
The intermediate ! sub-domain (!9 to !12) is located around the homodimer 
two-fold non-crystallographic symmetry rotation axis. It is therefore implicated 
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in BceC homodimerisation and, as it also includes the catalytic centre (see 
below), it will be assigned here as the dimerisation and catalytic sub-domain 
(DCSD). It is composed of two pairs of helices connected by a 20 residue long 
loop, between !10 and !11, which surrounds the nucleotide-sugar substrate. 
The DCSD is initiated by a 30 residue !-helix (!9), a conserved helix that 
connects two Rossmann-like folds in NAD-dependent dehydrogenases 
(Kutzenko et al. 1998). In this context it is relevant to note that the fit of NBDs 
from UGDs and GDP-mannose dehydrogenase (GMD, Snook et al. 2003) also 
leads to the superposition of this long interconnecting helix (not shown), 
although the second Rossmann-like domain of GMD is swapped and overlaps 
the first Rossmann-like domain of the dimer mate in UGDs (Snook et al. 2003).  
The DCSD of UGDs/GMDs has been classified as belonging to the                  
6-phosphogluconate dehydrogenase C-terminal domain-like super family in 
SCOP 1.73 (Murzin et al. 1995; Andreeva et al. 2008), or clan in PFAM (Finn 
et al. 2008), being characterised as a multi-helical common core formed around 
two long anti-parallel helices related by (pseudo) twofold symmetry. 
Additionally, these two databanks define 12 or 6 families of domains 
homologous to the UGDs/GMDs DCSD, respectively. A search for the closest 
homologue domains in the PDB (Berman et al. 2000) using DALI (Holm et al. 
2008) and the coordinates of BceC residues within the range 207-302, led to the 
structures of NDP-N-acetyl-D-galactosaminuronic acid dehydrogenase from 
Methanosarcina (M.) mazei (Malashkevich et al. 2009, unpublished, PDB entry 
3G79), in "-hydroxyacid dehydrogenases (Papagrigoriou et al. 2006, 
unpublished, PDB entry 2GF2; Reitz et al. 2008, PDB entry 3CKY), and in 
cytokine-like nuclear factor N-pac protein (Tickle et al. 2007, unpublished, 
PDB entry 2UYY), for cut-offs in the DALI Z-score down to 3 and in rmsd up 
to 3 Å, for the 96 C! atoms used. Whilst the NDP-N-acetyl-D-
galactosaminuronic acid dehydrogenase is clearly homologous to UGD 
structures, with their two Rossmann-like dinucleotide binding domains linked 
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by the DCSD, the two !-hydroxyacid dehydrogenases and the cytokine-like 
nuclear factor N-pac protein structures form another set of similarly folded 
protein that contain only one Rossmann-like dinucleotide binding domain 
followed by an entirely "-domain, similar to UGD’s DCSD. These structures 
diverge from UGDs mainly by lacking the second Rossmann-like fold, by 
having different paths in the DCSD intermediate 20 residue long loop and in the 
DCSD fourth helix, which is shortened to the first three turns. A packing 
analysis of these structures confirms that they all homodimerise via interactions 
between their DCSDs. It is noteworthy that the catalytic residues in all the 
mentioned enzymes are provided by their DCSD.  
The C-terminal "!" domain ("13 to !14) has the internal six stranded pleated !-
sheet surrounded by eight helices. In contrast to a low 12% sequence identity it 
shows a rather high 3D structural similarity against the NBD domain, with a 
rmsd of 1.8 Å between 96 pairs of C" atoms (out of 154 residues) upon fit of 
the two domains using a superposition radius cut-off of 1.75 Å. Such a strong 
homology between the two Rossmann-like domains has already been noted in 
S. pyogenes UGD (Campbell et al. 2000), as well as in general to NAD 
dependent dehydrogenases (Kutzenko et al. 1998) or to other related enzymes 
(Campbell et al. 2000). The observation of proteins containing remarkable 
chain-fold similarities without apparent sequence conservation has been usually 
attributed to a gene duplication event at an ancestor form of the protein, which 
upon evolution retained the functional tertiary structure but lost sequence 
conservation (Lang et al. 2000).  
 
3.4.6. Quaternary structure of BceC 
 
Oligomeric structures of nucleotide sugar dehydrogenases may vary, e.g. the 
bovine and human enzymes occur as hexamers (Franzen et al. 1980) while 
BceC displays a dimeric form (Figure 3.5. a, b), as deduced by the ca. 100 kDa 
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single particles found in solution according to dynamic light scattering (DLS) 
or gel filtration chromatography assays (see section 2.). They correspond to 
approximately two times the expected molecular mass of the 470 residue 
protein monomer and thus show that the dimer is the functional unit of BceC, 
similarly to E. coli (Sieberth et al. 1995) and to P. aeruginosa (Hung et al. 
2007) UGDs.  The analysis of the crystal packing corroborates such a dimeric 
arrangement, with the four molecules in the asymmetric unit associated in two 
dimers. The dimer formation gives an occlusion of about 2.6x103 Å2 that 
corresponds to 13% of otherwise solvent accessible surface. Each of the 
remaining crystal packing interacting regions does not exceed 3.5% of the 
monomers solvent accessible areas.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. The BceC dimer structure. 
(a) “Front” view of the BceC dimer. One monomer is displayed as cartoon representation with a 
docked UDP-GlcA molecule in stick representation (both coloured as in Figure 3.4.), and the 
second monomer is represented by its solvent accessible surface (grey).  
(a) 
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Figure 3.5. (cont.) The BceC dimer structure.  
(b) Topology of the BceC dimer, with triangles representing !-strands and circles representing 
"-helices. In the monomer on the left, dark blue and dark red represent the features common to 
both the dinucleotide binding Rossmann-like domains, in contrast to the different, light blue and 
light red, secondary structure elements. The dimerisation sub-domain is shown in green. The 
monomer on the right is colour coded in cyan, pink and light green for the N-terminal, C-
terminal and intermediate subdomain, respectively. Secondary structure elements were labelled 
numerically both for "-helical or !-strand elements. Residues delimiting BceC secondary 
structure elements are numbered black. Catalytic loop represented by the red line. Image 
prepared with Tops (Westhead et al. 1999). 
 
As described above, dimerisation involves several inter-helical interactions 
between the DCSDs of the dimer partners, with particular relevance to an anti-
parallel coupling of the two mates long central helices "9. The dimerisation 
interface involves sixty-five residues (of the one hundred residues that compose 
each DCSD) and involves ca. 20 hydrogen bond interactions. 
(b) 
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3.4.7. The cofactor Binding Pocket 
 
The three dimensional structures presented here, were obtained only upon 
addition of both the reaction product UDP-GlcA and the cofactor NAD
+
, to the 
protein solution, even if no cofactor molecule could be successfully positioned 
and refined in any of the structures. In an attempt to compare the BceC 
cofactor-binding pocket with those of the human and S. pyogenes UGDs, a 
superposition of their 3D models was performed (Figure 3.6.).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6.  BceC cofactor binding pocket with a docked NAD
+
/NAD(H) model. 
Superposition of BceC against S. pyogenes and human UGD-NAD(H) complexes led to a 
model of NAD(H) docked in BceC (atoms as sticks colored blue for nitrogen, red for oxygen, 
orange for phosphorus and white or yellow for carbon atoms in BceC or NAD(H) model, 
respectively). The black dashed lines illustrate hydrogen bond network between BceC and its 
cofactor model, defining a stretch of residues that in the UDP-glucose/GDP-mannose family is 
characterised by the GXGXXG sequence (Bellamacina 1996; Snook et al. 2003).  
 
In BceC, the cofactor lies in a solvent accessible cleft near the carboxy ends of 
strands !1, !4 and !5 and is shown in an extended conformation, similarly to 
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several NAD
+
-enzyme complexes (Bellamacina 1996; Snook et al. 2003), with 
most of its atoms exposed to the solvent. This is in agreement with a “Bi-Uni-
Uni-Bi ping pong” mechanism (Ordman & Kirkwood, 1977; Ge et al. 2004), 
where the UDP-Glc binds first and the UDP-GlcA is released last, with the 
cofactor molecules being readily reduced and released to the medium, without 
causing major structural changes in the protein domains. Several conserved 
residues in the UDP-glucose/GDP-mannose family are involved in cofactor-
protein interactions. At the beginning of the Rossmann fold a stretch of 30-35 
amino acid residues shows a high degree of similarity, reminiscent of different 
types of dehydrogenases such as alcohol or aldehyde dehydrogenases, being 
denominated as the fingerprint region (Bellamancina 1996). The side-chain of 
Asp30, a conserved residue in this region of the dinucleotide-binding domain, 
establishes hydrogen bonds with the adenine ribose O2 and O3 hydroxyls. Also 
located in the fingerprint region is the glycine-rich consensus sequence, 
GXGXXG, also known as the phosphate-binding loop, where main-chain 
amides hydrogen bond, either directly or via bridging water molecules, to the 
pyrophosphate moiety. Interestingly, conservation in this UGD/GMD family of 
proteins seems to go beyond the three glycine residues, as the fourth position in 
this motif is strictly conserved (Tyr10 in BceC, see below). Another important 
residue interacting with the pyrophosphate moiety is the strictly conserved 
Arg338, located in a !-loop formed by residues 328-340 that includes 5 
internal hydrogen bonds, which was pointed by Campbell as responsible for 
sequestering the reaction intermediates (Campbell et al. 2000). !-loops are 
non-regular secondary structures that account for about one quarter of all 
residues in globular proteins (Leszczymski & Rose, 1986; Fetrow 1995). They 
are characterised by a polypeptide chain that follows a 3D loop-shaped course 
(Leszczymski & Rose, 1986), and although they do not contain repeating 
backbone dihedral angles or regular patterns of hydrogen bonds, they have been 
shown to play significant roles in protein function and stability (Fetrow 1995). 
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3.4.8.  The substrate/product binding pocket 
 
In the substrate-binding pocket, where the reaction product was found, six 
residues are within van der Waals distances to UDP-GlcA, which establishes 
hydrogen bonds with further eleven residues and ten solvent water molecules. 
The UDP moiety is flanked by a coiled stretch comprising residues 259-267. 
The uracyl and Phe259 rings show a !-edge stacking similar to that observed on 
Phe265 and Tyr249, in the homologous proteins from H. sapiens ((Kavanagh et 
al. 2007a), unpublished, PDB entry 2QE3) and S. pyogenes (Campbell et al. 
2000) UGDs, respectively. A list of BceC hydrogen bond interactions in the 
substrate binding pocket is presented in Table 3.3., together with those found in 
the UGD structures of H. sapiens, and in the thoroughly described S. pyogenes 
structure (Campbell et al. 2000). Almost all N or O atoms of the substrate are 
engaged in hydrogen bonding interactions with the enzyme. Main-chain 
interactions are prevalent with uracyl or ribose moieties, while the interactions 
with glucose, usually in multiple hydrogen bonds, occur mainly with residue 
side-chains (Figure 3.7.). Also noteworthy is the higher residue conservation in 
the vicinity of the active site, when compared with the remaining substrate 
binding pocket. Regarding the enzyme interactions with the glucuronate moiety 
one finds Arg254 from the dimer mate extending its side-chain into the 
partner’s active site, in particular with its guanidinium group forming hydrogen 
bonds with the O2’ and O3’ hydroxyls of the sugar. Additionally, the Lys214 "-
amino group forms a hydrogen bond with O4’ and, together with Asn218 side-
chain amide, also hydrogen bonds to O61 of the carboxylic group, which O62 is 
in turn involved in hydrogen bonds with the sulfydryl of catalytic Cys270 and 
further with the hydroxyl of Tyr10 and the carboxylic of Glu154.  
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Table 3.3. Hydrogen bonding interactions within the UGDs substrate’s binding pocket. BceC 
(this structure), H. sapiens (Kavanagh et al. 2007, not published, PDB entry 2Q3E) and S. 
pyogenes (Campbell et al. 2000, PDB entry 1DLJ) UGDs are represented. The substrate is 
divided into uracyl, ribose, diphosphate and glucose/glucuronic acid sections (first column). 
Equivalent atom labels of reaction substrate/product (second column) appear in the residue’s 
rows (columns 3-5) to which they form hydrogen bonds (defined up to 3.2 Å initial cut-off 
distance, but homologous interactions up to 3.4 Å were included). Conserved residues are 
highlighted in bold; residues bridged to the reaction substrate/product via a solvent water 
molecule are presented in italic within parenthesis. Hydrogen-bonding distance values (Å) are 
within parentheses. Contacts with the active cysteine (or its serine mutant) are marked with *. 
 
  BceC H. sapiens UGD S. pyogenes UGD 
O4, O4, O4’ Tyr261_N (3.0) Lys267_N (3.2) Asn251_N (2.9) 
(R401_NE) 
N3 Tyr261_O (3.0) Lys267_O (2.8) Asn251_O (2.9) 
 
U
r
a
c
y
l 
 
O2 (Asn229_ND2) 
Arg431_NH1 (3.2) 
Ser269_OG (2.8) Ser253_OG (2.8) 
O2*, O2C, O2D  
 
(Glu406_OE1, 2) 
Arg442_NH1 (2.9) 
Arg442_NH2 (3.1) 
(Glu416_OE2) 
 
 
Asp402_OXT (2.7) 
R
ib
o
se
 
O3*, O3C, O3D Gly267_N (3.1), 
Phe330_O (3.0) 
Gly273_N (2.9), 
Phe338_O (2.7) 
Gly257_N (2.9), 
Met319_O (2.8) 
O1A (Lys331_NZ) 
 
Lys339_NZ (2.7) 
(Arg260_NH1) 
Lys320_NZ (3.2) 
(Asp402_OD1) 
O2A   Tyr249_OH (2.7) 
O3A Lys331_NZ (3.3) Lys339_NZ (3.2) Lys320_NZ (3.4) 
O1B (Glu158_OE1) 
(Gly267_O) 
(Cys270_N) 
(Phe_271_N) 
 
(Gly273_O) 
 
(Phe277_N) 
(Glu145_OE1) 
(Gly275_O) 
(*Ser260_N) 
(Leu261_N) 
D
ip
h
o
sp
h
a
te
 
 
O2B Glu158_N (3.3) 
Lys331_NZ (2.8)  
Glu165_N (2.9) Glu145_N (2.9), 
Lys320_NZ (2.8) 
O2’ Arg254_NH1 (2.9) Arg260_NH1 (2.8) Arg244_NH1 (3.1) 
O3’ (Phe155_O) 
Arg254_NH2 (2.9) 
(Lys214_NZ) 
(Asn218_OD1) 
Phe162_O (2.7), 
Arg260_NH2 (3.0) 
 
(Asn224_OD1) 
Phe142_O (2.70) 
Arg244_NH2 (3.2) 
(Lys204_NZ) 
(Asn208_OD1) 
O4’ Leu156_O (2.7) 
Lys214_NZ (3.0) 
Leu163_O(2.5) 
Lys220_NZ (3.1) 
Leu143_O(2.6) 
Lys204_NZ,  (3.0) 
O61, O6’, O’P Lys214_NZ (2.8), 
Lys218_ND2 (3.0) 
(Thr121_OG1) 
(Asp274_OD2) 
*Cys270_SG (3.4) 
Lys220_NZ (2.9), 
Lys224_ND2 (2.9) 
(Thr131_OG1) 
(Asp280_OD2) 
*Cys276_SG (3.6) 
Lys204_NZ (2.8) 
Lys208_ND2 (2.9) 
(Thr118_OG1) 
(Asp264_OD2) 
*Ser260_OG (3.4) 
G
lu
c
o
se
 
O62, O’Q Tyr10_OH (2.5) 
Glu154_OE1 (2.6) 
*Cys270_SG (3.2) 
 
N/A 
 
 
*Ser260_OG (2.3) 
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Figure 3.7. The substrate/product binding pocket of BceC. 
Several BceC residues interact via main-chain or water mediated bonds with the UDP-GlcA (by 
analogy the substrate UDP-Glc). However, whilst the sugar crevice shows a myriad of strictly 
conserved residues and hydrogen bonds, including the catalytic amino acids, the pyrophosphate 
and uridine binding pockets show many main-chain or water mediated interactions, hence a 
lower sequence conservation when compared for example, with the co-factor NAD
+
 binding-
pocket. Residues and UDP-GlcA in stick representation coloured as in Figure 3.6. Distances of 
the hydrogen bonds were removed for clarity. For further details see Table 3.3. above. 
 
These two last interactions are not observed either in S. pyogenes or in human 
UGDs. However, these structures were obtained as ternary complexes including 
both reactants, while in the present study no NAD
+ 
could be found. 
Superposition of the three structures shows that the actual side-chain 
conformations of Tyr10 and Glu154 in BceC would produce severe clashes 
with the nicotinamide carboxamide group of NAD
+
, if docked into the enzyme. 
In contrast to the cofactor cleft, the substrate-binding pocket is buried deeper in 
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the protein, requiring protein structural changes for access and release of 
reactant and product. The side-chain of Lys331, a conserved residue belonging 
to the !-loop, hydrogen bonds with O3A atom of the pyrophosphate moiety. As 
described above, the !-loop includes another strictly conserved residue, 
Arg338, which by analogy with the H. sapiens or S. pyogenes structures should 
interact with the pyrophosphate from NAD
+
. The two salt bridges with both 
reactants are thought to ensure the loop’s “closed” conformation, whereby 
substrate intermediates are locked in place during the different reaction steps. 
The O1B atom of the pyrophosphate is hydrogen bonded to a solvent water 
molecule that in turn forms several hydrogen bonds in the immediate vicinity of 
the catalytic site, namely with main-chain amide from Gly268, Cys270 and 
Phe271, and thus helps to set the catalytic positioning of substrate and Cys270.  
One aim of this study was to accomplish a detailed comparison of human and 
BceC structures in order to explore potential medicinal applications. However 
the substrate binding pockets of both proteins revealed to be too similar for the 
design of a potentially selective inhibitor. 
 
3.4.9. The UDP/GMD-6-dehydrogenase catalytic mechanism 
 
The alcohol to carboxylic acid transformation catalysed by the UGD/GMD 
family involves a four electrons oxidation of the pyranose C6 atom, and 
corresponds to a global replacement of methylene by an acyl group. The 
reaction includes two successive steps of hydride transfer to NAD
+ 
and a final 
hydrolysis of a thioester intermediate, which allows the incorporation of a 
second oxygen atom into C6. The elucidation of the reaction mechanism (see 
Figure 3.11.) has been successively fine-tuned since the early scheme proposed 
by Campbell and co-workers for S. pyogenes UGD (Campbell et al. 1997; Ge et 
al. 1998; Campbell & Tanner 1999; Easley et al. 2007). By analogy with the 
mechanism described by Easley and collaborators, the reaction in BceC is 
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initiated by the activation of a structural water molecule (Ge et al. 2004; Easley 
et al. 2007). The water is deprotonated by the carboxylate group of Asp274, to 
which it is hydrogen bonded. The general base capacity of Asp274 is enhanced 
by the close proximity of the !-amino group of Lys273 (at hydrogen bonding 
distance) (Sommer et al. 2004). As both Asp274 carboxylate and Lys273 !-
amino groups are solvent accessible, they may function as an exit route for the 
two protons that will be extracted from UDP-Glc during the overall reaction. 
The generated hydroxide is kept in place by a hydrogen bond with the side-
chain of Thr121 (Ge et al. 2004), whose positioning is assured by hydrogen 
bonds with Ser120 and Pro123 residues. Upon deprotonation of the UDP-Glc 
hydroxyl at O6 position by the hydroxide, the intermediate oxyanion is 
stabilised by electrostatic interactions with the nearby !-amino group of Lys214 
at hydrogen bonding distance (Campbell et al. 2000), until a first hydride at C6 
is transferred to NAD
+
. The resulting aldehyde intermediate (Campbell et al. 
1997) remains sequestered by the enzyme (Nelsestuen & Kirkwood 1971; Ge et 
al. 2004). With the increase of the C6 oxidation state it becomes susceptible to 
nucleophilic attack, due to the electron withdrawing effect of the now double 
bonded oxygen. The catalytic water/hydroxide is also neighboring the sulfydryl 
group of Cys270 and thus may also extract its proton. The formed nucleophilic 
thiolate readily attacks the acyl C6 leading to the formation of a covalently 
bonded thiohemiacetal intermediate (Ge et al. 2004; Sommer et al. 2004; 
Chaikuad et al. 2009, not published). The resulting oxyanion is stabilised once 
more by electrostatic interactions with the nearby !-amino group of Lys214 
(Campbell et al. 2000) until transfer of the second hydride at C6 to a freshly 
docked NAD
+
, and the global oxidation of C6 is accomplished with the 
thioester formation. The final hydrolysis step involves a second nucleophilic 
attack to C6, most likely by the catalytic water/hydroxyl, which will disrupt the 
sulfur-carbon bond and generate the final carboxylic group at C6. This is the 
rate-limiting step of the reaction (Ordman & Kirkwood 1997) and requires the 
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stabilisation of the forming thiolate. However, as the !-amino group of Lys214 
is located at the opposite side of C6, it is too far away to be invoked for 
catalysis, and the relevant catalytic agent has until now remained elusive. 
 
3.4.10. UGD/GMDs final hydrolysis step is catalysed by the 
conserved Y of their GXGYXG motif 
 
Sequence alignment within the UDP-Glucose and GDP-Mannose 
dehydrogenase family (Granja et al. 2007) shows the conservation of a tyrosine 
residue (Figure 3.8.) at the second “X” position of the Rossmann fold glycine 
rich motif (Bellamacina, 1996).  
 
 
 
 
 
 
 
 
 
 
Figure 3.8. The conserved tyrosine residue at the Rossmann fold phosphate-binding motif. 
A 3D superposition of UGD structures shows that the side-chain of Tyr10 (BceC residue 
numbering) populates a variety of Chi1 torsional conformations. Noteworthy, only for the BceC 
and P. gingivalis UGD structures does Tyr10 assume a gauche (+) conformation. This 
conformation is not possible for the other structures, because they all contain a ligand in the 
cofactor-binding pocket, which would imply severe clashes with such a Tyr conformation. 
UGDs colouring scheme as follows (PDB entries within parentheses): BceC in dark green; S. 
elodea UgdG in orange (Rocha et al. 2009a); S. pyogenes in blue (1DLI); C. elegans UGD in 
yellow (2O3J); H. sapiens UGD in red (2QE3); and P. gingivalis UGD (3GG2) in light green. 
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In the native BceC structure the hydroxyl group of the conserved tyrosine 
residue establishes a hydrogen bond with the carboxylic group of UDP-GlcA 
similarly to that found in P.gingivalis UGD (PDB code 3GG2; Bonnano et al. 
2009, not published). We proceeded to carry out mutagenesis studies on BceC 
whereby the Tyr10 residue was mutated into a phenylalanine, a serine or a 
lysine and followed their activity under saturating concentrations of substrate 
and cofactor at pH 8.7 (see section 3.3.3.). The mutants show severely impaired 
activity (Figure 3.9.) although a latent activity was nevertheless detected. 
Interestingly, while studying B. subtilis UGD, Mijakovic and co-workers have 
also pointed out Y10 as critically important, as the Y10F mutation on this UGD 
led to an accentuated decrease in the enzyme activity (Mijakovic et al. 2004).  
 
 
 
 
 
 
 
 
 
Figure 3.9. Graphical representation of the native and Y10 BceC mutant’s activity.  
The UDP-glucose dehydrogenase activity was measured as the conversion of NAD
+
 to NADH, 
in the presence of saturating conditions of substrate and cofactor and plotted as the mean ± 
standard deviation of three independent determinations.  
 
Comparison of BceC with the Y10S/K mutant three-dimensional structures 
shows no differences apart from the referred mutation (Figure 3.10.). In BceC, 
the hydroxyl group of Tyr10 is involved in hydrogen bonds with the 
carboxylate of UDP-GlcA, two water molecules and the thiol group of Cys270. 
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Figure 3.10. Structures of native BceC and its mutants Y10K and Y10S. 
(a) In native BceC Tyr10 hydroxyl is involved in a hydrogen bond with the UDP-GlcA 
carboxylate; (b) In the Y10K mutant a salt bridge is formed between the Lys10 !-amino group 
and UDP-GlcA; (c) In the Y10S mutant two solvent water molecules are involved in a 
hydrogen bonding network between Ser10 O! and UDP-GlcA carboxylate. Residues are in stick 
representation coloured yellow for carbon, blue for nitrogen, red for oxygen and orange for 
phosphorus atoms. Electron density 2mFo – DFc maps represented in blue mesh contoured at 
1.0". Hydrogen bonds depicted in dashed black lines with corresponding distances in Å.   
 
The pratical loss of activity upon Tyr10 mutations implies that Tyr10 is 
involved in the final hydrolysis step of the enzymatic mechanism, as it is well 
positioned to function as stabiliser of the thiolate leaving group, after the 
nucleophilic attack by the catalytic hydroxide to acyl C6 of the thioester 
intermediate. 
(a) (b) 
(c) 
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Figure 3.11. Mechanism of BceC enzymatic conversion of UDP-Glc to UDP-GlcA.  
By analogy with the mechanistic characterisation in S. pyogenes and human UGDs, successive 
deprotonations of the catalytic water initiate the processes leading to two hydride transfers from 
methylene C6 of UDP-Glc, generating aldehyde and thioester intermediates. That catalytic 
water is also proprerly positioned to perform a nucleophilic attack to the thioester. Tyr10, 
located at the opposite side relative to the acyl group, functions as a proton conveyer from the 
aqueous media to the forming thiolate, thus catalysing the hydrolysis of the thioester with 
formation of UDP-glucuronic acid (insert). The active and passive residues in each step of the 
catalytic mechanism are highlighted in black and grey, respectively. 
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Tyr10 may therefore work as a proton conveyer from the aqueous hydrogen 
bonding proton-wire system to the forming thiolate (see Figure 3.11. above). 
All three mutants lack this capacity at residue 10. In Y10F there is no hydroxyl 
group. In Y10S an O! hydroxyl exists, but the side-chain is too short for an 
effective proton transfer to thiolate. In Y10K at biological pH the "-amino 
group is in the protonated ammonium form, and therefore there is no electron 
doublet free to convey protons from the aqueous media to the forming thiolate. 
In spite of their similar pKa’s (above 10) tyrosine and lysine show contrasting 
catalytic capacities, because the conveyance of aqueous protons by tyrosine is 
not dependent upon its general acid-base properties – due to the two hydrogen 
bonded water molecules a proton always remains attached to the Tyr10 
hydroxyl, throughout the catalytic process.  
 
3.5. Acknowledgements  
 
The authors would like to thank the staff at ESRF in Grenoble, for the use of 
synchrotron radiation. Joana Rocha (JR) acknowledges the PhD fellowship 
SFRH/BD/24216/2005, from Fundação para a Ciência e Tecnologia (FCT). 
Alma Popescu (AP) at Instituto Superior Técnico (IST) did the cloning of 
native BceC and y10f_bceC genes. JR, following AP experience and protocols, 
performed the cloning of the y10k_bceC and y10s_bceC mutants, and the three 
proteins expression and purification, as well as the crystallisation, data 
collection, phase determination, structural solution and analysis.  
This work was funded by FCT grants POCTI/BME/38859/2001, 
POCI/BIO/58401/2004 and PTDC/QI/67925/23006.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UDP-glucose 
dehydrogenase from 
Sphingomonas elodea 
ATCC 31461 (UgdG) 
  
UDP-glucose dehydrogenase from S. elodea ATCC 31461 (UgdG) 
 
 
Page 91 
4. Cloning, expression, purification, crystallisation and 
preliminary crystallographic studies of UgdG, an UDP-
glucose dehydrogenase from Sphingomonas elodea 
ATCC 31461  
 
The work described here is based on the published refereed paper but now including a 
more detailed description of the materials and methods, as well as new figures. 
Reference: Rocha, J.; Granja, A. T.; Sá-Correia, I. Fialho, A. and Frazão, C. (2010a) 
“Cloning, expression, purification, crystallisation and preliminary crystallographic 
studies of UgdG, an UDP-glucose dehydrogenase from Sphingomonas elodea ATCC 
31461”. Acta Crystallographica F66, 69-72. 
 
4.1. Abstract 
 
Gellan gum, a commercial gelling agent produced by Sphingomonas elodea 
ATCC 31461, is a high-value exopolysaccharide (EPS). UDP-glucose 
dehydrogenase (UGD; EC 1.1.1.22) is responsible for the NAD dependent 
twofold oxidation of UDP-glucose into UDP-glucuronic acid, one of the key 
components for gellan biosynthesis.  
S. elodea ATCC 31461 UGD, termed UgdG, was cloned, expressed, purified 
and crystallised in both native and SeMet derivatised forms, in hexagonal and 
tetragonal space groups, and diffracting X-rays up to 2.40 and 3.40 Å 
resolution, respectively. Experimental phases were obtained for the tetragonal 
SeMet derivatised crystal form from a single anomalous dispersion (SAD) 
experiment. This structure was successfully used as a molecular replacement 
probe for the hexagonal crystal form of the native protein. 
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4.2. Introduction 
 
Bacterial exopolysaccharides (EPS) are biotechnology products of high interest 
due to their rheological properties. This is the case of gellan gum; a 
multifunctional gelling agent produced in high yields by the non-pathogenic 
bacteria strain Sphingomonas elodea ATCC 31461. It has approval in the US 
and EU for food use as a gelling, stabilizing and suspending agent, either alone 
or in combination with other hydrocolloids. In its native form, gellan is a linear 
high molecular weight anionic EPS based on a tetrasaccharide repeat unit 
composed of two molecules of D-glucose, one of L-rhamnose and one of D-
glucuronic acid. The native gellan is partially esterified with acyl substituents (1 
mole of glycerate and 0.5 mol of acetate) per repeat unit (Jay et al. 1998). 
Gellan and gellan-like polymers have unique characteristics and find many 
applications, particularly in the food, pharmaceutical and biomedical fields (Sá-
Correia et al. 2002; Fialho et al. 2008). Due to the broadness of its commercial 
applications, the biosynthetic pathway leading to the production of gellan has 
gained a significant amount of interest (Aragão et al. 2007, Sá-Correia et al. 
2002). Gellan gum biosynthesis is a multi-step process that starts with the 
production of nucleotide-sugar precursors uridine-5'-diphosphoglucose (UDP-
glucose or UDP-Glc), UDP-glucuronic acid (UDP-GlcA) and deoxythymidine-
diphospho-L-rhamnose (dTDP-L-Rha), followed by formation of the 
tetrasaccahride repeating unit, gellan polymerisation and export (Moreira et al. 
2004;  Fialho et al. 2008). Three gene clusters necessary for gellan production 
have been described (Harding et al. 2004) but interestingly, genes encoding the 
enzymes for the UDP-Glc and UDP-GlcA synthesis (pgmG, ugpG and ugdG) 
are located at different positions of the S. elodea genome, perhaps indicating a 
broader function of these enzymes (Harding et al. 2004, Silva et al. 2005, 
Granja et al. 2007; Aragão et al. 2007). The identification of key genes like 
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those mentioned above, and the elucidation of the crucial steps in the gellan 
pathway indicate that possibilities now exist for exerting control in gellan 
production by acting, for example, on the expression levels/activity of these 
genes/enzymes. Our interest in the S. elodea ATCC 31461 UDP-glucose 
dehydrogenase, termed UgdG (EC 1.1.1.22), derives from its crucial role in 
providing UDP-GlcA, one of the precursors for gellan biosynthesis. In this 
work we report the crystallisation and phase problem determination of UgdG 
from S. elodea ATCC 31461. 
 
4.3. Materials and Methods 
 
4.3.1. Cloning and Expression of native and SeMet derivatised 
UgdG 
 
The complete sequence of the ugdG gene from S. elodea ATCC 31461 was 
amplified by polymerase chain reaction (PCR; Granja et al. 2007) using the 
cosmid pCG8 as the template DNA, Pwo DNA polymerase (Roche Diagnostics, 
Mannheim, Germany), and the oligonucleotides UGD1 (5’-
AAAGGATCCGTGCGCATTGCGATG-3’) and UGD2 (5’-
AAAAAGCTTTCAGTCGCGGCTCG-3’), which were designed based on the 
ugdG nucleotide sequence. The PCR product (1,320 bp) was digested with 
BamHI and HindIII (recognition sites underlined in the primers used) and 
cloned into the vector pWH844 (Schirmer et al., 1997), generating pUgdG. 
This plasmid carries the ugdG gene preceded by a sequence coding for six 
histidine residues present for purification purposes. The DNA insert cloned in 
pUgdG was sequenced to confirm the fidelity of DNA amplification. Over-
expression of the ugdG gene was carried out by cultivation of Escherichia coli 
BL21 transformants harbouring the plasmid pUgdG in 600ml LB medium 
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supplemented with 100 µg!ml-1 of ampicillin at 310 K, until an OD600nm of 0.6 
was reached. Expression was then induced with 0.3mM isopropyl !-D-
thiogalactoside (IPTG) for 3 h, harvested by centrifugation (10 000 g, 30 min, 
277 K) and the obtained pellets stored at 253 K. For the production of the 
SeMet-UgdG derivatised protein (Molecular Dimensions protocol), methionine-
auxotrophic strain E. coli B834 (DE3) carrying pUgdG was cultivated in       
600 ml of LB medium (supplemented with 100 µg!ml-1 of ampicillin) at 310 K, 
until an OD600nm of 0.6 was reached. Cells were harvested by centrifugation   
(10 000 g, 10 min, 277 K) and gently resuspended in SelenoMet Medium Base 
(Molecular Dimensions, UK). This process was repeated three times to remove 
any traces of LB medium containing methionine. Finally, cells were 
resuspended in SelenoMet medium and 250x concentrated seleno-methionine 
solution was added (Molecular Dimensions, UK). Induction occurred for 3 h 
after the addition of 0.3 mM IPTG, and cells were harvested by centrifugation 
(10 000 g, 30 min, 277 K). The supernatant was discarded and the pellet stored 
at 253 K. 
 
4.3.2. Purification of native and SeMet derivatised UgdG 
 
The following purification protocol was used for both the native and SeMet 
derivative UgdG proteins. Cells were resuspended in 20 mM phosphate pH 7.4,  
20 mM imidazole, 1 M NaCl and disrupted in a French press.  
Crude cell extract was obtained by centrifugation (27 000 g for 40 min at      
277 K), and the supernatant applied onto a 5 ml HisTrap column (GE 
Healthcare) pre-equilibrated with 20 mM phosphate pH 7.4, 20 mM imidazole 
and 1 M NaCl, connected to an ÄKTA Explorer Instrument (GE Healthcare) 
according to the manufacturer's recommendation. 
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Imidazole Gradient 
(up to 500 mM) 
Buffer A (wash): 
20 mM phosphate pH 7.4 
1M sodium chloride 
20 mM Imidazole 
 Buffer B (elution): 
20 mM phosphate pH 7.4 
1M sodium chloride 
500 mM Imidazole 
 
(b) Imidazole Gradient 
(upto 500 mM) 
Buffer A (wash): 
20 mM phosphate pH 7.4 
1M sodium chloride 
20 mM Imidazole 
 
Buffer B (elution): 
20 mM phosphate pH 7.4 
1M sodium chloride 
500 mM Imidazole 
 
(a) 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. The purification of the native and SeMet derivatised UgdG.  
(a) Affinity chromatogram for the purification of the His-tagged native UgdG protein. (b) 
Affinity chromatogram for the purification of the His-tagged SeMet derivatised UgdG. Protein 
detected by UV absorbance (mAU) at 280nm and 254 nm (y coordinates; blue and red lines). 
UgdG elutes almost pure in a symmetrical peak at approximately 250 mM of imidazole 
concentration (green line). The experimental conditions were the same for both protein forms. 
 
The column was washed with buffer A (20 mM phosphate pH 7.4, 20 mM 
imidazole, 1 M NaCl) to remove any unbound protein, and a gradient of 
imidazole 20-500 mM was applied. His6-UgdG recombinant protein was eluted 
at approximately 250 mM imidazole in a symmetrical chromatography peak 
(see above Figure 4.1.a). Imidazole was removed from the eluted fractions of 
the UgdG protein, replacing the buffer with 25mM Tris-HCl pH 8.3, 50 mM 
NaCl, 2.5 mM dithiothreitol (DTT) supplemented with 1 mM of oxidised 
nicotinamide adenine dinucleotide (NAD+), or 0.5 mM UDP-GlcA and 1 mM 
NAD+, using a PD10 desalting column (GE Healthcare). In the case of SeMet-
UgdG derivatised protein, the eluted fractions were pooled together and buffer-
exchanged with 25 mM Tris-HCl pH 8.3, 50 mM NaCl, 2.5 mM DTT and 1 mM 
NAD+, using a PD10 desalting column (GE Healthcare; see Figure 4.1. b).  
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Figure 4.2. SDS-Page analysis for the purifications of native and SeMet derivatised UgdG.  
(a) SDS-Page gel for the purification of the His-tagged native UgdG using Coomassie blue 
staining. The protein migrates as a single polypeptide with an estimated molecular mass of 
approximately 48.5 kDa (47.2 kDa of native protein plus 1.3 kDa of His6-tag). Legend: 1. Wide 
range Sigma Marker; 2-8. Native UgdG eluted fractions; 9. Soluble fraction; 10: Low range 
Sigma Marker. (b) SDS-Page gel for the purification of the His-tagged SeMet derivatised UgdG 
using Coomassie blue staining. The protein migrates to a slightly higher molecular weight than 
the native UgdG due to the Selenium atoms. Legend: 1. Wide range Sigma Marker; 2-11. 
SeMet derivatised UgdG eluted fractions. Fractions of both UgdG forms were pooled, buffer 
exchanged and concentrated up 10 mg!ml-1 and 5.5 mg!ml-1 for native and derivative, 
respectively. 
 
Both UgdG native protein and SeMet-UgdG derivative protein were 
concentrated in Vivapore 10/20 concentrators (Vivascience Ltd, UK) to          
4.5 mg!ml-1 and 5.5 mg!ml-1 respectively, before storage at 193 K. The 
composition and purity of both proteins were confirmed to be homogenous by 
SDS-polyacrylamide gel electrophoresis (see Figure 4.2. above). The 
derivatised protein migrates to a slightly higher molecular weight due to the 
presence of selenium methionines that substitute the sulphur methionines of 
native UgdG. Protein concentration was determined by Bradford's method 
(Bradford, 1976) and by measurement of absorbance at 280 nm in a NanoDrop 
ND-1000 Spectrophotometer using an extinction coefficient of 18490 M-1!cm-1. 
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4.3.3. Crystallisation of native and SeMet derivatised UgdG 
 
An initial crystallisation screen of native UgdG in the presence of NAD+ was 
performed in batch mode on an Oryx6 crystallisation robot (Douglas 
Instruments), using 96 solutions from the Classic Screen from Qiagen Canada 
Inc. (Montreal, Canada). Drops consisting of 0.5 µl of protein solution at               
4.5 mg!ml-1 in 25 mM Tris-HCl pH 8.3, 50 mM NaCl, 2.5 mM DTT and 1 mM 
NAD+ plus 0.5 µl of precipitant solution were left equilibrating at 293 K under 
paraffin oil. Crystals formed within 24 hours for conditions H5 (200 mM 
Li2SO4, 100 mM Tris-HCl pH 8.5 and 30% (w/v) PEG 4K) and A7 (100 mM 
Na-citrate pH 5.6, 20% (v/v) isopropanol and 20% (w/v) PEG 4K). Crystals 
appearing in condition H5 had dimensions up to 0.3, 0.15, 0.01 mm (thin 
plates), but could not be reproduced. Other, mostly hexagonal shaped prismatic 
crystals appeared in condition A7, were reproducible and could be further 
optimised (Figure 4.3. a) adding 50 mM sodium fluoride as additive to the 
mother liquor. Cryoprotection of these crystals was achieved by passing 
crystals through a solution of their mother liquor supplemented with 25% (v/v) 
glycerol. Crystallisation screens on the SeMet derivatised protein were 
performed using a "Honeybee" Microsys 4000 XL Cartesian™ Dispensing 
Systems robot (Genomic Solutions, USA) using the vapour-diffusion method. 
Drops consisting of 100 nl of 5.5 mg!ml-1 protein solution in 25 mM Tris-HCl 
pH 8.3, 50 mM NaCl, 2.5 mM DTT, 1 mM NAD+ and 100 nl of precipitant 
solution were equilibrated against 100 µl of 672 conditions of precipitant 
solutions from the crystallisation screens Classics, PEG, MbClass, MbClass II, 
pHClear, pHClear II and MPD screens from Qiagen Canada Inc. (Montreal, 
Canada). Crystalline precipitate was found in several conditions from different 
screens. From those, solution A7 from PEG screen (100 mM MES pH 6.5 and 
40% (v/v) PEG 200) produced the most promising crystallites.  
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Upon optimisation, octahedral-like crystals appeared within 24-48 h, and grew 
to approximate dimensions of 0.05, 0.05, 0.08 mm (Figure 4.3. b) in drops also 
containing other precipitated material.  
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Crystals of native and SeMet derivatised UgdG.  
(a) Native UgdG in hexagonal space-group (dimensions ca. 0.04, 0.04 and 0.06 mm). (b) 
SeMet-UgdG derivative crystal in tetragonal space-group (crystal dimensions ca. 0.05, 0.05 and 
0.08 mm). 
 
Crystals had to be “washed” with mother liquor to remove this precipitate prior 
to cryoprotection, which was achieved by quick soaking in mother liquor 
augmented with 20% (v/v) PEG 400. Crystals were then flash cooled and stored 
in liquid nitrogen for diffraction data collection.  
 
4.3.4. X-ray diffraction analysis and phase problem solution 
 
Cryoprotected crystals under a nitrogen stream at 100 K were measured using 
the European Synchrotron Radiation Facility (ESRF), (Grenoble, France), at 
stations ID23-1 (UgdG) and ID14-3 (SeMet-UgdG). The diffraction images 
from native protein crystals (Figure 4.4.a) were processed with MOSFLM (Leslie 
1992) and the corresponding intensities were scaled and merged together using 
(a) (b) 
0.05mm 0.05mm 
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SCALA (Evans 2006) from the CCP4 suite (The CCP4 suite: programs for 
protein crystallography, 1994).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. X-ray diffraction images for Sphingomonas elodea UgdG. 
(a) Image for native UgdG; (b) Image for UgdG SeMet derivatised form. Data sets were 
collected at the ESRF beamlines ID23-1 and ID14-3 for native and SeMet derivatised UgdG 
crystals, respectively. UgdG native crystals diffracted to 2.4 Å resolution, whilst the Se 
derivatives diffracted only to 3.4 Å resolution. 
 
The diffraction images of the SeMet derivatised protein (Figure 4.4.b) were 
integrated with DENZO, and intensities were scaled and merged together with 
SCALEPACK (Otwinowski & Minor 1997). Final magnitudes from both crystals 
were calculated with TRUNCATE (French & Wilson 1978). Crystallographic data 
and processing statistics are presented in Table 4.1. 
 
 
 
 
 
 
(a) (b) 
Doctoral Thesis by Joana Rocha (2010)  
 
 
Page 100 
Table 4.1. Crystal and diffraction data statistics for the native and SeMet derivatised UgdG. 
crystals. 
 
UgdG crystal Native SeMet Derivative 
ESRF Beamline ID23-1 ID14-3 
Wavelength (Å) 1.074 0.931 
Resolution (Å) 45.98–2.40 (2.53–2.40) 48.76–3.40 (3.52–3.40) 
Space-group P622 P43212 
a = b (Å) 167.4 109.0 
c (Å) 84.3 175.8 
No. reflections 335219 (48456) 197981 (12797) 
No. unique 27740  (3957) 15086 (1444) 
Redundancy 12.1 (12.2) 13.1 (13.5) 
(I/!(I)) 5.2 (1.7) 25.1 (3.8) 
Rpim
a 0.029 (0.129) 0.023 (0.204) 
Rrim
b 0.102 (0.460) 0.085 (0.763) 
Rsym
 c 0.098 (0.441) 0.082 (0.729) 
Ranom
d N/A 0.038 (0.189) 
Completeness (%) 100.0 (100.0) 99.2 (99.5) 
Mosaicity (º) 0.28 0.65 
VM (Å
3Da-1) 3.62 2.65 
Solvent content 0.66 0.53 
No. of molecules in a.u. 1 2 
Wilson B (Å2) 44.4 85.0 
 
Data within parentheses refer to outer resolution shells. aRpim = "h [1/(N-1)]
1/2 "i |Ii(h) - <I(h) >| / "h "i Ii 
(h), where N is the data redundancy, I is the observed intensity and <I> is the average intensity of multiple 
observations from symmetry-related reflections. It is an indicator of the precision of the final merged and 
averaged data set (Weiss 2001). bRrim = Rmeas = ! h ["/("#1)]
1/2 ! i |Ii(h) - <I(h)>| / ! h ! i Ii (h), where N is 
the data redundancy, I is the observed intensity and <I> is the average intensity of multiple observations of 
symmetry-related reflections.  It is an indicator of the average spread of the individual measurements 
(Weiss 2001). cRsym = "h "i |Ii(h) - <I(h)> / | "h "i Ii (h), where I is the observed intensity and <I> is the 
average intensity of multiple observations from symmetry-related reflections. dRanom = "h |I(h) - I(#) / | "h I 
(h), expresses the magnitude of the anomalous signal. 
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Assuming two molecules in the a.u. and according to the resolution dependent 
distribution of the Matthews coefficient, the tetragonal form of S. elodea UgdG 
crystal has a calculated solvent content of 53 % and a VM of 2.65 Å
3Da-1 with 
an estimated probability of 89 % (Matthews 1968; Kantardjieff & Rupp 2003). 
Initial attempts to obtain phases by molecular replacement using the, at the 
time, available UGD model from Streptococcus pyogenes (PDB entry 1DLJ 
(Campbell et al. 2000), with a sequence identity against UgdG of 23 %) were 
unsuccessful. Single anomalous dispersion (SAD) phasing was thus used with 
the diffraction data from the S. elodea UgdG seleno-methionine derivatised 
tetragonal crystal form. The automated protocol of SOLVE (Terwilliger 2004) 
located 18 selenium sites, as expected from two molecules in the a.u., and 
calculated initial experimental phases and electron density maps. The selenium 
atom sub-structure allowed the determination of the NCS operator within the 
a.u., which programs DM (Cowtan & Main 1998) and RESOLVE (Terwilliger 
2004) used to improve the experimental phases via NCS averaging of the 
electron density, up to a figure of merit of 0.83. RESOLVE (Terwilliger 2004) 
and FFEAR (Cowtan 1998) were further used to localise protein chain 
fragments, mainly as poly-Ala chains. Their inspection with Xfit (McRee 1999) 
on a stereo-graphics workstation taking into account the NCS operator, allowed 
their two-fold degeneracy to be resolved and an initial model of S. elodea UgdG 
monomer, with 346 out of 438 residues (albeit including 318 poly-Ala 
residues), was accordingly produced (Figure 4.5.). Molecular replacement was 
attempted once more on the 2.4 Å native data, but this time using the 
preliminary UgdG monomeric model derived from the Se-methionine data as 
search probe. PHASER (McCoy et al. 2005) was successful and located the 
monomer position in the hexagonal a.u. (final z-scores of RFZ = 3.5 and TFZ = 
9.1). The validity was corroborated by examination of omit maps (Figure 4.5.). 
The model completion and structural refinement of the UDP-glucose 
dehydrogenase from S. elodea ATCC 31461 is in progress. 
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Figure 4.5. Electron density map sections showing a helical motif of S. elodea native and SeMet 
derivatised UgdG.  
(a) Experimental SeMet derivative !A map (Read, 1986) obtained by RESOLVE (Terwilliger 
2004) after a two-fold NCS averaging at 3.4 Å resolution, and contoured at 2! (dark blue 
mesh); (b) Molecular replacement solution by PHASER (McCoy et al. 2005), after a !A omit map 
(Read 1986) calculation, at 2.4 Å resolution and contoured at 1.5! (dark blue mesh). Four 
residues of the helical motif were omitted from the model in the map calculation using 
REFMAC5 (Murshudov et al. 1997). Bonds in stick representation, with carbons in yellow, 
nitrogen in blue and oxygen in red.  
 
4.4. Results  
 
Uridine-diphospho-glucose dehydrogenase from Sphingomonas elodea ATCC 
31461 was cloned and expressed. Extensive crystallisation screens were 
performed in order to address the phase problem. Well diffracting hexagonal-
shaped crystals were obtained and diffraction data were collected and 
characterised. The best diffracting crystal belongs to the hexagonal space group 
P622 and diffracted up to 2.4 Å resolution. The phase problem was solved by 
single anomalous dispersion (SAD) using the SeMet derivatised protein. The 
UgdG SeMet crystals diffracted up to 3.4 Å resolution and belong to the 
tetragonal P43212 space group, with a dimer in the asymmetric unit. The native 
crystal contains one molecule of UgdG in the asymmetric unit, but the dimeric 
(a) (b) 
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protein can be generated by the crystal’s symmetry, corroborating the 
experimental results obtained in solution with other biochemical techniques 
indicating that UgdG is a dimeric protein under physiological conditions. 
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5. The three dimensional structure of the Sphingomonas 
elodea ATCC 31461 Uridine-5’-diphosphoglucose 
dehydrogenase (UgdG) 
 
The work described in the following sections is based on paper prepared for 
submission to a referee evaluated journal but now including a more detailed 
description of the materials and methods, as well as new figures and results. 
Reference: Rocha, J.; Fialho, A.; Sá-Correia, I. and Frazão, C. “The three dimensional 
structure of the Sphingomonas elodea ATCC 31461 Uridine-5’-diphosphoglucose 
dehydrogenase (UgdG) (2010d). 
 
5.1. Abstract 
 
Gellan is an exopolysaccharide (EPS) produced by the non-pathogenic 
bacterium Sphingomonas elodea ATCC 31461, which is used on a wide range 
of biotechnological applications. Uridine-5'-diphosphoglucose dehydrogenase 
(UGD) is the enzyme responsible for the NAD-dependent two fold oxidation of 
UDP-glucose (UDP-Glc) to UDP-glucuronic acid (UDP-GlcA), which is a key 
step in gellan gum biosynthesis. UDP-GlcA is the precursor for the glucuronate 
moiety that constitutes this EPS. Here we report the X-ray crystal structure of S. 
elodea ATCC 31461 UGD, termed UgdG, in complex with its cofactor 
NAD(H). UgdG exhibits two dinucleotide binding Rossmann fold domains at 
the N- and C-terminal regions connected by a 4-helical bundle subdomain, 
responsible for homodimerisation and where the active site and catalytic 
residues are located. Its structural comparison with the available UGDs shows a 
strong conservation, both in primary and tertiary structures. A phyletic analysis 
based on the 3D structures shows that prokaryotic UGDs split into two distinct 
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groups, with UgdG belonging to group I, which is closely related to the 
eukaryotic members. 
 
5.2. Introduction 
 
The increased demand for natural polymers for various industrial applications 
in recent years has led to a renewed interest in exopolysaccharide  (EPS) 
production by microorganisms (Chi & Fang, 2005; Kumar et al. 2007). Many 
gram-negative bacteria synthetise and secrete extracellular polymers which may 
have diverse biological roles, such as virulence factors in plant and animal 
pathogens, signalling molecules in bacteria-plant interactions and protection 
against predation (from protozoans) or osmosis (Sutherland 2001). 
Interestingly, some of these bacterial polymers are potential or already accepted 
products of biotechnology (Sá-Correia et al. 2002), which are gradually proving 
economically at par with natural gums produced by algae and plants. In effect, 
the advantages of microbial EPS over plants or marine microalgae 
polysaccharides are their novel functions, constant chemical and physical 
properties and stable supply (Sutherland 1997; Broadbent et al. 2003; Chi & 
Fang 2005). Gellan is a high molecular weight EPS produced in high yields by 
the non-pathogenic bacterium Sphingomonas elodea ATCC 31461, formerly 
known as Pseudomonas elodea (Harding et al. 2004; Silva et al. 2005). The 
polymer is composed of a tetrasaccharide repeating unit containing two 
molecules of D-glucose, one of L-rhamnose and one of D-glucuronic acid. In the 
native form, it has also O-acetyl and L-glyceryl substituents in one of the D-
glucose monomers (Sá-Correia et al. 2002). The rheological properties of gellan 
vary considerably with several external factors such as temperature or the 
presence of cations in solution, but more importantly, the degree of acetylation 
of the polymer. Chemical deacylation of gellan causes the conversion of a soft, 
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elastic and thermoreversible gel to a harder, firm and brittle gel (Sutherland 
1997; Jay et al. 1998). When compared to other polysaccharides, gellan 
presents several advantages such as excellent thermal and acid stability, 
adjustable elasticity and rigidity; high transparency and good flavor release 
(Fialho et al. 2008).  
Due to these characteristics, gellan has been used in different biotechnological 
applications ranging from bioremediation to food industry applications. Also 
known as the food additive code E418, gellan is being used as a gelling, 
stabilising and suspending agent in dessert gels, icings, sauces, puddings and 
microwavable food, but also in several personal care products, such as lotions, 
creams and toothpaste (Sutherland 2001). In the biomedical field, gellan also 
found its place being used as an excipient for nasal, ocular, gastric and colonic 
drug delivery (Jansson et al. 2005). It has also proved to be a suitable material 
for the construction of 3D scaffolds for tissue engineering as well as a substitute 
for agar in bacterial and plant tissue culture media (Ciardelli et al. 2005; Smith 
et al. 2007). Regarding the environmental field, gellan is used in the 
degradation of gasoline or for the encapsulation of bacteria for bioaugmentation 
of contaminated aquifers (Moslemy et al. 2003; Moslemy et al. 2004). It is one 
of the few bacterial gums with gelling properties. There are approximately 900 
worldwide patents over the applications of gellan, with the number increasing 
each year, suggesting that gellan has an attractive commercial market as it is 
proving to be one of the most important commercialised bacterial 
exopolysaccharides. The characterisation of the gellan biosynthetic genes and 
the genetic engineering of the pathway, together with the comparison of the 
yield and the properties of the polymers produced, are therefore of great 
importance, and will allow the understanding of crucial aspects in the regulation 
as well as the major bottlenecks of the gellan metabollic pathway (Fialho et al. 
2008). The metabolic pathway of gellan production is a multi-step process that 
initiates with the intracellular formation of the nucleotide sugar-precursors, 
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followed by the formation of the repeating unit and ultimately, gellan 
polymerisation and export (Sá-Correia et al. 2002; Harding et al. 2004).  
One of the enzymes involved in this complex process is uridine-diphospho-
glucose dehydrogenase (UGD; EC 1.1.1.22), which catalyses the NAD-
dependent two fold oxidation of UDP-Glc to UDP-GlcA (Granja et al. 2007). 
UGD belongs to a small family of nucleotide-sugar modifying enzymes widely 
spread in nature (Ge et al. 2004). It can be found in the mamallian liver where 
UDP-GlcA is the substrate for several glucuronosyl transferases involved in 
xenobiotic solubilisation, allowing the excretion of these agents out of the 
organism (Tukey et al. 2000), or the production of hyaluronic acid, a matrix 
polysaccharide present in human connective tissues (Spicer et al. 1998; Huh et 
al. 2004). In plants, UDP-GlcA is the precursor for other activated sugars such 
as uridine-diphospho-arabinose (UDP-Ara) or uridine-diphospho-xylose (UDP-
Xyl), which constitute the plants matrix polysaccharides (Kärkönen 2005; 
Klinghammer & Tenhaken 2007). In bacteria, UDP-GlcA is used for the 
production of extracellular polymers that play different roles according to the 
microorganism and the ecological niche surrounding it (Broadbent et al. 2003; 
Kumar et al. 2007).  
Our interest in the S. elodea ATCC 31461 UDP-glucose dehydrogenase, termed 
UgdG, arises from its pivotal role in the gellan gum biosynthetic pathway. It is 
the only bacterial source of the glucuronate moiety that composes the 
tetrasaccharide repeating unit of the polymer. UgdG is therefore a perfect target 
for enzyme manipulation and the design of activity enhancers. The knowledge 
of its three-dimensional structure is essential to enable this.  
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5.3. Experimental Procedures 
 
5.3.1. Protein purification and crystallisation 
 
UgdG wild type and SeMet derivatised proteins were expressed and purified as 
previously described in detail (see sections 4.3.1. and 4.3.2.). Briefly, cells 
harbouring the plasmid constructs for native or SeMet derivatised UgdG 
expression, were grown in LB supplemented with ampicillin, harvested, and 
resuspended in sodium chloride (1 M) and phosphate buffer (20 mM) at pH 7.4. 
After disruption, the cell free extracts were applied onto a nickel-chelating 
column (Histrap FF, GeHealthcare). Proteins were eluted using a linear 
imidazole gradient and the pure fractions were pooled and buffer exchanged to 
a suitable storage buffer. Both proteins were confirmed to be homogenous and 
of high purity by SDS-polyacrylamide gel electrophoresis, and their 
concentration determined both by Bradford's method (Bradford, 1976) or direct 
measurement of their absorbance at 280 nm, using a extinction coefficient of 
18490 M-1!cm-1. The proteins were stored at -80º C with final concentrations of 
approximately 4.5 and 5.5 mg!ml-1 for native and SeMet derivatised proteins, 
respectively. Wild-type crystals were firstly obtained in a microbatch 
experiment (see section 4.3.3.) but the availability of a "Honeybee" Microsys 
4000 XL Cartesian™ Dispensing Systems robot (Genomic Solutions, USA) 
allowed the screening of new conditions using vapour diffusion techniques. 
New crystals of native UgdG were obtained with solution 56 of the PEG II 
screen from Qiagen Canada Inc. (100 mM MES pH 6.0, 10% (w/v) PEG 6000, 
1M LiCl). SeMet derivatised crystals were obtained as described previously 
(see section 4.3.3.). Cryoprotection of UgdG native crystal was achieved by a 
quick soak in a solution of their mother liquor including 25% glycerol, in order 
to minimise the risk of crystal damage in X-rays. Crystals were then flash 
cooled and stored in liquid nitrogen for diffraction data collection.  
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5.3.2. Diffraction data collection and processing 
 
Native UgdG diffraction data were measured at beam line ID23-1 of the 
European Synchrotron Radiation Facility (ESRF), Grenoble, France. The 
diffraction images were processed with MOSFLM (Leslie 1992), intensities were 
scaled and merged with SCALA (Evans, 2006) and final magnitudes were 
calculated with TRUNCATE (French & Wilson 1978) from the CCP4 suite (The 
CCP4 suite: programs for protein crystallography, 1994).  
 
5.3.3. Structural solution and refinement 
 
Native crystal UgdG phases were obtained by molecular replacement using 
PHASER (McCoy et al. 2005) and the preliminary model of the seleno-
methionine derivative UgdG (see section 4.3.4.) as the search structure. Model 
editing and completion against electron density maps at a graphics workstation 
and iterative structural refinement of the UgdG monomer were performed with 
COOT (Emsley & Cowtan 2004) and REFMAC5 (Murshudov et al. 1997), 
respectively. The progress of the refinement was monitored by the use of Rfree, 
where 5% of the reflections were constantly set aside for cross-validation. 
 
5.3.4. Structural analysis 
 
Molecular stereochemistry was evaluated using the program PROCHECK 
(Laskowsky et al. 1993). Inter-molecular contacts and crystallographic packing 
were checked with PISA (Krissinel & Henrick 2007), and structural 
superposition of homologous models were produced with SSM (Krissinel & 
Henrick 2004) and MODELLER (Sali & Blundell 1993). Images were produced 
with PYMOL (Delano 2008). 3D-structural comparisons were performed with 
MAMMOTH (Lupyian et al. 2005), a multiple structure sequence-independent 
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alignment program based on “all-against-all” pairwise comparison of protein 
models. Briefly, an overall alignment based on models coordinates is 
performed. The models are divided into heptapeptides, and for each successive 
C! pair, a unit vector is computed. These unit vectors are then grouped at a 
same origin, the root mean square distance between all pairs of heptapeptides is 
calculated and a similarity matrix is generated. The latter is then used for 3D 
alignment based on backbone (local) similarity. A similarity score is computed 
and output as a dendogram file. The obtained dendogram was fed into PHYLIP 
(Felsenstein 1993) to create a structural-based phyletic relationship tree.  
 
5.4. Results and Discussion 
 
5.4.1. Crystallographic data 
 
UgdG was produced, purified and crystallised as described elsewhere (see 
section 4.3.). Crystals were further optimised with the new crystallisation 
conditions (see Experimental Procedures) leading to improved diffraction data 
up to 2.37 Å resolution. They belong to space-group P622 with cell dimensions 
a=b=167.6 Å, c= 84.8 Å, containing one molecule in the asymmetric unit (a.u.), 
which corresponds to a Matthews coefficient of 3.6 Å3Da-1 and a calculated 
solvent content of 66 %. Crystallographic statistics are presented in Table 5.1.  
 
5.4.2. Phase problem solution and structural refinement of UgdG 
 
Since initial molecular replacement attempts of native UgdG using the, at that 
time, available structure of UGD from S. pyogenes (Campbell et al. 2000) as 
the search structure were not successful (sequence identity 23 %), seleno-
methionine derivatised UgdG (SeMet-UgdG) was produced and crystallised.  
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Table 5.1. Crystallographic parameters and data-collection statistics for native UgdG crystals. 
Crystal UgdG 
ESRF Beamline ID14-3 
Wavelength (Å) 0.931 
Resolution (Å) 59.55–2.37 (2.50–2.37) 
Space-group P622 
a, b, c (Å) 167.6, 167.6, 84.8 
No. reflections 329626 (48366) 
No. unique 29012  (4161) 
Redundancy 11.4 (11.6) 
(I/!(I)) 6.6 (1.9) 
Rpim
a 0.024 (0.124) 
Rrim
b 0.082 (0.429) 
Rsym
 c 0.078 (0.411) 
Completeness (%) 100.0 (100.0) 
Mosaicity (º) 0.27 
VM (Å
3Da-1) 3.64 
Solvent content (%) 66.2 
No. of molecules in a.u. 1 
Wilson B (Å2) 42.7 
 
Data within parentheses refer to outer resolution shells. aRpim = "h [1/(N-1)]
1/2 "i |Ii(h) - <I(h) >| / "h "i Ii (h), where N is the data redundancy, I is the observed intensity and <I> is the average intensity of 
multiple observations from symmetry-related reflections. It is an indicator of the precision of the final merged and averaged data-set (Weiss, 2001). bRrim = Rmeas = ! h ["/("#1)]
1/2 ! i |Ii(h) - <I(h)>| / ! h ! i 
Ii (h), where N is the data redundancy, I is the observed intensity and <I> is the average intensity of multiple observations of symmetry-related reflections. It is an indicator of the average spread of the 
individual measurements (Weiss, 2001). cRsym = "h "i |Ii(h) - <I(h)> / | "h "i Ii (h), where I is the observed intensity and <I> is the average intensity of multiple observations from symmetry-related 
reflections. 
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The crystals belonging to tetragonal space-group P43212, diffracted up to 3.4 Å 
resolution, and their phases were obtained by single anomalous dispersion 
methods (SAD), leading to an incomplete, mostly poly-Ala truncated model 
(only 346 out of 438 residues). Using this preliminary SeMet-UgdG model, a 
molecular replacement solution for the initial diffraction data set to 2.4 Å 
resolution of the hexagonal native crystals was readily obtained by PHASER 
(McCoy et al. 2007), with final Z-scores RFZ = 3.5 and TFZ = 9.1 (section 
4.3.4.). Readily interpretable electron density maps were produced, which 
included density of the NAD(H) cofactor nestled into the UgdG monomer. The 
model was improved through successive cycles of manual building and 
refinement using the later obtained higher resolution data (2.37 Å), until 
convergence of Rwork/Rfree to 18.2/22.6 %. The last refinement cycle included the 
use of three TLS groups, determined with the TLSMD server (Painter & Merrit 
2006). The final R factor deduced for all data is 18.4 %. Further refinement 
statistics are presented in Table 5.2. 
 
5.4.3. UgdG crystal contents 
 
While the two residues of the linker between the His-tag and the first valine 
residue of the UgdG protein could be modelled as Gly-1 and Ser0, the 6 
histidines of the N-terminal tag and residues 90-92 and 191-192 were not 
visible in the electron density maps due to crystallographic disorder, and 
therefore omitted from the models. Globally, the native structure of UgdG 
contains 433 out of the 440 (2+438) residues, 125 solvent water molecules and 
two chloride solvent species.  
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Table 5.2. Refinement statistics and stereochemistry assessment for native UgdG. 
A stereochemical analysis of the final UgdG model, revealed 91.3%, 8.7%, 0.0% and 0.0% of the residues are located in the most favourable, additional 
allowed, generously allowed and disallowed regions of the Ramachandran plot, respectively.  
 
Parameter UgdG 
Rwork (%) 18.2 
Rfree (%) 22.6 
R (%) 18.4 
Number of residues 433 
Solvent water molecules 125 
Other ligand molecules 
(NAD(H), chloride, glycerol) 
4 
Average protein atoms <a.d.p.> (Å2) 43.2 
Average main-chain <a.d.p.> (Å2) 42.0 
Average side-chain <a.d.p.> (Å2) 44.4 
Nicotinamide adenine dinucleotide [NAD(H)] 
<a.d.p.> (Å2)  
46.8 
Average solvent  <a.d.p.> (Å2) 42.0 
Deviations from the ideal  
Bond distances rmsd (Å) 0.014 
Bond angles rmsd (º) 1.51 
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These were introduced whenever the initially modelled waters did not 
compensate for persistent positive m|Fo|-D|Fc| density (Read 1986), were 
refined to too low atomic displacement parameters (a.d.p.’s) when compared 
with neighbouring atoms, or had a positively charged close environment, since 
1 M LiCl was present in the crystallisation media. Additionally, the protein 
molecule also exhibits a docked cofactor molecule modelled as adenine-
diphospho-ribose with occupancy of 70%, as the residual !A density maps 
(Read, 1986) presented no evident density that could account for the 
nicotinamide moiety of the cocrystallised NAD+ cofactor molecule. 
 
5.4.4. UgdG monomeric topology 
 
The single UgdG monomer in the crystal a.u. has dimensions of approximately 
70, 40 and 38 Å, and is composed of two domains with an !/" topology 
connected by an !-helical bundle domain (Figure 5.1.). Both N- and C-terminal 
exhibit a three-layer !"! sandwich-like domain with a central "-sheet flanked 
on both sides by !-helices, typical of a dinucleotide-binding fold. The N-
terminal domain (residues 1-199) shows a six-stranded parallel "-sheet ("1-"6) 
interspersed with seven !-helices (!1-!7), a canonical Rossmann fold that 
serves as the nicotinamide adenine dinucleotide (NAD(H)) binding domain, 
followed by an anti-parallel "-!-" extension ("7-!8-"8), that leads straight into 
the central domain. This is an entirely !-helical region (residues 200-307), 
composed of a four-helical bundle (!9-!12) and it is responsible for the 
homodimerisation of UgdG. This structural arrangement is present in several 
dehydrogenases whose homodimerisation is also produced via interactions 
between the central helical domains of the two interacting monomers. The      
C-terminal region of the UgdG molecule (residues 308-438) also exhibits a 
dinucleotide binding like Rossmann fold, with a "-sheet core ("9 to "14) 
flanked on both sides by several !-helices (!13 to !17). 
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Figure 5.1. Three-dimensional structure of the UgdG monomer with an incomplete cofactor 
NAD(H) bound.  
The UDP-glucose dehydrogenase from S. elodea ATCC 31461 (UgdG) exhibits an !/" fold 
found in other nucleotide-sugar dehydrogenases and comprises two !"! sandwich type 
dinucleotide binding Rossmann-like domains, at the N- (blue) and C-terminal (red) parts, 
connected by an !-helical sub-domain (green). Secondary structure details were classified 
numerically for both !-helical or for "-strands elements. Cofactor molecule in stick 
representation coloured yellow for carbon, blue for nitrogen, red for oxygen and orange for 
phosphorus.  
 
The N- and C-terminal domains show a striking similarity when superimposed, 
except for some missing !-helical elements on the C-terminal domain (Figure 
5.2), even if their sequence identity is low (ca. 17%). The presence of two 
similar domains in one protein was first described for bovine liver rhodanese 
(Ploegman et al. 1978) and has been found in many protein structures (Lang et 
al. 2000). 
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Figure 5.2. The superposition of the N-and C-terminal domains of UgdG.  
The two dinucleotide-binding Rossmann-like domains, the N- (blue) and C-terminal (red) 
exhibit a striking similarity when superposed, with an rmsd of 2.7 Å2 over 101 alpha carbons 
(Krissinel & Henrick 2007). 
 
5.4.5. The interface of the UgdG dimer 
 
An analysis of the crystal packing contacts strongly suggests that UgdG forms 
dimeric species, as each molecule uses 2650 Å2 (13.4% of its otherwise    
19718 Å2 solvent accessible surface) to form an interface with its closest crystal 
neighbour (Figure 5.3. a, b, c). The dimeric mates are related by a 
crystallographic two-fold rotation axis, which brings the N-domain of one 
monomer closer to the C-domain of the other. This oligomerisation is consistent 
to what has been described for other members of this family (Campbell et al. 
2000; Snook et al. 2003; Hung et al. 2007), although in some cases a higher 
quaternary arrangement is also observed. This is the case of the most studied 
eukaryotic UGDs, such as bovine and human, where a “trimer of dimers” was 
found to be the predominant arrangement although the role of subunit 
association is not clear, as it is not necessary for activity (Easley et al. 2007).
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Figure 5.3. The quaternary arrangement and the dimer interface of UgdG.  
(a) and (b) Perpendicular views of the UgdG dimer with one monomer shown as a cartoon with the N- and C-terminal domains in blue and red, 
respectively, and the middle subdomain in green. The other monomer is represented by its solvent accessible surface coloured (in grey). The (incomplete) 
cofactor molecule is represented in sticks coloured yellow for carbon, blue for nitrogen, red for oxygen and orange for phosphorus. (c) Zoomed view of the 
dimeric interface showing a chloride ion (red sphere) on a crystallographic two-fold axis. Residues side-chains are presented in sticks with atoms coloured 
green or grey for carbon in each monomer, and in blue for nitrogen and red for oxygen atoms. A 2mFo-DFc electron density contoured at 1! is shown as a 
blue mesh around the chloride ion. Hydrogen bonds represented as black dashed lines with distances in Å. 
(b) (a) (c) 
3.3 
3.2 
3.1 
3.2 
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Additionally, the rat and the Cryptococcus fungi UGDs have been described as 
tetrameric and dimeric, respectively (Sivaswami et al. 1972; Bar-Pelled et al. 
2004). On the other hand, prokaryotic UGDs seem to be dimeric (Sieberth et al. 
1995), even though the UGD monomer of Streptococcus pyogenes was also 
described as active (Campbell et al. 1997). Interestingly, the UgdG dimer 
interface shows a chloride ion lying exactly at the two-fold symmetry axis that 
relates the two monomers. This is likely to be a crystallisation artefact, as the 
precipitant solution contained 1 M lithium chloride (see section 4.3.3.) and it 
has not been described for any of the nucleotide (NDP)-sugar dehydrogenase 
members of the family. The ion interacts with the main-chain and side-chain 
amines of Gly250 and Lys218, respectively, of the symmetrically related 
monomers (see Figure 5.3. c). The interface is built mainly by interactions 
between the helical subdomains of both monomers, a scheme verified for other 
dehydrogenases and NAD-binding proteins (Kutzenko et al. 1998). 
 
Table 5.3. Hydrogen bonding network at the dimeric interface of UgdG.  
Residues involved and the respective bond distances were defined using PISA (Krissinel & 
Henrick 2007). 
Hydrogen bonds at the UgdG dimeric interface 
Chain A Distance (Å) Chain B 
Asn247 [N] 2.7 Asp166 [OD2] 
Asp235 [N] 3.0 Thr203 [OG1] 
Ile285 [N] 3.2 Glu224 [OE1] 
Arg284 [N] 2.8 Glu224 [OE2] 
Arg202 [NH1] 2.8 Val232 [O] 
Arg167 [NH2] 2.7 Gly242 [O] 
Lys218 [NZ] 3.1 Arg248 [O] 
Asp166 [OD2] 2.7 Asn247 [N] 
Thr203 [OG1] 3.0 Asp235 [N] 
Glu224 [OE1] 3.2 Ile285 [N] 
Glu224 [OE2] 2.8 Arg284 [N] 
Val232 [O] 2.8 Arg202 [NH1] 
Gly242 [O] 2.7 Arg167 [NH2] 
Arg248 [O] 3.1 Lys218 [NZ] 
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Dimerisation occurs upon the close packing of both central helices (!9) of the 
two subdomains, through an extensive network of hydrogen bonds and van der 
Waals interactions, even if the primary structure conservation is very low in this 
region. Amongst these interactions, 14 are hydrogen bonds (see Table 5.3. 
above), the remainder being van der Waals contacts. The interface involves 
interactions between 63 of the about hundred residues that compose the 
subdomain, but also a few N-terminal residues, such as the strictly conserved 
Phe152 and Arg167. Several aromatic residues are involved in the interface 
formation, including Phe214, Phe221, Phe253 and Phe265 (Figure 5.4.). The 
majority of these residues are not strictly conserved but some aromatic 
character conservation is observed, when compared to other UGDs. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4. The hydrophobic character of the dimer interface.  
The UgdG dimeric interface has a strong hydrophobic character with conservation of aromatic 
residues. Monomer A is in cartoon representation and monomer B in its transparent solvent 
accessible surface. Residues represented in sticks coloured as in Figure 5.3.  
 
For example, S. pyogenes UGD has tyrosine residues at these equivalent 
positions (Campbell et al. 2000), while human UGD also has phenylalanine 
residues except for a serine on position 232, equivalent to Phe221 on UgdG. 
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This might contribute to the higher similarity of UgdG and eukaryotic UGDs, 
as pointed by Granja and co-workers (Granja et al. 2007). Arg248, one of the 
few strictly conserved residues present at the interface, was proposed by 
Campbell (Campbell et al. 2000) to be determinant of substrate specificity since 
the residue’s side-chain contacts with the active site and with the substrate from 
the partner. Such an interaction is not detected in UgdG due to the absence of 
the substrate in the respective binding pocket. Other strictly conserved residues 
involved in dimerisation are Leu215, Asp 246, Ile249 and Leu272 (Leu227, 
Asp258, Ile261 and Leu284 for human, and Leu211, Asp242, Ile 245 and 
Leu268 for S. pyogenes UGDs). 
 
5.4.6. The NAD(H) cofactor binding pocket of UgdG 
 
Despite all of the efforts to produce a UgdG-NAD(H) complex with a complete 
cofactor bound, one observes a lack of density at the nicotinamide ring of the 
co-crystallised NAD(H). Therefore, only its adenosine, diphosphate and ribose 
groups could be modelled into the electron density map (Figure 5.5.). Such a 
phenomenon was also observed in other NAD-binding proteins, and has been 
justified by the possibility of different conformations of the ring within the 
crystal, or by a possible hydrolysis of the glycosidic bond, under the 
experimental conditions, originating several subproducts (Margolis et al. 1976; 
Miksic & Brown 1978; Bellamacina 1996). In UGDs, an inspection of available 
NAD(H) complexes seems to indicate that cofactor degradation is pH 
dependent, originating the adenosine-diphospho-ribose (ADP-ribose) 
subproduct. In S. pyogenes and human UGD-NAD(H) structures (Campbell et 
al 2000; Kavanagh et al. 2007), where the cofactor molecule is complete, 
crystallisation occurred at pH 7.8 and 6.5, respectively. In the case of GMD, 
where an incomplete cofactor molecule was found bound to the protein (Snook 
et al. 2003), crystallisation occurred at an acidic pH 4.6, similar to that of UgdG 
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(pH 5.6 or 6; see sections 4.3.3. and 5.3.1). Moreover, the 2mFo-DFc and   
mFo-DFc electron density maps of UgdG show the change in the chirality of 
the NAD(H)-ribose at C1D, suggesting the substitution of the N1N amine group 
by a hydroxyl group, leading to ADP-ribose, and release of the nicotinamide 
moiety to the media. Also, NAD+ binding is a fast and labile state, as the 
cofactor must exchange rapidly to allow enzyme turnover, and full oxidation of 
the alcohol to acid. This helps to explain why the cofactor could not be refined 
to its full occupation, but to a value of 70% (see section 5.4.3.). The visible part 
of the cofactor adopts an extended conformation in a cleft within the N-terminal 
domain, nearby the N-extremities of !1 and !4. A comparison with available 
UGD-NAD(H) complexes (Campbell et al. 2000; Kavanagh et al. 2007 not 
published) shows that the hydrogen bonding network between the protein and 
the visible part of the cofactor is maintained, and that if the side-chain of 
Glu151 had adopted a Chi1 trans conformation, as in ternary complexes of 
human and S. pyogenes UGDs, there would be room available for the (not 
visible) nicotinamide ring of NAD (Figure 5.5.). Instead, it adopts a gauche (+) 
conformation also found in the BceC structure without any docked cofactor 
(section 3.). Modelling the fragment as ADP-ribose allows an extra hydrogen 
bond between UgdG and the truncated cofactor fragment (see Figure 5.5.). In 
other UGD/GMD structures (Campbell et al. 2000; Snook et al. 2003), the 
nicotinamide ring is found binding in a syn orientation; with its C4 carbon 
(where the hydride transfer occurs) located near the catalytic Cys264 as 
required for catalysis, and its carboxamide group pointing to the side-chain of 
Glu155 (not shown). A detailed description of the hydrogen bonding 
interactions between the cofactor and the already characterised UGDs is given 
on Table 5.4. The adenine moiety lies on a patch formed by several 
hydrophobic residues, some conserved like Val84 and Tyr99, and other non-
conserved residues such as Lys31 and Ala103 (substituting Val31 and Val102 
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in GMD). All of these residues are within van der Waals distance from the base 
(Figure 5.5.; Snook et al. 2003). 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5. The cofactor NAD+/NADH binding pocket of UgdG. 
The electron density at the cofactor binding pocket shows a docked NAD(H) fragment, where 
the nicotinamide ring is absent in the 2mFo-DFc map. The cofactor fragment was therefore 
modelled as an incomplete NAD+, resembling an adenosine-diphospho-ribose (ADP-ribose), 
represented as sticks coloured yellow for carbon, blue for nitrogen, red for oxygen and orange 
for phosphorus, and representing interacting UgdG residues with carbon atoms in grey, and a 
conserved water molecule (see text) as a red sphere. 2mFo-DFc electron density map around the 
cofactor fragment at 1.5 ! is represented as a blue mesh. Hydrogen bond interactions are shown 
in black dashed lines with distances in Å. 
 
One conserved residue of the Rossmann fold, Asp30 forms hydrogen bonds 
with the hydroxyls of the adenine ribose ring. The pyrophosphate group is 
bound to the protein by the GXGXXG (glycine-rich) motif, known as one of the 
fingerprint regions of NAD(H) binding proteins with a classical Rossmann fold 
(Bellamancina 1996). The first glycine residue of the loop, Gly7, allows a tight 
turn of the peptide chain whilst the other two, Gly9 and Gly12, interact with the 
pyrophosphate group, allowing the correct positioning of the cofactor molecule. 
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Table 5.4. Hydrogen bonding interactions within UGDs cofactor binding pockets. UgdG (this 
structure), BceC with NAD(H) in silico model  (see section 3.), P. gingivalis (Bonanno et al. 
2009, not published, PDB entry 3GG2) with NAD(H) in silico model, H. sapiens (Kavanaugh et 
al. 2007, not published, PDB entry 2Q3E) and S. pyogenes (Campbell et al. 2000, PDB entry 
1DLJ) UGDs are represented. The cofactor is divided into adenosine, diphosphate, ribose and 
nicotinamide sections (first column). Equivalent atom labels of reaction substrate/product 
(second column) appear in the residue rows (columns 3-5) to which they form hydrogen bonds 
(defined up to 3.2 Å initial cut-off distance, but homologous interactions up to 4 Å were 
included). Conserved residues are highlighted in bold; residues bridged to the cofactor via a 
solvent water molecule are presented in italic within parenthesis. Direct hydrogen-bonding 
distance values (Å) are within parentheses.  
 
 
 
UgdG BceC (section 3.) 
with NAD(H) in 
silico model 
P. gingivalis UGD  
(3GG2) with 
NAD(H) in silico 
model 
H. sapiens UGD 
(2Q3E) 
S. pyogenes UGD 
(1DLJ) 
N1A 
    (Ser67_OG) (2.7) 
(Tyr71_OH) (2.8) 
(Glu103_OE1) (2.8) 
N6A (Tyr99_O) (3.0) (Tyr98_O) (2.7) Tyr176_O (2.7)   
N7A (Tyr99_O) (3.0)     
O2B 
 
Asp30_OD1 (2.5) 
 
Asp30_OD1 (3.9) 
 
Asp108_OD1 (2.8) 
 
Asp36_OD1 (2.6) 
(Asn38_ND2) (3.1) 
Asp29_OD1 (2.8) 
A
d
en
o
si
n
e
 
O3B 
 
Asp30_OD2 (2.7) 
 
Asp30_OD2 (4.2) 
Lys35_NZ (2.7) 
 
Asp108_OD2 (3.5) 
 
Asp36_OD2 (2.8) 
Arg41_NH2 (2.9) 
(Asn38_ND2) (3.1) 
Asp29_OD2 (2.7) 
Lys34_NZ (3.0) 
O1A  (Arg338_NH1) (2.9)  (Arg346_NH1) (2.8) Arg327_NH1 (3.1) 
O2A 
 
   Arg41_NH1 (3.1) 
(Arg41_NH2) (3.0) 
(Lys34_NZ) (2.9) 
O1N 
   
Arg412_NH2 (4.3) 
 
Arg346_NH1 (3.0) 
Arg346_NH2 (2.9) 
(Ser275_OG) (2.8) 
 
Arg327_NH2 (2.9) 
O2N 
 
Tyr10_N (2.9) 
Val11_N (2.9) 
(Gly9_N) (3.0) 
(Gly12_N) (2.9) 
(Ala83_O) (2.8) 
Tyr10_N (3.5) 
Val11_N (3.0) 
(Gly9_N) (3.0) 
(Gly12_N) (2.9) 
(Ala83_O) (2.6) 
Tyr88_N (2.5) 
Val89_N (3.0) 
(Gly87_N) (3.0) 
(Gly90_N) (2.9) 
(Ala161_O) (2.7) 
Tyr14_N (3.1) 
Val15_N (3.0) 
(Gly13_N) (2.9) 
(Gly16_N) (2.9) 
(Ser88_O) (2.9) 
Tyr10_N (3.2) 
Val11_N (3.1) 
(Gly9_N) (3.0) 
(Gly12_N) (2.8) 
(Ala80_O) (2.8) 
D
ip
h
o
sp
h
a
te
 
O5D    (Ser275_OG) (2.8)  
O2D 
 
Lys267_NZ (3.4) 
(Thr122_OG1) (3.2) 
(Asp268_OD2) (3.0) 
Lys273_NZ (2.7) 
(Thr121_OG1) (2.8) 
(Asp274_OD2) (2.8) 
Lys347_NZ (2.7) 
(Thr199_OG1) (2.9) 
(Asp348_OD2) (2.5) 
Lys279_NZ (2.8) 
(Thr131_OG1) (2.6) 
(Asp280_OD2) (2.6) 
Lys263_NZ (2.9) 
(Thr118_OG1) (2.5) 
(Asp264_OD2) (2.6) 
R
ib
o
se
 
O3D 
 
Thr86_OG1 (2.7) 
Thr122_N (3.2) 
Thr86_OG1 (2.9) 
Thr121_N (2.7) 
 Thr91_OG1 (2.7) 
Thr131_N (3.0) 
Thr83_OG1 (2.5) 
Thr118_N (3.2) 
N1N 
Thr122_OG1 (2.6) 
Glu151_OE2 (2.9) 
    
N
ic
o
ti
n
a
m
id
e 
N7N 
 
N/A 
Clash with Tyr10 
Clash with Glu154 
Clash with Tyr88  
 
Glu165_OE2 (2.8) 
 
 
Glu145_OE2 (3.1) 
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However, whilst the main-chain amines of Tyr10 and Val11, two conserved 
residues of the phosphate-binding loop, hydrogen bond directly with the 
pyrophosphate, the main-chain amines of these two glycines contiguous to them 
interact with the group via a water molecule which has been frequently 
described as characteristic of the classical dinucleotide-binding Rossmann fold 
proteins (Bottoms et al. 2002; see above Figure 5.5.). 
 
5.4.7. The substrate binding pocket of UgdG 
 
Despite all the attempts, it was not possible to obtain UgdG as a ternary 
complex with cofactor and substrate or analogues. Having obtained the 
homologous structure of Burkholderia cepacia UGD, BceC, in complex with its 
reaction product, UDP-GlcA (see section 3.), its coordinates were used to map 
the UgdG substrate-binding pocket (Figure 5.6.).  
 
 
 
 
 
 
 
 
 
Figure 5.6. The model of UgdG substrate binding pocket. 
The 3D structure of BceC with a docked UDP-GlcA was superimposed onto the homologue 
UgdG, generating a hydrogen bonding network, illustrated by dotted lines, between UgdG and a 
UDP-GlcA model in its substrate binding pocket. Bonds represented as sticks, in yellow for 
ligand carbon atoms, grey for protein carbon atoms, blue for nitrogen, red for oxygen, orange 
for phosphorus and dark yellow for sulphur. Solvent water molecules represented as red 
spheres.  
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Table 5.5. Hydrogen bonding interactions within UGDs substrate binding pockets. UgdG with 
UDP-GlcA in silico model, BceC (see section 3.), P. gingivalis (Bonanno et al. 2009, not 
published, PDB entry 3GG2), H. sapiens (Kavanaugh et al. 2007, not published, PDB entry 
2Q3E) and S. pyogenes (Campbell et al. 2000, PDB entry 1DLJ) UGDs are represented. The 
substrate/product is divided into uridine, diphosphate, and glucose/glucuronate moieties (first 
column). Equivalent atom labels of reaction substrate/product (second column) appear in the 
residue’s rows (columns 3-7) to which they form hydrogen bonds (defined up to 3.2 Å initial 
cut-off distance, but homologous interactions up to 4 Å were included). Conserved residues are 
highlighted in bold; residues bridged to the substrate via a water molecule are presented in italic 
within parenthesis. Hydrogen-bonding distance values (Å) are within parentheses. * Represents 
the catalytic cysteine (or serine in S. pyogenes Cys260Ser mutant UGD). 
 
  UgdG with UDP-
GlcA in silico model 
BceC 
(See section 3.) 
P. gingivalis (3GG2) H. sapiens  
(2Q3E) 
S. pyogenes  
(1DLJ) 
O4 His255_N (3.3) Tyr261_N (3.0) Tyr335_N (2.9) Lys267_N (3.1) Asn250_N (3.1) 
Asn251_N (2.9) 
N3 His255_O (3.4) Tyr261_O (3.0) Tyr335_O (2.9) Lys267_O (2.8) Asn251_O (2.9) 
O2  
 
Arg414_NH2 (4.3) 
(Asn229_ND2)(3.1) 
(Gly265_N) (3.0) 
Arg431_NH1 (3.2) 
(Asn303_ND2)(3.1) 
(Gly339_N)(3.1) 
Arg495_NH1 (3.1) 
 
Ser269_OG (2.7) 
 
Ser253_OG (2.8) 
O2* 
O2C 
O2D 
 
Arg414_NH2 (3.7) 
 
 
(Glu406_OE1)(2.6) 
(Glu406_OE2)(2.8) 
 
(Glu470_OE1)(3.0) 
 
Arg442_NH1 (2.9) 
Arg442_NH2 (3.1) 
(Glu416_OE2)(2.8) 
(Gly255_O) (2.9) 
(Asn380_ND2)(2.9) 
Asp402_OXT (2.7) 
U
r
id
in
e
 
O3* 
O3C 
O3D 
Gly267_N (3.6)  
Phe324_O (3.8) 
Gly267_N (3.0)  
Phe330_O (3.0) 
Gly341_N (3.0)  
Phe404_O (2.8) 
Gly273_N (2.9) 
Phe338_O (2.7) 
Gly257_N (2.9) 
Met319_O (2.8) 
O1A Lys326_NZ (3.7) (Lys331_NZ)(2.7) 
 
Lys405_NZ (2.7) 
 
Lys339_NZ (2.8) 
(Arg260_NH1)(3.0) 
Lys320_NZ (3.2) 
(Asp402_OD1)(2.5) 
O2A (Arg248_NH1)(3.4)    Tyr249_OH (2.7) 
O3A Lys326_NZ (2.6) Lys331_NZ (3.3)  Lys339_NZ (3.2) Lys320_NZ (3.4) 
O1B  
(Gly261_O)(2.7) 
(Cys264_N)(3.1) 
(Phe265_N)(2.9) 
(Glu158_OE1)(3.2) 
(Gly267_O)(2.8) 
(Cys270_N)(3.2) 
(Phe271_N)(2.9) 
 
(Gly341_O)(2.9) 
(Cys344_N)(3.2) 
(Phe345_N)(2.9) 
 
(Gly273_O)(2.7) 
(Cys276_N) 3.0) 
(Phe277_N)(3.1) 
(Glu145_OE2)(2.7) 
(Gly257_O) (3.3) 
(*Ser260_N) (3.1) 
(Leu261_N) (2.6) D
ip
h
o
sp
h
a
te
 
O2B  
 
Lys326_NZ) (2.4) 
Glu158_N (3.4) 
 
Lys331_NZ (2.7)  
Glu236_N (2.8) 
 
Glu165_N (3.0) 
(Glu165_OE2)(3.2) 
 
Glu145_N (2.9) 
 
Lys320_NZ (2.8) 
O2' (Arg248_NH1)(2.1) Arg254_NH1 (2.9) Arg328_NH1 (2.8) Arg260_NH1 (2.8) Arg244_NH1 (2.9) 
O3' Phe152_O (4.2) 
(Arg248_NH2)(2.5) 
(Phe155_O) (2.8) 
Arg254_NH2 (2.9) 
(Lys214_NZ)(3.2) 
(Asn218_OD1)(2.8) 
Phe233_O (2.7) 
Arg328_NH2 (3.0) 
(Lys288_NZ)(3.7) 
(Asn292_OD1)(2.7) 
Phe162_O (2.6) 
Arg260_NH2 (3.0) 
(Lys220_NZ)(3.5) 
(Asn224_OD1)(2.7) 
Phe142_O (2.7) 
Arg244_NH2 (3.1) 
(Lys204_NZ) (3.2) 
(Asn208_OD1)(2.8) 
O4' Leu153_O (3.7) 
Lys208_NZ (2.6) 
Leu156_O (2.7) 
Lys214_NZ (3.0) 
Leu234_O (2.7) 
Lys288_NZ (3.0) 
Leu163_O (2.7) 
Lys220_NZ (2.9) 
Leu143_O (2.6) 
Lys204_NZ (3.0) 
O61 
O6' 
O'P 
Lys208_NZ (2.8) 
Asn212_ND2 (2.9) 
(Thr122_OG1)(3.2) 
(Asp268_OD2)(3.0) 
*Cys264_SG (3.4) 
Lys214_NZ (2.8) 
Asn218_ND2 (3.0) 
(Thr121_OG1)(2.8) 
(Asp274_OD2)(2.8) 
*Cys270_SG (3.4) 
Lys288_NZ (2.8) 
Asn292_ND2 (2.9) 
(Thr199_OG1)(2.9) 
(Asp348_OD2)(2.5) 
*Cys344_SG (3.7) 
Lys220_NZ (2.8) 
Asn224_ND2 (2.7) 
(Thr131_OG1)(2.6) 
(Asp280_OD2)(2.6) 
*Cys276_SG (3.6) 
Lys204_NZ (2.8)  
Asn208_ND2 (2.9) 
(Thr118_OG1)(2.5) 
(Asp264_OD2)(2.6) 
*Ser260_OG (3.4) 
G
lu
c
o
se
 /
 G
lu
c
u
r
o
n
ic
 m
o
ie
ty
 
O62 
O'Q 
 
Glu151_OE2 (3.1) 
*Cys264_SG (3.3) 
Tyr10_OH (2.5) 
Glu154_OE1 (2.6) 
*Cys270_SG (3.2) 
Tyr88_OH (2.5) 
 
*Cys344_SG (3.5) 
 
N/A 
 
 
*Ser260_OG (2.3) 
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The majority of the protein contacts with the modeled UDP-GlcA reside within 
the helical subdomain that connects the N- and C-terminal nucleotide binding 
Rossmann-like domains. A detailed description of all available UGDs 
hydrogen-bonding network is given on Table 5.5. (see above). A 15-residue 
stretch of the polypeptide chain (residues 253-269) makes an extensive series of 
contacts with the sugar nucleotide, from the uracyl moiety and running 
lengthwise to the glucuronate moiety. This includes contacts from several 
residues in the active site signature sequence GGXCXXXD (residues 261-268) 
characteristic of the nucleotide-sugar dehydrogenases (Campbell et al. 2000). In 
contrast to the absence of direct contacts between the enzyme and the adenine 
moiety of NAD(H) cofactor, a number of direct and water mediated hydrogen 
bonds were modelled between UgdG and the uracyl moiety of the reaction 
product. Interestingly, many of these contacts are made by backbone atoms of 
the protein, which may limit the accommodation of different orientations and 
types of bases. It might be one of the reasons why UGDs are specific to UDP-
sugars. Phe253 stacks against the uracyl ring through van der Waals 
interactions. Three residues within the signature sequence, Gly261, Cys264, 
and Phe265, also coordinate to make a contact via the same water molecule to 
the O2B atom of pyrophosphate group. A fourth signature residue, Asp268, 
hydrogen bonds the carboxylate group of UDP-GlcA via a water molecule. 3D 
analysis shows that this is the catalytic water (Ge et al. 2004; Easley et al. 
2007), held in place at the active site and rendering the enzyme ready for 
catalysis initiation, even if the substrate is not yet present, as in the case of 
UgdG. A single residue from the N-terminal dinucleotide binding fold, Glu151, 
may interact through its side-chain with the carboxylate group of the reaction 
product. This interaction is only possible when no cofactor is bound or as in this 
case, if the cofactor lacks its nicotimide ring (see above).The strictly conserved 
Thr122 on the other hand, establishes an indirect contact using the catalytic 
water molecule, kept in place by Asp268. Arg248 from the other dimer subunit 
UDP-glucose dehydrogenase from S. elodea ATCC 31461 (UgdG) 
 
Page 127 
establishes two hydrogen bonds with the sugar hydroxyls. Others have pointed 
this residue as being involved in substrate specificity (Campbell et al. 2000). 
 
5.4.8. 3D phyletic analysis of the UGD/GMD family 
 
A previous phylogenetic analysis of sequences from UgdG and other 46 
members of the UDP-glucose/GDP-mannose dehydrogenase family (31 and 12 
eukaryotic and prokaryotic UGDs, respectively, and five prokaryotic GMDs) 
led to a systematisation of this family into four groups: eukaryotic UGDs group, 
prokaryotic UGDs groups I and II, and prokaryotic GMDs group (Granja et al. 
2007). The actual availability of 3D structures from these four groups now 
allows a 3D structural based phyletic analysis of this NDP-sugar-6-
dehydrogenase family (Figure 5.7.).  
  
 
 
 
 
 
 
 
 
 
Figure 5.7. Three-dimensional phyletic dendogram of the UGD/GMD family. 
There is at least one 3D representative for each of the four UGD/GMD sub-families, 
highlighted in a circle. Structures are identified by the first two letters of the genus followed by 
the first two letters of the species: Stpy_UGD, PDB entry 1DLJ (Campbell et al. 2000); 
Hosa_UGD, PDB entry 2Q3E (Kavanagh et al. 2007, not published); Buce_BceC (see section 
3.); Spel_UgdG, this structure; Pogi_UGD, PDB entry 3GG2 (Bonnano et al. 2009, not 
published); Psae_GMD, PDB entry 1MV8 (Snook et al. 2003).  
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Similarly to UGDs, the available GMD structure shows two dinucleotide 
binding Rossmann-like domains, at its N- and C-terminal sequence regions 
(Snook et al. 2003). However, the domains spatial arrangement does not follow 
the compact monomer fold of UGDs, but they rather adopt the positioning of 
the complementary domains from the dimer mates in an equivalent UGD, thus 
enabling an effective overlap of UGDs and GMDs dimers. Such a domain swap 
in P. aeruginosa GMD relative to UGDs results from the backbone angles in 
the Asp248 to Leu253 loop, the hinge loop between the first two helices of 
GMD helical region (Snook et al. 2003). The GMD dimer has therefore hybrid 
active sites, with similar contributions from residues of the N- and C-terminal 
domains of both monomers. A chimeric GMD “monomer” with N- and C-
terminal domains from each dimer mate was used in the 3D-structural 
comparison with UGDs, in order to avoid bias in the phyletic distance 
calculations due to its different quaternary structure. The resulting dendogram 
corroborates the 1D structural results of Granja et al. 2007, where GMD 
constitutes a branch of the UGD/GMD family. UgdG belongs to the prokaryotic 
UGDs group I, closer to the eukaryotic UGDs group than to the other 
prokaryotic UGDs group II. The prokaryotic group II UGD structure from S. 
pyogenes shows the same overall fold, but is ca. 30 residues shorter at the C-
terminus. This bends into the protein interior, into the substrate/product binding 
pocket, and thus limits its exposure to the solvent (Campbell, 2000). It is 
noteworthy that the other sequences in this group show a high conservation 
degree, probably indicating similar substrate accessibility. In group I 
prokaryotic UGDs, although with a longer C-terminus, the substrate/product 
binding pocket is less occluded. The polypeptide bends to the exterior, with a 
further helix and adds up to two strands to the central !-sheet. These additional 
secondary structure elements certainly contribute to the divergence within 
prokaryotic UGDs and their division into two groups. Only with more 
structures may these differences be further clarified. 
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6.  Crystal Structure of NprA, the major nitroreductase 
from Rhodobacter capsulatus B10 bound to acetate 
 
The work here described corresponds to the X-ray crystallographic part of a paper in 
preparation in collaboration with C. Moreno-Vivián and M. D. Roldán, Uni. Córdoba, 
Spain, E. Mitchell, ESRF, France and C. Frazão, B. Victor and C. Soares, ITQB-UNL, 
Portugal.  
6.1. Abstract 
 
Rhodobacter capsulatus B10 is a purple nonsulphur photosynthetic bacterium 
that exhibits a wide variety of metabolic pathways and can be found in a 
multitude of natural environments. Its major nitroreductase (NR) enzyme can 
catalyse the reduction of several nitroaromatic compounds, such as 2,4-
dinitrophenol, a powerful energetic uncoupler often found as a soil 
contaminant, making this enzyme a suitable candidate for bioremediation 
processes.  
The R. capsulatus B10 NR, termed NprA, belongs to the Type I oxygen-
insensitive NRs, and uses both NADH and NADPH as electron donors. Several 
members of this family have already been characterised, both biochemically 
and structurally. However, the physiological role(s) of these enzymes, as well 
as the residues involved in catalysis are still unknown. In the present work, 
native NprA was expressed, purified and crystallised. Several attempts to also 
crystallise NprA complexed with different ligands were unsuccessful, thus 
mapping its catalytic residues using crystallographic techniques alone proved to 
be an impossible task. Here we report the crystal structure of the R. capsulatus 
B10 NprA enzyme bound to FMN and acetate, at 2.0 Å resolution, solved by 
the molecular replacement method. Crystals belong to the monoclinic space 
group C2 and contain two molecules in the asymmetric unit. 
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6.2. Introduction 
 
The technological development human society has experienced since the 18th 
century with the Industrial Revolution, has contributed to an improved quality 
of life. However, this fast industrial rising was accompanied with a massive 
mobilisation of natural resources and the production of chemical compounds 
that were inadvertently released and accumulated in the environment, becoming 
a major environmental concern (Kulkarni & Chaudhari 2007). Most of these 
xenobiotic compounds persist in the environment because they exhibit 
structural elements or substituents that are not common in nature, thus limiting 
their biodegradability and potentially causing a huge impact on living 
organisms and ecosystems (Esteve-Núñez et al. 2001). The most common 
amongst such compounds are the nitroaromatic or nitroheterocyclic compounds 
used in the synthesis of explosives, pesticides, herbicides, dyes, 
pharmaceuticals, etc. They are characterised by the presence of one or more 
nitro (NO2) groups on a heterocyclic or aromatic nucleus that confer additional 
stability, rendering their degradation difficult (Blasco & Castillo 1997; Kulkarni 
& Chaudhari 2007). Nevertheless, some microorganisms, mostly bacteria, have 
developed the capacity to metabolise some nitroaromatic compounds, either by 
aerobic or anaerobic processes. Aerobic degradation occurs mainly through the 
action of mono- and di-oxygenases and it is the principal degradation 
mechanism for mononitroaromatic and even for some dinitroaromatic 
compounds (Roldán et al. 1998; Caballero et al. 2005a). In the case of 
polynitroaromatic compounds, the deficiency of electrons in the ring caused by 
the nitro groups impairs the action of oxygenases, and thus, reduction is 
favoured, both in aerobic or anaerobic conditions (Johnson & Spain 2003; Kim 
and Song 2005). This process can occur either by the reduction of the aromatic 
ring through hydride-Meisenheimer complex formation or by the action of 
bacterial nitroreductases.  
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Nitroreductases belong to the family of flavin-coupled dehydrogenases and 
reductases that are able to reduce a broad range of nitroaromatic compounds as 
well as quinones and flavins, using both reduced nicotinamide adenine 
dinucleotide (NADH) or reduced NADPH for catalysis (Haynes et al. 2002; 
Chaignon et al. 2006; Choi et al. 2008). Enzymatic nitroreduction can be 
performed either through a one- or two-electron mechanism, generating the 
nitroso, hydroxylamine and amino derivatives. In the first case, the catalysts can 
only mediate the reduction of nitroaromatics under anaerobic conditions 
(Watanabe et al. 1998; Lee at al. 2008). They are termed oxygen-sensitive or 
type II nitroreductases, because the formed radicals are easily reoxidised to the 
parent compounds by O2 generating superoxide, in the so called “futile cycle”. 
In the latter case, the enzymes catalyse the reduction of nitro groups through the 
addition of sequential electron pairs from NAD(P)H, and are denominated 
oxygen-insensitive or type I nitroreductases, because this process does not 
produce superoxide. Nitroreductases are widely distributed in the bacterial 
kingdom but although several nitroreductases have been characterised both 
structurally and biochemically, particularly the minor nitroreductase from E. 
coli, NfnB (Zenno et al. 1996b, c; Parkinson et al. 2000; Race et al. 2002; 
Johanson et al. 2003), the physiological role of these proteins is still an 
unanswered question. Nevertheless, due to their capacity to reduce many types 
of polynitrated compounds, their role in detoxification has been well accepted 
but the potential application of emergent nitroreductases from different bacterial 
sources remains unexplored (Roldán et al. 2008). Rhodobacter capsulatus B10 
is a purple nonsulphur gram-negative bacterium that exhibits an extensive range 
of metabolic capacities (Pérez-Reinado et al. 2005), including photosynthesis, 
lithotrophy, and aerobic and anaerobic respiration. This biochemical versatility 
together with its genetic characteristics allows the bacterium to survive in a 
variety of habitats, including nitroaromatic contaminated environments (Blasco 
& Castillo 1997). Genomic studies on this bacterium have shown the presence 
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of several nitroreductases (Blasco & Castillo 1993) one of which, classified as 
its major nitroreductase and termed NprA, is highly induced by several 
aromatic, nitroaromatic and heterocyclic compounds, including benzopyrene, 
nitrofurazone, the prodrug CB1954, paraquat and 2,4-dinitrophenol, and 
inhibited by dicoumarol or copper (Pérez-Reinado et al. 2008). Our interest in 
R. capsulatus NprA arises from its potential in different biotechnological 
applications. Here we report the three-dimensional structure of NprA with the 
bound flavin mononucleotide (FMN) and acetate, a known inhibitor of the type 
I oxygen-insensitive nitroreductases (Haynes et al. 2002).  
6.3. Materials and Methods 
 
6.3.1. Expression and purification of npra gene from R. 
capsulatus B10  
 
The expression and purification of the major nitroreductase from R. capsulatus 
have been described elsewhere (Pérez-Reinado et al. 2005). Briefly, cells of 
Escherichia coli JM109 harbouring the His6-tagged npra gene were grown in 
2L of LB medium supplemented with 100 !g!ml-1 of ampicillin at 310 K, until 
an OD600nm of approximately 0.6 was reached. The cells were then induced with     
0.3 mM isopropyl-!-D-thiogalactoside (IPTG) for 3h at 301 K, harvested by 
centrifugation (10 000g, 30 min, 277 K) and the obtained pellets were stored at 
253 K, until further use. Cells were resuspended in TIDC Buffer (50 mM Tris-
HCl pH 8.0, 3 mM imidazole, 0.2 mM 2,4-dinitrophenol, supplemented with a 
cocktail of protease inhibitors) and disrupted by sonication (90W for 15s). 
Unless stated differently, all of the following purification protocol was 
manually executed at 4°C. Crude cell extract was obtained by centrifugation at 
27 000g for 40 min, and 1.5 M of NaCl and 10% (v/v) of glycerol were added to 
the collected supernatant. The clarified extract was then applied onto a 1 ml Ni-
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NTA affinity column (Qiagen), pre-equilibrated with buffer A (50 mM Tris-
HCl pH 8.0, 3 mM imidazole, 0.2 mM 2,4-dinitrophenol, 1.5 M NaCl, and 10 % 
(v/v) glycerol) at a flow rate of approximately 0.5 ml!min-1. The column was 
washed thoroughly with buffer A, followed by buffer B (50 mM Tris-HCl pH 
8.0, 3 mM imidazole, 0.2 mM, 2,4-dinitrophenol, 0.15 M NaCl, and 5 % (v/v) of 
glycerol) to remove any unbound protein, before a gradient of buffer B and 
buffer C (50 mM Tris-HCl pH 8.0, 250 mM imidazole, 0.2 mM                      
2,4-dinitrophenol, 0.15 M  NaCl, 5 % (v/v) of glycerol) was applied. The eluted 
fractions of NprA were immediately pooled, buffer-exchanged with 50 mM 
Tris-HCl pH 8.0, 75 mM NaCl, and 0.2 mM 2,4-dinitrophenol, and concentrated 
using Vivaspin 500 concentrators (Vivascience Ltd, UK) with a 10 kDa cut-off. 
The composition and purity of the eluted fractions were confirmed by SDS-
Page analysis and only homogenous fractions were used subsequently. The 
protein concentration was determined by absorbance at 280 nm in a NanoDrop 
ND-1000 Spectrophotometer using an extinction coefficient of 26930 M-1!cm-1. 
The protein was concentrated in a Vivapore 10/20 concentrator (Vivascience 
Ltd, UK) to approximately 10 mg!ml-1 before storage at 193 K.  
 
6.3.2. Protein crystallisation  
 
Protein crystallisation screens were performed in a Cartesian PixSys 4200 robot 
(Genomic Solutions, U.K.) using the vapour-diffusion method. 384 sitting 
drops consisting of 100 nl of protein solution at 10 mg!ml-1 plus 100 nl of 
precipitant solution were equilibrated against 100 µl of precipitant solutions 
from crystallisation screens Index and Crystal Screens I & II from Hampton 
Research (Aliso Viejo, USA), JCSG and PACT screens from Qiagen Canada 
Inc. (Montreal, Canada). A crystalline precipitate was found in various drops 
from the different screens, but only solution B7 (100 mM sodium acetate pH 
4.6 and 8% (w/v) polyethylene glycol 4000) from the JCSG screen gave visible 
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single crystals. Manual reproduction and further optimisation of these 
conditions to promote crystal growth proved to be unsuccessful, and X-ray 
diffraction analysis was performed with the micro-crystals obtained in the 
above condition directly from the robot. Cryoprotection of crystals was 
achieved by transferring them into a solution of mother liquor with higher 
precipitant concentration (12% (w/v) of PEG 4K instead of the initial 8%) 
supplemented with 25% (v/v) glycerol. The same crystallisation screens were 
also tried with NprA at 10 mg!ml-1 incubated (for 30 minutes) with different 
ligands namely (1) 200 µM of CB1954 prodrug, (2) 200 µM of 6,7-dimethyl-
5,6,7,8-tetrahydropterine (DMPH4), (3) 160 µM furazolidone and (4) 0.2 mM of 
reduced nicotinamide adenine dinucleotide (NADH) (Pérez-Reinado et al. 
2008). Due to their reduced solubility, the first three ligands were prepared in 
20% DMSO. All the different ligands produced crystalline material only with 
solution G2 (100 mM HEPES pH 7.5, 22% (w/v) polyacrylic acid 5100 sodium 
salt and 20 mM magnesium chloride) of the JCSG screen, but once again the 
original conditions were found not to be reproducible by hand. In the end, these 
tries led only to NprA-NADH plate-like crystals, which were suitable for 
manipulation and X-ray analysis. Cryoprotection was obtained by quick 
soaking into a solution of mother liquor supplemented with 200 µM of NADH 
(to avoid back soaking and release of the ligand) and 25% (v/v) glycerol. All 
ligands were purchased from Sigma (Sigma-Aldrich, France). 
 
6.3.3. X-ray diffraction analysis and data processing 
 
Cryoprotected native and NADH-bound NprA crystals were flash frozen in 
liquid nitrogen and diffraction data collected at the European Synchrotron 
Radiation Facility (ESRF), Grenoble, France, at station ID23-2. Reflection 
intensities were processed with MOSFLM (Leslie 1992), scaled and merged 
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together with SCALA, and reduced to structure factor amplitudes using TRUNCATE 
from the CCP4 Suite (Collaborative Computational Project, Number 4, 1994).  
 
6.3.4. Structural solution and refinement 
 
NprA phases were obtained by molecular replacement using PHASER (McCoy et 
al. 2005) and the model of Enterobacter cloacae nitroreductase (NTR; PDB 
code 1KQB; Haynes et al. 2002) as the search structure that shares, according 
to the CLUSTALW alignment program (Higgins et al. 1994), a sequence identity 
of 30% with the R. capsulatus NprA. ARPWARP was used to correct the sequence 
and extend the docked model (Perrakis et al. 2001), which was iteratively 
completed and corrected on a graphics workstation using COOT (Emsley & 
Cowtan 2004) and structurally refined with PHENIX.REFINE (Afonine et al. 
2005). Whenever persistent positive (mFo-DFc) (Read 1986) density blobs 
were found, solvent molecules were added as water, acetate or glycerol 
molecules, based on the particular electron density shape and chemical 
environment. The progress of the refinement was monitored by the use of Rfree, 
where 5% of the reflections were consistently set aside for cross-validation. 
 
6.3.5. Structural analysis of NprA 
 
Molecular stereochemistry was evaluated with PROCHECK (Laskowsky et al. 
1993), intermolecular contacts and crystallographic packing was checked with 
PISA (Krissinel & Henrick 2007), structural comparisons among produced 
models were performed with SSM (Krissinel & Henrick 2004). The CCP4 
(CCP4 1994) program BAVERAGE was used to determine average atomic 
displacement parameters (a.d.p.). Images were prepared using Pymol (Delano 
2008). 
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6.4. Results and discussion  
 
6.4.1. NprA crystal characterisation  
 
The eluted protein fractions obtained using the described procedures (section 
6.3.1.) were analysed on an SDS-Page gel. The protein migrates as a single 
polypeptide with an estimated molecular mass of 25.3 kDa (23.0 kDa of the 
peptide plus 2.3 kDa of the tag). Only the fractions containing pure NprA 
(Figure 6.1.) were used in the crystallisation trials.    
 
 
 
 
 
 
 
 
Figure 6.1. Purification of the NprA native protein.  
SDS-Page analysis of purified NprA using Coomassie blue staining. Fractions containing pure 
NprA were pooled together and concentrated up 10 mg!ml-1. Legend Gel1: 1. Before induction; 
2. After induction; 3. Insoluble fraction; 4. Soluble fraction; 5. Column flow-through; 6-10. 
Eluted NprA fractions; Legend Gel2: 1-10. Eluted fractions of NprA. 
 
A data set to 2.0 Å resolution (Figure 6.2.) from the best native NprA crystal 
was collected. The crystal belongs to space group C2, with unit cell dimensions 
of 103.19, 53.95 and 79.11 Å, and !=101.31. An estimation of the number of 
molecules in the asymmetric unit (a.u.) based on the resolution dependent 
distribution of the Matthews coefficient (Matthews 1968; Kantardjieff & Rupp 
2003) indicates the presence of two molecules in the a.u., with a probability of 
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99 %, which corresponds to a Matthews Coefficient VM= 2.35 Å
3/Dalton and a 
solvent content of 47.6 % (see Table 6.1. for diffraction data statistics).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2. Crystals of NprA and their diffraction pattern.  
(a) NprA forms yellow polyhedral crystals in the nano droplets in the crystallisation robot, after 
6h of growing time. (b) NprA crystal mounted on a mesh-loop at the beamline ID23-2 at the 
ESRF (France) ready for data collection. (c) Diffraction image showing spots up to 2 Å 
resolution of the NprA crystal taken at the micro focus beamline ID23-2 at the ESRF (France) 
(d) NprA-NADH crystals in the crystallisation robot droplets after 3 days of growth (e) NprA-
NADH crystal mounted on a litho-loop (f) Diffraction pattern showing spots up to 8 Å 
resolution for the NprA-NADH crystal taken at ID23-2 beamline at the ESRF (France), prior to 
data collection. 
(c) 
(f) 
(a) 0.1 mm 
(d) 0.1 mm 
(b) 0.05 mm 
(e) 0.05 mm 
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Table 6.1. Crystal and diffraction data statistics for native NprA. 
 
Crystal
 
NprA_native
 
ESRF beamline ID23-2 
Wavelength (Å) 0.873 
Resolution (Å) 39.01-2.0 (2.11-2.00) 
Space group C2 
Unit cell dimensions a, b, c (Å) 103.19, 53.95, 79.11 
! (°) 101.31 
No. of measured reflections 115101 (16425) 
No. of unique reflections 
29030 (4165) 
Reflections redundancy 4.0 (3.9) 
<I>/<! (I)> 5.0 (1.5) 
R
pim
a
 0.079 (0.29) 
R
rim
b
 0.160 (0.58) 
R
sym
c
 0.138 (0.50) 
Completeness (%) 100.0 (100.0) 
Mosaicity (º) 0.7 
V
M
 (Å
3
Da
-1
) 2.35 
Solvent content (%) 47.6 
Wilson B (Å
2
) 13 
Estimated no. of molecules in ASU 2 
 
Data within parenthesis refer to the outer resolution shell; 
a
R
pim
 = !
h 
[1/(N-1)]
1/2
 !
i
 |I
i
(h)
 
- <I(h) >| / !
h
 !
i
 I
i 
(h), where N is the data redundancy, I is the observed intensity and <I> is the average intensity of multiple 
observations from symmetry-related reflections. It is an indicator of the precision of the final merged and averaged data set; 
b
R
rim
 = R
meas
 = !
 " 
[#/(#$1)]
1/2
 !
 i
 |I
i
(h)
 
- <I(h)>| / !
 
h
 !
 i
 I
i 
(h), where N is the data 
redundancy, I is the observed intensity and <I> is the average intensity of multiple observations of symmetry-related reflections.  It is an indicator of the average spread of the individual measurements; 
c
R
sym
 = !
h
 !
i
 |I
i
(h)
 
- 
<I(h)> / | !
h
 !
i
 I
i 
(h), where I is the observed intensity and <I> is the average intensity of multiple observations from symmetry-related reflections. 
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Regarding the fragile NADH-bound plate-like crystals (see above Figure 6.2.), 
diffraction data was very poor (! 8 Å resolution), and no further X-ray analysis 
was performed.  
 
6.4.2. Phasing and structural refinement of NprA 
 
A molecular replacement search by PHASER (McCoy et al. 2005) using the 30% 
sequence identity model of NTR from Enterobacter cloacae (PDB code 1KQB; 
Haynes et al. 2002) as target structure, led to final translational z-scores of 5.0 
and 18.3, for each of the two molecules.   
Readily interpretable electron density maps were produced, however due to the 
initial treatment of the E. cloacae NTR model with CHAINSAW, truncating all 
non-conserved residues to alanines, the molecular replacement solution lacked 
most of the side-chains. The MR solution was visually inspected using COOT 
and some regions of the structure were missing. The initial NprA model was 
then fed into the automated building program ARPWARP (Perrakis et al. 2001), 
extending the protein chain to 374 (out of 420) residues, all correctly docked in 
the sequence. The protein and solvent structure were examined at a graphics 
workstation against their !A-weighted maps (Read 1986), and the model 
completed and improved to fit their features. Consecutive cycles of structure 
refinement and manual editing were repeated until convergence of Rwork/Rfree to 
18.3/20.6 %. Using all data the final R factor is 18.0 %. The stereochemical 
analysis of the refined model of native NprA, using PROCHECK (Laskowsky et 
al. 1993) revealed 99.3%, 0.7%, 0.0% and 0.0% of residues in the most 
favourable, additional allowed, generously allowed and disallowed regions of 
the Ramachandran plot, respectively. 
 
Doctoral Thesis by Joana Rocha (2010) 
 
Page 144 
Table 6.2. Refinement and model quality statistics for native NprA. 
 
 
Parameter NprA (Native) 
R
work
 (%) 18.3 
R
free
 (%) 20.6 
R (%) 18.0 
Average <a.d.p.> protein (Å
2
)  14.3 
Flavin mononucleotide (FMN) <a.d.p.> (Å
2
)  8.6 
Number of residues 425 
Solvent water molecules 234 
Ligand molecules (FMN, acetate, glycerol) 5 
Number of atoms (monomer A) 1663 
Number of atoms (monomer B) 1618 
Results for monomers (A and B) 
Average <a.d.p.>  protein (Å
2
) 14.1, 14.4 
Average <a.d.p.>  main-chain (Å
2
) 12.1, 12.6 
Average <a.d.p.>  side-chain (Å
2
) 16.3, 16.4 
 Average <a.d.p.>  Flavin mononucleotide (Å
2
) 8.1, 9.0 
Average <a.d.p.>  acetate (Å
2
) 17.8, 17.6 
Deviations from the ideal 
Bond distances (Å) 1.549 
Bond angles (º) 0.018 
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6.4.3. NprA crystal contents 
 
Even though a methionine residue is reported as the first residue in the NprA 
sequence, the DNA manipulations and the cloning of the npra gene into the 
pQE32 vector (Pérez-Reinado et al. 2005) have created a linker of about 10 
residues between the 6x histidine tag and the first protein residue, modifying it 
to a glycine. This linker has the sequence “GIFENGLYFQ”, however, only the 
last five residues (GLYFQ) of this long linker are visible in the electron density 
map, and only in one of the monomers. All remaining 210 residues could be 
found in the electron density for each monomer, although some side-chains, not 
entirely visible in the electron density maps needed to be modelled 
stereochemically. They belonged to hydrophilic residues exposed to the solvent, 
and their refined a.d.p. values reflect their disordered behaviour. Each monomer 
of NprA binds a flavin mononucleotide (FMN) molecule, and an acetate ion 
was found near the prosthetic group binding site. The final model includes a 
total of 425 amino acid residues, 2 FMN cofactors and 2 acetate ions as ligands, 
234 solvent molecules modelled as waters and 1 molecule as glycerol (see 
Table 6.2. above for further details). 
 
6.4.4. NprA overall structure 
 
Although only low to moderate sequence identities exist between Rhodobacter 
capsulatus NprA and the other members of the family with available tertiary 
structure, being 30% for the closest related structure, the E. cloacae NTR 
(Haynes et al. 2002), the three-dimensional superposition of NprA with other 
nitroreductase (NR) structures shows a conserved overall fold. Both the E. 
cloacae NTR and the major nitroreductase from R. capsulatus belong to group 
B of the Type I oxygen-insensitive NRs, which reduce a wide variety of 
nitroaromatic compounds, and use NADH and NADPH as electron donors.  
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In effect, the ability to use both molecules distinguishes these proteins from 
their homologues of group A, represented by the E. coli NfsA (PDB entry 
1F5V; Kobori et al. 2001), which use only NADPH as the electron donor, even 
though their overall fold is essentially the same (but see below).  
NprA is a homodimer of about 46 kDa. Each monomer exhibits an !+" fold 
with a 3-layer !"!-sandwich architecture common to the group B NRs, such as 
the representative member NfnB from E. coli, the NTR from E. cloacae or the 
FRaseI from V. fischeri (PDB entries 1DS7, 1KQB and 1VFR, respectively; 
Koike et al. 1998; Parkinson et al. 2000; Haynes et al. 2002). However, the 
domain organisation of NR family members has been differently characterised. 
Parkinson and co-workers have considered the E. coli NfnB as a three-domain 
protein, with a major central domain, a smaller flexible !-helical domain, and a 
C-terminal region tightly involved with the second monomer (Parkinson et al. 
2002). NR dimerisation involves residues from different regions of the peptide 
chains (discussed below) other than the C-terminal residues as referred for 
NfnB. In the classification used for the E. cloacae NTR (Haynes et al. 2002) 
and the V. fischeri FRaseI (Koike et al. 1998), both authors consider a two-
domain protein with a major central domain and a minor flexible domain. In the 
NprA structure described here we will follow the latter classification where 
each of the 210 residue monomers is composed of two domains (Figure 6.3.): a 
major central core formed by a twisted "-sheet surrounded on one side by two 
large !-helices, !2 and !6, and on the other side by two smaller !-helices, !3 
and !7; and a minor and flexible domain, comprising two !-helices, !4-!5 
located at one edge of the major domain !-sheet. This minor domain is thought 
to be important for substrate specificity (Koike et al. 1998; Parkinson et al. 
2000).  
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Figure 6.3. The monomeric structure of R. capsulatus B10 nitroreductase (NprA). 
NprA exhibits a three-layer (!"!) sandwich architecture. It comprises a major core (blue) 
formed by a central four-stranded anti-parallel twisted "-sheet surrounded by helical elements, 
two large !-helices on one side and two smaller ones on the other side; and a minor flexible 
domain (red) composed by two !-helices, thought to be involved in substrate specificity. 
Secondary structure elements are labelled numerically for both !-helical and "-strand 
components. 
 
When the protein dimerises, each minor domain blocks the access to the FMN 
of the dimer partner (see Figure 6.4. a, b). The minor helical domain is therefore 
responsible for the size of the substrate binding pocket, which explains in part, 
why NRs exhibit different substrate specificities and functions.  
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Figure 6.4. Three-dimensional structure of the dimeric NprA from R. capsulatus B10.  
(a) Cartoon representation of the physiological dimer of NprA with bound flavin 
mononucleotide and acetate ion (in stick representation and colour coded yellow for carbon, 
blue for nitrogen, red for oxygen and orange for phosphorus). The major domain is represented 
in blue and the smaller domain in red (dark and light colours are used for each monomer, 
respectively). Both polypeptide termini of the dark colours monomer are labelled. (b) Topology 
diagram of the NprA dimer, with !-helices represented as cylinders and "-strands as arrows 
(coloured as in a). Image prepared with TopDraw (Bond 2003). 
(a) 
(b) 
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Structural analysis of NprA shows an extensive interaction between the two 
monomers, involving their major and minor domains and both cofactors, 
pointing the dimer as the physiological unit, as reported for the other NRs.  
These interactions involve residues from the large central helix (!6), the !2 
helix, and interactions within the central mixed !-sheet. Similar to the other 
group B structures, the central "-sheet contains four anti-parallel strands, "1 to 
"4, joined to a fifth strand, "5, from the C-terminal part of the other dimer-
mate, which runs parallel to strand "1, thus forming a five-stranded sheet (see 
Figure 6.4. above). When compared to the other NRs, NprA shows a short "3-
strand (residues 151-153) whilst other structures have "3 with five residues. An 
analysis of the dimer structure indicates an interface area of 3180Å2 (26% of the 
total area of the monomer) corroborating the dimeric nature of NprA. It 
involves 81 residues (39%) of each monomer in a total of 66 polar interactions 
of which 53 hydrogen bonds and 13 salt bridges. The interface spans 
throughout the molecule, maintaining the enzyme as a compact dimeric unit, 
where N- and C-terminal residues are in close contact with the other monomer. 
The overall fold of NprA is similar to that of NfsA from E. coli (PDB entry 
1F5V; Kobori et al. 2001), representative of Group A NRs.  
The most obvious difference between them is in the small domain (Figure 6.5. 
a, b). In NprA it consists of helices "4 and "5 involving 30 residues, located 
between !2 and "6 of the major core domain, while in NfsA it consists of 16 
residues that include helix ("E), located between !2 and "F, of its major 
domain. However, 60 extra residues at the C-terminus of NfsA create an 
equivalent region (helices I and J), which superposes with the smaller domain 
of NprA second monomer (Figure 6.5. b). These differences make the substrate-
binding pockets of the two NRs different from each other.  
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Figure 6.5. The 3D superposition of NprA and NfsA Type I nitroreductases.  
The two enzymes belong to different families of the Type I NRs. NfsA (PDB entry 1F5V; 
Kobori et al. 2001) uses only NADP(H) as electron donor and is a member of Group A, whilst 
NprA uses both NADPH or NADH and belongs to the Group B (see Thesis Background for 
more information). (a) 3D superposition of NprA and NfsA monomers (coloured as in panel. (b) 
3D superposition of the NprA and NfsA dimers. Macromolecules in cartoon representation 
coloured blue and red for the major and minor domains of NprA (lighter colours for the dimer 
partner) and grey for NfsA.  
!I 
!J 
(a) 
(b) 
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While in the NprA, the smaller domain of one monomer hinders the access to 
the cofactor of the other subunit and models the substrate binding cavity (see 
Figure 6.4. and below), in NfsA, the cofactor and substrate binding pockets are 
modelled by a single peptide chain. Moreover, NprA can use either NADH or 
NADPH as an electron donor (Perèz-Reinado et al. 2005), while NfsA only 
uses NADPH (Kobori et al. 1999). Interestingly, another type of nitroreductase 
has been identified in bacteria, namely the hypothetical nitroreductase from 
Bacillus cereus (PDB entry 1YWQ, Zhang et al. to be published) or the 
minimal ydjA from E. coli (PDB code 3BM1; Choi et al. 2008; see Figure 1.16 
in section 1.2. for further details). These, as yet biochemically uncharacterised 
type I oxygen-insensitive nitroreductases, have the same fold as the Group B 
NRs, except for the absence of the minor helical domain. Because these 
different secondary structure elements are located near the FMN cofactor and 
substrate sites, in both Group A and Group B, it is probably the explanation for 
the different substrate specificity, but also to the different biological roles 
attributed to the several members of the NR family. Nevertheless, the similar 
overall fold reinforces the evolutionary relationship between the different group 
members and their origin in a common ancestral flavoprotein. 
 
6.4.5.  The flavin mononucleotide (FMN) binding pocket 
 
Each prosthetic group is located in a deep pocket at the interface of the NprA 
dimer, where they are firmly held in place by interactions with residues from 
both monomers (Figure 6.6). The flavin stacks against !3, at one edge of the 
central !-sheet and the phosphate interacts with the residues from the loop 
following !1. Residues from the other monomer, between helix "2 and strand 
!1, cap the other side of the flavin and create an interface crevice where the 
latter is nestled.  
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Figure 6.6. The flavin mononucleotide binding pocket of NprA.  
(a) Cross-eyes stereo representation of the FMN (with bonds as sticks coloured in yellow for 
carbon, blue for nitrogen, red for oxygen and orange for phosphorous) bound to the NprA dimer 
represented as a cartoon with a transparent representation of its solvent accessible surface 
mapped with a calculated electrostatic potential. NprA major and minor domains are coloured 
in dark blue and red respectively, and the other subunit is represented in the correspondent light 
colours. (b) FMN hydrogen-bonding interactions with peptide and solvent molecules 
(represented in black dashed lines). Solvent water molecules represented as red spheres. 
Residues are represented as sticks with carbon atoms in grey for one monomer and cyan for the 
dimer mate, nitrogen in blue and oxygen in red.  
(b) 
(a) 
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The cofactor exhibits a bent conformation characteristic of the NR family 
(Haynes et al. 2002). This distortion of the isoalloxazine ring has been termed 
as the “butterfly conformation” to indicate a bending about the N5–N10 axis 
(Johansson et al. 2003). Only a few residues amongst those involved in FMN 
interactions are conserved, although the protein-cofactor interactions are similar 
to the NR Type I family. In the NprA structure there are a total of four 
hydrogen bonds between the isoalloxazine ring and the protein although only 
Gly157 is conserved. Its main-chain amine forms a hydrogen bond with O4 
from the ring system (see above Figure 6.6.). The Glu156 main-chain amine 
interacts with N5, which is thought to be the site for the hydride transfer 
between the flavin and NAD(P)H (Koike et al. 1998; Johansson et al. 2003). In 
the FMN reduced state N5 is protonated and therefore the interaction with the 
main-chain amine of Glu156 cannot occur. Studies on different oxidation states 
of NfnB and NTR show an increase of the “butterfly bending” effect upon 
reduction, with an increase of the distance between the amine and N5, which 
moves out of the C4, N5 and C5 plane (see Figure 6.6. b; Johansson et al. 
2003). The Gln66 OE1 establishes a hydrogen bond with the N3 atom. In the V. 
fischeri FRaseI or the E. cloacae NTR structures, this residue is substituted by 
an asparagine (Asn73 or Asn71, respectively) while in the Streptococcus 
pyogenes structure (PDB code 2HAY; Kim et al. 2006, to be published) the 
residue at this position is a glycine (Gly71). A 3D superposition of these 
structures shows that the regions where these residues are located exhibit 
secondary structure variability, although the prosthetic groups of each 
superpose closely (see Figure 6.7.). Whilst in the S. pyogenes structure the 
main-chain interacts directly with FMN, the corresponding interaction in 
FRaseI and NTR is obtained via the side-chain of an Asn residue in an !-helix, 
and in the case of NprA the interaction comes from a loop located further away 
from the FMN, but using a residue with a longer side-chain, Gln66.  
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Figure 6.7. Variability of the peptide region harbouring the interaction with FMN N3 atom.  
The 3D-structural superposition of S. pyogenes NR (pink) (PDB code 2HAY; Kim et al. 2006, 
to be published), V. fisherii FRaseI (light blue) (PDB code 1VFR; Koike et al. 1998), E. 
cloacae NTR (green) (PDB code 1KQB; Haynes et al. 2002) and R. capsulatus NprA (in 
yellow) show the secondary structure variability of the region harbouring the conserved 
interaction between the peptide chain and the N3 atom from the cofactor. The NprA cofactor 
and Glu66 are represented in sticks coloured in yellow for carbons, blue for nitrogens and red 
for oxygen. The remaining cofactors are coloured according to the respective peptide structure.  
 
The O2 atom from the flavin interacts with NZ from Lys13. The positive charge 
at this position seems to be conserved throughout almost all the family 
members, with either an Arg or a Lys residue at this position. The exceptions 
are the putative nitroreductase ydfN from B. subtilis (PDB code 3BEM; Joint 
Centre for Structural Genomics, not published) and the uncharacterised 
nitroreductase ydjA from E. coli (PDB code 3BM1; Choi et al. 2008) where a 
serine can be found at this position, and the putative nitroreductase from 
Streptococcus mutans UA159 (PDB code 2IFA; Forouhar et al., not published) 
with a tyrosine. The O2 atom is also involved in two water-mediated hydrogen 
bonds with OE1 of Gln66 and NE2 of Gln68, respectively. Whilst the polar 
GLY-71 
ASN-73 
ASN-71 
GLN-66 
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region of the isoalloxazine ring is accessible to the solvent, the benzenoid 
portion of the ring system is buried in a hydrophobic patch composed of 
residues from both monomers (Figure 6.5. b), namely Tyr135, Phe138 and 
Pro154 from the monomer where the FMN docks, and Ser39 and Ile136 from 
the monomer that caps the other side of the flavin. The Ser39 side-chain lies 
above the central ring of the flavin, while the other residues establish van der 
Waals interactions with the apolar region of the FMN. Although the ribityl 
moiety of FMN shows no interactions with protein residues, but solely with 
solvent water molecules, it is well defined in the electron density as both its 
ends are firmly docked in the structure. The O2’ and O4’ hydroxyl groups 
interact indirectly with Lys13 N! and His96 NE2 from the dimer mate through 
two ordered water molecules. The same is not true for the phosphate group, 
which interacts extensively with the protein residues side-chains and main-
chain amines. O1P atom establishes hydrogen bonds with Lys197 NZ and NH1 
and NH2 from Arg199. O2P forms hydrogen bonds with NH1 and NH2 from 
the strictly conserved Arg9, while Ala11 donates its main-chain amine to 
hydrogen bond with O3P from the pyrophosphate moiety. In fact, in Group B 
NRs one observes a conservation of the positively charged network, although 
the involved residues are not always sequentially homologous.  
 
6.4.6.  The acetate binding pocket 
 
During the structure refinement and completion steps, triangular shaped 
features of positive density were detected above the isoalloxazine ring of each 
FMN (Figure 6.8). They were modelled as acetate ions in accordance with the 
crystallisation media (with an acetate concentration ca. 100 mM) and to the 
shape and size of the electron density. Upon refinement, their a.d.p. values 
converged to about 18 Å2 (see Table 6.2. above), in accordance with the average 
value for other solvent molecules. The acetate ions are held in place by 
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hydrophobic interactions with the isoalloxazine rings (at ca. 3.3 Å distance) and 
by hydrogen interactions with the ribityl O2’ hydroxyl and with the main-chain 
amine of residue Ser40 (from the dimer mate).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.8. Cross-eye stereo view of NprA substrate binding pocket with bound acetate. 
The small inhibitor molecule binds directly above C4 and C10 atoms of the cofactor’s central 
ring at approximately 3.3 Å establishing van der Waals interactions (magenta dashes). It 
interacts with both the cofactor and Ser40 main-chain amine from the dimer mate. NprA 
represented by its solvent accessible surface mapped with its electrostatic potential. Residues 
and ligands are represented as sticks, in red for oxygen, blue for nitrogen, orange for phosphate 
and grey or yellow for carbons in the peptide or ligand, respectively. The electron density map 
(2mFo-DFc) represented as light blue mesh contoured at 1.5!. 
 
Acetate is a known inhibitor of Type I nitroreductases as it is capable of acting 
competitively with the substrate NAD(P)H for the first half reaction, the flavin 
reduction, and uncompetitively for the second part of the reaction, the reduction 
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of the nitroaromatic (Koder et al. 1998; Haynes et al. 2002). Both the NTR 
from E. cloacae and E. coli NfnB structures have been determined in the 
presence of this small ligand (PDB code Haynes et al. 2002; PDB code 1YLR; 
Race et al. 2005). Other NR structures, determined in the presence of different 
ligands, helped to understand the inhibition phenomenon, especially the case of 
the NfnB from E. coli, bound to nicotinic acid (PDB code 1ICR, Lovering et al. 
2001), a substrate analogue for the first half of the reaction, with its carboxylic 
group at exactly the same position as the carboxylate of the small organic 
inhibitor. According to Haynes and co-workers the binding of carboxylate 
groups near the positive charges of NfnB Lys14 and Lys74, causes electrostatic 
interactions with these residues and may be the principle reason for the binding 
of these inhibitors (Haynes et al. 2002). In the NprA structure Lys14 and Gln68 
occupy these equivalent positions.  
A 3D structural comparison of E. coli and E. cloacae NRs against NprA shows 
a bigger substrate cavity for the latter, with wider putative access routes (Figure 
6.9. a). It is noteworthy, that in NprA one does not find a residue homologous 
to Phe124 of E. coli and E. cloacae NRs, which was found stacking with 
aromatic rings of different substrates (Figure 6.9. b; Parkinson et al. 2000; 
Lovering et al. 2001; Haynes et al. 2002). Due to the broad specificity of 
substrates and the low amino acid sequence conservation of Type I 
nitroreductases, it is still not clear what residues are relevant in the electron 
transfer with FMN, and what is the physiological role(s) of these proteins in 
their biological systems. Several attempts were carried out in order to elucidate 
the residues involved both in substrate binding and electron transfer. NprA was 
incubated with different ligands, including the 6,7-dimethyl-5,6,7,8-
tetrahydropterine (DMPH4), suggested as in-vivo product analogue, as NprA 
seems to have dihydropterine reductase activity (Péréz-Reinado et al. 2008). 
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Figure 6.9. The substrate cavities of NprA and E. coli NfnB.  
(a) NprA solvent accessible surface with docked FMN and acetate represented as sticks 
coloured in yellow for carbon, blue for nitrogen, red for oxygen and orange for phosphorus. (b) 
NfnB with docked FMN and CB1954 molecules, represented as in A. (c) Zoomed view of 
NprA and NfnB superposition, represented as in A and B, showing only NprA ligands. In 
NprA, the small domain (grey cartoon) shows an open conformation relative to NfnB (orange 
cartoon). In NfnB, Tyr68 and Phe124 define the substrate binding pocket. While Tyr68 of NfnB 
seems homologous to NprA Phe64, Phe124, considered an important residue in NfnB 
selectivity, has no apparent homologue in NprA. However, other aromatic residues, like Tyr110 
and Tyr118, may play its role.  
(a) (b) 
(c) 
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Crystallisation trials were assayed with the Nanodrop Crystallisation Robot in 
order to obtain crystals of NprA complexes with different ligands, using several 
crystallisation screens (see section 6.3.2.). Only plate-like crystals of NprA-
NADH could be obtained. They were very fragile, diffracted poorly up to 8 Å 
resolution (Figure 6.2. d, e, f) and were rather sensitive to radiation damage. 
Several attempts were tried to reproduce and optimise these crystals at micro 
litre scale, but they remained unsuccessful, as found with the native NprA 
crystals.  
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7. General Conclusions and future perspectives 
 
The work described in this thesis brings new information to the research 
community in both structural determination of two uridine-5’-diphospho-
glucose dehydrogenases (UGDs) from Burkholderia cepacia IST 408 and 
Sphingomonas elodea ATCC 31461, as well as new insights in their enzymatic 
mechanism, revealing the role of a conserved residue. Additionally, a Type I 
nitroreductase from Rhodobacter capsulatus B10, an enzyme with potential 
biotechnological applications, was also structurally characterised. The key 
results from four years of scientific research are summarised below. 
 
7.1. UDP-Glucose Dehydrogenase from 
Burkholderia cepacia IST 408 (BceC) 
 
BceC was produced and crystallised, and its native crystal structure was 
determined. Phases were obtained by molecular replacement (MR) using the 
homologous structure of Sphingomonas elodea UGD as the search model. The 
BceC crystal structure was refined to 1.75 Å resolution. BceC crystals belong 
to orthorhombic space group P212121 and exhibit 4 molecules of the binary 
complex BceC:UDP-GlcA in the asymmetric unit. BceC monomer has 
dimensions of approximately 75, 45 and 35 Å, and it is composed of two 
domains with !/" topology, connected by a four-helical bundle. Both N- and C-
terminal domains exhibit dinucleotide-binding Rossmann-like folds in a 3-layer 
!"! sandwich architecture, suggesting possible gene duplication in its origin. 
Curiously, whilst the N-terminal domain is used for cofactor (NAD+) binding, 
the C-terminal domain is not conventionally used for nucleotide-sugar binding. 
Instead, the substrate (UDP-Glc) binds in a cavity of the connecting !-helical 
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subdomain. This contains both the catalytic site and the homodimerisation 
responsible region. These characteristics are common to all known structures of 
the UGD/GMD family. In fact, all its members are known as active dimers, 
evidenced also in BceC by in vitro studies and the crystal packing analysis.  
A detailed 3D structural comparison of known UGDs shows that protein-
ligand(s) interactions are highly conserved in substrate and cofactor binding 
pockets. Similarly to P. gingivalis UGD, BceC shows an extra hydrogen bond 
between UDP-GlcA and its Tyr10 hydroxyl group. Tyr10 belongs to the N-
terminal Rossmann fold glycine rich signature motif, which in UGD/GMD 
family includes a further conserved tyrosine, GXGYXG. Except for P. 
gingivalis UGD, all other known UGD structures were obtained with a docked 
cofactor, which localisation necessarily obviated such an interaction due to a 
stereochemical overlap. A set of Tyr10 BceC mutants were produced, Y10F, 
Y10S and Y10K, of which the two latter could be crystallised, and their 
structures determined. Enzymatic studies of the mutants showed them to be 
almost inactive, thus highlighting the Tyr10 catalytic importance.  
In spite of the several literature available studies, with mutagenic and structural 
work on the enzymatic mechanism of the UGD/GMD family, the residue(s) 
involved in the final catalytic step, the hydrolysis of a thioester-intermediate, 
have as yet remained elusive. The BceC structural and mutagenic results 
presented in this Thesis show that Tyr10 functions as the catalytic, final proton 
conveyer from the aqueous system to a forming thiolate group, upon hydrolysis 
of the intermediate thioester, which results in UDP-GlcA.To further confirm 
this thesis, the kinetic analysis of BceC Y10E mutant, as well as mass 
spectrometry assays of the existing mutants are desirable. It is expected that 
Y10E will still enhance hydrolysis but, due to its negative charge, with 
efficiency lower than that of native BceC. Additionally, mass spectrometry 
studies of the almost inactive mutants may lead to identification of the thioester 
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intermediate covalently bound to BceC, if incubated with the reaction 
substrates.  
Another purpose of the present work was the comparison of BceC against 
human UGD, in order to explore potential medicinal applications. However, the 
high similarity of both structures may render difficult the design of a potentially 
selective inhibitor. Nevertheless, the insight into BceC structure and the 
explanation of its complete catalytic mechanism (and consequently, of the 
whole UGD/GMD family) should at least help and facilitate efforts towards the 
design of potential antibiotics based on structure-based inhibitors, to 
specifically combat this pathogen by hindering its capacity for cepacian 
production and biofilm formation.   
 
7.2. UDP-Glucose Dehydrogenase from 
Sphingomonas elodea ATCC 31461 (UgdG) 
 
Both native and seleno-methionine derivatised UgdGs were produced and 
crystallised, and diffraction data of their crystals were collected. The selenium 
derivative data enabled the crystal phasing at 3.4 Å resolution by single 
wavelength anomalous dispersion (SAD). The resulting structure was used in 
molecular replacement (MR) of the native crystals, which led to the 
crystallographic structure of UgdG at 2.37 Å resolution. 
UgdG is a member of the UGD/GMD family, which includes NAD+ dependent 
nucleotide sugar 6-dehydrogenases that convert alcohols into carboxylic acids. 
It is a macromolecule of 438 amino acids, where N- and C-terminal halves 
show analogous tertiary structures but irrelevant sequence homologies, 
suggesting probable gene duplication of the ancestral protein. UgdG comprises 
three-domains: a canonical Rossmann domain at the N-terminal part, which 
functions as core for the NAD+ cofactor binding, a central !-helical sub-
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domain, responsible for both the catalysis and homodimerisation, and a second 
Rossmann-like domain at the C-terminal part. A bound cofactor molecule was 
found present in the structure, even though the nicotinamide ring of NAD(H) 
was not visible in the electron density. Therefore it was modelled as an 
adenosine-diphosphoribose. Attempts to co-crystallise or soaking the complete 
cofactor remained unsuccessful, suggesting that the cofactor suffers degradation 
under the crystalisation conditions. A 3D structural comparison with other 
UGD-NAD(H) complexes revealed that the protein-cofactor (visible region) 
interactions were almost totally conserved, involving mainly residues of the 
Rossmann fold fingerprint region, the GXGXXG motif, the carboxylic acid 
(Asp30 in UgdG) and a conserved structural water molecule, characteristic in 
NAD-binding proteins. Similar to its bacterial homologues, UgdG is a dimeric 
protein, with the two subunits related by a non-crystallographic 2-fold rotation 
axis, where the N-terminal of one is in close proximity with the C-terminal of 
the other. A 3D phyletic comparison of the UGD/GMD family members has 
confirmed what the previous 1D analysis had suggested. The family is divided 
into four groups, with the prokaryotic members separated into two subfamilies. 
UgdG belongs to group I of prokaryotic UGDs closer to the eukaryotic 
members than the group II prokaryotic UGDs. Future work on this project may 
include an analysis of UGD/GMD family oligomerisation, in an attempt to 
correlate the different oligomeric states observed in the four subfamilies. 
 
7.3. Nitroreductase from Rhodobacter capsulatus 
B10 (NprA) 
  
The major Type I oxygen-insensitive NprA was produced and crystallised. Its 
crystal structure was solved by molecular replacement, using Enterobacter 
cloacae NTR as search model, and refined at 2.0 Å resolution.  
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Each NprA monomer is an !+" folded 210 residues peptide, exhibiting a 3-
layer !"! sandwich architecture, common of Type I group B nitroreductases. It 
is composed of two domains, a major central core formed by a twisted "-sheet 
surrounded by !-helices, and a minor flexible domain, comprising two helices 
that pack against an edge of the core "-sheet. NprA dimerisation occludes 26% 
of each monomer solvent accessible area, involving helices !6 and !2 of the 
major domain and residues from the C-terminus that surround the dimer mate 
and originate a five-stranded twisted "-sheet. In the dimer, the minor domain of 
one subunit caps the FMN cofactor of the other subunit, and helps form the 
substrate-binding pocket. The dimer contains two docked flavin 
mononucleotide (FMN) molecules, one for each chain, bound at the interface 
and establishing contacts with both subunits. Only a few residues are conserved 
in protein-cofactor hydrogen bonding interactions, as these involve mainly 
main-chain atoms and/or water molecules.  
Detailed 3D comparison of available Type I oxygen-insensitive NR structures 
from groups A and B shows a similar overall fold, with the major difference 
lying on the presence or absence of the minor domain, and its location in the 
structure. These differences may explain the diversity of substrates and the 
different biological roles attributed to the several members of the Type I NRs. 
Moreover, they reinforce the evolutionary relationship between the different 
NR members and the possibility of a common ancestral flavoprotein.  
Several attempts to obtain NprA-ligand complexes were carried out aiming to 
determine the residues involved in substrate binding and catalysis, in order to 
clarify its physiological role within R. capsulatus. Among the ligands tried in 
NprA complexes formation, we included NAD(H), one of the electron donors 
used by NRs, the prodrug CB1954, used in cancer therapy, as well as some 
nitroheterocyclic substrates, and dimethyltetrahydropterine (DMPH4), as NprA 
was pointed as a possible dihydropteridine reductase (DHPR). Unfortunately, 
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all complexes crystallisation attempts failed. One should however bear in mind 
that even the native crystals were obtained only twice, and their crystallisation 
conditions could never be reproduced or optimised, in spite of numerous 
attempts.  
Future work on this project should include an optimisation of the purification 
protocol by minimising manual procedures and by using mostly automated 
chromatographic systems, in order to reduce the actual level of crystallisation 
irreproducibility; further attempts of protein-ligands complex crystallisation, as 
well as in silico ligand docking studies. Such an approach would allow the use 
of actual 3D data to map the residues that most probably are involved in 
interactions with e.g. the CB1954 prodrug. Together, the results may not only 
elucidate the important residues involved in NprA activity but also give hints on 
the physiological role of NprA, and possibly extend it to the Type I oxygen-
insensitive family of NRs. 
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Appendix I. Signature Amidases 
 
8. The Amidase from Achromobacter xylosoxidans 
(Ana) 
 
 
This appendix describes the expression, purification, crystallisation and preliminary 
crystallographic studies of an amidase from Achromobacter xylosoxidans (Ana). The 
Escherichia coli clone harbouring the constructed plasmid pAna, was kindly given by 
Dr. Gang Cai and co-workers from the Laboratory of Molecular Biology, Institute of 
Plant Physiology and Ecology, of the Chinese Academy of Sciences (Shanghai, China: 
see reference Cai et al. 2005). 
 
 
8.1. Amidase signature (AS) family 
 
 
Peptide bonds are the most commonly occurring class of carbon-nitrogen bonds 
found in Nature. However, there is a wide range of other C-N bonds whose 
metabolism is not so well understood. These comprise the nitriles (R-C!N), 
acid amides (R-C(=O)-NH2), secondary amides (R-C(=O)-NH-R’) and others, 
which are the substrates for the nitrilase superfamily. This superfamily groups 
13 different branches based on their structure and sequence similarities. 
However, the substrate specificity is only known for some of these branches 
and the physiological role of these enzymes is still not clearly understood 
(Brenner 2002; Sharma et al. 2009). Historical reasons led to the classification 
of these enzymes as nitrilase-related, but only one of these branches exhibits 
true nitrilase activity (hydrolysis of nitrile generating the corresponding acid 
plus ammonia), whilst the remaining eight have apparent amidase or amidase-
condensation activities (see Figure 8.1.; Pace & Brenner 2001).  
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Figure 8.1. Types of reactions catalysed by the nitrilase superfamily members.  
(a) The nitrilase reaction is performed by branch one of the superfamily, where nitrile is 
hydrolysed to the corresponding acid and ammonia; (b) The amidase reaction is the most 
common throughout all of the superfamily, and involves enzymes from branches two, three, 
four, seven and eight, including the acylamide amidohydrolases; (c) the carbamylase reaction is 
a special case of the amidase reaction and it is catalysed by enzymes of branches five and six. 
Branch nine comprises the N-acyltransferases that catalyse the reverse amidase reaction (not 
shown), transferring a fatty acid to the N-terminal of polypeptides. Figure adapted from Pace 
and Brenner 2001. 
 
Acylamide amidohydrolases (EC 3.5.1.4) included in this superfamily cleave C-
N bonds and share the same !/" hydrolase fold, but can be divided into two 
different groups on the basis of their catalytic site and preferred substrate. The 
first group of amido hydrolases has a catalytic site composed of a Glu-Lys-Cys 
triad and can rapidly hydrolyse short-chain aliphatic amides like acetamide and 
acrylamide (Cilia et al. 2005).  
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Amino acid sequence comparisons have shown that this group has high 
similarity and motif conservation with the nitrilase branch of the superfamily. 
Members of this group possess the invariant cysteine and glutamate residues 
involved in the nitrilase catalysis, display a similar catalytic mechanism and are 
therefore also able to act on several nitrile compounds (Bork & Koonin 1994; 
Sharma et al. 2009). Pseudomonas aeruginosa (Andrade et al. 2007) and 
Helicobacter pylori (Skouloubris et al. 1997) amidases belong to this group.  
The second group of amido hydrolases includes the amidase signature (AS) 
members acting on mid-chain amides, some arylamides, !-aminoamides and !-
hydroxyamides, such as isobutyramide, valeramide, benzamide, 
phenylpropionamide and nicotinamide amongst others (Fournand & Arnaud 
2001). Enzymes included in this group are, for example, the enantioselective 
amidases from Bacillus sp. BR449 (Kim & Oriel 2000) and Rhodococcus sp. 
(Mayaux et al. 1991). Their biochemical role varies widely but they all possess 
an active centre composed of a Ser-cisSer-Lys catalytic triad. Besides this 
classical triad, some members of the family possess a putative additional Cys-
cisSer-Lys catalytic centre, which confers their bifunctionality, acting on both 
amides and nitriles (Cilia et al. 2005). This is the case of the well characterised 
signature amidases from Rhodococcus rhodochrous J1 (RhorhJ1; Kobayashi et 
al. 1993; Kobayashi et al. 1998) and Sulfolobus solfataricus (SsAH; Scotto 
d’Abusco et al. 2001). All of the AS members exhibit acyl transfer activity in 
the presence of hydroxylamine, leading to the formation of the corresponding 
hydroxamic acids (Fournand & Arnaud 2001; Andrade et al. 2007). The AS 
sequence was first identified by Mayaux (Mayaux et al. 1991) in a group of 
enzymes containing a highly conserved stretch of approximately 50-130 serine-
rich and glycine-rich amino acids, located in the centre of the protein structure 
(Chebrou et al. 1996; Shin et al. 2002). Moreover, this segment contains the 
consensus motif GGSS, which is strictly conserved in this class of amidases.  
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The AS family is a large class of enzymes spread throughout all of the three 
domains of living organisms. They are ubiquitous enzymes that catalyse the 
hydrolysis of C-N bonds (other than peptide bonds), and act on various 
endogenous and foreign aliphatic and aromatic amides (Scotto d’Abusco et al. 
2005; Andrade et al. 2007). A search in the protein databases shows more than 
200 members (most of them are putative, being derived from DNA sequences) 
distributed amongst 90 different organisms ranging across Bacteria, Archaea 
and Eukarya (Labahn et al. 2002; Shin et al. 2003). Whilst the biological 
function (the cleavage of the RCO-NH2 bond) of the AS family is common to 
all of the members, the biochemical function of these enzymes varies widely. It 
is important to point out that one microorganism can contain several amidases, 
like Rhodococcus sp. R312 (bacteria), from which a L-!-aminoamidase, an 
enantioselective amidase, an aliphatic amidase and specific formamide, 
nicotinamide and urea amidases have been annotated (Fournand & Arnaud 
2001). Several amidases have also been described for Aspergillus nidulans (a 
fungus), namely a formamidase (with formamide and glycinamide as 
substrates), an acetamidase (cleaving butyramide and valeramide amongst 
others) and a wide-spectrum amidase (hydrolysing aliphatic amides, but also 
arylamides like benzamide and phenylacetamide) (Hynes & Pateman 1970a; 
1970b; Frazer et al. 2001). Candida utilis (yeast) also possesses a wide-
spectrum amidase which efficiently breaks down acetamide, proprionamide, 
acrylamide, butyramide amongst others (Brady 1969). Kammermeier-Steinke 
and co-workers purified a peptide amidase from oranges (plants), a highly 
selective enzyme that hydrolyses C-terminal amide groups in peptides or N-
protected amino acids (Kammermeier-Steinke et al. 1993). However, most of 
the currently known and described amidases belong to bacteria, and span many 
different genera, such as Rhodococcus, Pseudomonas, Bacillus, Streptomyces, 
Alcaligenes (also known as Achromobacter), Helicobacter and others 
(Fournand & Arnaud 2001).  
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Three-dimensional structures have been determined for several members of the 
acylamide amidohydrolases (EC 3.5.1.4), both for the short-chain aliphatic 
amidases and the signature amidases (mid-chain aliphatic amidases) (groups I 
and II, respectively), either in their native form, or with bound substrates (Table 
8.1.). Bacterial amidases are widespread and their ability to hydrolyse several 
amides into the corresponding carboxylic acids and ammonia is of growing 
interest in biotechnology with potential applications in chemical and 
pharmaceutical industries, as well as in bioremediation. Moreover, their 
additional acyl transfer activity in the presence of hydroxylamine leads to the 
production of hydroxamic acids known for their chelating properties (Fournand 
et al. 1998). These compounds have a great variety of biological functions and 
low toxicities leading to potential use in different therapeutic applications 
(Vanjari & Pande 2003). As potent inhibitors of metalloproteases, they have 
also been investigated for treatment of anti-human immunodeficiency virus 
(Gao et al. 1995) and even applied to the treatment of ureaplasma infections or 
anemia (Holmes 1996). They have also been described for use as anti-malarial 
(Tsafack et al. 1995), antitumoural and anticancer agents (Kikushi et al. 2002), 
or as antibiotics (Komatsu et al. 2001). Apart from these medical applications, 
hydroxamic acids (particularly mid- and long-chain hydroxamic acids) have 
also been explored for their potential in wastewater treatments, as a way to 
eliminate contaminating metal ions (Koide et al. 1987). 
 
8.2. Ana from Achromobacter xylosoxidans 
 
Achromobacter xylosoxidans (A. xylosoxidans), also known as Alcaligenes 
denitrificans subsp. xylosoxydans, is an aerobic gram-negative motile rod with 
flagella. 
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Table 8.1. Structures of several acylamide amidohydrolases (EC 3.5.1.4) belonging either to group I, the short-chain aliphatic amidases, or group II, the 
amidase signature enzymes. 
 
 Organism Protein PDB code Reference 
Pseudomonas aeruginosa Amidase 2UXY Andrade et al. 2007 
Geobacillus pallidus Amidase 2PLK Agarkar et al. 2006 
S
h
o
rt-ch
ain
 alip
h
atic 
am
id
ases  (G
ro
u
p
 I) 
Helicobacter pylori Formamidase (AmiF) 2DYU, 2DYV, 2E2K, 2E2L Hung et al. 2007 
Thermatoga maritima Amido transferase 2GI3 
Joint Center for Structural 
Genomics (JCSG) 
Thermus thermophilus Probable amidase 2DC0 
RIKEN Structural Genomics/ 
Proteomics Initiative (RSGI)  
Stenotrophomonas 
maltophilia 
Peptide amidase (Pam) 1M21, 1M22 Labahm et al. 2002 
Rattus norvegicus Fatty acid amide hydrolase 1MT5, 2VYA, 2WAP 
Bracey et al. 2002; Mileni et al. 
2008; Ahn et al. 2009 
Staphylococcus aureus 
tRNA-Dependent 
Amidotransferase GatCAB 
2F2A, 2DF4, 2G5H, 2G5I Nakamura et al. 2006 
A
m
id
ase S
ig
n
atu
re (A
S
) en
zy
m
es 
(G
ro
u
p
 II) 
Bradyrhizobium japonicus Malonamidase E2 
1OBL, 1O9O, 1OBK, 1OCK, 1OCH, 
1OCL, 1O9P, 1OBJ, 1O9Q, 1O9N, 
1OBI 
Shin et al. 2003 
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In recent years, this microorganism has become an infrequent, but potentially 
serious nosocomial pathogen and an important cause of bacteremia, with a 
predilection for immunocompromised individuals, including cystic fibrosis 
patients. However, since it is often confused in clinical specimens with other 
non-fermentative, gram-negative rods, especially Pseudomonas species, its role 
as a significant pathogen may be underestimated. The strains involved in the 
infection are usually multiply resistant to antimicrobial therapy. This is 
probably due to the fact that this bacterium harbours three kinds of !-lactam 
acylases or !-lactamases (EC 3.5.2.6), capable of degrading !-lactam 
antibiotics such as penicillins, cephalosporins (which are relatively resistant to 
!-lactamase activity), cephamycins, and carbapenems. These antibiotics contain 
the four-atom !-lactam ring as a common element (Figure 8.2.).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.2. Structure of several antibiotics, belonging to the penicillin, cephalosporin, 
cephamycin and carbapenems classes.  
The !-lactamase enzymes are capable of degrading one or several of these compounds. 
Amidase (ana) from A. xylosoxidans has acylase activity towards some synthetic derivatives of 
cephalosporin. Figure adapted from www.wikipedia.org. 
Penicillin G 
Amoxicillin (penicillins) 
Ampicillin (penicillins) 
Cephalosporin C 
Cefoxitin (cephamycins) Meropenem (carbapenems) 
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The lactamase enzyme breaks the !-lactam ring open, deactivating the 
molecule’s antibacterial properties. A. xylosoxidans genome harbours a 
thermostable penicillin G acylase (Cai et al. 2004), a putative cephalosporin 
acylase (Zhu et al. 2003) and a !-lactam acylase capable of degrading 
ampicillin, cephalexin and amoxicillin (Plhackova et al. 2003). It is probably 
one of the few bacterial strains yet characterised with three kinds of !-lactam 
acylases. Whilst screening for a cephalosporin acylase in A. xylosoxidans, Cai 
and co-workers found a novel amidase (Ana) with deacylation activity for 
several cephalosporin structural analogues (Cai et al. 2005). This amidase is a 
509 residue peptide that belongs to the signature amidase family. In this work 
the overexpression, purification, crystallisation trials as well as preliminary 
analysis of the X-ray data for this novel amidase from A. xyloxidans are 
described, with the aim of structural characterisation and comparison with other 
members of the acyl amidohydrolase family. 
 
8.3. Expression and purification of Ana 
 
Overexpression of the ana gene was carried out by cultivation of Escherichia 
coli BL21 (DE3) transformants harbouring the plasmid pAna, in 1000 ml of LB 
medium supplemented with 50 µg.ml
-1
 of kanamycin at 310 K, until an OD600nm 
of 0.8 was reached. The cells were then induced with 0.5 mM isopropyl !-D-
thiogalactoside (IPTG) for approximately 4h at 299 K, harvested by 
centrifugation in a Beckman Instrument (10 000g, 30 min, 277 K) and the 
pellets obtained were stored at 253 K. Cells were resuspended in 50 mM 
sodium phosphate buffer at pH 8.0, supplemented with 10 mM imidazole,      
500 mM NaCl, and 10 µl of benzonase (Novagen), incubated for 10 min at 4°C 
and disrupted in a French press. The crude cell extract was obtained by 
centrifugation at 27 000g for 40 min at 277 K (Beckman Instrument; JA-20 
rotor) and the supernatant was applied onto a 5 ml HisTrap FF column (GE 
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Healthcare), previously equilibrated with 50 mM phosphate buffer pH 8.0, 
supplemented with 10 mM imidazole and 0.5 M NaCl (buffer A), and connected 
to an ÄKTA Explorer Instrument (GE Healthcare) according to the 
manufacturer's recommendation. The column was washed with buffer A to 
remove any unbound protein, and a gradient of concentration of imidazole (10-
500 mM) was applied. The A. xylosoxidans amidase eluted at approximately 
200 mM imidazole in a symmetrical chromatography peak (Figure 8.3.). The 
composition and purity of the eluted fractions were confirmed by SDS-Page 
analysis and only homogenous fractions were used (Figure 8.4.). The protein 
samples were immediately pooled and buffer-exchanged with 25 mM Tris-HCl 
pH 8.0, 100 mM NaCl and 1 mM dithiothreitol (DTT), using a PD10 desalting 
column (GE Healthcare).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.3. Affinity purification chromatogram of Ana from A. xylosoxidans.  
The protein absorbance (mAU) was measured at 280 nm (blue line). The protein eluted in a 
symmetrical peak at approximately 200 mM imidazole concentration (green line), on the 
HisTrap FF (5 ml) column (GE Healthcare). 
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Figure 8.4. SDS-page gel from the purification of Ana from A. xylosoxidans.  
The eluted fractions were loaded on a 10% acrylamide SDS-Page gel and stained with 
Coomasie Blue dye. Ana migrates as a single peptide band with molecular weight of ! 53 kDa. 
The Sigma Marker Wide Range (range from 6,500-200,000 Da; Sigma Aldrich) was used for 
calibration. All of the fractions showing pure protein were pooled and the protein concentrated 
up to 10 mg!ml
-1
 and stored at 193 K, until further use. 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.5. Molecular weight estimation of Ana using size exclusion chromatography.  
Size exclusion chromatogram for Ana (10 mg!ml
-1
) using a 24 ml Superdex 200 GL 10/300 (GE 
Healthcare), shows a single peak eluting with an approximate volume of 13.1 ml. Eluent buffer 
composition as follows: 25 mM Tris-HCl buffer pH 8.0 + 150 mM of NaCl + 1 mM DTT. The 
calibration curve of the molecular weight standards (Biorad) used (Thyroglobulin 669 kDa (9 
ml), Catalase 232 kDa (12 ml), Ovalbumin 43 kDa (15.2 ml), Chymotrypsinogen 25 kDa (15.7 
ml) and Ribonuclease 13.7 kDa (17.7 ml)) is shown (inset). 
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The protein was concentrated in a Vivapore 10/20 concentrator (Vivascience 
Ltd, UK) to approximately 10 mg!ml
-1
 before storage at 193K. The protein 
concentration was determined by direct measurement of absorbance at 280 nm 
in a NanoDrop ND-1000 Spectrophotometer using an extinction coefficient of 
47 245 M
-1
!cm
-1
. The homogeneity and oligomerisation state of the protein in 
the referred solution was analysed by size exclusion chromatography using a   
24 ml Superdex 200 GL 10/300 (GE Healthcare). The chromatographic results 
show a unique symmetrical peak, indicating a homogeneous species with a 
unique oligomerisation state (see Figure 8.5. above). The protein elutes from 
the column at 13.1 ml of buffer volume. This corresponds to an estimated 
molecular weight of about 110 kDa, suggesting that Ana displays a dimeric 
arrangement (under these experimental conditions), as the monomer has a 
molecular weight of 52.8 kDa. 
 
8.4. Crystallisation of Ana 
 
Protein crystallisation screens were performed using a Cartesian PixSys 4200 
crystallisation robot (Genomic Solutions, U.K.) using the vapour-diffusion 
method. 576 sitting drops consisting of 100 nl of protein solution at 10 mg!ml
-1
 
(or 5 mg!ml
-1
) plus 100 nl of precipitant solution were equilibrated against    
100 µl of precipitant solutions from crystallisation screens PACT, JCSG, Index, 
Crystal Screen I and II from Hampton Research (Aliso Viejo, USA) and 
QuickScreen, Grid screens Ammonium Sulphate, Sodium Malonate/Sodium 
Formate, MembFac and Natrix from Qiagen Canada Inc. (Montreal, Canada). 
Crystalline precipitates were found in various drops from the different screens, 
but only the Index and the JCSG screens gave three-dimensional crystals 
(Figure 8.6. a, b). Manual reproduction and optimisation of these conditions 
were tried in order to decrease nucleation and promote further crystal growth. 
Finally, only condition E7 from the JCSG screen (200 mM Zn(CH3COO)2,   
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100 mM Na(CH3)2AsO2 pH 6.5 and 10% (v/v) 2-propanol) showed 
reproducible results at the µl scale. Crystals were further improved (size and 
nucleation) by changing several parameters such as the ratio of protein vs. 
precipitant, the use of additives and detergents (Hampton Research, Aliso 
Viejo, USA), or even by the change of the initial precipitants, for example, use 
of ethylene glycol and glycerol instead of 2-propanol.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.6. Crystals of amidase from Achromobacter xylosoxidans.  
(a) Crystals obtained with the crystallisation robot in the precipitant solution E7 of the JCSG 
Screen from Hampton (200 mM Zn(CH3COO)2, 100 mM Na(CH3)2AsO2 pH 6.5 and 10% (v/v) 
2-propanol); (b) Manually reproduced crystals in the same conditions; (c) Optimised crystals 
(microlitre scale) obtained with the precipitant solution 200 mM Zn(CH3COO)2, 100 mM 
Na(CH3)2AsO2 pH 5.5, 8% (v/v) 2-propanol and 3% (w/v) 6-aminohexanoic acid. Crystals are 
quadrangular pyramidal shaped with dimensions of approximately 0.05, 0.05, 0.08 mm. 
 
The best shaped crystals (see Figure 8.6. c) were obtained at 293 K from sitting 
drops of 1 µl of protein solution at 5 mg!ml
-1
 and 1 µl of precipitant solution 
(200 mM Zn(CH3COO)2, 100 mM Na(CH3)2AsO2 pH 5.5, 8% (v/v) 2-propanol 
(a) (b) 
(c) 
0.05 mm 
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and 3% (w/v) of 6-aminohexanoic acid (aminocaproic acid) as additive, against 
500 µl of reservoir solution. Cryoprotection was achieved by passing the 
crystals through a cryostabilising solution of mother liquor supplemented with 
25% glycerol. The crystals were then cryocooled by plunging into liquid 
nitrogen and stored in the same conditions, until X-ray diffraction analysis was 
performed. 
 
8.5. X-ray diffraction analysis of the Ana crystals 
 
Crystals were tested and measured at the ESRF (Grenoble, France), on the 
beamline ID14-2, and the majority diffracted up to approximately 2.5 Å 
resolution (Figure 8.7.). Diffraction data were indexed and reduced, belonging 
to space group P212121 with unit cell dimensions of a=85.0 Å, b=86.3 Å, and 
c=264.4 Å. Data processing statistics for the best data set are given in Table 8.2. 
The Matthews coefficient (Matthews 1968) calculation, points to the existence 
of four molecules of amidase in the asymmetric unit of the crystals. 
 
 
 
 
 
 
 
 
 
 
Figure 8.7. Diffraction images for Ana crystals.  
The crystals were tested at the ESRF (Grenoble, France) at ID14-2 beamline. Crystals diffracted 
up to 2.45 Å and belong to space group P212121.  
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Table 8.2. Data processing statistics for native Ana’s crystal. Reflections were integrated with MOSFLM (Leslie et al. 1992), intensities scaled, merged with 
SCALA, and further reduced to structure factors magnitudes with TRUNCATE, programs from the CCP4 suite (CCP4 1994).  
 
Crystal Native Ana 
ESRF beamline ID14-2 
Wavelength (Å) 0.933 
Resolution (Å) 44.68-2.45 (2.58-2.45) 
Spacegroup P2
1
2
1
2
1 
a, b, c (Å) 85.0, 86.3, 264.4 
No. measured refs. 523575 (73248) 
No. unique refs. 72582 (10466) 
Redundancy 7.2 (7.0) 
I/!(I) 3.4 (1.9) 
R
pim
a
 0.059 (0.154) 
R
rim
b
 0.160 (0.411) 
R
sym
c
 
0.148 (0.380) 
Completeness (%) 100.00 (100.00) 
Mosaicity (º) 0.63 
V
M
 ( Å
3
Da
-1
) 2.30 
Solvent content (%) 46.5 
No. molecules in a.u. 4 
Wilson B (Å
2
) 38.0 
 
Data within parentheses refer to the outer resolution shell; 
a
Rpim = !
h 
[1/(N-1)]
1/2
 !
i
 |I
i
(h)
 
- <I(h) >| / !
h
 !
i
 I
i 
(h), where N is the data redundancy, I is the observed intensity and <I> is the 
average intensity of multiple observations from symmetry-related reflections. It is an indicator of the precision of the final merged and averaged data-set; 
b
Rrim = Rmeas = 
"
 # 
[$/($%1)]
1/2
 "
 i
 |I
i
(h)
 
- <I(h)>| / "
 
h
 "
 i
 I
i 
(h), where N is the data redundancy, I is the observed intensity and <I> is the average intensity of multiple observations of symmetry-related 
reflections.  It is an indicator of the average spread of the individual measurements; 
c
Rsym = !
h
 !
i
 |I
i
(h)
 
- <I(h)> / | !
h
 !
i
 I
i 
(h), where I is the observed intensity and <I> is the average 
intensity of multiple observations from symmetry-related reflections. 
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8.6. Preliminary results and discussion 
 
According to the sequence alignment performed with CLUSTALW (Thompson et 
al. 1997), the closest homologues of Ana having an available 3D structure, are 
the Glutamyl-tRNA amidotransferase subunit A (tm1272) from Thermatoga 
maritima (pdb code 2GI3, JCSG not published), the peptide amidase (Pam) 
from Stenotrophomonas maltophilia (pdb code 1M21, Labahn et al. 2002), the 
malonamidase E2 from Bradyrhizobim japonicum (pdb code 1OBK, Shin et al. 
2003), the fatty acid amide hydrolase from Rattus norvegicus (pdb code 1mt5, 
Bracey et al. 2002) and the tRNA-dependent amidotransferase (GatCAB) from 
Streptococcus aureus (pdb code 2F2A, Nakamura et al. 2006). Molecular 
replacement was attempted using these structures as search models, either 
singularly or combined as an ensemble and also using the programs PHASER 
(McCoy et al. 2005) or BALBES (Long et al. 2008). Unfortunately, all of the 
programs used failed to produce a solution. This is probably due to the low 
homology between Ana and the structures available, which is around 25-30%.  
 
While preparing this manuscript, the structure of the 6-aminohexanoate cyclic 
dimer hydrolase from Arthrobacter sp. KI72 was deposited (PDB entries 3A2P 
and 3A2Q; Yasuhira et al. 2010). By amino acid sequence alignment (Figure 
8.8.), this protein proved to be the closest homologue to Ana ever reported (32 
% and 51 % of sequence identity and similarity, respectively). For this reason, a 
molecular replacement was performed using the program MOLREP (Vagin & 
Teplyakov 1997) and the Arthrobacter hydrolase as a search model. The 
program was able to locate the four monomers present in the asymmetric unit of 
the crystals, with score values (contrast) of 3.07, 3.15, 5.19 and 5.93 for each of 
the four molecules.  
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Figure 8.8. Amino acid sequence alignment of Ana and its homologue from Arthrobacter sp. 
(PDB entry 3A2P).  
The sequence alignment performed with the program ClustalW (Thompson et al. 1997) shows 
the high sequence homology (marked with “*” or “:” for identical or homologue residues, 
respectively) between the two members of the amidase signature (AS) family. The GGSS motif 
that characterises these proteins is shown in blue (see above section 8.1.). 
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(b) (a) 
RESOLVE, with automatically implemented four-fold NCS averaging and the 
“prime and switch” procedure (Terwilliger 2004b) was used to improve the 
phases of the molecular replacement solution. Readily interpretable electron 
density maps were produced with a figure of merit for phasing of 0.68, and a 
model with 1285 out of 2036 possible residues (of which 308 docked in 
sequence) was produced (Figure 8.9. a, b).  
 
 
 
 
 
 
 
 
 
 
Figure 8.9. Electron density maps and amidase model obtained after density modification with 
the program RESOLVE (Terwilliger 2004b).  
(a) 2mFo-DFc electron density map (blue mesh) contoured at 1.0! covering the whole Ana 
crystal asymmetric unit with its four monomers. (b) Section of the 2mFo-DFc electron density 
map (light blue mesh) contoured at 1.0! showing a partial model with the sequence docked. 
The model is represented in sticks, coloured yellow for carbon, blue for nitrogen, red for 
oxygen and green for sulphur atoms. Images were prepared with COOT (Emsley & Cowtan 
2004). 
 
The protein and solvent structure were examined at a graphics workstation 
against their !A maps (Read 1986), and the model was extended and improved 
accordingly, using the program COOT (Emsley & Cowtan 2004). Steps of 
consecutive model editing and refinement with the program PHENIX (Afonine et 
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al. 2005) are now being carried out in order to obtain a complete three-
dimensional structure for the amidase of Achromobacter xylosoxidans. 
 
Note: Due to the fact that this manuscript was at its final stage of preparation 
when the homologue structure of Arthrobacter sp. hydrolase became available, 
no further work regarding the amidase from Achromobacter xylosoxidans was 
performed.  This lead to very preliminary and yet incomplete results on the 3D 
structure determination of Ana, hence this section was included as an appendix, 
instead of being a complete chapter of the PhD thesis. Carrying out the 
structural refinement and complete characterisation of Ana is one of the future 
objectives and perspectives. 
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Appendix II. Macromolecular Crystallography 
 
9. General Concepts  
 
X-ray crystallography is an efficient way of obtaining three-dimensional 
models of molecules that precipitate as single crystals revealing the exact 
position of most of its atoms. For enzymes these models can give detailed 
information about activity, recognition mechanisms towards substrate and/or 
cofactor binding and the conformational changes that those proteins might 
undergo. In this sense, 3D structures of macromolecules allow us to understand 
biological processes at the most basic level: how molecules interact, how 
enzymes catalyse reactions, how drugs act and, in some cases, it may help to 
understand the basics of diseases and help to develop new drugs. The 
determination of a three-dimensional protein structure is not a trivial process, 
although the dramatic development of X-ray crystallography in the last twenty 
years, linked partly with the availability of third generation synchrotron 
sources, has pushed forwards the understanding of some of the issues related 
with the technique, such as resolving the phase problem (see below). 
 
9.1.  The need for X-rays  
 
The human eye has difficulty in distinguishing details less than 0.1 mm in size, 
and for an enhanced visualisation of such small objects, we currently make use 
of optical microscopes. These work with visible light, making use of lenses that 
allow the formation of a magnified image of the object. However, even the 
most advanced optical microscopes fail to separate details less than about      
0.5 µm. Visible light is composed of electromagnetic waves spanning from 
wavelengths of about 350 nm (far violet) to 700 nm (deep red). 
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Considering that it is not possible to resolve features smaller than the 
wavelength of the light used in their analysis, to use visible light with 
wavelengths in the order of the hundreds of nanometres makes, for example, the 
distinction of objects separated by only 1 Å (0.1 nm) impossible. This is the 
case of covalently bound atoms at about 1-2 Å apart, or the case of strong polar 
interactions and hydrogen bonds, where distances vary between 2.5-3.5 Å. 
Thus, using light of equal wavelength or even smaller, to the size of the object 
under study, is imperative. X-rays are therefore essential in protein structure 
determination, as they can provide the correct wavelength, typically between 
1.9 and 0.6Å (with corresponding energies of 6 keV and 20 keV, respectively) 
to resolve atoms in a biological molecule (Blow 2002).  
In a conventional optical microscope, light strikes the object and is scattered in 
several directions and a lens collects the scattered rays and overlaps them, 
forming an image of the object. Unfortunately, microscopes that can collect X-
rays scattered from an object and use a lens or device to form an image of it are 
not available. 
 
9.2. The need for protein crystals 
 
In protein crystals the scattering results from a large 3D array of protein 
molecules, arranged in an ordered manner and in the same orientation (Figure 
9.1.). Protein crystals can thus act as signal amplifiers; working with single 
molecules would give rise to weak signals extremely difficult to detect. Of 
course, radiation damage (see below) will always occur, even for a protein 
crystal, because just as for any organic or living material, proteins are sensitive 
to ionising radiation (in this case, X-ray). 
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Figure 9.1. Arrangement of molecules in a crystal. 
The crystal structure is a periodic arrangement of a motif in a lattice. The motif or asymmetric 
unit can be a single atom or a protein molecule or a combination of related molecules. The unit 
cell describes the basic building block for the crystal, and is characterised by the lengths of its 
three edges (a,b,c) and the angles between them (!,",#). The crystal is built from unit cells 
arranged into a three-dimensional lattice, also known as the crystal lattice (adapted from 
http://www-structmed.cimr.cam.ac.uk/Course/Overview/Overview.html). 
 
The ionisation events created by X-rays interacting with the crystal result in the 
production of free radicals, which can destroy the protein crystal, particularly if 
one uses the very intense beams from synchrotron sources. However, even if 
the X-rays destroy some of the protein molecules, the overall effect on the 
scattering will not be as serious as for just one molecule. X-ray sources used in 
home laboratories are less intense, but less deleterious for the crystal sample.  
 
9.3. Protein crystallisation 
 
There are a number of potential bottlenecks in determining a three-dimensional 
structure of a protein, but growing a useful crystal is one of the most serious 
and time consuming.  
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The first stages of any protein crystallographic study are the purification and 
crystallisation of the protein sample, that is, the production of well-ordered 
single crystals of sufficient quality to diffract an X-ray beam, and to record the 
corresponding diffraction. However, to succeed in crystallisation one needs to 
control many different experimental variables both of thermodynamic and 
kinetic nature. Their refinement is still achieved today, only via empirical 
procedures. Crystallisation is the process in which a protein is transferred from 
a soluble state to a highly organised solid state (see Figure 9.1. above). Firstly, 
the formation of a periodically ordered initial aggregate of critical size has to 
occur (the nucleation step; Figure 9.2.). These nuclei have to be 
thermodynamically stable to allow more molecules to orderly aggregate, 
promoting the growth of a crystal (the growth step; Figure 9.2.).  
 
 
 
 
 
 
 
 
 
Figure 9.2.  The phase diagram for protein crystallisation. 
The two-dimensional phase diagram illustrates the change of protein concentration against the 
precipitant concentration. The concentration space is divided by the protein solubility curve into 
the undersaturated and supersaturated states. The supersaturated region comprises the 
metastable, nucleation and precipitation zones (adapted from Ducruix and Griege 1992). 
 
In both cases, a non-equilibrium super-saturated state is required that will cause 
the protein molecules to pass from the soluble to a solid crystalline state (Riès-
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Kautt 1999). A number of techniques have been developed for bringing a 
protein solution into a supersaturation state. Amongst them, the most frequently 
used methods in protein crystallisation are vapour diffusion, micro-batch and 
dialysis, and less frequently the use of matrix gels, like agarose (Unge 1999). 
Supersaturation of the protein solution can be achieved by all of these 
techniques, however the underlying principles of these methods vary. The 
vapour diffusion technique is the most common method in protein 
crystallisation, as it requires relatively small amounts of protein, thereby 
allowing many variables to be screened with the protein available (Figure 9.3.).  
 
 
 
 
 
 
 
 
Figure 9.3. Vapour diffusion experimental set-up in a) hanging drop and b) sitting drop 
techniques.  
In a sealed compartment, a drop mixture of protein solution and precipitant is allowed to 
equilibrate against a reservoir containing the precipitant solution at higher concentrations. The 
drop can be set on the compartment cover (hanging drop technique) or in a well inside the 
reservoir (sitting drop technique). 
 
This technique uses the evaporation and diffusion of water between solutions of 
different concentrations as a means of approaching and achieving 
supersaturation of protein macromolecules. In the experimental set-up, a protein 
solution (in concentrations ranging from 2-50 mg·ml
-1
) is mixed in a drop with 
the reservoir solution containing precipitant(s).  
(a) (b) 
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When the precipitant concentration in the protein/precipitant drop is lower than 
in the reservoir solution, water evaporates from the drop into the reservoir, 
increasing both protein and precipitant concentrations in the drop, thus 
promoting supersaturation. Crystals may form when the concentration of 
protein in solution passes its limit of solubility, reaching the nucleation zone of 
the supersaturated state (see above Figure 9.2.). When the first crystals appear, 
concentration of protein in solution decreases. Ultimately, these crystals will 
grow until the concentration of the protein in the drop reaches the solubility 
curve. Finding the best precipitant solution is the result of an empirical search. 
A common starting point is the so called sparse matrix approach, in which the 
above procedure is repeated hundreds or thousands of times, sampling different 
combinations of buffers and precipitating agents to find at least one condition 
that may lead to crystal formation. Optimisation of parameters such as protein 
concentration, protein/precipitant ratio, temperature, pH, ionic strength and 
additives can also be assayed once a first crystallisation condition has been 
found. In recent years, automation has played an increasing role in protein 
crystallisation since robots are able to produce, routinely and reliably, protein 
drops of about 100 nl. They are able to set thousands of conditions in a few 
hours, using less protein than previously necessary (Bergfors 1999). The 
visualisation of the crystallisation drops is also becoming increasingly 
automated, overcoming the problems of tedious manual inspection of such 
small and numerous of drops. Finally, once a suitably sized crystal has been 
found it has to be tested for X-ray diffraction and reproducibility. In this field, 
automation has also evolved tremendously over the last few years and the auto-
mounting of crystals is now routine at many synchrotron beamlines, allowing 
rapid crystal evaluation.  
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As referred to earlier, X-ray radiation is ionising, interacting with the molecules 
within the crystal and causing what is known as radiation damage. The extent of 
this damage is related to the absorbed radiation dose. The chemical damage in 
organic materials by X-rays or other forms of ionising radiation is believed to 
consist of two kinds of damage: primary and secondary. Primary damage is 
caused by direct interaction between the radiation beam and electrons, which 
may lead to the breaking of chemical bonds by the radiation, thus causing the 
destruction of molecules. Secondary damage arises from the resulting radiolytic 
products, e.g. free radicals that diffuse through the crystal, causing further 
chemical reactions that alter the structure of the molecules in the crystal lattice 
and damage the intermolecular contacts that stabilise the crystal (Teng & 
Moffat 2000; Holton 2009). Whilst primary radiation damage depends upon the 
energy and number of photons absorbed, secondary damage varies with the 
nature of the solvent and with factors such as temperature or the presence or 
absence of free-radical scavengers that affect the mobility and reactivity of the 
radiolytic products (Garman & Owen 2006). One way of decreasing the 
secondary radiation damage caused by X-rays is to cool the crystals using a 
nitrogen gas stream at about 100 K, thus slowing down the kinetics of radical 
diffusion (Garman 2003). However, one has to be careful not to produced ice 
during the cooling process, due to the solvent (water) content of protein 
crystals. If ice is formed during cryocooling, its expansion in the crystal solvent 
channels will create heterogeneities with concomitant crystal breakdown. 
Cryoprotectants, are compounds that increase the viscosity of the mother liquor, 
hindering aqueous hydrogen bond formation and prevent ice during cooling. 
Glycerol or polyethylene glycol (PEG), already present or added to the mother 
liquor, allow effective cryoprotection of protein crystals (Garman & Owen 
2006). 
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9.4. Interaction of X-rays and matter: the diffraction 
experiment 
 
When a protein crystal is exposed to X-ray radiation, the electron magnetic 
waves that constitute the X-ray beam will make the atomic electrons vibrate at 
the same frequency. This oscillation of the electrons will modify the 
electromagnetic field in the space around the crystal. Each unit cell in the 
crystal will behave as an emitter of electromagnetic waves that interact and 
interfere with the waves from the other unit cells. If the difference in the lengths 
of the paths taken by each wave, from different scattering elemental volumes is 
a multiple of the radiation wavelength, then the waves will scatter in phase, 
their amplitudes will add up and this will give rise to a diffraction spot, 
recorded at the detector device. Diffraction spots are often called reflections, 
because one can compare crystals to sets of thousands of “mirrors” that reflect 
the X-rays. These “mirrors” are called Bragg planes (Figure 9.4.). 
 
 
 
 
 
 
 
Figure 9.4.  Diagram of Bragg’s law for the X-ray diffraction. 
When an X-ray beam (wavelength !) strikes the crystal surface, the rays of the incident beam 
are always in phase and parallel up to the point at which the top beam strikes the top layer at 
atom z. The second beam continues to the next layer where it is scattered by atom B. The 
second beam must travel the extra distance AB + BC if the two beams are to continue travelling 
adjacent and parallel. This extra distance must be an integral (n) multiple of the wavelength (!) 
for the phases of the two reflected beams to be the same (adapted from 
www.eserc.stonybrook.edu/ProjectJava/Bragg). 
Bragg 
planes 
Incident  
beam 
Reflected 
beam 
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In order for the unit cells to diffract in phase, the Bragg planes must pass 
through the same points in all the unit cells in the crystal, this is to say, if the 
sets of planes are separated by one unit or an integral fraction of the unit cell 
edge, then they will pass through equivalent atoms in the different unit cells. On 
the other hand, if the planes divide the unit cell edge by a non-integral number, 
the different unit cells will diffract out of phase and the waves will cancel out. 
This is described by Bragg’s Law, described mathematically by the equation, 
n!=2dsin". The record of the intensity and position of all these reflections is 
called X-ray diffraction (see Figure 9.5.). The diffraction pattern consists of 
reflections of different intensity. Typically many hundreds or thousands of 
reflections need to be collected to record a complete data set. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.5.  The X-ray diffraction experiment.  
 The protein crystal is exposed to an incident X-ray beam from which diffraction results, upon 
interaction with the electrons present in the crystal. The intensity and position of the diffracted 
beams are recorded as images, from small incremental crystal rotations, the so-called “rotation 
method”. Data collection proceeds until a sufficient amount of diffraction data has been 
collected for structure determination. 
 
Crystal on a 
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Rotational 
Diffraction 
Pattern 
Cryostream  
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9.5. The final stage: 3D-structure determination 
 
9.5.1.  Crystal symmetry and space groups 
 
Protein crystals are aggregates of ordered and regular three-dimensional arrays 
of a polypeptide, in a repetitive and periodic geometrical arrangement. This 
geometrical arrangement is described by the crystal symmetry. Several 
symmetry operations can occur in a three-dimensional body, such as rotation, 
inversion, reflection, screw axis, glide planes or translation. A crystallographic 
point group is a combination of rotation, reflection and inversion operations 
that when applied to a crystal, leave a point fixed whilst moving every other 
atom to an equivalent position, making the crystal look the same before and 
after these symmetry operations are applied. A Bravais lattice corresponds to an 
infinite set of points that are generated by translational symmetry applied to all 
the atoms in the crystal. The crystal looks the same when viewed from any of 
these lattice points. In the case of proteins, some of the symmetry operations are 
not allowed. Proteins lack a centre of symmetry and are therefore called chiral. 
They possess “handedness”, because their C-alpha carbons are linked to four 
different moieties. An inversion of the naturally occurring L-amino acids (that 
compose proteins) would produce D-amino acids. This is also valid for mirror 
symmetry, as the reflection in a mirror of a left-handed object (e.g. L-amino 
acid) will give rise to a right-handed object (e.g. D-amino acid). In effect, only 
rotational and translational symmetry are allowed in protein crystals. However, 
crystal space and unit cell shape impose restrictions on these two symmetry 
operations. The stacking of unit cells in the crystal has to fill the complete space 
while obeying the rotational symmetry. Therefore, rotational symmetry follows 
n-fold symmetry (where n is an integer and an integral fraction of 360°), but 
only the 2-fold, 3-fold, 4-fold and 6-fold rotational axes may exist. It is not 
MACROMOLECULAR CRYSTALLOGRAPHY
 
Page 199 
possible to fill the complete crystal space with regular pentagons or heptagons, 
therefore no crystal lattice exists with 5, 7- or higher-fold rotational symmetry. 
Molecular assemblies, on the other hand, can have such symmetries inside the 
unit cells.  
Based on the possible combinations of the different symmetry operations and 
restrictions, 230 space groups exist (International Tables of Crystallography, 
Vol. I). Due to chirality of protein molecules, only 65 space groups are allowed 
for protein crystals, which are described in Table 9.1. Diffraction data 
collection involves several steps, such as testing the crystal to radiation 
(whether it diffracts or not), how much it diffracts (resolution), the dimensions 
of the unit cell (the repeating unit of the crystal), the internal arrangement of the 
molecules inside the crystal (space group), how it is ordered (mosaicity), etc. 
This is often achieved by analysis of a few diffraction images, at different 
crystal orientations. There are several software programs that allow the indexing 
(space group and unit cell determination) and reduction of the data (overall 
corrections of the experiment, accounting for errors and crystal damage, by 
scaling the data). In this thesis, different software packages were used for 
indexing and data reduction: MOSFLM / SCALA (Leslie 1992; Evans 2006) and 
DENZO / SCALEPACK (Otwinowski and Minor 1997). 
 
9.5.2. The phase problem 
 
The process of data collection of a biological macromolecule crystal in a 
diffraction experiment produces an enormous amount of data. Each diffraction 
spot (see Figure 9.5. above) represents a set of diffracted waves, defined by an 
amplitude and a phase (related to the intensity of the spot and to the relative 
arrival time of diffracted photons, respectively). Mathematically, each 
diffracted wave can be treated as vector, with amplitude and a phase or, in 
crystallographic language, a structure factor. 
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Table 9.1. The non-centrosymmetric space groups for protein crystals (Adapted from Blundell & Johnson 1976) 
Crystal System 
Axes of symmetry 
(rotational ) 
Geometrical  lattice 
constrains 
Possible 
Bravais 
Lattices 
Point 
groups 
Space groups 
Triclinic No axes of symmetry a!b!c !!"!# P 1 P1 
Monoclinic 2-fold axis parallel to b a!b!c !=#=90° !" P, C 2 P2, P2
1
, C2 
Orthorhombic 3 orthogonal 2-fold axes 
a!b!c !="=#=90° 
P, C, I, F 222 
P222, P2
1
2
1
2
1
, P2
1
2
1
2, P222
1
, C222, 
C222
1
, I222, I2
1
2
1
2
1
, F222 
Tetragonal 4-fold axis parallel to c a=b!c !="=#=90° P, I 
4 
422 
P4, P4
1
, P4
2
, P4
3
, I4, I4
1
 
P422, P42
1
2, P4
1
22, P4
1
2
1
2, P4
2
22, 
P4
2
2
1
2, P4
3
22, P4
3
2
1
2, I422, I4
1
22 
Trigonal 3-fold axis parallel to c 
a=b!c !="=90° #=120° 
a=b=c !="=#<120°, !90° 
P 
(or R) 
3 
32 
P3, P3
1
, P3
2
, R3 
P312, P321, P3
1
21, P3
1
12, P3
2
12, P3
2
21, R32 
Hexagonal 6-fold axis parallel to c 
a=b!c !="=90° #=120° 
P 
6 
622 
P6, P6
1
, P6
2
, P6
3
, P6
4
, P6
5
 
P622, P6
1
22, P6
2
22, P6
3
22, P6
4
22, P6
5
22 
Cubic 
four 3-fold axis along the 
diagonals of the cube 
a=b=c !="=#=90° 
P, I, F 
23 
432 
P23, F23, I23, P2
1
3, I2
1
3 
P432, P4
1
32, P4
2
32, P4
3
32, F432, F4
1
32, I432, 
I4
1
32 
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The inverse Fourier transform of the structure factors is the electron density 
(Figure 9.6.), which maps out all the crystal contents, in particular the electron 
density of the protein molecule. The amplitude of the structure factor is the 
square root of the observed intensity in each measured spot. However, the 
relative phase of the waves is not directly measurable during the diffraction 
experiment. This is known as the phase problem and, together with the 
crystallisation stage, is often one of the major bottlenecks in protein 
crystallography.  
 
 
 
 
Figure 9.6. The electron density equation.  
The x, y and z variables are the atomic coordinates that is, the position of each protein atom in 
the considered crystal volume, V. The Miller indices (h, k, l) define each set of Bragg planes, 
whereas F(h, k, l) is the corresponding structure factor, originated by the plane diffracted wave. 
 
Phases are crucial for the reconstruction of structural information and a large 
part of crystallography is devoted to solve the phase problem. Furthermore, the 
contribution of the phase information is dominant with respect to structure 
factor amplitudes in the calculation of the electron density map. It is therefore 
important to obtain accurate phases to determine a macromolecular structure.  
A miscalculated set of phases can lead to wrong or “fake” electron density map 
(www.ysbl.york.ac.uk/~cowtan/fourier/fourier.html). There are several methods 
by which the phases can be determined, requiring different diffraction 
experiments with different experimental conditions, or even the chemical 
modification of the protein crystal under study. These methods are briefly 
outlined below; two of which were used in the present studies: the molecular 
replacement (MR) and the single anomalous dispersion (SAD) methods.  
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1. Molecular Replacement. This method is used when a model from a 
similar protein exists, as in the case of homologous proteins. As the 
availability of newly determined protein structures increases every day, the 
possibility that an unknown structure shares common features with one or 
more characterised proteins (even if not necessarily participating in the 
same biological processes) becomes greater. The molecular replacement 
method consists of positioning the available 3D model in the unit cell of 
the target crystal, in such a way that the calculated diffraction of the model 
matches the experimentally measured data. In other words, making the 
model to fit the experimental data, and retrieving an electron density map 
using the calculated phases and the measured amplitudes. The positioning 
of the model (probe) is given by rotational and translational parameters, 
which fully describe the orientation and position of the probe in the unit 
cell (Figure 9.7.). There are several software packages available to perform 
molecular replacement. For the work described in this thesis, the programs 
PHASER  (McCoy et al. 2005) and MOLREP (Vagin & Teplyakov 1997) were 
used. 
 
 
 
 
 
 
Figure 9.7. Visual representation of the principles underlying the Molecular Replacement 
method.  
The model or probe is represented by A and the target molecule by A'. Rotating (orientating) 
and then translating (positioning) the probe, superimposes it onto the target molecule. [R] is the 
rotation matrix, and T is the translation vector. (Adapted from http://www-
cryst.bioc.cam.ac.uk/~dima/whitepapers/mr-in-action). 
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2. Single or Multiple Isomorphous Replacement (SIR/MIR). This method 
is based on the comparison of at least two protein crystals diffraction data 
sets. They should differ in one (or more) strong scatterer(s) present in one 
of the crystals but absent in the other, which will cause comparable 
differences between the measured intensities. This is achieved by 
crystallising the protein with (derivative) and without (native) the strong 
scatterer, which is normally a heavy atom, such as Hg or Pt. An alternative 
method is to soak native crystals in a solution containing heavy atoms, 
hoping that the heavy atom will bind tightly to a specific site(s) of the 
protein. This method requires that the native and derivative crystals have 
the same unit cell dimensions and symmetry (isomorphism). Of course, 
introducing these atoms in a protein will always disturb the protein 
structure (in the worst cases, completely destroying the crystal), so 
isomorphism is never perfect. The determination of the heavy atom 
substructure and combination of the native and derivative data, allows the 
calculation of preliminary experimental phases for the native protein, 
which in turn will be used to build an experimental protein model. The 
difference between the SIR and MIR methods is the number of derivatives 
used for the phase determination. With the SIR method one cannot 
determine a unique set of phases, still having to resolve the true hand of the 
structure. This can be performed using more derivatives (the MIR method). 
Several programs to calculate the experimental phases from a MIR/SIR 
experimental data are available, such as SOLVE/RESOLVE (Terwilliger 
2004a), SHARP (Vonrheim et al. 2005) and SHELXD/SHELXE (Sheldrick 
2008). 
 
3. Multiple and Single-wavelength Anomalous Dispersion (MAD/SAD). 
These techniques are dependent upon the presence of (mostly heavy) atoms 
in a protein structure, which cause small changes in the diffraction pattern 
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of a protein crystal. If the incident X-ray beam has the correct energy to 
excite the inner electrons in these atoms (absorption edge) part of the 
energy will be absorbed and electronic transitions occur. When the 
electrons return to the resting state, fluorescence will be emitted, and waves 
will be scattered. These waves will have a different phase but also a 
different intensity, as part of the energy is absorbed during the transition. 
This phenomenon is called anomalous scattering. The use of these methods 
has become very popular in phase determination firstly, due to the 
development of techniques to modify natural proteins by substitution of the 
sulphur (in methionine or cysteine amino acids) into selenium. Secondly, 
with the increase on the number of tuneable beam lines at synchrotrons, 
which allow the X-ray wavelength to be set to values close to an absorption 
edge of an anomalous scatterer. A fluorescence edge scan allows the 
measurement of the absorption edge of the anomalous scatterer(s) in the 
crystal, and should always be performed prior to a MAD/SAD diffraction 
experiment. The programs used on a MAD/SAD experiment are the same as 
for isomorphous replacement (see above). In this work only the programs 
SOLVE/RESOLVE (Terwilliger 2004a) and SHELXD/SHELXE (Sheldrick 2008) 
were used. 
 
4. Multiple Isomorphous Replacement with Anomalous Scattering 
(MIRAS). This method uses a combination of the MIR and MAD methods 
(as outlined above), and is effective when the heavy atom has enough 
measurable anomalous signal at the working wavelength. The differences 
in intensities from both the isomorphous signal and the anomalous 
scattering due to the presence of the heavy metal(s) in the crystal are used 
to calculate the experimental phases. 
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5. Ab Initio Phase Determination (Direct Methods). This phasing method 
relies on the use of arbitrary starting phases and it is based on a series of 
assumptions, such as that the atomicity condition is satisfied, that is, 
diffraction data to a resolution equal to or better than 1.2 Å. It has been 
widely used in small-molecule crystallography, however success of the 
method is dependent on the size of the molecule, as well as the resolution. 
Hence, for macromolecular entities, like proteins, the use of this technique 
is very limited, as proteins have a large number of atoms and in general, 
they do not diffract to atomic resolution. Several programs are available for 
direct methods phase determination, such as ACORN (Foadi et al. 2000) or 
SHELXD/SHELXE (Schneider & Sheldrick 2002). 
 
9.5.3.  Density modification: phase improvement 
 
Once experimental phases have been determined, the Fourier transform of these 
with the measured amplitudes, results in a calculated electron density map. 
Depending on several factors, like data quality, resolution and phase errors, the 
map may be clear or difficult to interpret. However, before attempting to trace a 
structure into a scarcely interpretable map, one has several possibilities of 
improving the electron density. These are known as density modification 
methods, and are used for phase improvement.  
 
1. Solvent flattening: Since protein crystals have typically 30-70% of the 
unit cell volume as disordered solvent, a mean value of electron density can 
be attributed to the solvent regions, and new “flattened” electron density is 
obtained. This improved electron-density map is then converted by an 
inverted Fourier transform into new set of phases, which when combined 
with the experimental amplitudes originates a new, “improved” density 
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map. The result is like enhancing the contrast of the protein region of the 
map, against the solvent regions. 
 
2. Histogram matching: This technique makes use of the known electron 
density distribution for typical protein structures. The minimum, maximum 
and intermediate values of electron density are adjusted to those that can be 
found in a protein electron density map, at the same resolution, again 
resulting in an improved density map, from which new phases, and 
ultimately new improved maps are calculated. 
 
3. Non-Crystallographic Symmetry averaging: this map improvement is 
based on the extra information available when several copies of the 
molecule exist within the asymmetric unit of a crystal. In fact, protein 
molecules often crystallise as oligomers, and their internal arrangement is 
not described by the crystal symmetry. This gives a “local” symmetry 
within the asymmetric unit, also called non-crystallographic symmetry 
(NCS). In this technique, the electron density of the different monomers is 
averaged locally, which results in a randomisation of the noise and in 
increased signal for the molecular features, leading to a more precise 
representation of the calculated phases that are fed into the calculation of 
new improved maps. 
 
4. Prime-and-switch as implemented in RESOLVE: Used after molecular 
replacement. MR relies on the use of the phases obtained from a 
homologous protein structure, and this poses the problem of model bias, as 
phases are calculated from the positioned probe model. The prime-and-
switch method is based upon the definition of a map probability calculated 
independently from any prior phase information. This allows the intrinsic 
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model bias from the calculated phases of a molecular replacement solution 
to be reduced. 
 
The methods of density modification are of great use for the improvement of 
the initial electron density maps and for eliminating phase errors. Again, several 
programs are available, using one, or several methods combined. In the present 
work only DM (Cowtan 1994; Cowtan 1998) and RESOLVE prime-and-switch 
(Terwilliger 2004b) were used. 
 
9.5.4.  Model building and structure refinement 
 
Once the initial phases are good enough to calculate an interpretable electron 
density map, a first (usually inaccurate and incomplete) model can be built. 
Several programs are able to auto-trace an initial model, such as ARPWARP 
(Perrakis et al. 1999) or RESOLVE (Terwilliger 2004a). Of course, their chance 
of success is higher when good resolution data are available and accurate 
phases have been obtained in the previous steps. In less favourable cases, when 
only poor initial phase information is available, or the resolution is not high 
enough (current auto-build programs fail at around 3-3.5 Å), human 
intervention is needed to identify secondary structure features of the protein and 
to build an initial poly-Ala trace. This can be done manually and interactively 
using graphics software such as COOT (Emsley & Cowtan 2004). Model 
building will generate a new phase set that can be used to generate improved 
electron density maps (by combination with initial experimental phases). In 
general, model building is performed in iterative cycles together with the 
structure refinement, thus generating improved maps. Structure refinement is 
the process in which the protein model is altered with the scope of matching, as 
much as possible, the calculated structure factors Fcalc, to the experimental ones 
Fobs, aiming to obtain the best fit of the model to the crystallographic 
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observations. In other words, refinement consists in the determination of the 
best possible combination of atomic positions, atomic displacement parameters 
(B factors) and atomic occupancies for protein residues, ligands and solvent 
molecule. The aim of model building and refinement is to construct a model 
that adequately explains the experimental observations, whilst making physical, 
chemical and biological sense. The goal is to produce electron density maps that 
allow detection and correction of the initial model errors. However, one has to 
be careful when tracing a structure into an electron density map, because one 
may inadvertently create a model containing errors and artefacts, resulting from 
errors in the experimental data. In this way, without care on the part of the 
crystallographer, a refinement program can produce an over-fitted, inaccurate 
model. Maps from refinement should improve as the model becomes more 
accurate, hence improving the calculated phases. Due to the limited resolution 
typically obtained in protein crystallography, the experimental data is 
complemented with a priori chemical information, for instance geometric 
information concerning bond lengths and angles. This information is used 
during the refinement, in the form of geometric parameter dictionaries. Several 
statistical parameters are used to assess if refinement was successful and if the 
structural model is being over-fitted to the X-ray data namely, the Rfactor and 
Rfree factors. Rfactor compares the observed structure factors with the calculated 
ones (Figure 9.8.). The smaller the differences between the two terms, the better 
they agree.  
 
 
 
Figure 9.8. The Rfactor equation. 
The Rfactor is calculated over a group of reflections (h), which can be all of the reflections, or a 
particular group, like the case of the “test set” used in the Rfree calculation. 
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The progress of the refinement can be monitored by the fall on the Rfactor. This 
parameter is dependent upon the data resolution and crystal quality. Moreover, 
it can be reduced by erroneous adjustments in the structure, like refining 
individual atomic displacement parameters or modelling alternative 
conformations at resolutions where this is not warranted; by removal of data 
(low-resolution cut-offs) or adding spurious entities, such as solvent molecules. 
Structural models with low Rfactors do not necessarily represent accurate and 
correct three-dimensional structures. For this reason, a cross-validation tool was 
introduced in macromolecular crystallography, the Rfree factor (Brunger 1992). 
The idea is to set aside a small fraction of the data, the “test set”, not used in the 
refinement, but for which an R factor is calculated. This parameter does not 
have the problem of bias (it is not used in refinement) and decreases of the Rfree 
value represent real improvements in the model. Because the Rfree is calculated 
with reflections that are not used in the refinement process, the value is higher 
than the conventional Rfactor. Comparison of both conventional Rfactor and the 
“unbiased” Rfree factor values, their behaviour and the gap between values 
during the building/refinement cycles reveals the extent to which the model has 
been overfitted to the experimental data as well as about the quality of model 
and data. In this thesis, the programs REFMAC5 (Murshudov et al. 1997) and 
PHENIX.REFINE (Afonine et al. 2005) were used for the structural refinement of 
the proteins under study. 
 
9.5.5. Structure quality and validation 
 
As referred to above, the overall quality of a final structure can be assessed by 
the crystallographic R-values, and the difference between them. However, 
reasonable R factors can be obtained for an overall correct molecule, even if 
small parts of it may be wrong in terms of geometry and chemical 
environments. In this sense, parameters like the stereochemistry, deviations 
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from ideality of bond lengths, bond angles and violations of dihedral, flatness 
and chirality restraints, for both side chains and main chain (Ramachandran 
plot; Figure 9.9.; Ramachandran et al. 1963), side-chain rotamer analysis, 
average B values for ordered and disordered protein residues, ligand, substrate 
and solvent molecules (waters or others), intermolecular interactions and 
contacts, have to be analysed and validated before a structure can be submitted 
to the Protein Data Bank (PDB; Berman et al. 2000). However, values deviated 
from ideality can sometimes be correct, if supported by the electron density 
maps, and may highlight particularly interesting (and unusual) parts of the 
structure under study. 
 
 
 
 
 
 
 
 
 
Figure 9.9. The Ramachandran plot.  
This graphical representation is based on the analysis of the ! (C(O)-N-C"-C(O)) and # (N-
C"-C(O)-N) torsion angles (which are affected by steric hindrance of residues side-chains), of 
several protein structures with resolutions equal or better to 2.0 Å and Rfactor not greater than 
20%. The plot is divided in four different colour-coded areas: the generally favoured (blue); 
generally allowed (cyan); glycine favoured (orange); and glycine allowed (light orange). A 
good model is expected to have more than 98% in the favoured regions. Residues in 
“disallowed” areas may highlight poor areas of the structure, refinement/modelling errors, or 
interesting residues relevant to the protein folding or catalytic activity (adapted from 
http://www.ccp4.ac.uk).  
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Several crystallographic validation programs are available either in software 
packages or on Internet servers. In the present studies, the programs 
WHATCHECK (Hooft et al. 1996), PROCHECK (Laskowski et al. 1993) and 
MOLPROBITY (Davis et al. 2007) were used. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bibliographic 
References 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BIBLIOGRAPHIC REFERENCES
 
Page 215 
Afonine, P. V.; Grosse-Kunstleve, R. W. and Adams, P. D. (2005) “A robust bulk-solvent 
correction and anisotropic scaling procedure.” Acta Crystallogr D Biol Crystallogr, 61: 
850-855. 
Agarkar, V. B.; Kimani, S. W.; Cowan, D. A., Sayed, M. F. and Sewell, B. T. (2006) “The 
quaternary structure of the amidase from Geobacillus pallidus RAPc8 is revealed by its 
crystal packing”. Acta Crystallogr Sect.F, 62: 1174-1178.  
Ahmad, F. and Hughes, J.B. (2002) “Reactivity of partially reduced arylhydroxylamine and 
nitrosoarene metabolites of 2,4,6-trinitrotoluene (TNT) toward biomass and humic 
acids”. Environ Sci Technol, 36: 4370–4381. 
Ahn, K.; Johnson, D. S.; Mileni, M.;  Beidler, D.;  Long, J. Z.;  Mckinney, M. K.;  Weerapana, 
E.;  Sadagopan, N.;  Liimatta, M.;  Smith, S. E.;  Lazerwith, S.;  Stiff, C.;  Kamtekar, 
S.;  Bhattacharya, K.;  Zhang, Y.;  Swaney, S.;  Vanbecelaere, K.;  Stevens, R. C. 
and  Cravatt, B. F. (2009) “Discovery and Characterisation of a Highly Selective Faah 
Inhibitor that Reduces Inflammatory Pain”. Chem Biol, 16: 411-420  
Andrade, J.; Karmalik, A.; Carrondo, M. A. and Frazão, C. (2007) “Structure of Amidase from 
Pseudomonas aeruginosa showing a trapped acyl transfer reaction intermediate state”.  J 
Biol  Chem, 282: 19598-19605. 
Andreeva, A.; Howorth, D.; Chandonia, J. M.; Brenner, S. E.; Hubbard, T. J.; Chothia, C. and 
Murzin, A. G. (2008) “Data growth and its impact on the SCOP database: new 
developments”. Nucleic Acids Res, 36: 419-425. 
Anlezark, G. M.; Melton, R.G.; Sherwood, R.F.; Coles, B.; Friedlos, F. and Knox, R. J. (1992) 
“The Bioactivation of 5-(aziridin-1-yl)-2, 4-dinitrobenzamide (CB1954) - I. Purification 
and properties of a nitroreductase enzyme from Escherichia coli – a potential enzyme for 
antibody directed enzyme prodrug therapy (ADEPT)”. Biochem Pharmacol, 44: 2289–
95. 
Anlezark, G. M.; Vaughan, T.; Fashola-Stone, E.; Michael, N. P.; Murdoch, H.; Sims, M. A.; 
Stubbs, S.; Wigley, S. and Minton, N. P. (2002) “Bacillus amyloliquefaciens orthologue 
of Bacillus subtilis ywrO encodes a nitroreductase enzyme which activates the prodrug 
CB1954”. Microbiology, 148: 297-306. 
Aragão, D., Fialho, A. M.; Marques, A. R.; Mitchell, E. P.; Sá-Correia, I. and Frazão, C. (2007) 
“The complex of Sphingomonas elodea ATCC 31461 glucose-1-phosphate 
uridylyltransferase with glucose-1-phosphate reveals a novel quaternary structure, 
unique among nucleoside diphosphate-sugar pyrophosphorylase members”. J Bacteriol, 
189(12): 4520-8. 
Doctoral Thesis by Joana Rocha (2010) 
 
Page 216 
Arrecubieta, C., Garcia, E. and López, R. (1996) “Demonstration of UDP-glucose 
dehydrogenase activity in cell extracts of Escherichia coli expressing the pneumococcal 
cap3A gene required for the synthesis of type 3 capsular polysaccharide”. J Bacteriol, 
178(10): 2971-4. 
Bajaj, I. B.; Survase, S. A.; Saudagar, P. S. and Singhal, R. S. (2007) “Gellan Gum: 
Fermentative Production, Downstream Processing and Applications”. Food Technol 
Biotechnol, 45 (4): 341-354.  
Bar-Peled, M., Griffith, C. L.; Ory, J. J. and Doering, T. L. (2004) “Biosynthesis of UDP-GlcA, 
a key metabolite for capsular polysaccharide synthesis in the pathogenic fungus 
Cryptococcus neoformans”. Biochem J, 381(Pt 1): 131-6. 
Bayman, P. and Radkar, G.V. (1997) “Transformation and tolerance of TNT (2,4,6-
trinitrotoluene) by fungi”. International Biodeterioration and Biodegradation, 39: 45–
53. 
Bellamacina, C. R. (1996) “The nicotinamide dinucleotide binding motif: a comparison of 
nucleotide binding proteins”.  FASEB Journal, 10: 1257-1269.  
Bergfors, T. M. (1999) “Crystallisation Strategies.” In Protein crystallisation: techniques, 
strategies, and tips: a laboratory manual. Terese. M. Bergfors (ed), Internat'l University 
Line, 69-76. 
Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. 
N. and Bourne, P. E. (2000) “The Protein Data Bank”. Nucleic Acids Res, 28: 235-242. 
Blanch, M., Legaz, M. E. and Vicente, C. (2006) “Purification and properties of an unusual 
UDP-glucose dehydrogenase, NADPH-dependent, from Xanthomonas albilineans”. 
Microbiol Res, Article in Press. 
Blasco, R. and Castillo, F. (1992) “Light-dependent degradation of nitrophenols by the 
phototrophic bacterium Rhodobacter capsulatus E1F1”. Appl Environ Microbiol, 58: 
690-695. 
Blasco, R. and Castillo, F. (1993) “Characterisation of a nitrophenol reductase from the 
phototrophic bacterium Rhodobacter capsulatus E1F1”. Appl Environ Microbiol, 59: 
1774-1778. 
Blasco, R. and Castillo, F. (1997) “Characterisation of 2,4-Dinitrophenol Uptake by 
Rhodobacter capsulatus”. Pesticide Biochemistry and Physiology, 58: 1–6. 
Blow, D. (2002) “Outline of Crystallography for biologists.” Oxford University Press. 
Blundell, T. L. and Johnson, L. N. (1976) “Protein Crystallography”. Academic Press. 
BIBLIOGRAPHIC REFERENCES
 
Page 217 
Bonanno, J. B.; Freeman, J.; Bain, K. T.; Chang, S.; Sampathkumar, P.; Wasserman, S.; Sauder, 
J. M.; Burley, S. K. & Almo, S. C. (2009). “Crystal Structure of UDP-glucose 6-
dehydrogenase from Porphyromonas gingivalis bound to product UDP-glucuronate”: 
New York SGX Research Centre for Structural Genomics (NYSGXRG). 
Bond, C. S. (2003) “TopDraw: a sketchpad for protein structure topology cartoons”. 
Bioinformatics, 19: 311-312.  
Bork, P. and Koonin, E.V. (1994) “A new family of carbon-nitrogen hydrolases”. Protein 
Science, 3: 1344-1346. 
Bottoms, C. A., Smith, P. E. and Tanner, J. J. (2002) “A structurally conserved water molecule 
in Rossmann dinucleotide-binding proteins.” Protein Sci, 11: 2125-2137. 
Bracey, M. H.; Hanson, M. A.; Masuda, K. R.; Stevens, R. C. and Cravatt, B. F. (2002) 
“Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid 
Signaling”. Science, 298: 1793-1796. 
Bradford, M. M. (1976) “A rapid and sensitive method for the quantification of microgram 
quantities of protein utilizing the 521 principle of protein-dye binding.” Anal Biochem, 
72: 248-254. 
Brady, B. L. (1969) “The acylamide amidohydrolase of Candida utilis: purification and 
properties”. Journal of General Microbiology, 59: 47-55. 
Brenner, C. (2002) “Catalysis in the nitrilase superfamily”. Curr Opin Struct Biol, 12: 775-782. 
Broadbent, J. R.; McMahon, D. J.; Welker, D. L.; Oberg, C. J. and Moineau, S. (2003) 
“Biochemistry, Genetics and Applications of Exopolysaccharide Production in 
Streptococcus thermophilus: A review”. J Dairy Sci, 86: 407-423. 
Brunger, A. T. (1992) “Free R value – a novel statiscal quantity for assessing the accuracy of 
crystal structures”. Nature, 355: 472-475. 
Brunger, A. T. and Rice, L. M. (1997) “Crystallographic refinement by simulated annealing”. 
Methods Enzymol, 277: 243-269. 
Bryant, C. & DeLuca, M. (1991) “Purification and characterisation of an oxygen-insensitive 
NAD(P)H nitroreductase from Enterobacter cloacae”. J Biol Chem, 266: 4119–4125. 
Bryant, C.; Hubbard, L. and McElroy, W. D. (1991) “Cloning, nucleotide sequence, and 
expression of the nitroreductase gene from Enterobacter cloacae.” J Biol Chem, 266: 
4126–4130. 
Bryant, C.; McCalla, D. R.; Leeksma, M. and Laneuville, P. (1981) “Type I nitroreductases of 
Escherichia coli.” Can J Microbiol, 27: 853–859. 
Doctoral Thesis by Joana Rocha (2010) 
 
Page 218 
Bylund, J.; Burgess, L. A.; Cescutti, P.; Ernst, R. K. and Speert, D. P. (2006) 
“Exopolysaccharides from Burkholderia cenocepacia inhibit neutrophil chemotaxis and 
scavenge reactive oxygen species”. J Biol Chem, 281: 2526–2532. 
Caballero, A.; Esteve-Núñez, A.; Zystra, G. J. and Ramos, J. L. (2005a) “Assimilation of 
nitrogen from nitrite and trinitrotoluene in Pseudomonas putida JLR11.” J Bacteriol, 
187: 396-399. 
Caballero, A.; Lázaro, A.; Ramos, J. L. and Esteve-Núñez, A. (2005b) “PnrA, a new 
nitroreductase-family enzyme in the TNT degrading strain Pseudomonas putida JLR11.” 
Environ Microbiol, 7: 1211–1219. 
Cai, G.; Zhu, S. C.; Yang, S.; Zhao, G. P. and Jiang, W. H. (2004) “Cloning, overexpression, 
and characterisation of a novel thermostable penicillin G acylase from Achromobacter 
xylosoxidans: Probing the molecular basis for its high thermostability”. Appl Env 
Microbio, 70 (5): 2764-2770.  
Cai, G.; Zhu, S.; Wang, X. and Jiang, W. (2005) “Cloning, sequence analysis and expression of 
the gene encoding a novel wide-spectrum amidase belonging to the amidase signature 
superfamily from Achromobacter xylosoxidans”. FEMS Microbiol Lett, 249:15-21. 
Campbell, R. E. and Tanner, M. E. (1999) “UDP-Glucose Analogues as Inhibitors and 
Mechanistic Probes of UDP-Glucose Dehydrogenase”, J Org Chem, 64: 9487-9492. 
Campbell, R. E.; Mosimann, S. C.; van De Rijn, I.; Tanner, M. E. and Strynadka, N. C. (2000) 
“The first structure of UDP-glucose dehydrogenase reveals the catalytic residues 
necessary for the two-fold oxidation”. Biochemistry, 39: 7012-7023. 
Campbell, R. E.; Sala, R. F.; van de Rijn, I. and Tanner, M. E. (1997) “Properties and kinetic 
analysis of UDP-glucose dehydrogenase from group A streptococci. Irreversible 
inhibition by UDP-chloroacetol.” J Biol Chem, 272 (6): 3416-3422. 
CCP4 (1994) “Collaborative Computational Project, N.4” Acta Crystallogr Sect D Biol 
Crystallogr, 50: 760-763. 
Cerantola, S.; Bounery, J.-D.; Segonds, C.; Marty, N. and Montrozier, H. (2000) 
“Exopolysaccharide production by mucoid and non-mucoid strains of Burkholderia 
cepacia”. FEMS Microbio Lett, 185(2): 243-6. 
Cerantola, S.; Lemassu-Jacquier, A. and Montrozier, H. (1999) “Structural elucidation of a 
novel exopolysaccharide produced by a mucoid clinical isolate of Burkholderia cepacia. 
Characterisation of a trisubstituted glucuronic acid residue in a heptasaccharide repeating 
unit.” Eur J Biochem, 260: 373-383.  
BIBLIOGRAPHIC REFERENCES
 
Page 219 
Cescutti, P.; Bosco, M.; Picotti, F.; Impallomeni, G.; Leitão, J. H.; Richau, J. A. and Sá-Correia, 
I. (2000) “Structural study of the exopolysaccharide produced by a clinical isolate of 
Burkholderia cepacia”. Biochem Biophys Res Comm, 273: 1088-1094. 
Chaignon, P.; Cortial, S.; Ventura, A. P.; Lopes, P.; Halgand, F.; Laprevote, O. and Ouazzani, J. 
(2006) “Purification and identification of a Bacillus nitroreductase: Potential use in 3,5-
DNBTF biosensoring system”. Enzyme and Microbial Technology 39: 1499-1506. 
Chakuad, A.; Egger, S.; Yue, W. W.; Guo, K.; Sethi, R.; Filippakopoulos, P.; Muniz, J. R. C.; 
von Delft, F.; Bountra, C.; Arrowsmith, C. H.; Weigelt, J.; Edwards, A. M.; Kavanagh, 
K. L.; Nidetzky, B. and Oppermann, U. (2009) “ Structure of Human UDP-glucose 
dehydrogenase Glu161Gln, in complex with thiohemiacetal intermediate”, Structural 
Genomics Consortium (SGC). (To be published) 
Chandrasekaran, R. and Radha, A. (1995) “Molecular architectures and functional properties of 
gellan gum and related polysaccharides”, Trends in Food Science & Technology, 6: 143-
148. 
Chang, K. W.; Weng, S. F. and Tseng, Y. H. (2001) “UDP-glucose dehydrogenase gene of 
Xanthomonas campestris is required for virulence.” Biochem Biophys Res Commun, 287: 
550-555. 
Chebrou, H.; Bigey, F.; Arnaud, A. and Galzy, P. (1996) “Study of the amidase signature 
group.” Biochimica and Biophysica Acta, 1298: 285-293. 
Chen, J.; Dai, R. J.; Tong, B.; Xiao, S. Y. and Meng, W. (2007) “Reduction of 4-nitrophenol 
catalyzed by nitroreductase.” Chinese Chemical Letters, 18: 10-12. 
Chi, Z. and Fang, Y. (2005) “Exopolysaccharides from marine bacteria.” J Ocean Univer 
China, 4(1): 67-74. 
Choi, J.-W.;  Lee, J.; Nishi, K.; Kim, Y.-S.; Jung, C.-H. and  Kim, J.-S. (2008) “Crystal 
Structure of a Minimal Nitroreductase, ydjA, from Escherichia coli K12 with and 
without FMN Cofactor”. J Mol Biol, 377: 258-267. 
Ciardelli, G.; Chiono, V.; Vozzi, G.; Pracella, M.; Ahluwalia, A.; Barbani, N.; Cristallini, C. 
and Giusti, P. (2005) “Blends of poly- (epsilon-caprolactone) and polysaccharides in 
tissue engineering applications”. Biomacromolecules, 6: 1961-1976. 
Cilia, E.; Fabbri, A.; Uriani, M.; Scialdone, G. G. and Ammendola, S. (2005) “The signature 
amidase from Sulfolobus solfataricus belongs to the CX3C subgroup of enzymes 
cleaving both amides and nitriles. Ser195 and Cys145 are predicted to be the active site 
nucleophiles”. FEBS J, 272: 4716-4724. 
Doctoral Thesis by Joana Rocha (2010) 
 
Page 220 
Conway, B.-A. D.; Chu, K. K.; Bylund, J.;  Altman, E. and Speert, D. P. (2004) “Production of 
Exopolysaccharide by Burkholderia cenocepacia: Results in Altered Cell-Surface 
Interactions and Altered Bacterial Clearance in Mice”. Journal of Infectious Diseases, 
190: 957-66. 
Cowtan, K. (1994) “DM: An automated procedure for phase improvement by density 
modification”. Jnt CCP4 ESF-EACBM Newsl Protein Crystallogr, 31: 34-38.   
Cowtan, K. (1998) “Modified phased translation functions and their application to molecular- 
fragment location.” Acta Crystallogr D Biol Crystallogr, 54: 750-756. 
Cunha, M. V.; Sousa, S. A.; Leitão, J. H.; Moreira, L. M.; Videira, P. A. and Sá-Correia, I. 
(2004) “Studies on the involvement of the exopolysaccharide produced by cystic 
fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation 
and in persistence of respiratory infections”. J Clin Microbiol, 42: 3052–3058. 
Davis, I. W.; Leaver-Fay, A.; Chen, V. B.; Block, J. N.; Kapral, G. J.; Wang, X.; Murray, L. 
W.; Arendall III, W. B.; Snoeyink, J.; Richardson, J. S. and Richardson, D. C. (2007) 
“MolProbity: all-atom contacts and structure validation for proteins and nucleic acids”. 
Nucleic Acids Research, 35: 375-383.  
De Luca, C.; Lansing, M.; Crescenzi, F.; Martini, I.; Shen, G.-J.; O’Regan, M. and Wong, C.-H. 
(1996) “Overexpression, one-step purification and characterisation of UDP-glucose 
dehydrogenase and UDP-N-acetylglucosamine pyrophosphorylase”. Bioorg Med Chem, 
4(1): 131-41. 
De Vuyst, L. and Degeest, B. (1999) “Heteropolysaccharides from lactic acid bacteria”. FEMS 
Microbiol Rev, 23:153-177. 
DeLano, W.L. (2008) “The PyMOL Molecular Graphics System”. DeLano Scientific LLC, Palo 
Alto, California, USA. World Wide Web http://www.pymol.org. 
Dillert, R.; Brandt, M.; Fornefett, I.; Siebers, U. and Bahnemann, D. (1995) “Photocatalytic 
degradation of trinitrotoluene and other nitroaromatic compounds”. Chemosphere, 
30(12): 2333-2341. 
Dougherty, B. A. & van de Rijn, I. (1993) “Molecular characterisation of hasB from an operon 
required for hyaluronic acid synthesis in group A streptococci. Demonstration of UDP-
glucose dehydrogenase activity.” J Biol Chem, 268(10): 7118-7124.  
Ducruix, A. and Giege, R. (1992) “Crystallisation of nucleic acids and proteins. A practical 
approach.” Oxford University Press.  
BIBLIOGRAPHIC REFERENCES
 
Page 221 
Dudman, W. F. (1977) “The role of surface polysaccharides in natural environments.” In: 
Sutherland, I.W. (Editor), Surface Carbohydrates of the Prokaryotic Cell, Academic 
Press, Ed. 3: 357-414. 
Easley, K. E.; Sommer, B. J.; Boanca, G., Baricki, J. J. and Simpson, M. A. (2007) 
“Characterisation of human UDP-glucose dehydrogenase reveals critical catalytic roles 
for lysine 220 and aspartate 280”. Biochemistry, 46(2): 369-78. 
Emptage, C. D.; Knox, R. J.; Danson, M. J. and Hough, D. W. (2009) “Nitroreductase from 
Bacillus licheniformis: A stable enzyme for prodrug activation”. Biochemical 
Pharmacology, 77: 21-29. 
Emsley, P. and Cowtan, K. (2004) “Coot: model-building tools for molecular graphics”. Acta 
Crystallogr D Biol Crystallogr, 60: 2126-2132. 
Esteve-Núñez, A.; Caballero, A. and Ramos, J. L. (2001) “Biological degradation of 2,4,6-
trinitrotoluene.” Microbiol Mol Biol Rev, 65: 335-352. 
Evans, P. (2006) “Scaling and assessement of data quality”. Acta Crystallogr D Biol 
Crystallogr, 62: 72-82. 
Feingold, D. S. and Franzen, J. S. (1981) “Amino acid sequence of the tryptic peptide 
containing the catalytic-site thiol group of bovine liver uridine diphosphate glucose 
dehydrogenase”. Trends Biochem Sci, 6: 103-105. 
Felsestein, J. (1993) “ Phylip (Phylogeny Inference Package) version 3.5c. Distributed by the 
author. Department of Genetics, University of Washington, Seatlle. 
Fetrow, J. S. (1995). “Omega loops: nonregular secondary structures significant in protein 
function and stability”. FASEB J, 9: 708-717. 
Fialho, A. M.; Moreira L. M.; Granja, A. T.; Popescu, A. O.; Hoffmann, K. and Sá-Correia, I. 
(2008) “Occurrence, production, and applications of gellan: current state and 
perspectives”. Appl Microbiol Biotechnol, 79: 889-900. 
Finn, R. D.; Tate, J.; Mistry, J.; Coggill, P. C.; Sammut, S. J.; Hotz, H. R.; Ceric, G.; Forslund, 
K.; Eddy, S. R.; Sonnhammer, E. L. and Bateman, A. (2008) “The Pfam protein families 
database”. Nucleic Acids Res, 36: 281-288. 
Fiorella, P. and Spain, J. (1997) “Transformation of 2,4,6-trinitrotoluene by Pseudomonas 
pseudoalcaligenes JS52.” Appl Environ Microbiol, 63:2007-2201. 
Foadi, J.; Woolfson, M. M.; Dodson, E. J.; Wilson, K. S.; Jia-xing, Y. and Chao-de, Z. (2000) 
“A flexible and efficient procedure for the solution and phase refinement of protein 
structures”. Acta Crystallogr D Biol Crystallogr, 56: 1137-1147. 
Doctoral Thesis by Joana Rocha (2010) 
 
Page 222 
Fonstein, M. and Haselkorn, R. (1993) “Chromossomal structure of Rhodobacter capsulatus 
SB1003: Cosmid encyclopedia and high-resolution physical and genetic map.” Proc Natl 
Acad Sci, 90: 2522-2526. 
Forouhar, F.; Chen, Y.; Xiao, R.; Ma, L. C.; Byler, T.; Acton, T. B.; Montelione, G. T.; Tong, 
L. and Hunt, J. F. “Crystal Structure of the putative nitroreductase (SMU 260) in 
complex with FMN from Streptococcus mutans”. Northeast Structural Genomics 
Consortium (NESG). (Not published)  
Fournand, D. and Arnaud, A. (2001) “Aliphatic and enetioselective amidases: from hydrolysis 
to acyl transfer”. J Appl Microbiol, 9: 381-393. 
Fournand, D.; Bigey, F. and Arnaud, A. (1998) “Acyl transfer activity of an amidase from 
Rhodococcus sp. R312: Formation of a wide range of hydroxamic acids”. Applied and 
Environmental Microbiology, 64: 2844-2852. 
Fraser, J. A.; Davis, M. A. and Hynes, M. J. (2001) “The Formamidase Gene of Aspergillus 
nidulans: Regulation by Nitrogen Metabolite Repression and Transcriptional Interference 
by an Overlapping Upstream Gene”. Genetics, 157: 119-131. 
French, S. and Wilson, K. (1978) “On the treatment of negative intensity observations.” Acta 
Cryst A, 34: 517-525. 
Funk, S. B.; Crawford, D. L. and Crawford R. L. (1996) “Bioremediation of nitroaromatic 
compounds”. In: Bioremediation: principles and applications, Don L. Crawford 
(Editor), Cambridge University Press, 195-208. 
Gainey, P. A. and C. F. Phelps (1975) “Interactions of urdine diphosphate glucose 
dehydrogenase with the inhibitor urdine diphosphate xylose”. Biochem J, 145(2): 129-
34. 
Gao, W. Y.; Mitsuya, H.; Driscoll, J. S. and Johns, D. G. (1995) “Enhancement by hydroxyurea 
of the anti-human immunodeficiency virus type 1 potency of 29-b-fluoro-29, 39-
dideoxyadenosine in peripheral blood mononuclear cells”. Biochem Pharmacol, 50: 274-
276. 
Garman, E (2003) “Cool’ crystals: macromolecular cryocrystallography and radiation damage.” 
Curr Opin Struct Biol, 13:545–551. 
Garman, E. F. and Owen, R. L. (2006) “Cryocooling and radiation damage in macromolecular 
crystallography”. Acta Crystallogr D Biol Crystallogr, 62: 32-47. 
Ge, X.; Campbell, R. E.; van de Rijn, I. and Tanner, M. E. (1998) “Covalent adduct formation 
with a mutated enzyme: Evidence for a thioester intermediate in the reaction catalyzed 
by UDP-glucose dehydrogenase.” J Am Chem, 120: 6613-6614. 
BIBLIOGRAPHIC REFERENCES
 
Page 223 
Ge, X.; Penney, L. C.; van de Rijn, I. and Tanner, M. E. (2004) “Active site residues and 
mechanism of UDP-glucose dehydrogenase.” Eur J Biochem, 271(1): 14-22. 
Geremia, R. and Rinaudo M. (2004) “Biosynthesis, structure and physical properties of some 
bacterial polysaccharides”. In: Severian Dimitriu, Editor, 2004. Polysaccharides: 
Structural diversity and functional versatility, CRC Press, Ed.2: 411-430. 
Giavasis, I.; Harvey, L. M. and McNeil, B. (2000) “Gellan gum.” Crit Rev Biotechnol, 20:177–
211. 
Goldberg, J. (2007) “Polysaccharides of Burkholderia spp.” In: Coenye T. and Vandamme P., 
Editors, 2007. Burkholderia Molecular Microbiology and Genomics, Horizon Scientific 
Press, 93-110. 
Gonçalves, V. M. F.; Reis, A.; Domingues, M. R. M.; Lopes-da-Silva, J. A.; Fialho, A. M.; 
Moreira, L. M.; Sá-Correia, I. and Coimbra M. A. (2009) “Structural analysis of gellans 
produced by Sphingomonas elodea strains by electrospray tandem mass spectrometry”. 
Carbohydrate Polymers. ARTICLE IN PRESS 
González-Pérez, M. M.; van Dillewijn, P.; Wittich, R.-M. and Ramos, J. L. (2007) “Escherichia 
coli has multiple enzymes that attack TNT and release nitrogen for growth”. 
Environmental Microbiology, 9(6): 1535-1540. 
Govan, J. R. and V. Deretic (1996) “Microbial pathogenesis in cystic fibrosis: mucoid 
Pseudomonas aeruginosa and Burkholderia cepacia”. Microbiol Rev, 60(3): 539-74. 
Granja, A. T., Popescu, A.; Marques, A. R.; Sá-Correia, I. and Fialho, A. M. (2007) 
“Biochemical characterisation and phylogenetic analysis of UDP-glucose dehydrogenase 
from the gellan gum producer Sphingomonas elodea ATCC 31461”. Appl Microbiol 
Biotechnol, 76(6): 1319-27. 
Green, N. K.; Kerr, D. J.; Mautner, V.; Harris, P. A. and Searle, P. F. (2004) “The 
nitroreductase/CB1954 enzyme-prodrug system.” Methods Mol Med, 90: 459-477. 
Griffith, C. L.; Klutts, J. S.; Zhang, L.; Levery, S. B. and Doering, T. L. (2004) “UDP-glucose 
dehydrogenase plays multiple roles in the biology of the pathogenic fungus 
Cryptococcus neoformans”. J Biol Chem, 279(49): 51669-76. 
Harding, N. E.; Patel, Y. N. and Coleman R. J. (2004) "Organisation of genes required for 
gellan polysaccharide biosynthesis in Sphingomonas elodea ATCC 31461". J Ind 
Microbiol Biotechnol, 31(2): 70-82. 
Hawari, J.; Beaudet, S.; Halasz, A.; Thiboutot, S. and Ampleman, G. (2000) “Microbial 
degradation of explosives: biotransformation versus mineralisation”. Appl Microbiol 
Biotechnol, 54: 605–618. 
Doctoral Thesis by Joana Rocha (2010) 
 
Page 224 
Haynes, C. A.; Koder, R. L.; Miller, A.-F. and Rodgers, D. S. (2002) “Structures of 
nitroreductase in the three states. Effect of inhibitor binding and reduction.” J Biol 
Chem, 13: 11513–11520. 
Hecht, H. J.; Erdmann, H.; Park, H. J.; Sprinzl, M. and Schmid, R. D. (1995) “Crystal structure 
of NADH oxidase from Thermus thermophilus”. Nat Struct Biol, 2 (12): 1109-14. 
Hempel, J.; Perozich, J.; Romovacek, H.; Hinich, A.; Kuo, I. and Feingold, D. S. (1994) “UDP-
glucose dehydrogenase from bovine liver: primary structure and relationship to other 
dehydrogenases”. Protein Sci, 3(7): 1074-80. 
Herasimenka, Y.; Cescutti, P.; Impallomeni, G.; Campana, S.; Taccetti, G.; Ravenni, N.; 
Zanetti, F. and Rizzo, R. (2007) “Exopolysaccharides produced by clinical strains 
belonging to the Burkholderia cepacia complex”. Journal of Cystic Fibrosis, 6: 145-152. 
Higgins, D.; Thompson, J.; Gibson, T.; Thompson, J. D.; Higgins, D. G. and Gibson, T. J. 
(1994) “CLUSTAL W: improving the sensitivity of progressive multiple sequence 
alignment through sequence weighting, position-specific gap penalties and weight matrix 
choice”. Nucleic Acids Research, 22: 4673-4680. 
Higson, F. K. (1992) “Microbial Degradation of Nitroaromatic compounds.” In: Advances in 
Applied Microbiology. Saul L. Neidleman, Allen I Laskin (Editors), Academic Press, 
1997, 1-21. 
Hirooka, T.; Nagase, H.; Hirata, K. and Miyamoto, K. (2006) “Degradation of 2,4-dinitrophenol 
by a mixed culture of photoautotrophic microorganisms.” Biochemical Engineering 
Journal, 29: 157-162. 
Holm, L.; Kääriäinen, S.; Rosenström, P. and Schenkel, A. (2008) “Searching protein structure 
databases with DaliLite v.3.” Bioinformatics, 24(23): 2780-2781.  
Holmes, L. B. (1996) “Hydroxamic acid: a potential human teratogen that could be 
recommended to treat ureaplasma”. Teratology, 53: 227-229. 
Holton, J. M. (2009) “A beginner’s guide to radiation damage”. J Synchrotron Rad, 16:133-
142. 
Honeycutt, M. E.; Jarvis, A S. and McFarland, V. A. (1996) “Cytotoxicity and mutagenicity of 
2,4,6-trinitrotoluene and its metabolites”. Ecotoxicol Environ Saf, 35: 282-287. 
Hooft, R. W. W.; Vriend, G.; Sander, C. and Abola E. E. (1996) “Errors in protein structures.” 
Nature, 381: 272-272. 
Hughes, J. E.; Stewart, J.; Barclay, G. R. and Govan J. R. W. (1997) “Priming of neutrophil 
respiratory burst activity by lipopolysaccharide from Burkholderia cepacia.” Infect 
Immun, 65(10): 4281-7. 
BIBLIOGRAPHIC REFERENCES
 
Page 225 
Huh, J. W.; Yoon, H. Y.; Lee, H.-J.; Choi, W.-B.; Yang, S.-J. and Cho, S.-W. (2004) 
“Importance of Gly-13 for the coenzyme binding of human UDP-glucose 
dehydrogenase”. J Biol Chem, 279(36): 37491-8. 
Hung, C.-L.;  Liu, J.-H.;  Chiu, W.-C.;  Huang, S.-W.;  Hwang, J.-K. and  Wang, W.-C. (2007a) 
“Crystal structure of Helicobacter pylori formamidase AmiF reveals a cysteine-
glutamate-lysine catalytic triad”. J Biol Chem, 282: 12220-12229  
Hung, R.-J.; Chien, H.-S.; Lin, R.-Z.; Lin, C.-T., Vatsyayan, J.; Peng, H.-L. and Chang, H.-Y. 
(2007b) “Comparative Analysis of Two UDP-glucose Dehydrogenases in Pseudomonas 
aeruginosa PAO1”. The Journal of Biological Chemistry, 282 (24): 17738-17748. 
Hwang, H. Y. and Horvitz, H. R. (2002) “The Caenorhabditis elegans vulval morphogenesis 
gene sqv-4 encodes a UDP-glucose dehydrogenase that is temporally and spatially 
regulated”. Proc Natl Acad Sci, 99: 14224-14229. 
Hynes, M. J. and Pateman, J. A. (1970a) “The use of amides as nitrogen sources by Aspergillus 
nidulans”. Journal of General Microbiology 63: 317-324. 
Hynes, M. J. and Pateman, J. A. (1970b) “The genetic analysis of regulation of amidase 
synthesis in Aspergillus nidulans. II. Mutants resistant to fluoroacetamide.” Molecular 
and General Genetics, 108: 107-116. 
Iyer, A.; Mody, K. H. and Jha, B. (2004) “Accumulation of hexavalent chromium by an 
exopolysaccharide producing marine Enterobacter cloaceae.” Mar Poll Bull, 49: 974-
977. 
Jansson, B.; Hagerstrom, H.; Fransen, N.; Edsman, K. and Björk, E. (2005) “The influence of 
gellan gum on the transfer of fluorescein dextran across rat nasal epithelium in vivo.” 
Eur J Pharm Biopharm, 59(3): 557-64. 
Jay, A. J.; Colquhoun, I. J.; Ridout, M. J.; Brownsey, G. J.; Morris, V. J.; Fialho, A. M.; Leitão, 
J. H. and Sá-Correia, I. (1998) “Analysis of structure and function of gellans with 
different substitution patterns”. Carbohydr Polym, 35:179–188. 
Johansson, E.; Parkinson, G. N.; Denny, W. A. and Neidle, S. (2003) “ Studies on the 
nitroreductase prodrug-activating system. Crystal Structure of complexes with the 
inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form.” J 
Med Chem, 46 (19): 4009-4020. 
Johnson, G. R. and Spain, J. C. (2003) “Evolution of catabolic pathways for synthetic 
compounds: bacterial pathways for degradation of 2,4-dinitrotoluene and nitrobenzene”. 
Appl Microbiol Biotechnol, 62: 110-123. 
Doctoral Thesis by Joana Rocha (2010) 
 
Page 226 
Joint Center for Structural Genomics (JCSG) “Crystal structure of putative nitroreductase ydfN 
(2632848) from Bacillus subtilis at 1.65 A resolution.” (To be published) 
Joint Center for Structural Genomics (JCSG) ”Crystal structure of Glutamyl-tRNA (Gln) 
amidotransferase subunit A (tm1272) from Thermatoga maritima at 1.80 A resolution.” 
(To be published) 
Jolly, L.; Vincent, S. J.; Duboc, P. and Neeser, J. R. (2002) “Exploiting expolysaccharides from 
lactic acid bacteria”. Antonie Van Leeuwenhoek, 82(1-4): 367-74. 
Jones, A. M.; Dodd, M. E. and Webb, A. K. (2001) “Burkholderia cepacia: current clinical 
issues, environmental controversies and ethical dilemmas”. Eur Respir J, 17(2): 295-
301. 
Kahng, H.-Y.; Lee, B.-U.; Cho, Y.-S. and Oh, K.-H. (2007) “Purification and Characterisation 
of the NAD(P)H-nitroreductase for the Catabolism of 2,4,6-trinitrotoluene (TNT) in 
Pseudomonas sp. HK-6”. Biotechnology and Bioprocess Engineering, 12: 433-440. 
Kammermeier-Steinke, D.; Schwarz, A.; Wandrey, C. and Kula, M.-R. (1993) “Studies on the 
substrate specificity of a peptide amidase partially purified from orange flavedo”. 
Enzyme and Microbial Technology, 15: 764-769. 
Kanekar, P.; Doudpure, P. and Sarnaik, S. (2003) “Biodegradation of nitroexplosives.” Indian 
Journal of Experimental Biology, 41: 991-1001. 
Kaneko, T. and Kang, K. S. (1979) “Agar-like polysaccharide produced by a Pseudomonas 
species: Taxonomical studies.” Abstracts of the 79th Annual Meeting of the American 
Society for Microbiology, Washington DC, USA. 
Kaneko, T.; Katoh, T.; Sato, S.; Nakamura, A.; Asamizu, E. and Tabata, S. (2000) “Structural 
analysis of Arabidopsis thaliana chromosome 3.II. Sequence features of the 4,251,695 
bp regions covered by 90 P1, TAC and BAC clones.” DNA Res, 7(3): 217-221.  
Kantardjieff, K. and Rupp, B. (2003) “Matthews coefficient probabilities: Improved estimates 
for unit cell contents of proteins, DNA, and protein-nucleic acid complex crystals”. 
Protein Sci, 12: 1865-1871. 
Kärkönen, A. (2005) “Biosynthesis of UDP-GlcA: Via UDPGDH or the myo-inositol oxidation 
pathway?” Plant Biosystems, 139 (1): 46-49. 
Kärkönen, A. and Fry, S. C. (2006) “Novel characteristics of UDP-glucose dehydrogenase 
activities in maize: non-involvement of alcohol dehydrogenases in cell wall 
polysaccharide biosynthesis”. Planta, 223(4): 858-70. 
BIBLIOGRAPHIC REFERENCES
 
Page 227 
Kärkönen, A.; Murigneux, A.; Martinant, J.-P.; Pepey, E.; Tatout, C.; dudley, B. J. and Fry, S. 
C. (2005) “UDP-glucose dehydrogenases of maize: a role in cell wall pentose 
biosynthesis”. Biochem J, 391(Pt 2): 409-15. 
Kavanagh, K. L.; Guo, K.; Bunkoczi, P.; Savitsky, E.; Pilka, E.; Bhatia, C.; Smee, C.; Berridge, 
G.; Von Delft, F.; Wiegelt, J.; Arrowsmith, C.; Sundstrom, M.; Edwards, A. and 
Oppermann, U. (2007a) “Structure of human UDP-glucose dehydrogenase complexed 
with NADH and UDP-glucose”. Structural Genomics Consortium (SGC). (To be 
published) 
Kavanagh, K. L.; Guo, K.; Bunkoczl, P.; Savitsky, E.; Pilka, E.; Bhatia, C.; Smee, C.; Berridge, 
G.; Von Delft, F.; Wiegelt, J.; Arrowsmith, C.; Sundstrom, M.; Edwards, A. and 
Oppermann, U. (2007b) “Structure of human UDP-glucose dehydrogenase complexed 
with NADH and UDP-glucuronate”. Structural Genomics Consortium (SGC). (To be 
published) 
Khan, T. A.; Bhadraand, R. and Hughes, J. (1997) “Anaerobic transformation of 2,4,6-TNT and 
related nitroaromatic compounds by Clostridium acetobutylicum”. J Ind Microbiol 
Biotechnol, 18: 198–203. 
Kikuchi, T.; Itoh, F.; Toyota, M.; Suzuki, H.; Yamamoto, H.; Fujita, M.; Hosokawa, M. and 
Imai, K. (2002) “Aberrant methylation and histone deacetylation of cyclooxygenase 2 in 
gastric cancer”. Int J Cancer, 97: 272-277. 
Kim, H.-Y. and Song, H.-G. (2005) “Purification and characterisation of NAD(P)H-dependent 
nitroreductase I from Klebsiella sp. C1 and enzymatic transformation of 2,4,6-
trinitrotoluene”. Appl Microbiol Biotechnol, 68: 766-773. 
Kim, H.-Y.; Bennett, G. N. and Song, H.-G. (2003) “Degradation of 2,4,6-trinitrotoluene by 
Klebsiella sp. isolated from activated sludge”. Biotechnol Lett, 24: 2023–2028. 
Kim, S.-H. and Oriel, P. (2000) “Cloning and expression of the nitrile hydratase and amidase 
genes from Bacillus sp. BR449 into Escherichia coli”. Enzyme and Microbial 
Technology, 27: 492-501. 
Kim, Y.; Duggan, E.; Clancy, S. and Joachimiak, A. (2006) “The Crystal Structure of the 
Putative NAD(P)H-Flavin Oxidoreductase from Streptococcus pyogenes M1 GAS”. (To 
be published) 
Kimura, N.; Shinozaki, Y.; Suwa, Y. and Urushigawa, Y. (2000) “Phylogenetic and phenotypic 
relationships of microorganisms that degrade uncoupler compound, 2,4-dinitrophenol”. J 
Gen Appl Microbiol, 46: 317–322. 
Doctoral Thesis by Joana Rocha (2010) 
 
Page 228 
Kirner, S.; Hammer, P. E.; Hill, D. S.; Altman, A.; Fischer, I.; Weislo, L. J.; Lanahan, M.; van 
Pee, K. H. and Ligon, J. M. (1998) “Functions encoded by pyrrolnitrin biosynthetic 
genes from Pseudomonas fluorescens”. J Bacteriol, 180: 1939-1943. 
Klinghammer, M. and Tenhaken, R. (2007) “Genome-wide analysis of the UDP-glucose 
dehydrogenase gene family in Arabidopsis, a key enzyme for matrix polysaccharides in 
cell walls”. Journal of Experimental Botany, 58 (13): 3609-3621. 
Kobayashi, M.; Goda, M. and Shimizu, S. (1998) “The catalytic mechanism of amidase also 
involves nitrile hydrolysis.” FEBS Letters, 439: 325-328. 
Kobayashi, M.; Komeda, H.; Nagasawa, T.; Nishiyama, M.; Horinouchi, S.; Beppu, T.; 
Yamada, H. and Shimizu, S. (1993) “Amidase coupled with low molecular-mass nitrile 
hydratase from Rh. rhodochrous J1”. European Journal of Biochemistry, 217:327-336. 
Kobori, T.; Sasaki, H.; Lee, W. C.; Zenno, S.; Saigo, K.; Murphy, M. E. P. and Tanokura, M. 
(2001) “Structure and site-directed mutagenesis of a flavoprotein from Escherichia coli 
that reduces nitrocompounds: alteration of pyridine nucleotide binding by a single amino 
acid substitution”. J Biol Chem, 276: 2816-2823.  
Koder, R. L. and Miller, A. F. (1998) “Overexpression, isotopic labelling and spectral 
characterisation of Enterobacter cloacae nitroreductase”. Protein Expr Purif , 13: 53–60. 
Koder, R. L.; Oyedele, O. and Miller, A. F. (2001) “Retro-nitroreductase, a putative 
evolutionary precursor to Enterobacter cloacae strain 96-3 nitrorreductase.” Antioxid 
Redox Signal, 3: 747-755. 
Koide, Y.; Uchino, M. and Yamada, K. (1987) “Studies of collectors. IX. The flotation of a 
trace amount of uranium by using 2-(alkylamino)propionohydroxamic acid and 
cotelomer-type surfactants bearing hydroxyaminocarbonyl and pyridyl groups”. Bull 
Chem Soc Jpn, 60: 3477-3483. 
Koike, H.; Sasaki, H.; Kobori, T.; Zenno, S.; Saigo, K.; Murphy, M. E. P.; Adman, E. T. and 
Tanokura, M. (1998) “1.8Å Crystal structure of the major NAD(P)H:FMN 
oxidoreductase of a bioluminescent bacterium, Vibrio fisheri: overal structure, cofactor 
and substrate-binding, and comparison with related flavoproteins.” J Mol Biol, 280: 259-
273. 
Komatsu, Y.; Tomizaki, K. Y.; Tsukamoto, M.; Kato, T.; Nishino, N.; Sato, S.; Yamori, T.; 
Tsuruo, T.; Furumai, R.; Yoshida, M.; Horinouchi, S. and Hayashi, H. (2001) “Cyclic 
hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor 
with antitumor activity”. Cancer Res, 61: 4459-4466. 
BIBLIOGRAPHIC REFERENCES
 
Page 229 
Kong, J.; Lee, H.; Hong, J.; Kang, Y.; Kim, J.; Chang, M. and Bae, S. (1998) “Utilisation of a 
cell-bound polysaccharide produced by the marine bacterium Zooglea sp.: New 
biomaterial for metal adsorption and enzyme immobilisation”. J Mar Biotechnol, 6: 99-
103. 
Krissinel, E. and Henrick, K. (2004) “Secondary-structure matching (SSM), a new tool for fast 
protein structure alignment in three dimensions”. Acta Crystallogr D Biol Crystallogr, 
60: 2256-2268. 
Krissinel, E. and Henrick, K. (2007) “Inference of macromolecular assemblies from crystalline 
state”. J Mol Biol, 372: 774-797.  
Kulkarni, M. A. and Chaudhari, A. B. (2007) “Microbial remediation of nitro-aromatic 
compounds: an overview”. Journal of Environmental Management, 85(2): 496-512. 
Kulkarni, M.A. and Chaudhari, A. B. (2006) “Biodegradation of p-nitrophenol by P. putida”. 
Bioresource Biotechnology, 97: 982-988. 
Kumar, A. S.; Mody, K. and Jha, B. (2007) “Bacterial exopolysaccharides – a perception.” 
Journal of Basic Microbiology, 47: 103-117. 
Kutty, R. and Bennett, G. N. (2005) “Biochemical characterisation of trinitrotoluene 
transforming oxygen-insensitive nitroreductases from Clostridium acetobutylicum 
ATCC 824.” Arch Microbiol, 184: 158-167. 
Kutzenko, A. S.; Lamzin, V. S. and Popov, V. O. (1998) “Conserved supersecondary structural 
motif in NAD-dependent dehydrogenases.” FEBS Lett, 423 (1): 105-109. 
Labahn, J.; Neumann, S.; Buldt, G.; Kula, M. R. and Granzin, J. (2002) “An alternative 
mechanism for amidase signature enzymes.” J Mol Biol, 322:1053-1064. 
Landstein, D.; Graves, M. V.; Burbank, D. E.; deAngelis, P. and Van Etten, J. L. (1998) 
“Chlorella virus PBCV-1 encodes functional glutamine: fructose-6-phosphate 
amidotransferase and UDP-glucose dehydrogenase enzymes”. Virology, 250(2): 388-96. 
Lang, D.; Thoma, R.; Henn-Sax, M.; Sterner, R. and Wilmanns, M. (2000) “Structural Evidence 
for Evolution of the !/" Barrel Scaffold by Gene Duplication and Fusion.” Science, 
289: 1546-1550. 
Laskowski, R. A.; MacArthur, M. W.; Moss, D. S. and Thornton, J. M. (1993) “PROCHECK: a 
program to check the stereochemical quality of protein structures”.  J App Cryst, 26: 
283-291.  
Lee, B.-U.; Park, S.-C.; Cho, Y.-S.; Kahng, H.-Y. and Oh, K.-H. (2008) “Expression and 
Characterisation of the TNT Nitroreductase of Pseudomonas sp. HK-6 in Escherichia 
coli”. Curr Microbiol, 56: 386–390. 
Doctoral Thesis by Joana Rocha (2010) 
 
Page 230 
Lei, B.; Liu, M.; Huang, S and Tu, S.-C. (1994) “Vibrio harveyi NADPHflavin oxidoreductase: 
cloning, sequencing and overexpression of the gene and purification and characterisation 
of the cloned enzyme”. J Bacteriol, 176: 3552-3558. 
Leid, J. G.; Willson, C. J.; Shirtliff, M. E.; Hassett, D. J.; Parsek, M. R. and Jeffers, A. K. 
(2005) “The Exopolysaccharide Alginate Protects Pseudomonas aeruginosa Biofilm 
Bacteria from IFN-!-Mediated Macrophage Killing”. Journal of Immunology, 7512-
7518. 
Leslie, A. G. W. (1992)  “Recent changes to the MOSFLM package for processing film and 
image plate data.” Jnt CCP4/ESF-EACBM News Protein Crystallogr, 26. 
Leszczymski, J. F. & Rose, G. D. (1986) “Loops in globular proteins: a novel category of 
secondary structure.” Science, 234: 849-55. 
Levander, F. and Rådström, P. (2001) “Requirement for phosphoglucomutase in 
exopolysaccharide biosynthesis in glucose- and lactose-utilizing Streptococcus 
thermophilus”. Appl Environ Microbiol, 67: 2734-2738. 
Li, J.; Kamath, K. and Dwivedi, C. (2001) “Gellan film as an implant for insulin delivery.” J 
Biomater Appl, 15:321–343. 
Lindhorst, T. K. (2007) “Essentials of Carbohydrate Chemistry and Biochemistry.” Ed.3, 
Wiley-VHC Publications. 
Linker, A.; Evans, L. R. and Impallomeni, G. (2001) “The structure of a polysaccharide from 
infectious strains of Burkholderia cepacia.” Carbohydr Res, 335 (1): 45-54. 
Liochev, S. I.; Hausladen, a. and Fridovich, I. (1999) “Nitroreductase A is regulated as a 
member of the soxRS regulon of Escherichia coli.” Proc Natl Acad Sci, 96: 3537-3539. 
Long, F.; Vagin, A.; Young, P.and Murshudov, G. N. (2008) “BALBES: a Molecular 
Replacement Pipeline”. Acta Crystallogr D Biol Crystallogr, 64: 125-132. 
Lupyan, D.; Leo-Macias, A. and Ortiz, A. R. (2005) “A new progressive-iterative algorithm for 
multiple structure aligment.” Bioinformatics, 21 (15): 3255-3263. 
Maeda, T.; Nakamura, R.; Kadokami, K. and Ogawa, H. I. (2007) “Relationship between 
mutagenicity and reactivity or biodegradability for nitroaromatic compounds.” 
Environmental toxicology and chemistry, 26(2): 237-41. 
Mahenthiralingam, E.; Baldwin, A. and Vandamme, P. (2002) “Burkholderia cepacia complex 
infection in patients with cystic fibrosis.” J Med Microbiol, 51: 533-538. 
Malashkevich, V. N.; Sauder, J. M.; Burley, S. K.; Almo, S. C. (2009) “Crystal structure of 
NDP-N-acetyl-D-galactosaminuronic acid dehydrogenase from Methanosarcina mazei 
Go1”. (To be published) 
BIBLIOGRAPHIC REFERENCES
 
Page 231 
Margolls, S. A.; Howell, B. F. and Schaffer, R. (1976) “Purification and Analysis of the Purity 
of NADH.” Clin Chem, 22 (8): 1322-1329. 
Marques de Oliveira, I.; Pêgas Henriques, J. A. and Bonatto, D. (2007) “In silico identification 
of a new group of specific bacterial and fungal nitroreductase-like proteins.” Biochem 
Biophys Res Commu, 355: 919-925. 
Martins, L. O. and Sá-Correia, I. (1993) “Temperature profile of gellan gum synthesis and 
activities of biosynthetic enzymes, Biotechnol Appl Biochem, 20: 385–395. 
Marvin-Sikkema, F. D. and Bont, J. A. (1994) “Degradation of nitroaromatic compounds by 
microorganisms.” Applied microbiology and biotechnology, 42(4): 499-507.  
Matthews, B. W. (1968) “The Solvent Content of Protein Crystals”. Mol Biol, 33: 491-497. 
Mayaux, J.-F.; Cerbelaux, E.; Soubrier, F.; Yeh, P.; Blanche, F. and Pétré, D. (1991) 
“Purification, cloning, and primary structure of a new enantiomer-selective amidase from 
a Rhodococcus strain: structural evidence for a conserved genetic coupling with nitrile 
hydratase”. Journal of Bacteriology, 173: 6694-6704. 
McCoy, A. J.; Grosse-Kunstleve, R. W.; Adams, P. D.; Winn, M. D.; Storoni, L. C. and Read, 
R. J. (2007) “Phaser crystallographic software”. J. Appl. Cryst, 40: 658-674. 
McFee, R. B.; Caraccio, T. R.; McGuigan, M. A.; reynolds, S. A. and Bollomeyer, P. (2002)  
“Dying to be thin—hyperpyrexia and weight loss: a case report of a dinitrophenol (DNP) 
related fatality”. Journal of Toxicology Clinical Toxicology, 57: 622. 
McRee, D. E. (1999) “XtalView/Xfit – A Versatile Program for Manipulating Atomic 
Coordinates and Electron Density.” J Structural Biology, 125: 156-165. 
Miksic, J. R. and Brown, P. R. (1978) “Reactions of Reduced Nicotinamide Adenine 
Dinucleotide in Acid: Studies by Reversed-Phase High-pressure Liquid 
Chromatography.” Biochem, 17 (11): 2234-2238. 
Mileni, M.; Johnson, D. S.; Wang, Z.; Everdeen, D. S.; Liimatta, M.; Pabst, B.; Bhattacharya, 
K.; Nugent, R. A.; Kamtekar, S.; Cravatt, B. F.; Ahn, K. and Stevens, R. C. (2008) 
“Structure-Guided Inhibitor Design for Human Faah by Interspecies Active Site 
Conversion”. Proc Natl Acad Sci USA, 105: 12820-12824. 
Mijakovic, I.; Petranovic, D. & Deutscher, J. (2004) “How Tyrosine Phosphorylation Affects 
the UDP-Glucose Dehydrogenase Activity of Bacillus subtilis YwqF.” J Mol Microbiol 
Biotechnol, 8:19–25 
Moreira, L. M.; Videira, P. A.; Sousa, S. A.; Leitão, J. H.; Cunha, M. V. and Sá-Correia, I.  
(2003) “Identification and physical organisation of the gene cluster involved in the 
Doctoral Thesis by Joana Rocha (2010) 
 
Page 232 
biosynthesis of Burkholderia cepacia complex exopolysaccharide.” Biochem Biophys 
Res Commun, 312(2): 323-33. 
Morin, A. (1998). “Screening of polysaccharide-producing microorganisms, factors influencing 
the production and recovery of microbial polysaccharides”. In: Severian Dumitriu, 
Editor, 1998, Polysaccharides - Structural Diversity and Functional Versatility, Marcel 
Dekker Inc. Publication, 275-296. 
Moslemy, P.; Guiot, S. R. and Neufeld, R. J. (2004) “Activated sludge encapsulation in gellan 
gum microbeads for gasoline biodegradation.” Bioprocess Biosyst Eng, 26:197–204. 
Moslemy, P.; Neufeld, R. J.; Millette, D. and Guiot, S. R. (2003) “Transport of gellan gum 
microbeads through sand: an experimental evaluation for encapsulated cell 
bioaugmentation”. J Environ Manage, 69: 249-59. 
Moyrand, F. and Janbon, G. (2004) “UGD1, encoding the Cryptococcus neoformans UDP-
glucose dehydrogenase, is essential for growth at 37 degrees C and for capsule 
biosynthesis”. Eukaryot Cell, 3(6): 1601-8. 
Murshudov, G. N.; Vagin, A. A. and Dodson, E. J. (1997) “Refinement of Macromolecular 
Structures by the Maximum-Likelihood method.” Acta Crystallogr D Biol Crystallogr, 
53: 240-255.  
Murzin, A. G.; Brenner, S. E.; Hubbard, T. and Chothia, C. (1995) “SCOP: a structural 
classification of proteins database for the investigation of sequences and structures”. J 
Mol Biol, 247: 536-540. 
Nakamura, A.; Yao, M.; Chimnaronk, S.; Sakai, N. and   Tanaka, I. (2006) “Ammonia channel 
couples glutaminase with transamidase reactions in GatCAB.” Science, 312: 1954-1958. 
Nelsestuen, G. L. and Kirkwood, S. (1971) “The mechanism of action of uridine 
diphosphoglucose dehydrogenase. Uridine diphosphohexodialdoses as intermediates.” J 
Biol Chem, 246: 3824-3834. 
Ohmori, T.; Hagiwara, S.; Ueda, A.; Minoda, Y. and Yamada, K. (1978) “Production of 
pyoluteorin and its derivatives from n-paraffin by Pseudomonas aeruginosa S10B2.” 
Agric Biol Chem, 42: 2031–2036. 
Ohshima, T.; Sakuraba, H.; Ebihara, A.; Kanagawa, M.; Nakagawa, N.;  Kuroishi, C.;  Satoh, 
S.;  Kuramitsu, S. and Yokoyama, S.  RIKEN Structural Genomics/Proteomics Initiative 
(RSGI) ”Crystal structure of amidase”. (To be published) 
Omoto, T.; Uno, Y. and Asai, I. (1999) “The latest technologies for the application of gellan 
gum”. Progr Colloid Polym Sci, 114: 123-126. 
BIBLIOGRAPHIC REFERENCES
 
Page 233 
Ordman, A. B. & Kirkwood, S. (1977) “UDP-glucose dehydrogenase. Kinetics and their 
mechanistic implications.” Biochim Biophys Acta, 48: 25-32. 
Ortega, X. P.; Cardona, S. T.; Brown, a. R.; Loutet, S. A.; Flannagan, R. s.; Campopiano, D. J.; 
Govan, J. R. W. and Valvano, M. A. (2007) “A putative gene cluster for aminoarabinose 
biosynthesis is essential for Burkholderia cenocepacia viability”. J Bacteriol, 189(9): 
3639-44. 
Otwinowski, Z. and Minor, W. (1997) “Processing of X-ray Diffraction Data Collected in 
Oscillation Mode”. Methods in Enzymology, 276: 307-326. 
Pace, H. C. and Brenner, C. (2001) “The nitrilase superfamily: classification, structure and 
function.” Gen Biol, 2: 1-9. 
Pace, S. A. and Pace, A. (2002) “Dinitrophenol oral ingestion resulting in death.” Journal of 
Toxicology Clinical Toxicology, 199:683. 
Padda, R. S.; Wang, C.; Hughes, J. B.; Kutty, R. and Bennett, G. N. (2003) “Mutagenicity of 
nitroaromatic degradation compounds”. Environ Toxic and Chem, 22(10): 2293-7.  
Painter, J. and Merritt E. A., (2006) “TLSMD web server for the generation of multi-group TLS 
models.” J Appl Cryst, 39: 109-111.  
Papagrigoriou, E.; Salah, E.; Turnbull, A. P.; Smee, C.; Burgess, N.; Gileadi, O.; Von Delft, F.; 
Gorrec, F.; Arrowsmith, C. H.; Weigelt, J.; Sundstrom, M.; Edwards, A. M. and 
Oppermann, U. (2006) “Crystal structure of human hydroxyisobutyrate dehydrogenase”. 
(To be published) 
Parkinson, G. N.; Skelly, J. V. and Neidle, S. (2000) “Crystal structure of FMN-dependent 
nitroreductase from Escherichia coli B: a prodrug-activating enzyme”. J Med Chem, 43: 
3624-3631.  
Pearl, F. M. G.; Lee, D.; Bray, J. E.; Sillitoe, I.; Todd, A. E.; Harrison, A. P.; Thornton, J. M. 
and Orengo, C. A. (2000) “Assigning genomic sequences to CATH”. Nucleic Acids 
Research, 28(1): 277-282. 
Pérez-Reinado, E.; Blasco, R.; Castillo, F.; Moreno-Vivián, C. and Roldán, M. D. (2005) 
“Regulation and characterisation of two nitroreductase nprA and nprB genes of 
Rhodobacter capsulatus.” Appl Environ Microbiol, 71: 7643-7649. 
Pérez-Reinado, E.; Roldán, M. D.; Castillo, F. and Moreno-Vivián, C. (2008) “The NprA 
nitroreductase required for 2,4-dinitrophenol reduction in Rhodobacter capsulatus is a 
dihydropteridine reductase.” Environ Microbiol, 10(11): 3174–3183. 
Perrakis, A.; Morris, R. and Lamzin, V. S. (1999) “Automated protein model building 
combined with iterative structure refinement.” Nat Struct Biol, 6: 458-63. 
Doctoral Thesis by Joana Rocha (2010) 
 
Page 234 
Plhackova, K.; Becka, S.; Skrob F. and Kyslik, P. (2003) “Isolation and characterisation of a 
new strain of Achromobacter sp. with !-lactam antibiotic acylase activity.” Appl 
Microbio Biotech, 62 (5-6): 507-516.  
Ploegman, J. H.; Drent, G.; Kalk, K. H.; Hol, W. G.; Heinrikson, R. L.; Keim, P.; Weng, L. and 
Russell, J. (1978) “The covalent and tertiary structure of bovine liver rhodanese”. 
Nature, 273: 124-129. 
Pollock, T. J. (1993) “Gellan-related polysaccharides and the genus Sphingomonas”. J Gen 
Microbiol, 139:1939-1945. 
Race, P. R.; Lovering, A. L.; Green, R. M.; Ossor, A.; White, S. A.; Searle, P. F.; Wrighton, C. 
W. and Hyde, E. I. (2005) “Structural and mechanistic studies of Escherichia coli 
nitroreductase with the antibiotic nitrofurazone”. J Biol Chem, 280: 13256–13264. 
Race, P. R.; Lovering, A. L.; White, S. A.; Grove, J. I.; Searle, P. F.; Wrighton, C. W. and 
Hyde, E. I. (2007) “Kinetic and structural characterisation of Escherichia coli 
nitroreductase mutants showing improved efficacy for the prodrug substrate CB1954”. J 
Mol Biol, 368: 481-492. 
Ramachandran, G. N.; Ramakrishnan, C. and Sasisekharan, V. (1963) “Stereochemistry of 
polypeptide chain conformations.” J Mol Biol, 7: 95-99. 
Read, R. J. (1986) “Improved Fourier coefficients for maps using phases from partial structures 
with errors”. Acta Crystallogr A, 42: 140-49.  
Reitz, S.; Alhapel, A.; Essen, L. O. and Pierik, A. J. (2008) “Structural and Kinetic Properties of 
a beta-hydroxyacid Dehydrogenase Involved in Nicotinate Fermentation.” J Mol Biol, 
382: 802-811. 
Richau, J. A.; Leitão, J. H. and Sá-Correia, I. (2000a) “Enzymes leading to the nucleotide sugar 
precursors for exopolysaccharide synthesis in Burkholderia cepacia.” Biochem Biophys 
Res Commun, 276(1): 71-6. 
Richau, J. A.; Leitão, J. H.; Correia, M.; Lito, L.; Salgado, M. J.; Barreto, C.; Cescutti, P. and 
Sá-Correia, I. (2000b) “Molecular typing and exopolysaccharide biosynthesis of 
Burkholderia cepacia isolates from a Portuguese cystic fibrosis center”. J Clin 
Microbiol, 38(4): 1651-5. 
Riès-Kautt, M. (1999) “Strategy 2: An Alternative to Sparse Matrix Screens”. In Protein 
crystallisation: techniques, strategies, and tips: a laboratory manual. Terese. M. 
Bergfors (ed), Internat'l University Line, 91-110. 
BIBLIOGRAPHIC REFERENCES
 
Page 235 
Robb, F. T.; Maeder, D. L.; Brown, J. R.; Di Ruggiero, J.; Stump, M. D.; Yeh, R. K.; Weiss, R. 
B. & Dunn, D. M. (2001) “Genomic sequence of hyperthermophile, Pyrococcus furiosus: 
implications for physiology and enzymology.” Meth Enzymol, 330: 134-157.  
Roberts, I.S. (1996) “The biochemistry and genetics of capsular polysaccharide production in 
bacteria”. Annu Rev Microbiol, 50: 285–315. 
Robertson, B. K. and Jemba, P. K. (2005) “Enhanced bioavailability of sorbed 2,4,6-
trinitrotoluene (TNT) by a bacterial consortium”. Chemosphere, 58: 263-270. 
Rocha, J.; Granja, A. T.; Sá-Correia, I. Fialho, A. and Frazão, C. (2010a) “Cloning, expression, 
purification, crystallisation and preliminary crystallographic studies of UgdG, an UDP-
glucose dehydrogenase from Sphingomonas elodea ATCC 31461”. Acta 
Crystallographica Section F, 66: 69-72. 
Rocha, J.; Popescu, A.; Sá-Correia, I. Fialho, A.; and Frazão, C. (2010b) “Cloning, expression, 
purification, crystallisation and preliminary crystallographic studies of BceC, an UDP-
glucose dehydrogenase from Burkholderia cepacia IST 408.” Acta Crystallographica 
Section F, 66: 269-271. 
Rocha, J.; Popescu, A.; Sá-Correia, I.; Fialho, A. and Frazão, C. (2010c) “Structure of 
Burkholderia cepacia IST 408 UDP-glucose dehydrogenase (BceC) and the role of 
Tyr10 in the intermediate thioester hydrolysis.” (To be submitted) 
Rocha, J.; Fialho, A.; Sá-Correia, I. and Frazão, C. (2010d) “The three dimensional structure of 
the Sphingomonas elodea ATCC 31461 Uridine-5’-diphosphoglucose dehydrogenase 
(UgdG).” (To be submitted) 
Rocha, J.; Roldán, M. D.; Mitchell, E. and Frazão, C. (2010e) “Crystal Structure of NprA, the 
major nitroreductase from Rhodobacter capsulatus B10 bound to the inhibitor acetate.” 
(To be submitted)  
Roldán, M. D.; Blasco, R.; Caballero, F. J. and Castillo, F. J. (1998) “Degradation of p-
nitrophenol by the phototrophic bacterium Rhodobacter capsulatus.” Arch Microbiol, 
169: 36-42. 
Roldán, M. D.; Pérez-Reinado, E.; Castillo, F. and Moreno-Vivián, C. (2008) “Reduction of 
polynitroaromatic compounds: the bacterial nitroreductases”. FEMS Microbiol Rev, 32: 
474–500. 
Roman, E.; Roberts, I.; Lidholt, K. and Kusche-Gullberg, M. (2003) “Overexpression of UDP-
glucose dehydrogenase in Escherichia coli results in decreased biosynthesis of K5 
polysaccharide.” Biochem J, 374: 767-772. 
Doctoral Thesis by Joana Rocha (2010) 
 
Page 236 
Ruffing, A. and Chen, R. R. (2006) “Metabolic engineering of microbes for oligosaccharide and 
polysaccharide synthesis.” Microbial Cell Factories, 5: 25. 
Sá-Correia, I.; Fialho, A. M.; Videira, P.; Moreira, L. M.; Marques, A. R. and Albano, H. 
(2002) “Gellan gum biosynthesis in Sphingomonas paucimobilis ATCC 31461: genes, 
enzymes and exopolysaccharide production engineering”. J Ind Microbiol Biotechnol, 
29(4): 170-6. 
Salamanca-Pinzón, S. G.; Camacho-Carranza, R.; Hernández-Ojeda, S. L. and Espinosa-
Aguirre, J. J. (2006) “Nitrocompound activation by cell-free extracts of nitroreductase-
proficient Salmonella typhimurium strains.” Mutagenesis, 21: 369-374. 
Sali, A. and Blundell, T. L. (1993) “Comparative protein modelling by satisfaction of spatial 
restraints”. J Mol Biol, 234: 779-815. 
Savadogo, A.; Ouattara, C. A. T.; Savadogo, P. W.; Barro, N.; Ouattara, A. S. and Traoré, A.S. 
(2004) “Identification of exopolysaccharides-producing lactic acid bacteria from Burkina 
Faso fermented milk samples”. African Journal of Biotechnology, 3(3): 189-194. 
Schirmer, F.; Ehrt, S. and Hillen, W. (1997) “Expression, inducer spectrum, domain structure, 
and function of MopR, the regulator of phenol degradation in Acinetobacter 
calcoaceticus NCIB8250.” J Bacteriol, 179: 1329-1336. 
Schneider, T. R. and Sheldrick, G. M. (2002) “Substructure Solution with SHELXD”, Acta 
Crystallogr D Biol Crystallogr, 58: 1772-1779.  
Scotto d’Abusco, A.; Ammendola, S.; Scandurra, R. and Politi, L. (2001) “Molecular and 
biochemical characterisation of the recombinant amidase from hyperthermophilic 
archaeon Sulfolobus solfataricus.” Extremophiles, 5: 183-192. 
Scotto d’Abusco, A.; Casadio, R.; Tasco, G.; Giangiacomo, L.; Giartosio, A.; Calamia, V.; Di 
Marco, S.; Chiaraluce, R.; Consalvi, V.; Scandurra, R and Politi, R. (2005) 
“Oligomerisation of Sulfolobus solfataricus signature amidase is promoted by acidic pH 
and high temperature”. Archaea, 1: 411-423. 
Sharma, M.; Sharma, N. N. and Bhalla, T. C. (2009) “ Amidases: versatile enzymes in nature.” 
Rev Environ Sci Biotechnol, 8: 343-366. 
Sheldrick, G. M. (2002) “Macromolecular phasing with SHELXE.” Z Kristallogr, 217: 644-
650.  
Sheldrick, G. M. (2008) “A short history of SHELX.” Acta Crystallogr D Biol Crystallogr, 64: 
112-122.  
BIBLIOGRAPHIC REFERENCES
 
Page 237 
Shin, S.; Lee, T.-H.; Ha, N.-C.; Koo, H. M.; Kim, S.-Y.; Lee, H.-S.; Kim, Y. S. and Oh, B.-H. 
(2002) “Structure of malonamidase E2 reveals a novel Ser-cisSer-Lys catalytic triad in a 
new serine hydrolase fold that is prevalent in nature”. EMBO J, 21: 2509-2516. 
Shin, S.; Yun, Y. S.; Koo, H. M.; Kim, Y. S.; Choi, K. Y. and Oh, B.-H. (2003) 
“Characterisation of a novel Ser-cisSer-Lys catalytic triad in comparison with the 
classical Ser-His-Asp triad”. J Biol Chem, 278: 24937-24943. 
Sieberth, V.; Rigg, G. P.; Roberts, I. S. and Jann, K. (1995) “Expression and characterisation of 
UDPGlc dehydrogenase (Kfid), which is encoded in the type-specific region 2 of the 
Escherichia coli K5 capsule genes.” J Bacteriol, 177: 4562-4565. 
Silva, E.; Marques, A. R.; Fialho, A. M.; Granja, A. T. and Sá-Correia, I. (2005) “Proteins 
encoded by Sphingomonas elodea ATCC 31461 rmlA and ugpG genes, involved in 
gellan gum biosynthesis, exhibit both dTDP- and UDP-glucose pyrophosphorylase 
activities”. Appl Environ Microbiol, 71(8): 4703-12. 
Sist, P.; Cescutti, P.; Skerlajav, S.; Urbani, R.; Leitão, J. H.; Sá-Correia, I. and rizzo, R. (2003) 
“Macromolecular and solution properties of Cepacian: the exopolysaccharide produced 
by a strain of Burkholderia cepacia isolated from a cystic fibrosis patient”. Carbohydr 
Res, 338(18): 1861-7. 
Sivaswami, A.; Kelkar, S. M. and Nadkarni, G. B. (1972) “Uridine diphosphoglucose 
dehydrogenase from rat liver: purification and effect of pH on regulatory properties”. 
Biochim Biophys Acta, 276 (1): 43-52. 
Skouloubris, S.; Labigne, A. and De Reuse, H. (1997) “Identification and characterisation of an 
aliphatic amidase in Helicobacter pylori”. Molecular Microbiology, 25: 989-998. 
Smith, A. L.; Erwin, A. L.; Kline, T.; Unrath, W. C. T.; Nelson, K.; Weber, A. and Howald, W. 
N. (2007) “Chloramphenicol Is a Substrate for a Novel Nitroreductase Pathway in 
Haemophilus influenzae”. Antimicrobial Agents and Chemotherapy, 2820–2829. 
Smith, A. M.; Shelton, R. M.; Perrie, Y. and Harris, J. J. (2007) “An initial evaluation of gellan 
gum as a material for tissue engineering applications.” J Biomater Appl, 22:241–254. 
Snook, C. F.; Tipton, P. A. and Beamer, L. J. (2003) “Crystal structure of GDP-mannose 
dehydrogenase: a key enzyme of alginate biosynthesis in P. aeruginosa”. Biochemistry, 
42: 4658-4668. 
Somerville, C. C.; Nishino, S. F. and Spain, J. C. (1995) “Isolation and characterisation of 
nitrobenzene nitroreductase from Pseudomonas pseudoalcaligenes JS45.” J Bacteriol, 
177: 3837-3842. 
Doctoral Thesis by Joana Rocha (2010) 
 
Page 238 
Sommer, B. J.; Barycki, J. J. and Simpson, M. A. (2004) “Characterisation of human UDP-
glucose dehydrogenase. CYS-276 is required for the second of two successive 
oxidations”. J Biol Chem, 279: 23590–23596. 
Sousa, S. A.; Ulrich, M.; Bragonzi, A.; Burke, M.; Worlitzsch, D.; Leitão, J. H.; Meisner, C.; 
Eberl, L.; Sá-Correia, I. and Döring, G. (2007) “ Virulence of Burkholderia cepacia 
complex strains in gp91phox-/- mice.” Cell Microbiol, 9: 2817-2825. 
Spain, J. C. (1995) “Biodegradation of nitroaromatic compounds”. Annu Rev Microbiol, 49: 
523–555. 
Spain, J. C. (2000) “Biodegradation of nitroaromatic compounds and explosives”. In: Jim C. 
Spain, Joseph B. Hughes, Hans-Joachim Knackmuss (Editors), CRC Press. 
Spicer, A. P.; Kaback, L. A.; smith, T. J. and Seldin, M. F. (1998) “Molecular cloning and 
characterisation of the human and mouse UDP-glucose dehydrogenase genes”. J Biol 
Chem, 273(39): 25117-24. 
Stewart, D. C. and Copeland, L. (1998) “Uridine 5-Diphosphate-Glucose Dehydrogenase from 
Soybean Nodules.” Plant Physiol, 116: 349-355. 
Streker, K.; Freiberg, C.; Labischinski, H.; Hacker, J. and Ohlsen, J. (2005) “Staphylococcus 
aureus NfsA (SA0367) is a flavin mononucleotide-dependent NADPH oxidase involved 
in oxidative stress response”. J Bacteriol, 187: 2249-2256. 
Strominger, J. L.; Kalckar, H. M.; Axelrod, J. and Maxwell, E. S. (1954) “Enzymatic oxidation 
of uridine diphosphate glucose to uridine diphosphate glucuronic acid.” J Am Chem Soc, 
76: 6411–6412. 
Sutherland, I. W. (1994) “Structure-function relationships in microbial exopolysaccharides”. 
Biotechnol Adv, 12: 393-448. 
Sutherland, I. W. (1997) “Microbial exopolysaccharides – structural subtleties and their 
consequences ”. Pure and Appl Chem, 69(9): 1911-1917. 
Sutherland, I. W. (1998) “Novel and established applications of microbial polysaccharides.” 
Trends in Biotechnology, 16 (1): 41-6. 
Sutherland, I. W. (2001) “Biofilm exopolysaccharides: a strong and sticky Framework”. 
Microbiology, 147: 3-9. 
Sutherland, I. W. (2004) “Microbial Exopolysaccharides”. In: Severian Dimitriu (ed.) 
Polysaccharides: Structural diversity and functional versatility, CRC Press, Ed.2: 431-
457. 
Symons, Z. C. and Bruce, N. C. (2006) “Bacterial pathways for degradation of nitroaromatics.” 
Natural product reports, 23(6): 845-50.  
BIBLIOGRAPHIC REFERENCES
 
Page 239 
Takeda, K.; Iizuka, M.; Watanabe, T.; Nakagawa, J.; Kawasaki, S. and Niimura, Y. (2007) 
“Synechocystis DrgA protein functioning as nitroreductase and ferric reductase is 
capable of catalyzing the Fenton reaction”. FEBS J, 274: 1318-1327. 
Tanner, J. J.; Lei, B.; Tu, S.-C. and Krause, K. L. ( 1996) “Flavin reductase P: structure of a 
dimeric enzyme that reduces flavin”. Biochemistry, 35: 13531-13539. 
Teng, T.-Y. and Moffat, K. (2000) “Primary radiation damage of protein crystals by an intense 
synchrotron X-ray beam”. J Synchrotron Rad, 7:313-317. 
Terwilliger, T. (2004a) “SOLVE and RESOLVE: automated structure solution, density 
modification and model building.”  J Synchrotron Radiat, 11: 49-52. 
Terwilliger, T. (2004b) “Using prime-and-switch phasing to reduce model bias in molecular 
replacement”.  Acta Crystallogr D Biol Crystallogr, 60: 2144-2149. 
Thompson, J. D.; Higgins, D. G. and Gibson, T. J. (1997) “CLUSTAL W: Improving the 
sensitivity of progressive multiple sequence alignment through sequence weighting, 
position-specific gap penalties, and weight matrix choice”. Nucleic Acids Res, 22: 4673-
4680. 
Tichi, M. A. and Tabita, F. R. (2001) “ Interactive control of Rhodobacter capsulatus redox-
balancing systems during phototrophic metabolism.” J Bacteriol, 183 (21): 6344-6354. 
Tickle, J.; Pilka, E. S.; Bunkoczi, G.; Berridge, G.; Smee, C.; Kavanagh, K. L.; Hozjan, V.; 
Niesen, F. H.; Papagrigoriou, E.; Pike, A. C. W.; Turnbull, A.; Arrowsmith, C. H.; 
Edwards, A.; Sundstrom, M.; Weigelt, J.; Von Delft, F. and Oppermann, U. (2007) “The 
Structure of the Cytokine-Like Nuclear Factor N-Pac”. (To be published) 
Timmis, K. N. and Pieper, D. H. (1999) “Bacteria designed for bioremediation”. Trends 
Biotechnol, 17: 201-204. 
Tsafack, A.; Golenser, J.; Libman, J.; Shanzer, A. and Cabantchik, Z. I. (1995) “Mode of action 
of iron (III) chelators as antimalarials. III. Overadditive effects in the combined action of 
hydroxamate-based agents on in vitro growth of Plasmodium falciparum.” Mol 
Pharmacol, 47: 403-409. 
Tukey, R. H and Strassburg, C. P. (2000). “Human UDP-glucuronosyltransferases: metabolism, 
expression, and disease”. Annu Rev Pharmacol Toxicol, 40: 581–616.  
Unge, T. (1999) “Crystallisation Methods”. In Protein crystallisation: techniques, strategies, 
and tips: a laboratory manual. Terese. M. Bergfors (ed), Internat'l University Line, 7-18. 
Vagin, A. and Teplyakov, A. (1997)  “MOLREP: an automated program for molecular 
replacement.” J Appl Cryst, 30: 1022-1025. 
Doctoral Thesis by Joana Rocha (2010) 
 
Page 240 
Vanhooren, P. and Vandamme, E. J. (1998) “Biosynthesis, physiological role, use and 
fermentation process characteristics of bacterial exopolysaccharides”. Recent Res Devel 
Fermen Bioeng, 1: 253-299. 
Vanhooren, P. and Vandamme, E. J. (2000) “Microbial production of clavan, an L-fucose rich 
exopolysaccharide.” In: Bielecki, S., Tramper, J. and Polak, J., Editors, Food 
Biotechnology, Elsevier Science B.V.,109-114. 
Vanjari, H. and Pande, R. (2003) “Hydroxamic acids: proton donor and acceptor strength for 
use in drug design”. J Pharm Biomed Anal, 33: 783-788. 
Vartak, N. B.; Lin, C. C.; Cleary, J. M.; Fagan, M. J. and Saier Jr., M. H. (1995) “Glucose 
metabolism in Sphingomonas elodea: pathway engineering via construction of a glucose-
6-phosphate dehydrogenase insertion mutant”. Microbiol, 141: 2339-2350. 
Vasudevan, S. G.; Shaw, D. C. and Armarego, W. L. F. (1988) “Dihydropteridine reductase 
from Escherichia coli.” Biochem J, 255: 581–588. 
Ventura, C. L.; Cartee, R. T.; Forsee, W. T. and Yother, J. (2006) “Control of capsular 
polysaccharide chain length by UDP-sugar substrate concentrations in Streptococcus 
pneumoniae.” Mol Microbiol, 61(3): 723-33. 
Vigetti, D.; Ori, M.; Viola, M.; Genasetti, A.; Karousou, E.; Rizzi, M.; Pallotti, F.; Nardi, I.; 
Hascall, V. C.; De Luca, G. and Passi, A. (2006) “Molecular cloning and 
characterisation of UDP-glucose dehydrogenase from the amphibian Xenopus laevis and 
its involvement in hyaluronan synthesis”. J Biol Chem, 281(12): 8254-63. 
Vonrhein, C.; Blanc, E.; Roversi, P. and Bricogne, G. (2005) “Automated structure solution 
with autoSHARP.” In Crystallographic Methods, S. Doublie, Ed., Humana Press, 
submitted. 
Vuong, C.; Kocianova, S.; Voyich, J. M.; Yao, Y.; Fischer, E. R.; DeLeo, F. R. and Otto, M. 
(2004) “A Crucial Role for Exopolysaccharide Modification in Bacterial Biofilm 
Formation, Immune Evasion, and Virulence”. The Journal of Biological Chemistry, 
279(52): 54881–54886. 
Wang, H.; Wang, H.-L.; Jiang, W.-F. and Li, Z.-Q. (2009) “Photocatalytic degradation of 2,4-
dinitrophenol (DNP) by multi-walled carbon nanotubes (MWCNTs)/TiO2 composite in 
aqueous solution under solar irradiation”. Water Research, 43: 204-210. 
Wang, L.; Li, S.and Li, Y. (2003) “Isolation and sequencing of glycosyltransferase gene and 
UDP-glucose dehydrogenase gene that are located on a gene cluster involved in a new 
exopolysaccharide biosynthesis in Streptomyces.” DNA Seq, 14: 141-145. 
BIBLIOGRAPHIC REFERENCES
 
Page 241 
Watanabe, M.; Nishino, T.; Takio, K.; Sofuni, T. and Nohmi, T. (1998) “Purification and 
characterisation of wild-type and mutant ‘‘classical’’ nitroreductases of Salmonella 
typhimurium.” J Biol Chem, 273: 23922–23928. 
Weiss, M. S. (2001) “Global indicators of X-ray data quality.” J Applied Crystallography, 34: 
130-135. 
Westhead, D.R.; Slidel, T. W.; Flores, T. P. and Thornton, J. M. (1999) “Protein structural 
topology: Automated analysis and diagrammatic representation”. Protein Sci, 8: 897-
904. 
White, D. C.; Sutton, S. D. and Ringelberg, D. B. (1996) “The genus Sphingomonas: 
physiology and ecology”. Curr Opin Biotechnol, 7:301-306. 
Whiteway, J.; Koziarz, P.; Veall, J.; Sandhu, N.; Kumar, P.; Hoeler, B. and Lambert, I. B. 
(1998) “Oxygen-insensitive nitroreductases: analysis of the roles of nfsA and nfsB in 
development of resistance to 5-nitrofuran derivatives in Escherichia coli”. J Bacteriol, 
180: 5529-5539. 
Xiao, Y.; Wu, J. F.; Liu, H.; Wang, S. J.; Liu, S. J. and Zhou, N.Y. (2006) “Characterisation of 
genes involved in the initial reactions of 4-chloronitrobenzene degradation in 
Pseudomonas putida ZWL73”. Appl Microbiol Biotechnol, 73: 166-171. 
Yasuhira, K.; Shibata, N.; Mongami, G.;   Uedo, Y.;   Atsumi, Y.;   Kawashima, Y.;   Kato, D.;   
Takeo, M.;   Higuchi, Y. & Negoro, S. (2010) “X-ray crystallographic analysis of 6-
aminohexanoate cyclic dimer hydrolase: catalytic mechanism and evolution of an 
enzyme responsible for nylon-6 by-product degradation.” J Biol Chem, 285 (2): 1239-
1248. 
Zenno, S.; Kobori, T.; Masaru, T. and Saigo, K. (1998a) “Conversion of NfsA, the major 
Escherichia coli nitroreductase, to a flavin reductase with an activity similar to that of 
Frp, a flavin reductase in Vibrio harveyi, by a single amino acid substitution.” J 
Bacteriol, 180: 422-425. 
Zenno, S.; Kobori, T.; Tanokura, M. and Saigo, K. (1998b) “Purification and characterisation of 
NfrA1, a Bacillus subtilis nitro/flavin reductase capable of interacting with the bacterial 
luciferase.” Biosci Biotechnol Biochem, 62: 1978-1987. 
Zenno, S.; Koike, H.; Kumar, A. N.; Jayarman, R.; Tanokura, M. and Saigo, K. (1996a) 
“Biochemical characterisation of NfsA, the Escherichia coli mayor nitroreductase 
exhibiting a high amino acid sequence homology to Frp, a Vibrio harveyi flavin 
oxidoreductase”. J Bacteriol, 178: 4508-4514. 
Doctoral Thesis by Joana Rocha (2010) 
 
Page 242 
Zenno, S.; Koike, H.; Tanokura, M. and Saigo, K. (1996b) “Gene cloning, purification and 
characterisation of NfsB, a minor oxygeninsensitive nitroreductase from Escherichia 
coli, similar in biochemical properties to FRaseI, the major flavin reductase in Vibrio 
fischeri”. J Biochem, 120: 736-744. 
Zenno, S.; Koike, H.; Tanokura, M. and Saigo, K. (1996c) “Conversion of NfsB, a minor 
Escherichia coli nitroreductase, to a flavin reductase similar in biochemical properties to 
FRaseI, the major flavin reductase in Vibrio fischeri, by a single amino acid 
substitution”. Appl Environ Microbiol, 178: 4731-4733. 
Zenno, S.; Saigo, K.; Kanoh, H. and Inouye, S. (1994) “Identification of the gene encoding the 
major NAD(P)H-flavin oxidoreductase of the bioluminescent bacterium Vibrio fischeri 
ATCC 7744”. J Bacteriol, 176: 3536-3543. 
Zeyer, J. and Kocher, H. P. (1988) “Purification and characterisation of a bacterial nitrophenol 
oxygenase, which converts ortho-nitrophenol to catechol and nitrite”. Journal of 
Bacteriology, 170: 1789-1794. 
Zhang, R.; Li, H.; Collart, F.; Moy, S. and Joachimiak, A. “Crystal structure of a nitroreductase 
family protein from Bacillus cereus ATCC 14579.” (To be published). 
Zhang, Y.; Zhan, C.; Patskovsky, Y.; Ramagopal, U.; Shi, W.; Toro, R.; Wengerter, B. C.; 
Milstein, S.; Vidal, M.; Burley, S. K. and Almo, S. C. (2006) “Crystal Structure of 
Caenorhabditis Elegans Udp-Glucose Dehydrogenase”. New York SGX Research 
Centre for Structural Genomics (NYSGXRG). (To be published)  
Zhu, S. C.; Yang, Y. L.; Zhao, G. P. and Jiang, W. H. (2003) “A rapid and specific method to 
screen environmental microorganisms for cephalosporin acylase activity”. J Microbio 
Methods, 54 (1): 131-135. 
Zlosnik, J. E. A.; Hird, T. J.; Fraenkel, M. C.; Moreira, L. M.; Henry, D. A. and Speert, D. P. 
(2008) “Differential Mucoid Exopolysaccharide Production by Members of the 
Burkholderia cepacia Complex.” J Clinic Microbio, 46 (4): 1470-1473. 
 


